,drug_name,drug_type,Smiles
0,Ciprofibrate,4A11-Inducer,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
1,Clofibrate,4A11-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2,Clofibrate,4A11-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3,Dexamethasone,4A11-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4,Estrone,4A11-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
5,Ethanol,4A11-Inducer,CCO
6,Lansoprazole,4A11-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
7,"Mercury, Metallic",4A11-Inhibitor,[Hg]
8,Phenobarbital,4A11-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
9,Rifampicin,4A11-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
10,Valproic Acid,4A11-Inducer,CCCC(CCC)C(O)=O
11,Aminophenazone,CP2CI-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
12,Buprenorphine,CP2CI-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
13,Clobazam,CP2CI-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
14,Clotiazepam,CP2CI-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
15,Cyclophosphamide,CP2CI-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
16,Dapsone,CP2CI-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
17,Dexamethasone,CP2CI-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
18,Diazepam,CP2CI-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
19,Diclofenac,CP2CI-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
20,Fluconazole,CP2CI-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
21,Ifosfamide,CP2CI-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
22,Imipramine,CP2CI-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
23,Lansoprazole,CP2CI-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
24,Lidocain,CP2CI-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
25,Mephenytoin,CP2CI-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
26,Methadone,CP2CI-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
27,Omeprazole,CP2CI-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
28,Perphenazine,CP2CI-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
29,Phenazone,CP2CI-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
30,Phenobarbital,CP2CI-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
31,Phenytoin,CP2CI-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
32,Phenytoin,CP2CI-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
33,Propofol,CP2CI-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
34,Rifampicin,CP2CI-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
35,Thalidomide,CP2CI-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
36,Tolbutamide,CP2CI-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
37,Troleandomycin,CP2CI-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
38,Valproic Acid,CP2CI-Inhibitor,CCCC(CCC)C(O)=O
39,Warfarin,CP2CI-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
40,Aldosterone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
41,Aminogluthetimide,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
42,Aminophenazone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
43,Androstanolone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
44,Dexamethasone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
45,Insulin (human),Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
46,Metoclopramide,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
47,Progesterone,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
48,[32P]Natriumphosphat,Steroid_17_alpha_monooxygenase_Steroid_17_alpha_hydroxylase1720_lyase-Substrate,OP([O-])([O-])=O
49,Cefmetazole,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O
50,Cefoperazone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(CSC4=NN=NN4C)=C(N3C2=O)C(O)=O)C5=CC=C(O)C=C5)C(=O)C1=O
51,Ceftriaxone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CON=C(/C(=O)N[C@H]1[C@H]2SCC(CSC3=NC(=O)C(O)=NN3C)=C(N2C1=O)C(O)=O)C4=CSC(N)=N4
52,Dactinomycin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
53,Diclofenac,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
54,Docetaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
55,Docetaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
56,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
57,Estrone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
58,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
59,Hydroxycarbamide,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,NC(=O)NO
60,Methotrexate,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
61,Mitoxantrone,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
62,Paclitaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
63,Paclitaxel,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
64,Pancreozymin (cholecystokinin),Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
65,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
66,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
67,Technetium (99mTc) Mebrofenin,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CC1=C(Br)C(C)=C(NC(=O)CN(CC(O)=O)CC(O)=O)C(C)=C1
68,Telithromycin,Solute_carrier_organic_anion_transporter_family_member_1B3-Inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
69,Testosterone,Solute_carrier_organic_anion_transporter_family_member_1B3-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
70,Aminogluthetimide,19A-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
71,Anastrozole,19A-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
72,Androstanolone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
73,Betamethason,19A-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
74,Betamethason,19A-Substrate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
75,Bifonazole,19A-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
76,Bucladesine,19A-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
77,Buserelin,19A-Inducer,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@H]6CCC(=O)N6
78,Clofenotane,19A-Inhibitor,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
79,Clomifene,19A-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
80,Clonidine,19A-Inducer,ClC1=CC=CC(Cl)=C1NC2=NCCN2
81,Clotrimazole,19A-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
82,Cyproterone,19A-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
83,Danazol,19A-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
84,Dibutylphthalate,19A-Inducer,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
85,Diethylstilbestrol,19A-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
86,Dinoprostone,19A-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
87,Dopamine,19A-Inhibitor,NCCC1=CC(O)=C(O)C=C1
88,Econazole,19A-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
89,Ethanol,19A-Inducer,CCO
90,Etomidate,19A-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
91,Etretinate,19A-Inhibitor,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
92,Exemestane,19A-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
93,Fluconazole,19A-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
94,Formestane,19A-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O
95,Glutathione,19A-Inducer,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
96,Insulin (human),19A-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
97,Isoconazole,19A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
98,Isoprenaline,19A-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
99,Itraconazole,19A-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
100,Letrozole,19A-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
101,Letrozole,19A-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
102,Levacetylmethadol,19A-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
103,Levonorgestrel,19A-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
104,Mefloquine,19A-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
105,Melatonin,19A-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
106,Methadone,19A-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
107,Methyltestosterone,19A-Inducer,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
108,Miconazole,19A-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
109,Nandrolone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
110,Norepinephrine,19A-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
111,Oxycodone,19A-Inhibitor,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
112,Paclitaxel,19A-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
113,Phenylephrine,19A-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
114,Prasterone,19A-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
115,Raloxifene,19A-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
116,Tamoxifen,19A-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
117,Terbinafine,19A-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
118,Testosterone,19A-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
119,Tibolone,19A-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
120,Tinidazole,19A-Inhibitor,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
121,Tioconazole,19A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
122,Trastuzumab,19A-Inhibitor,NCC=C
123,Troglitazone,19A-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
124,Vorozole,19A-Inhibitor,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
125,Inosine,Solute_carrier_family_28_member_3-Inhibitor,OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(O)N=CN=C23
126,Mercaptopurine,Solute_carrier_family_28_member_3-Substrate,S=C1NC=NC2=C1NC=N2
127,Ribavirin,Solute_carrier_family_28_member_3-Substrate,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
128,Tioguanine,Solute_carrier_family_28_member_3-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
129,Tretinoin,Solute_carrier_family_28_member_3-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
130,Cisplatin,Probable_low_affinity_copper_uptake_protein_2-Substrate,N[Pt](N)(Cl)Cl
131,Silver,Probable_low_affinity_copper_uptake_protein_2-Inhibitor,[Ag]
132,Androstanolone,7B1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
133,Cefalexin,Multidrug_and_toxin_extrusion_protein_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
134,Chloroquine,Multidrug_and_toxin_extrusion_protein_1-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
135,Chloroquine,Multidrug_and_toxin_extrusion_protein_1-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
136,Mephenoxalone,Multidrug_and_toxin_extrusion_protein_1-Substrate,COC1=C(OC[C@H]2CNC(=O)O2)C=CC=C1
137,Metformin,Multidrug_and_toxin_extrusion_protein_1-Substrate,CN(C)C(=N)NC(N)=N
138,Trimethoprim,Multidrug_and_toxin_extrusion_protein_1-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
139,Acarbose,2E1-Inducer,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O
140,Acarbose,2E1-Inhibitor,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O
141,Acetic Acid,2E1-Substrate,CC(O)=O
142,Ademetionine,2E1-Inhibitor,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
143,Ademetionine,2E1-Substrate,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
144,Allopurinol,2E1-Inhibitor,OC1=NC=NC2=C1C=NN2
145,Alosetron,2E1-Inhibitor,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
146,Aminophylline,2E1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
147,Amitriptyline,2E1-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
148,Amitriptyline,2E1-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
149,Azelastine,2E1-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
150,Benzocaine,2E1-Inhibitor,CCOC(=O)C1=CC=C(N)C=C1
151,Benzydamine,2E1-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
152,Bifonazole,2E1-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
153,Bromazepam,2E1-Inhibitor,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
154,Brompheniramine,2E1-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
155,Bupropion,2E1-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
156,Caffeine,2E1-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
157,Capsaicin,2E1-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
158,Carbamide,2E1-Inducer,NC(N)=O
159,Carbinoxamine,2E1-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
160,Carvedilol,2E1-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
161,Chloroform,2E1-Substrate,ClC(Cl)Cl
162,Chloroxylenol,2E1-Substrate,CC1=CC(O)=CC(C)=C1Cl
163,Chlorpromazine,2E1-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
164,Chlorzoxazone,2E1-Inhibitor,OC1=NC2=C(O1)C=CC(Cl)=C2
165,Chlorzoxazone,2E1-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
166,Cimetidine,2E1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
167,Ciprofloxacin,2E1-Inducer,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
168,Cisplatin,2E1-Substrate,N[Pt](N)(Cl)Cl
169,Cisplatin,2E1-Inducer,N[Pt](N)(Cl)Cl
170,Citalopram,2E1-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
171,Clofibrate,2E1-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
172,Clomethiazole,2E1-Inhibitor,CC1=C(CCCl)SC=N1
173,Clomifene,2E1-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
174,Clotrimazole,2E1-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
175,Clozapine,2E1-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
176,Colchicine,2E1-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
177,Dacarbazine,2E1-Substrate,CN(C)N=NC1=C(N=CN1)C(N)=O
178,Dapsone,2E1-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
179,Desipramine,2E1-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
180,Dexfenfluramine,2E1-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
181,Dextromethorphan,2E1-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
182,Diazepam,2E1-Inducer,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
183,Diclofenac,2E1-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
184,Diethyl Ether,2E1-Inducer,CCOCC
185,Diethyltoluamide,2E1-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
186,Disulfiram,2E1-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
187,Disulfiram,2E1-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
188,Dopamine,2E1-Inhibitor,NCCC1=CC(O)=C(O)C=C1
189,Dorzolamide,2E1-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
190,Econazole,2E1-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
191,Enflurane,2E1-Substrate,FC(F)OC(F)(F)[C@H](F)Cl
192,Entacapone,2E1-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
193,Estrone,2E1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
194,Eszopiclone,2E1-Substrate,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
195,Ethanol,2E1-Inducer,CCO
196,Ethanol,2E1-Inhibitor,CCO
197,Ethanol,2E1-Substrate,CCO
198,Ethosuximide,2E1-Substrate,CC[C@]1(C)CC(=O)NC1=O
199,Etoposide,2E1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
200,Etoricoxib,2E1-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
201,Felbamate,2E1-Substrate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
202,Flufenamic Acid,2E1-Inducer,OC(=O)C1=CC=CC=C1NC2=CC=CC(=C2)C(F)(F)F
203,Flumequine,2E1-Inhibitor,C[C@@H]1CCC2=CC(F)=CC3=C2N1C=C(C(O)=O)C3=O
204,Fluoxetine,2E1-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
205,Fluphenazine,2E1-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
206,Flurazepam,2E1-Inhibitor,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
207,Fluvoxamine,2E1-Substrate,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
208,Folic Acid,2E1-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
209,Fomepizole,2E1-Inhibitor,CC1=CNN=C1
210,Furosemide,2E1-Substrate,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
211,Glucosamine,2E1-Substrate,N[C@@H]1[C@@H](O)O[C@@H](CO)[C@H](O)[C@H]1O
212,Glucose,2E1-Inhibitor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
213,Glycerol,2E1-Inducer,OCC(O)CO
214,Halothane,2E1-Substrate,FC(F)(F)[C@@H](Cl)Br
215,Histamine,2E1-Inducer,NCCC1=CNC=N1
216,Imipramine,2E1-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
217,Insulin (human),2E1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
218,Ipriflavone,2E1-Inducer,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
219,Isoflurane,2E1-Substrate,FC(F)O[C@@H](Cl)C(F)(F)F
220,Isoniazid,2E1-Inducer,NNC(=O)C1=CC=NC=C1
221,Isoniazid,2E1-Inhibitor,NNC(=O)C1=CC=NC=C1
222,Isoniazid,2E1-Substrate,NNC(=O)C1=CC=NC=C1
223,Isopropanol,2E1-Inducer,CC(C)O
224,Isopropanol,2E1-Inhibitor,CC(C)O
225,Isosorbide Dinitrate,2E1-Inhibitor,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
226,Itraconazole,2E1-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
227,Ketoconazole,2E1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
228,Levocarnitine,2E1-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
229,Levomepromazine,2E1-Inhibitor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
230,Medazepam,2E1-Inhibitor,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
231,Medrysone,2E1-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
232,Menadione,2E1-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
233,Meprobamate,2E1-Substrate,CCCC(C)(COC(N)=O)COC(N)=O
234,Methazolamide,2E1-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
235,Methoxyflurane,2E1-Substrate,COC(F)(F)C(Cl)Cl
236,Metyrapone,2E1-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
237,Mexiletine,2E1-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
238,Miconazole,2E1-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
239,Mitoxantrone,2E1-Substrate,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
240,Mizolastine,2E1-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
241,Monoethanolamine Oleate,2E1-Substrate,CCCCCCCCC=CCCCCCCCC(O)=O
242,Nicardipine,2E1-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
243,Nicotinamide,2E1-Inhibitor,NC(=O)C1=CC=CN=C1
244,Nicotine,2E1-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
245,Nicotine,2E1-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
246,Nicotine,2E1-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
247,Nifedipine,2E1-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
248,Nilvadipine,2E1-Substrate,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
249,Nortriptyline,2E1-Inhibitor,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
250,Ondansetron,2E1-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
251,Oxaliplatin,2E1-Substrate,N[C@@H]1CCCC[C@H]1N
252,Pancreozymin (cholecystokinin),2E1-Inhibitor,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
253,Paracetamol,2E1-Inducer,CC(=O)NC1=CC=C(O)C=C1
254,Paracetamol,2E1-Substrate,CC(=O)NC1=CC=C(O)C=C1
255,Paraoxon,2E1-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
256,Pargyline,2E1-Inhibitor,CN(CC#C)CC1=CC=CC=C1
257,Perazine,2E1-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
258,Phenacetin,2E1-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
259,Phenazone,2E1-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
260,Phenobarbital,2E1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
261,Phenobarbital,2E1-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
262,Phenol,2E1-Substrate,OC1=CC=CC=C1
263,Pilocarpine,2E1-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
264,Pimozide,2E1-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
265,Proguanil,2E1-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
266,Propofol,2E1-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
267,Propofol,2E1-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
268,Quinidine,2E1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
269,Retinol (vit A),2E1-Inducer,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
270,Retinol (vit A),2E1-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
271,Rifampicin,2E1-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
272,Rifampicin,2E1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
273,Ritonavir,2E1-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
274,Salicylic Acid,2E1-Inducer,OC(=O)C1=C(O)C=CC=C1
275,Selegiline,2E1-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
276,Sevoflurane,2E1-Substrate,FCOC(C(F)(F)F)C(F)(F)F
277,Sildenafil,2E1-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
278,Sodium Chloride,2E1-Inducer,[Na+].[Cl-]
279,Sodium Salicylate,2E1-Inducer,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
280,Streptozocin,2E1-Inducer,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
281,Sulconazole,2E1-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
282,Sulfadiazine,2E1-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
283,Sulfanilamide,2E1-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
284,Tamoxifen,2E1-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
285,Tegafur,2E1-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
286,Tegaserod,2E1-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
287,Tenofovir Disoproxil,2E1-Inhibitor,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C
288,Thalidomide,2E1-Inducer,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
289,Theobromine,2E1-Substrate,CN1C=NC2=C1C(=O)NC(=O)N2C
290,Theophylline,2E1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
291,Thiamazole,2E1-Inhibitor,CN1C=CNC1=S
292,Thiopental,2E1-Inhibitor,CCC[C@@H](C)[C@]1(CC)C(=O)NC(S)=NC1=O
293,Thioridazine,2E1-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
294,Thiosulfate,2E1-Inhibitor,[O-]S([S-])(=O)=O
295,Thiram,2E1-Substrate,CN(C)C(=S)SSC(=S)N(C)C
296,Tibolone,2E1-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
297,Ticlopidine,2E1-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
298,Tioconazole,2E1-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
299,Tiopronin,2E1-Inhibitor,C[C@H](S)C(=O)NCC(O)=O
300,Tocopherol (vit E),2E1-Inhibitor,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
301,Trabectedin,2E1-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
302,Tranylcypromine,2E1-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
303,Tretinoin,2E1-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
304,Trichloroethylene,2E1-Substrate,ClC=C(Cl)Cl
305,Trichloroethylene,2E1-Inhibitor,ClC=C(Cl)Cl
306,Trimethadione,2E1-Substrate,CN1C(=O)OC(C)(C)C1=O
307,Trospium,2E1-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
308,Ursodeoxycholic Acid,2E1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
309,Ursodeoxycholic Acid,2E1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
310,Vincamine,2E1-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
311,Voglibose,2E1-Inducer,OCC(CO)N[C@H]1C[C@@](O)(CO)[C@H](O)[C@@H](O)[C@@H]1O
312,Zafirlukast,2E1-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
313,Zopiclone,2E1-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
314,13_cis_retinoic_acid,2E1-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
315,2_acetylbenzothiophene,2E1-Substrate,CC(=O)C1=CC2=CC=CC=C2S1
316,2_nonanol,2E1-Substrate,CCCCCCCC(C)O
317,2n_propylquinoline,2E1-Substrate,CCCC1=CC=C2C=CC=CC2=N1
318,3_methylindole,2E1-Substrate,CC1=C[NH]C2=CC=CC=C12
319,4_nitrophenol,2E1-Substrate,OC1=CC=C(C=C1)[N](=O)=O
320,4_vinylcyclohexene,2E1-Substrate,C=CC1CCC=CC1
321,5_methylchrysene,2E1-Substrate,CC1=CC2=CC=CC=C2C3=CC=C4C=CC=CC4=C13
322,6_methylchrysene,2E1-Substrate,CC1=CC2=C3C=CC=CC3=CC=C2C4=CC=CC=C14
323,7_methoxy_4_trifluoro_methyl_coumarin,2E1-Substrate,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
324,7_methoxy_coumarin,2E1-Substrate,COC1=CC=C2C=C[C](=O)OC2=C1
325,ABT_438,2E1-Substrate,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1
326,acetaldehyde,2E1-Substrate,CC=O
327,acetaminophen,2E1-Substrate,CC(=O)NC1=CC=C(O)C=C1
328,acrylonitrile,2E1-Substrate,C=CC#N
329,antipyrine,2E1-Substrate,C[N]1[N]([C](=O)C=C1C)C2=CC=CC=C2
330,atrazine,2E1-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)C
331,BPR_0L075,2E1-Substrate,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC
332,bupropion,2E1-Substrate,C[C@@H](NC(C)(C)C)C(=O)C1=CC=CC(=C1)Cl
333,caffeine,2E1-Substrate,C[N]1C=NC2=C1[C](=O)[N](C)[C](=O)[N]2C
334,carbaryl,2E1-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
335,chlorzoxazone,2E1-Substrate,ClC1=CC2=C(O[C](=O)[NH]2)C=C1
336,cis_2_butene,2E1-Substrate,C\C=C/C
337,clozapine,2E1-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
338,cp_677_623,2E1-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
339,cyclohexene,2E1-Substrate,C1CCC=CC1
340,dacarbazine,2E1-Substrate,CN(C)N\N=C1/N=CN=C1C(N)=O
341,dapsone,2E1-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)C2=CC=C(N)C=C2
342,DDTC_Me,2E1-Substrate,CCN(CC)C(=S)SC
343,DETC_Me,2E1-Substrate,CCN(CC)C(=O)SC
344,diallylsulfide,2E1-Substrate,C=CCSSCC=C
345,diazinion,2E1-Substrate,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C
346,diethyl_meta_toluamide,2E1-Substrate,CCN(CC)C(=O)C1=CC(=CC=C1)C
347,diuron,2E1-Substrate,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl
348,DMF,2E1-Substrate,CN(C)C=O
349,enflurane,2E1-Substrate,FC(F)OC(F)(F)C(F)Cl
350,ethanol,2E1-Substrate,CCO
351,etoposide,2E1-Substrate,COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4OC5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC
352,eupatilin,2E1-Substrate,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC
353,halothane,2E1-Substrate,FC(F)(F)C(Cl)Br
354,hexane,2E1-Substrate,CCCCCC
355,imidacloprid,2E1-Substrate,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1
356,isoprene,2E1-Substrate,CC(=C)C=C
357,isoprene_epoxide_1,2E1-Substrate,CC1(CO1)C=C
358,isoprene_epoxide_2,2E1-Substrate,CC(=C)C1CO1
359,K11777,2E1-Substrate,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4
360,linoleic_acid,2E1-Substrate,CCCCC\C=C\C\C=C\CCCCCCCC(O)=O
361,MDE_R,2E1-Substrate,CCN[C@H](C)CC1=CC=C2OCOC2=C1
362,methyl_tert_butyl_ether,2E1-Substrate,COC(C)(C)C
363,mono_OH_methoxychlor,2E1-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
364,muraglitazar,2E1-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
365,N_methyl_ethyl_formamide,2E1-Substrate,CCN(C)C=O
366,N_nitroso_pyrrolidine,2E1-Substrate,O=NN1CCCC1
367,nabumetone,2E1-Substrate,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
368,NN_diethyl_nitrosoamine,2E1-Substrate,CCN(CC)N=O
369,NN_dimethyl_nitrosoamine,2E1-Substrate,CN(C)N=O
370,NN_methyl_butyl_nitrosoamine,2E1-Substrate,CCCCN(C)N=O
371,NN_methyl_ethyl_nitrosoamine,2E1-Substrate,CCN(C)N=O
372,NNK,2E1-Substrate,CN(CCCC(=O)C1=CC=CN=C1)N=O
373,O_phenylphenol,2E1-Substrate,OC1=C(C=CC=C1)C2=CC=CC=C2
374,p_cresol,2E1-Substrate,CC1=CC=C(O)C=C1
375,parathion,2E1-Substrate,CCO[P](=S)(OCC)OC1=CC=C(C=C1)[N](=O)=O
376,perazine,2E1-Substrate,CN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=CC=C4)CC1
377,phenytoin,2E1-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
378,promazine,2E1-Substrate,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13
379,quinidine,2E1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
380,quinoline,2E1-Substrate,C1=CC=C2N=CC=CC2=C1
381,rabeprazole_thioether,2E1-Substrate,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2
382,rutaecarpine,2E1-Substrate,O=[C]1[N]2CCC3=C([NH]C4=CC=CC=C34)C2=NC5=C1C=CC=C5
383,salicylate,2E1-Substrate,OC(=O)C1=CC=CC=C1O
384,selegiline,2E1-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
385,tegafur,2E1-Substrate,FC1=C[N](C2CCCO2)[C](=O)[NH][C]1=O
386,trans_phenylpropene,2E1-Substrate,C\C=C\C1=CC=CC=C1
387,trimethadione,2E1-Substrate,CN1C(=O)OC(C)(C)C1=O
388,xylene_para,2E1-Substrate,CC1=CC=C(C)C=C1
389,zileuton_R,2E1-Substrate,C[C@@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1
390,3_cyano_7_ethoxycoumarin,2E1-Substrate,CCOC1=CC=C2C=C(C#N)[C](=O)OC2=C1
391,4_nitroanisole,2E1-Substrate,COC1=CC=C(C=C1)[N](=O)=O
392,7_ethoxy_4_trifluoro_methyl_coumarin,2E1-Substrate,CCOC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
393,7_ethoxy_coumarin,2E1-Substrate,CCOC1=CC=C2C=C[C](=O)OC2=C1
394,7_methoxy_3_cyano_coumarin,2E1-Substrate,COC1=CC=C2C=C(C#N)[C](=O)OC2=C1
395,9_anthraldehyde,2E1-Substrate,O=CC1=C2C=CC=CC2=CC3=CC=CC=C13
396,ABT_761,2E1-Substrate,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O
397,butadienemonoxide,2E1-Substrate,C=CC1CO1
398,DMBA,2E1-Substrate,CC1=C2C=CC=CC2=C(C)C3=C4C=CC=CC4=CC=C13
399,ethyl_tert_butyl_ether,2E1-Substrate,CCOC(C)(C)C
400,indole,2E1-Substrate,[NH]1C=CC2=CC=CC=C12
401,lauric_acid,2E1-Substrate,CCCCCCCCCCCC(O)=O
402,myristic_acid,2E1-Substrate,CCCCCCCCCCCCCC(O)=O
403,N_amyl_N_methyl_nitrosamine,2E1-Substrate,CCCCCN(C)N=O
404,NN_diamyl_nitrosoamine,2E1-Substrate,CCCCCN(CCCCC)N=O
405,NN_dibutyl_nitrosoamine,2E1-Substrate,CCCCN(CCCC)N=O
406,NN_dipropyl_nitrosoamine,2E1-Substrate,CCCN(CCC)N=O
407,nonane,2E1-Substrate,CCCCCCCCC
408,oleic_acid,2E1-Substrate,CCCCCCCC\C=C/CCCCCCCC(O)=O
409,palmitic_acid,2E1-Substrate,CCCCCCCCCCCCCCCC(O)=O
410,safrole,2E1-Substrate,C=CCC1=CC=C2OCOC2=C1
411,stearic_acid,2E1-Substrate,CCCCCCCCCCCCCCCCCC(O)=O
412,styrene,2E1-Substrate,C=CC1=CC=CC=C1
413,tert_amyl_methyl_ether,2E1-Substrate,CCC(C)(C)OC
414,theophylline,2E1-Substrate,C[N]1[C](=O)[N](C)C2=C([NH]C=N2)[C]1=O
415,thioridazine_R,2E1-Substrate,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1
416,toluene,2E1-Substrate,CC1=CC=CC=C1
417,trans_2_butene,2E1-Substrate,C\C=C\C
418,xylene_meta,2E1-Substrate,CC1=CC=CC(=C1)C
419,xylene_ortho,2E1-Substrate,CC1=CC=CC=C1C
420,Acetylsalicylic Acid,GST-Inducer,CC(=O)OC1=C(C=CC=C1)C(O)=O
421,Adriamycin,GST-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
422,Amyl Nitrite,GST-Substrate,CC(C)CCON=O
423,Artemisinin,GST-Inhibitor,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
424,Artemisinin,GST-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
425,Ascorbic Acid (vit C),GST-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
426,Ascorbic Acid (vit C),GST-Inducer,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
427,Betacarotene,GST-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1
428,Bucladesine,GST-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
429,Busulfan,GST-Substrate,CS(=O)(=O)OCCCCOS(C)(=O)=O
430,Camphora,GST-Inducer,CC1(C)[C@H]2CC[C@]1(C)C(=O)C2
431,Capsaicin,GST-Inhibitor,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
432,Carmustine,GST-Substrate,ClCCNC(=O)N(CCCl)N=O
433,Chenodeoxycholic Acid,GST-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
434,Chinin,GST-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
435,Chlorambucil,GST-Inducer,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl
436,Chloroform,GST-Inhibitor,ClC(Cl)Cl
437,Chloroquine,GST-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
438,Cisapride,GST-Inducer,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
439,Cisplatin,GST-Substrate,N[Pt](N)(Cl)Cl
440,Cisplatin,GST-Inducer,N[Pt](N)(Cl)Cl
441,Clofibrate,GST-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
442,Clomipramine,GST-Inhibitor,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
443,Cocaine,GST-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
444,Cyproterone,GST-Inducer,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
445,Dactinomycin,GST-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
446,Dicoumarol,GST-Inhibitor,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
447,Diethyl Ether,GST-Substrate,CCOCC
448,Diethylcarbamazine,GST-Inducer,CCN(CC)C(=O)N1CCN(C)CC1
449,Doxepin,GST-Inhibitor,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
450,Doxorubicin,GST-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
451,Estradiol,GST-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
452,Etacrynic Acid,GST-Substrate,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
453,Etacrynic Acid,GST-Inhibitor,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
454,Finasteride,GST-Inhibitor,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
455,Flunarizine,GST-Inducer,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
456,Fosfomycin,GST-Substrate,C[C@H]1O[C@@H]1P(O)(O)=O
457,Gabapentin,GST-Inducer,NC[C@@]1(CCCCC1)CC(O)=O
458,Glucagon,GST-Inhibitor,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
459,Glyceryl Trinitrate,GST-Inducer,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O
460,Glycine,GST-Inducer,NCC(O)=O
461,Hematin,GST-Inhibitor,O[Fe++].CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C=C)C(C)=C([N-]4)C=C5N=C(C=C1[N-]2)C(C)=C5C=C)C(C)=C3CCC(O)=O
462,Hematin,GST-Substrate,O[Fe++].CC1=C(CCC(O)=O)C2=CC3=NC(=CC4=C(C=C)C(C)=C([N-]4)C=C5N=C(C=C1[N-]2)C(C)=C5C=C)C(C)=C3CCC(O)=O
463,Hydrocortisone,GST-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
464,Hydrogen Peroxide,GST-Inhibitor,OO
465,Hydrogen Peroxide,GST-Inducer,OO
466,Ibuprofen,GST-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
467,Imipramine,GST-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
468,Indometacin,GST-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
469,Indometacin,GST-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
470,Insulin (human),GST-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
471,Isosorbide Dinitrate,GST-Substrate,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
472,Ketoprofen,GST-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
473,Lamotrigine,GST-Inducer,NC1=NC(N)=C(N=N1)C2=C(Cl)C(Cl)=CC=C2
474,Lentinan,GST-Inhibitor,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]5O)[C@H]4O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
475,Levamisole,GST-Inducer,C1CN2C[C@@H](N=C2S1)C3=CC=CC=C3
476,Levetiracetam,GST-Inducer,CC[C@@H](N1CCCC1=O)C(N)=O
477,Melatonin,GST-Inducer,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
478,Melphalan,GST-Substrate,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O
479,Melphalan,GST-Inducer,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O
480,Mequinol,GST-Inducer,COC1=CC=C(O)C=C1
481,Mercaptamine,GST-Inhibitor,NCCS
482,Mersalyl,GST-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
483,Metamizole Sodium,GST-Inducer,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
484,Methionine,GST-Inducer,CSCC[C@H](N)C(O)=O
485,Methyldopa (levorotatory),GST-Inhibitor,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
486,Nabumetone,GST-Inducer,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
487,Nandrolone,GST-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
488,Nitric Oxide,GST-Inducer,N=O
489,Olanzapine,GST-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
490,Paracetamol,GST-Substrate,CC(=O)NC1=CC=C(O)C=C1
491,Paracetamol,GST-Inducer,CC(=O)NC1=CC=C(O)C=C1
492,Pentoxifylline,GST-Inducer,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
493,Perindopril,GST-Inhibitor,CCC[C@H](N[C@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC
494,Phenobarbital,GST-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
495,Phenytoin,GST-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
496,Pipamperone,GST-Inducer,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
497,Polihexanide,GST-Inhibitor,Cl.CCCCCCNC(=N)NC(N)=N
498,Primaquine,GST-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
499,Progesterone,GST-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
500,Progesterone,GST-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
501,Propylthiouracil,GST-Inhibitor,CCCC1=CC(=O)NC(=S)N1
502,Propylthiouracil,GST-Inducer,CCCC1=CC(=O)NC(=S)N1
503,Pyrimethamine,GST-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
504,Retinol (vit A),GST-Inducer,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
505,Rofecoxib,GST-Inducer,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
506,Sodium Nitrite,GST-Inhibitor,[O-]N=O
507,Sulfobromophthalein,GST-Inhibitor,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
508,Sulindac,GST-Inducer,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
509,Tacrine,GST-Substrate,NC1=C2CCCCC2=NC3=C1C=CC=C3
510,Tadalafil,GST-Inducer,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O
511,Tetracycline,GST-Inhibitor,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
512,Thiomersal,GST-Inhibitor,CC[Hg]SC1=C(C=CC=C1)C([O-])=O
513,Thiotepa,GST-Substrate,S=P(N1CC1)(N2CC2)N3CC3
514,Tiaprofenic Acid,GST-Inhibitor,C[C@@H](C(O)=O)C1=CC=C(S1)C(=O)C2=CC=CC=C2
515,Tienilic Acid,GST-Inhibitor,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2
516,Tioctic Acid,GST-Inducer,OC(=O)CCCC[C@@H]1CCSS1
517,Trabectedin,GST-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
518,Trichloroethylene,GST-Substrate,ClC=C(Cl)Cl
519,Troglitazone,GST-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
520,Valproic Acid,GST-Inducer,CCCC(CCC)C(O)=O
521,Verapamil,GST-Inducer,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
522,Warfarin,GST-Inducer,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
523,Adenosine,Sodiumbile_acid_cotransporter-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
524,Bosentan,Sodiumbile_acid_cotransporter-Inhibitor,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
525,Colestyramine,Sodiumbile_acid_cotransporter-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
526,Dexamethasone,Sodiumbile_acid_cotransporter-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
527,Rifampicin,Sodiumbile_acid_cotransporter-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
528,Ritonavir,Sodiumbile_acid_cotransporter-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
529,Rosuvastatin,Sodiumbile_acid_cotransporter-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
530,Aminogluthetimide,Aromatase_Estrogen_synthetase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
531,Anastrozole,Aromatase_Estrogen_synthetase-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
532,Androstanolone,Aromatase_Estrogen_synthetase-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
533,Betamethason,Aromatase_Estrogen_synthetase-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
534,Betamethason,Aromatase_Estrogen_synthetase-Substrate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
535,Bifonazole,Aromatase_Estrogen_synthetase-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
536,Bucladesine,Aromatase_Estrogen_synthetase-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
537,Buserelin,Aromatase_Estrogen_synthetase-Inducer,CCNC(=O)[C@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C34)NC(=O)[C@H](CC5=CNC=N5)NC(=O)[C@H]6CCC(=O)N6
538,Clofenotane,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
539,Clomifene,Aromatase_Estrogen_synthetase-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
540,Clonidine,Aromatase_Estrogen_synthetase-Inducer,ClC1=CC=CC(Cl)=C1NC2=NCCN2
541,Clotrimazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
542,Cyproterone,Aromatase_Estrogen_synthetase-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
543,Danazol,Aromatase_Estrogen_synthetase-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
544,Dibutylphthalate,Aromatase_Estrogen_synthetase-Inducer,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
545,Diethylstilbestrol,Aromatase_Estrogen_synthetase-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
546,Dinoprostone,Aromatase_Estrogen_synthetase-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
547,Dopamine,Aromatase_Estrogen_synthetase-Inhibitor,NCCC1=CC(O)=C(O)C=C1
548,Econazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
549,Ethanol,Aromatase_Estrogen_synthetase-Inducer,CCO
550,Etomidate,Aromatase_Estrogen_synthetase-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
551,Etretinate,Aromatase_Estrogen_synthetase-Inhibitor,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
552,Exemestane,Aromatase_Estrogen_synthetase-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
553,Fluconazole,Aromatase_Estrogen_synthetase-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
554,Formestane,Aromatase_Estrogen_synthetase-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O
555,Glutathione,Aromatase_Estrogen_synthetase-Inducer,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
556,Insulin (human),Aromatase_Estrogen_synthetase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
557,Isoconazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
558,Isoprenaline,Aromatase_Estrogen_synthetase-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
559,Itraconazole,Aromatase_Estrogen_synthetase-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
560,Letrozole,Aromatase_Estrogen_synthetase-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
561,Letrozole,Aromatase_Estrogen_synthetase-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
562,Levacetylmethadol,Aromatase_Estrogen_synthetase-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
563,Levonorgestrel,Aromatase_Estrogen_synthetase-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
564,Mefloquine,Aromatase_Estrogen_synthetase-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
565,Melatonin,Aromatase_Estrogen_synthetase-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
566,Methadone,Aromatase_Estrogen_synthetase-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
567,Methyltestosterone,Aromatase_Estrogen_synthetase-Inducer,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
568,Miconazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
569,Nandrolone,Aromatase_Estrogen_synthetase-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O
570,Norepinephrine,Aromatase_Estrogen_synthetase-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
571,Oxycodone,Aromatase_Estrogen_synthetase-Inhibitor,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
572,Paclitaxel,Aromatase_Estrogen_synthetase-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
573,Phenylephrine,Aromatase_Estrogen_synthetase-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
574,Prasterone,Aromatase_Estrogen_synthetase-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
575,Raloxifene,Aromatase_Estrogen_synthetase-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
576,Tamoxifen,Aromatase_Estrogen_synthetase-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
577,Terbinafine,Aromatase_Estrogen_synthetase-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
578,Testosterone,Aromatase_Estrogen_synthetase-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
579,Tibolone,Aromatase_Estrogen_synthetase-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
580,Tinidazole,Aromatase_Estrogen_synthetase-Inhibitor,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
581,Tioconazole,Aromatase_Estrogen_synthetase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
582,Trastuzumab,Aromatase_Estrogen_synthetase-Inhibitor,NCC=C
583,Troglitazone,Aromatase_Estrogen_synthetase-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
584,Vorozole,Aromatase_Estrogen_synthetase-Inhibitor,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
585,Acetylsalicylic Acid,SUL-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
586,Acetylsalicylic Acid,SUL-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
587,Adenosine,SUL-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
588,Aminobenzoic Acid,SUL-Substrate,NC1=CC=C(C=C1)C(O)=O
589,Apomorphine,SUL-Substrate,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
590,Bemiparin,SUL-Substrate,C1=CC=C(C=C1)C=CC(=O)O
591,Betamethason,SUL-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
592,Budesonide,SUL-Substrate,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
593,Calcitriol,SUL-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
594,Celecoxib,SUL-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
595,Celecoxib,SUL-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
596,Cholic Acid,SUL-Substrate,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
597,Clioquinol,SUL-Inhibitor,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
598,Clioquinol,SUL-Substrate,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
599,Corticotropin,SUL-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
600,Cortisone,SUL-Inhibitor,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
601,Diethyl Ether,SUL-Inducer,CCOCC
602,Digitoxin,SUL-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
603,Ephedrin,SUL-Substrate,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
604,Epinephrine,SUL-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
605,Epinephrine,SUL-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
606,Estradiol,SUL-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
607,Estradiol,SUL-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
608,Fluphenazine,SUL-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
609,Galactose,SUL-Substrate,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
610,Hydrocortisone,SUL-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
611,Hydrocortisone,SUL-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
612,Ibuprofen,SUL-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
613,Insulin (human),SUL-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
614,Methotrexate,SUL-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
615,Methyldopa (levorotatory),SUL-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
616,Minoxidil,SUL-Substrate,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
617,Naproxen,SUL-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
618,Paclitaxel,SUL-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
619,Pantoprazole,SUL-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
620,Paracetamol,SUL-Substrate,CC(=O)NC1=CC=C(O)C=C1
621,Pipamperone,SUL-Inhibitor,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
622,Progesterone,SUL-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
623,Progesterone,SUL-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
624,Promegestone,SUL-Inducer,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C
625,Pseudoephedrine,SUL-Substrate,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
626,Pyridoxal Phosphate,SUL-Inhibitor,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1
627,Ritodrine,SUL-Substrate,C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2
628,Salicylic Acid,SUL-Inhibitor,OC(=O)C1=C(O)C=CC=C1
629,Sodium Citrate,SUL-Inhibitor,OC(=O)CC(O)(CC(O)=O)C([O-])=O
630,Sodium Salicylate,SUL-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
631,Sulindac,SUL-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
632,Tamoxifen,SUL-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
633,Tamoxifen,SUL-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
634,Teicoplanin,SUL-Substrate,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]5NC(=O)[C@@H](Cc6ccc(Oc7cc4cc(Oc8ccc2cc8Cl)c7O[C@@H]9O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]9NC(=O)C)c(Cl)c6)NC(=O)[C@H](N)c%10ccc(O)c(Oc%11cc(O)cc5c%11)c%10)c%12ccc(O)c(c%12)c%13c(O[C@H]%14O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]%14O)cc(O)cc%13[C@H](NC3=O)C(=O)O
635,Testosterone,SUL-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
636,Tibolone,SUL-Substrate,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
637,Tibolone,SUL-Inducer,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
638,Triamcinolone,SUL-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
639,Triclosan,SUL-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
640,Warfarin,SUL-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
641,Warfarin,SUL-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
642,Amiodarone,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
643,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
644,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
645,Bezafibrate,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
646,Bosentan,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
647,Bucladesine,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
648,Cerivastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
649,Chenodeoxycholic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
650,Ciclosporin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
651,Digoxin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
652,Enalapril,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
653,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
654,Estrone,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
655,Ezetimibe,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
656,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
657,Gemfibrozil,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
658,Ibuprofen,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
659,Indium (111In) Pentetic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN3CCN4CCN(CC(O)=O)CC(=O)O[In](OC(=O)C4)OC(=O)C3)C(=O)N[C@H](CN[C@H](C[C@H]5C=NC6=C5C=CC=C6)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)CC7=CC=CC=C7
660,Ketoconazole,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
661,Lopinavir,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
662,Lovastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
663,Methotrexate,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
664,Phenobarbital,Solute_carrier_organic_anion_transporter_family_member_1B1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
665,Prasterone,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
666,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
667,Quinidine,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
668,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
669,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
670,Rifamycin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
671,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
672,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
673,Silymarin,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
674,Simvastatin,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
675,Torasemide,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
676,Ursodeoxycholic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
677,Ursodeoxycholic Acid,Solute_carrier_organic_anion_transporter_family_member_1B1-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
678,Acetylcholin,Methyltransferase-Inducer,CC(=O)OCC[N+](C)(C)C
679,Acetylsalicylic Acid,Methyltransferase-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
680,Ademetionine,Methyltransferase-Substrate,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
681,Angiotensinamide,Methyltransferase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
682,Argatroban,Methyltransferase-Inducer,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
683,Ascorbic Acid (vit C),Methyltransferase-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
684,Ascorbic Acid (vit C),Methyltransferase-Substrate,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
685,Azacitidine,Methyltransferase-Inhibitor,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
686,Azathioprine,Methyltransferase-Substrate,CN1C=NC(=C1SC2=C3NC=NC3=NC=N2)[N+]([O-])=O
687,Bendroflumethiazide,Methyltransferase-Inhibitor,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
688,Captopril,Methyltransferase-Substrate,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
689,Chlorhexidine,Methyltransferase-Inhibitor,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1
690,Chloroquine,Methyltransferase-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
691,Chlorphenamine,Methyltransferase-Inducer,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
692,Cocaine,Methyltransferase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
693,Deanol,Methyltransferase-Substrate,CN(C)CCO
694,Decitabine,Methyltransferase-Inhibitor,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
695,Dicycloverine,Methyltransferase-Inhibitor,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2
696,Diosmin,Methyltransferase-Inhibitor,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
697,Entacapone,Methyltransferase-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
698,Entacapone,Methyltransferase-Inducer,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
699,Epinephrine,Methyltransferase-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
700,Epinephrine,Methyltransferase-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
701,Estradiol,Methyltransferase-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
702,Estradiol,Methyltransferase-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
703,Folic Acid,Methyltransferase-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
704,Fosfocreatine,Methyltransferase-Inhibitor,CN(CC(O)=O)C(=N)NP(O)(O)=O
705,Glucagon,Methyltransferase-Inducer,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
706,Histamine,Methyltransferase-Substrate,NCCC1=CNC=N1
707,Hydralazine,Methyltransferase-Inducer,NN=C1NN=CC2=C1C=CC=C2
708,Hydrocortisone,Methyltransferase-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
709,Imipramine,Methyltransferase-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
710,Isoprenaline,Methyltransferase-Substrate,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
711,Ketoprofen,Methyltransferase-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
712,Ketotifen,Methyltransferase-Inducer,CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3
713,Levodopa,Methyltransferase-Substrate,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
714,Lidocain,Methyltransferase-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
715,Mepacrine,Methyltransferase-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
716,Mercaptopurine,Methyltransferase-Substrate,S=C1NC=NC2=C1NC=N2
717,Mesalazine,Methyltransferase-Inhibitor,NC1=CC(C(O)=O)=C(O)C=C1
718,Methotrexate,Methyltransferase-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
719,Methotrexate,Methyltransferase-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
720,Methyldopa (levorotatory),Methyltransferase-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
721,Methyldopa (levorotatory),Methyltransferase-Inhibitor,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
722,Moclobemide,Methyltransferase-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
723,Naproxen,Methyltransferase-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
724,Olsalazine,Methyltransferase-Inhibitor,OC(=O)C1=CC(=CC=C1O)N=NC2=CC(C(O)=O)=C(O)C=C2
725,Pargyline,Methyltransferase-Inhibitor,CN(CC#C)CC1=CC=CC=C1
726,Pargyline,Methyltransferase-Inducer,CN(CC#C)CC1=CC=CC=C1
727,Physostigmine,Methyltransferase-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
728,Plicamycin,Methyltransferase-Inhibitor,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O
729,Procaine,Methyltransferase-Inhibitor,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
730,Progesterone,Methyltransferase-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
731,Progesterone,Methyltransferase-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
732,Pyridoxine (vit B6),Methyltransferase-Inhibitor,CC1=C(O)C(CO)=C(CO)C=N1
733,Ribavirin,Methyltransferase-Inhibitor,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
734,Selenium Compounds,Methyltransferase-Inhibitor,[Se]
735,Tacrine,Methyltransferase-Inhibitor,NC1=C2CCCCC2=NC3=C1C=CC=C3
736,Tamoxifen,Methyltransferase-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
737,Temozolomide,Methyltransferase-Inhibitor,CN1N=NC2=C(N=CN2C1=O)C(N)=O
738,Tioguanine,Methyltransferase-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
739,Tioguanine,Methyltransferase-Inducer,NC1=NC2=C(N=CN2)C(=S)N1
740,Tolcapone,Methyltransferase-Inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
741,Trimethoprim,Methyltransferase-Inducer,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
742,Tubocurarine,Methyltransferase-Inhibitor,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1
743,Ubidecarenone,Methyltransferase-Substrate,COC1=C(OC)C(=O)C(CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C)=C(C)C1=O
744,Varenicline,Methyltransferase-Inhibitor,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
745,Vecuronium,Methyltransferase-Inhibitor,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N@@+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6
746,Virginiamycin,Methyltransferase-Inhibitor,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
747,Vorinostat,Methyltransferase-Inhibitor,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
748,Alfentanil,P450_HFLA-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
749,Alprazolam,P450_HFLA-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
750,Aminophenazone,P450_HFLA-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
751,Amiodarone,P450_HFLA-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
752,Amlodipine,P450_HFLA-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
753,Aprepitant,P450_HFLA-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
754,Aripiprazole,P450_HFLA-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
755,Astemizole,P450_HFLA-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
756,Atazanavir,P450_HFLA-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
757,Atazanavir,P450_HFLA-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
758,Atorvastatin,P450_HFLA-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
759,Aztreonam,P450_HFLA-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
760,Buspirone,P450_HFLA-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
761,Caffeine,P450_HFLA-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
762,Carbamazepine,P450_HFLA-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
763,Cerivastatin,P450_HFLA-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
764,Chinin,P450_HFLA-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
765,Chlorphenamine,P450_HFLA-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
766,Ciclosporin,P450_HFLA-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
767,Ciclosporin,P450_HFLA-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
768,Cimetidine,P450_HFLA-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
769,Cisapride,P450_HFLA-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
770,Clarithromycin,P450_HFLA-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
771,Clotiapine,P450_HFLA-Substrate,CN1CCN(CC1)C2=NC3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3
772,Clotrimazole,P450_HFLA-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
773,Cocaine,P450_HFLA-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
774,Codeine,P450_HFLA-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
775,Cortisone,P450_HFLA-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
776,Cyclophosphamide,P450_HFLA-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
777,Dapsone,P450_HFLA-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
778,Dexamethasone,P450_HFLA-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
779,Dexamethasone,P450_HFLA-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
780,Dextromethorphan,P450_HFLA-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
781,Dextropropoxyphene,P450_HFLA-Inducer,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
782,Diazepam,P450_HFLA-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
783,Diltiazem,P450_HFLA-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
784,Docetaxel,P450_HFLA-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
785,Domperidone,P450_HFLA-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
786,Doxylamin,P450_HFLA-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
787,Eplerenone,P450_HFLA-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
788,Erythromycin,P450_HFLA-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
789,Estradiol,P450_HFLA-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
790,Estriol,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
791,Ethinylestradiol,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
792,Ethosuximide,P450_HFLA-Substrate,CC[C@]1(C)CC(=O)NC1=O
793,Ethylmorphine,P450_HFLA-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
794,Felodipine,P450_HFLA-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
795,Fentanyl,P450_HFLA-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
796,Finasteride,P450_HFLA-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
797,Fluvoxamine,P450_HFLA-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
798,Glycyrrhizic Acid,P450_HFLA-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
799,Glycyrrhizic Acid,P450_HFLA-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
800,Haloperidol,P450_HFLA-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
801,Hydrocortisone,P450_HFLA-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
802,Ifosfamide,P450_HFLA-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
803,Imatinib,P450_HFLA-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
804,Imipramine,P450_HFLA-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
805,Indinavir,P450_HFLA-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
806,Indinavir,P450_HFLA-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
807,Irinotecan,P450_HFLA-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
808,Ketoconazole,P450_HFLA-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
809,Lercanidipine,P450_HFLA-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
810,Levacetylmethadol,P450_HFLA-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
811,Lidocain,P450_HFLA-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
812,Linopirdine,P450_HFLA-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
813,Lovastatin,P450_HFLA-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
814,Methadone,P450_HFLA-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
815,Mibefradil,P450_HFLA-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
816,Midazolam,P450_HFLA-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
817,Midazolam,P450_HFLA-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
818,Mifepristone,P450_HFLA-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
819,Nateglinide,P450_HFLA-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
820,Nefazodone,P450_HFLA-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
821,Nelfinavir,P450_HFLA-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
822,Nelfinavir,P450_HFLA-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
823,Neostigmine,P450_HFLA-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
824,Nifedipine,P450_HFLA-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
825,Nisoldipine,P450_HFLA-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
826,Nitrendipine,P450_HFLA-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
827,Norethisterone,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
828,Norfloxacin,P450_HFLA-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
829,Ondansetron,P450_HFLA-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
830,Ornidazole,P450_HFLA-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
831,Oxazepam,P450_HFLA-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
832,Oxycodone,P450_HFLA-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
833,Paclitaxel,P450_HFLA-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
834,Phenelzine,P450_HFLA-Inhibitor,NNCCC1=CC=CC=C1
835,Phenobarbital,P450_HFLA-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
836,Phenytoin,P450_HFLA-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
837,Pimozide,P450_HFLA-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
838,Pleconaril,P450_HFLA-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
839,Prasterone,P450_HFLA-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
840,Prasterone,P450_HFLA-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
841,Praziquantel,P450_HFLA-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
842,Progesterone,P450_HFLA-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
843,Progesterone,P450_HFLA-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
844,Propranolol,P450_HFLA-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
845,Quetiapine,P450_HFLA-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
846,Quinidine,P450_HFLA-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
847,Rifampicin,P450_HFLA-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
848,Rifapentine,P450_HFLA-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
849,Risperidone,P450_HFLA-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
850,Ritonavir,P450_HFLA-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
851,Ritonavir,P450_HFLA-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
852,Salmeterol,P450_HFLA-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
853,Saquinavir,P450_HFLA-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
854,Sildenafil,P450_HFLA-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
855,Simvastatin,P450_HFLA-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
856,Sirolimus,P450_HFLA-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
857,Tacrolimus,P450_HFLA-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
858,Tamoxifen,P450_HFLA-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
859,Telithromycin,P450_HFLA-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
860,Terfenadine,P450_HFLA-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
861,Testosterone,P450_HFLA-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
862,Trazodone,P450_HFLA-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
863,Triamcinolone,P450_HFLA-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
864,Triazolam,P450_HFLA-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
865,Troglitazone,P450_HFLA-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
866,Troglitazone,P450_HFLA-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
867,Verapamil,P450_HFLA-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
868,Verapamil,P450_HFLA-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
869,Vincristine,P450_HFLA-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
870,Zalcitabine,P450_HFLA-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
871,Zaleplon,P450_HFLA-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
872,Ziprasidone,P450_HFLA-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
873,Zolpidem,P450_HFLA-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
874,Acebutolol,2D6-Inhibitor,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1
875,Acetylcholin,2D6-Substrate,CC(=O)OCC[N+](C)(C)C
876,Ajmaline,2D6-Inhibitor,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
877,Ajmaline,2D6-Substrate,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
878,Almotriptan,2D6-Substrate,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
879,Alprenolol,2D6-Substrate,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C
880,Amfetamine,2D6-Inhibitor,C[C@@H](N)CC1=CC=CC=C1
881,Amfetamine,2D6-Substrate,C[C@@H](N)CC1=CC=CC=C1
882,Aminobutyric Acid,2D6-Substrate,NCCCC(O)=O
883,Aminophenazone,2D6-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
884,Amiodarone,2D6-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
885,Amiodarone,2D6-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
886,Amitriptyline,2D6-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
887,Amitriptyline,2D6-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
888,Amlodipine,2D6-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
889,Amodiaquine,2D6-Inhibitor,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
890,Amprenavir,2D6-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
891,Amsacrine,2D6-Substrate,COC1=C(NC2=C3C=CC=CC3=NC4=CC=CC=C24)C=CC(NS(C)(=O)=O)=C1
892,Aprindine,2D6-Substrate,CCN(CC)CCCN([C@H]1CC2=CC=CC=C2C1)C3=CC=CC=C3
893,Aripiprazole,2D6-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
894,Aripiprazole,2D6-Inhibitor,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
895,Aripiprazole,2D6-Inducer,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
896,Artemether,2D6-Substrate,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
897,Astemizole,2D6-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
898,Atomoxetine,2D6-Inhibitor,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
899,Atomoxetine,2D6-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
900,Azelastine,2D6-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
901,Azelastine,2D6-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
902,Barnidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
903,Befunolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=CC=CC2=C1OC(=C2)C(C)=O
904,Benidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
905,Benzatropine,2D6-Substrate,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
906,Benzethonium,2D6-Substrate,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
907,Benzydamine,2D6-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
908,Bepridil,2D6-Substrate,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
909,Betaxolol,2D6-Substrate,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
910,Betaxolol,2D6-Inhibitor,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
911,Bicalutamide,2D6-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
912,Biperiden,2D6-Inhibitor,O[C@](CCN1CCCCC1)([C@@H]2C[C@H]3C[C@@H]2C=C3)C4=CC=CC=C4
913,Bisoprolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1
914,Bortezomib,2D6-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
915,Bortezomib,2D6-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
916,Brompheniramine,2D6-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
917,Brompheniramine,2D6-Inhibitor,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
918,Budipine,2D6-Inhibitor,CC(C)(C)N1CC[C@](CC1)(C2=CC=CC=C2)C3=CC=CC=C3
919,Buflomedil,2D6-Substrate,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
920,Bupivacaine,2D6-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
921,Bupranolol,2D6-Substrate,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1
922,Buprenorphine,2D6-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
923,Buprenorphine,2D6-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
924,Bupropion,2D6-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
925,Bupropion,2D6-Inhibitor,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
926,Buspirone,2D6-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
927,Caffeine,2D6-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
928,Capsaicin,2D6-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
929,Captopril,2D6-Substrate,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
930,Carbinoxamine,2D6-Inhibitor,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
931,Carteolol,2D6-Inhibitor,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
932,Carteolol,2D6-Substrate,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
933,Carvedilol,2D6-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
934,Cefalexin,2D6-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
935,Celecoxib,2D6-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
936,Cevimeline,2D6-Substrate,CC1O[C@@]2(CS1)CN1CCC2CC1
937,Chinin,2D6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
938,Chlordiazepoxide,2D6-Substrate,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1
939,Chloroquine,2D6-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
940,Chloroquine,2D6-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
941,Chloroxylenol,2D6-Substrate,CC1=CC(O)=CC(C)=C1Cl
942,Chlorphenamine,2D6-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
943,Chlorphenamine,2D6-Inhibitor,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
944,Chlorpromazine,2D6-Substrate,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
945,Chlorpromazine,2D6-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
946,Chlorzoxazone,2D6-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
947,Cibenzoline,2D6-Substrate,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4
948,Ciclosporin,2D6-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
949,Cilostazol,2D6-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
950,Cimetidine,2D6-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
951,Cinacalcet,2D6-Substrate,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
952,Cinacalcet,2D6-Inhibitor,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
953,Cinnarizin,2D6-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
954,Cisapride,2D6-Inhibitor,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
955,Citalopram,2D6-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
956,Citalopram,2D6-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
957,Clemastine,2D6-Inhibitor,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
958,Clomipramine,2D6-Inhibitor,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
959,Clomipramine,2D6-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
960,Clotrimazole,2D6-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
961,Clozapine,2D6-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
962,Clozapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
963,Cocaine,2D6-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
964,Cocaine,2D6-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
965,Codeine,2D6-Inhibitor,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
966,Codeine,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
967,Colecalciferol,2D6-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
968,Cyclobenzaprine,2D6-Substrate,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
969,Deanol,2D6-Substrate,CN(C)CCO
970,Debrisoquine,2D6-Substrate,NC(=N)N1CCC2=C(C1)C=CC=C2
971,Delavirdine,2D6-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
972,Delavirdine,2D6-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
973,Desipramine,2D6-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
974,Desipramine,2D6-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
975,Desloratadine,2D6-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
976,Desvenlafaxine,2D6-Substrate,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
977,Desvenlafaxine,2D6-Inhibitor,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
978,Dexamethasone,2D6-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
979,Dexamfetamine,2D6-Inhibitor,C[C@H](N)CC1=CC=CC=C1
980,Dexamfetamine,2D6-Substrate,C[C@H](N)CC1=CC=CC=C1
981,Dexfenfluramine,2D6-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
982,Dexfenfluramine,2D6-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
983,Dexmedetomidine,2D6-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
984,Dextromethorphan,2D6-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
985,Dextromethorphan,2D6-Inhibitor,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
986,Dextropropoxyphene,2D6-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
987,Diclofenac,2D6-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
988,Diethyltoluamide,2D6-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
989,Dihydrocodeine,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
990,Diltiazem,2D6-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
991,Diltiazem,2D6-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
992,Dimethyl Sulfoxide,2D6-Inhibitor,CS(C)=O
993,Diphenhydramin,2D6-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
994,Diphenhydramin,2D6-Inhibitor,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
995,Diphenhydramine Methylbromide,2D6-Inhibitor,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
996,Disulfiram,2D6-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
997,Disulfiram,2D6-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
998,Dolasetron,2D6-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
999,Dolasetron,2D6-Inhibitor,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
1000,Domperidone,2D6-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
1001,Donepezil,2D6-Substrate,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1
1002,Dopamine,2D6-Substrate,NCCC1=CC(O)=C(O)C=C1
1003,Doxazosin,2D6-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5
1004,Doxepin,2D6-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
1005,Doxepin,2D6-Inhibitor,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
1006,Doxorubicin,2D6-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
1007,Doxorubicin,2D6-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
1008,Duloxetine,2D6-Substrate,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
1009,Duloxetine,2D6-Inhibitor,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
1010,Efavirenz,2D6-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
1011,Eletriptan,2D6-Substrate,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
1012,Emetine,2D6-Substrate,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
1013,Emetine,2D6-Inhibitor,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
1014,Encainide,2D6-Substrate,COC1=CC=C(C=C1)C(=O)NC2=C(C=CC=C2)[C@H](C)CN3CCCCC3
1015,Entacapone,2D6-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
1016,Epinastine,2D6-Inhibitor,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
1017,Epinastine,2D6-Substrate,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
1018,Escitalopram,2D6-Substrate,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
1019,Escitalopram,2D6-Inhibitor,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
1020,Ethylmorphine,2D6-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
1021,Etilamfetamine,2D6-Substrate,CCN[C@@H](C)CC1=CC=CC=C1
1022,Etoricoxib,2D6-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
1023,Felodipine,2D6-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
1024,Fenfluramine,2D6-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
1025,Fesoterodine,2D6-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
1026,Fexofenadine,2D6-Inhibitor,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1027,Flecainide,2D6-Substrate,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
1028,Flecainide,2D6-Inhibitor,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
1029,Fluconazole,2D6-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
1030,Flunarizine,2D6-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
1031,Fluoxetine,2D6-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
1032,Fluoxetine,2D6-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
1033,Fluphenazine,2D6-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
1034,Fluphenazine,2D6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
1035,Fluvastatin,2D6-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
1036,Fluvastatin,2D6-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
1037,Fluvoxamine,2D6-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
1038,Fluvoxamine,2D6-Substrate,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
1039,Formoterol,2D6-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
1040,Galantamine,2D6-Substrate,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24
1041,Gefitinib,2D6-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
1042,Gefitinib,2D6-Substrate,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
1043,Gepirone,2D6-Substrate,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
1044,Granisetron,2D6-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
1045,Granisetron,2D6-Inhibitor,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
1046,Granisetron,2D6-Inducer,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
1047,Guanoxan,2D6-Substrate,NC(=N)NC[C@H]1COC2=C(O1)C=CC=C2
1048,Halofantrine,2D6-Inhibitor,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
1049,Halofantrine,2D6-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
1050,Haloperidol,2D6-Inducer,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
1051,Haloperidol,2D6-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
1052,Haloperidol,2D6-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
1053,Halothane,2D6-Substrate,FC(F)(F)[C@@H](Cl)Br
1054,Histamine,2D6-Inhibitor,NCCC1=CNC=N1
1055,Hydrochloric Acid,2D6-Inhibitor,Cl
1056,Hydrocodone,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
1057,Hydrogen Peroxide,2D6-Substrate,OO
1058,Hydromorphone,2D6-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
1059,Hydroxycarbamide,2D6-Inducer,NC(=O)NO
1060,Hydroxycarbamide,2D6-Inhibitor,NC(=O)NO
1061,Hydroxychloroquine,2D6-Inhibitor,CCN(CCO)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
1062,Hydroxyzine,2D6-Inhibitor,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
1063,Idarubicin,2D6-Inhibitor,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O
1064,Idarubicin,2D6-Substrate,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O
1065,Imatinib,2D6-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
1066,Imatinib,2D6-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
1067,Imipramine,2D6-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
1068,Imipramine,2D6-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
1069,Indinavir,2D6-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
1070,Indinavir,2D6-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
1071,Indoramin,2D6-Substrate,O=C(N[C@H]1CCN(CC1)CCC2=CNC3=C2C=CC=C3)C4=CC=CC=C4
1072,Irbesartan,2D6-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
1073,Isoniazid,2D6-Inhibitor,NNC(=O)C1=CC=NC=C1
1074,Itraconazole,2D6-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
1075,Ketoconazole,2D6-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
1076,Labetalol,2D6-Inhibitor,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
1077,Labetalol,2D6-Substrate,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
1078,Lansoprazole,2D6-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
1079,Lercanidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
1080,Levodopa,2D6-Substrate,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
1081,Levomepromazine,2D6-Inhibitor,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
1082,Levomepromazine,2D6-Substrate,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
1083,Lidocain,2D6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
1084,Lidocain,2D6-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
1085,Lisuride,2D6-Substrate,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
1086,Lofepramine,2D6-Substrate,CN(CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2)CC(=O)C4=CC=C(Cl)C=C4
1087,Lomustine,2D6-Substrate,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
1088,Lomustine,2D6-Inhibitor,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
1089,Loperamide,2D6-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
1090,Lopinavir,2D6-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
1091,Loratadine,2D6-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
1092,Loratadine,2D6-Inducer,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
1093,Loratadine,2D6-Substrate,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
1094,Lovastatin,2D6-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1095,Manidipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
1096,Maprotiline,2D6-Substrate,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
1097,Medrysone,2D6-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
1098,Mefloquine,2D6-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
1099,Melperone,2D6-Inhibitor,C[C@H]1CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1
1100,Memantine,2D6-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
1101,Mephenytoin,2D6-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
1102,Mepyramine,2D6-Inhibitor,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
1103,Mequitazine,2D6-Substrate,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4
1104,Mesoridazine,2D6-Substrate,CN1CCCC[C@H]1CCN2C3=C(SC4=C2C=C(C=C4)S(C)=O)C=CC=C3
1105,Metamfetamine,2D6-Substrate,CN[C@@H](C)CC1=CC=CC=C1
1106,Metamfetamine,2D6-Inhibitor,CN[C@@H](C)CC1=CC=CC=C1
1107,Methadone,2D6-Inhibitor,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1108,Methadone,2D6-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1109,Methazolamide,2D6-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
1110,Methoxyflurane,2D6-Substrate,COC(F)(F)C(Cl)Cl
1111,Methoxyphenamine,2D6-Substrate,CN[C@@H](C)CC1=C(OC)C=CC=C1
1112,Methyldopa (levorotatory),2D6-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
1113,Methyprylon,2D6-Substrate,CCC1(CC)C(=O)NC[C@@H](C)C1=O
1114,Metoclopramide,2D6-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1115,Metoclopramide,2D6-Substrate,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
1116,Metoprolol,2D6-Substrate,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
1117,Metoprolol,2D6-Inhibitor,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
1118,Mexiletine,2D6-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
1119,Mianserin,2D6-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
1120,Mianserin,2D6-Inhibitor,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
1121,Mibefradil,2D6-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
1122,Miconazole,2D6-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
1123,Midodrine,2D6-Inhibitor,COC1=CC([C@H](O)CNC(=O)CN)=C(OC)C=C1
1124,Mifepristone,2D6-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
1125,Minaprine,2D6-Substrate,CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3
1126,Mirtazapine,2D6-Inhibitor,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
1127,Mirtazapine,2D6-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
1128,Mirtazapine,2D6-Inducer,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
1129,Mizolastine,2D6-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
1130,Moclobemide,2D6-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1131,Moclobemide,2D6-Inducer,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1132,Moclobemide,2D6-Substrate,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1133,Morphine,2D6-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
1134,Nateglinide,2D6-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
1135,Nebivolol,2D6-Substrate,O[C@@H](CNC[C@@H](O)[C@@H]1CCC2=C(O1)C=CC(F)=C2)[C@H]3CCC4=CC(F)=CC=C4O3
1136,Nefazodone,2D6-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
1137,Nelfinavir,2D6-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
1138,Nevirapine,2D6-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
1139,Nevirapine,2D6-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
1140,Nicardipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
1141,Nicardipine,2D6-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
1142,Nicergoline,2D6-Substrate,CO[C@]12C[C@@H](COC(=O)C3=CC(Br)=CN=C3)CN(C)[C@@H]1CC4=CN(C)C5=CC=CC2=C45
1143,Nicotinamide,2D6-Inhibitor,NC(=O)C1=CC=CN=C1
1144,Nicotine,2D6-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
1145,Nicotinic Acid,2D6-Inhibitor,OC(=O)C1=CC=CN=C1
1146,Nifedipine,2D6-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
1147,Nifedipine,2D6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
1148,Nitrofural,2D6-Substrate,NC(=O)NN=CC1=CC=C(O1)[N+]([O-])=O
1149,Nortriptyline,2D6-Inhibitor,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
1150,Nortriptyline,2D6-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
1151,Octopamine,2D6-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
1152,Olanzapine,2D6-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
1153,Olanzapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
1154,Omeprazole,2D6-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
1155,Ondansetron,2D6-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
1156,Ondansetron,2D6-Inhibitor,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
1157,Opipramol,2D6-Substrate,OCCN1CCN(CCCN2C3=C(C=CC=C3)C=CC4=C2C=CC=C4)CC1
1158,Orphenadrine (citrate),2D6-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
1159,Oxamniquine,2D6-Inhibitor,CC(C)NC[C@H]1CCC2=C(N1)C=C(C(CO)=C2)[N+]([O-])=O
1160,Oxatomide,2D6-Inhibitor,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
1161,Oxatomide,2D6-Substrate,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
1162,Oxprenolol,2D6-Inhibitor,CC(C)NC[C@@H](O)COC1=C(OCC=C)C=CC=C1
1163,Oxybutynin,2D6-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
1164,Oxycodone,2D6-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
1165,Palonosetron,2D6-Substrate,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
1166,Paracetamol,2D6-Inducer,CC(=O)NC1=CC=C(O)C=C1
1167,Paracetamol,2D6-Substrate,CC(=O)NC1=CC=C(O)C=C1
1168,Parecoxib,2D6-Inhibitor,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
1169,Paroxetine,2D6-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
1170,Paroxetine,2D6-Substrate,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
1171,Pentamidine Isethionate,2D6-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
1172,Pentoxyverine,2D6-Substrate,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2
1173,Pentoxyverine,2D6-Inhibitor,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2
1174,Perazine,2D6-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
1175,Perazine,2D6-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
1176,Pergolide,2D6-Inhibitor,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
1177,Perhexiline,2D6-Substrate,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
1178,Perhexiline,2D6-Inhibitor,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
1179,Perphenazine,2D6-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1180,Perphenazine,2D6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1181,Phenacetin,2D6-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
1182,Phenazone,2D6-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
1183,Phenazone,2D6-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
1184,Phenformin,2D6-Substrate,NC(=N)NC(=N)NCCC1=CC=CC=C1
1185,Phentermine,2D6-Inhibitor,CC(C)(N)CC1=CC=CC=C1
1186,Pimozide,2D6-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
1187,Pindolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
1188,Pindolol,2D6-Inducer,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
1189,Pindolol,2D6-Inhibitor,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
1190,Pioglitazone,2D6-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
1191,Piperazine,2D6-Substrate,C1CNCCN1
1192,Prajmaline,2D6-Substrate,CCC[N@+]12[C@H](O)[C@@H](CC)[C@@H]3C[C@H]1[C@@H]4N(C)C5=C(C=CC=C5)[C@]46C[C@H]2[C@H]3[C@H]6O
1193,Pravastatin,2D6-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
1194,Praziquantel,2D6-Inhibitor,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
1195,Primaquine,2D6-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
1196,Procainamide,2D6-Substrate,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
1197,Prochlorperazine,2D6-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1198,Progesterone,2D6-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
1199,Proguanil,2D6-Inhibitor,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
1200,Promethazine,2D6-Inhibitor,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
1201,Promethazine,2D6-Substrate,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
1202,Propafenone,2D6-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
1203,Propafenone,2D6-Substrate,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
1204,Propofol,2D6-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
1205,Propofol,2D6-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
1206,Propranolol,2D6-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
1207,Propranolol,2D6-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
1208,Protriptyline,2D6-Substrate,CNCCC[C@H]1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
1209,Pseudoephedrine,2D6-Substrate,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
1210,Pyrantel,2D6-Substrate,CN1CCCN=C1C=CC2=CC=CS2
1211,Pyrimethamine,2D6-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
1212,Quetiapine,2D6-Inhibitor,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
1213,Quetiapine,2D6-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
1214,Quinidine,2D6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
1215,Ranitidine,2D6-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
1216,Ranitidine,2D6-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
1217,Reboxetine,2D6-Inducer,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
1218,Reboxetine,2D6-Inhibitor,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
1219,Remoxipride,2D6-Substrate,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC
1220,Rifampicin,2D6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1221,Rifampicin,2D6-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1222,Rifapentine,2D6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
1223,Risperidone,2D6-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
1224,Risperidone,2D6-Inhibitor,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
1225,Ritonavir,2D6-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
1226,Ritonavir,2D6-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
1227,Rivastigmine,2D6-Inhibitor,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
1228,Ropinirole,2D6-Inhibitor,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
1229,Ropivacaine,2D6-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
1230,Rosiglitazone,2D6-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
1231,Roxatidine,2D6-Substrate,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
1232,Rutoside,2D6-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
1233,Saquinavir,2D6-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
1234,Saquinavir,2D6-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
1235,Selegiline,2D6-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
1236,Selegiline,2D6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
1237,Sertindole,2D6-Substrate,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
1238,Sertraline,2D6-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
1239,Sertraline,2D6-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
1240,Sildenafil,2D6-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
1241,Sildenafil,2D6-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
1242,Simvastatin,2D6-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1243,Simvastatin,2D6-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1244,Ezetimibe,2D6-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
1245,Somatostatin,2D6-Inhibitor,C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H](CC6=CC=CC=C6)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O
1246,Sparteine,2D6-Inhibitor,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1
1247,Sparteine,2D6-Substrate,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1
1248,Sulconazole,2D6-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1249,Sulfanilamide,2D6-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
1250,Sulfaphenazole,2D6-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
1251,Tamoxifen,2D6-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
1252,Tamoxifen,2D6-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
1253,Tamsulosin,2D6-Substrate,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
1254,Tegaserod,2D6-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
1255,Tegaserod,2D6-Substrate,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
1256,Telithromycin,2D6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
1257,Terbinafine,2D6-Inhibitor,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
1258,Terfenadine,2D6-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1259,Terfenadine,2D6-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1260,Tetrabenazine,2D6-Inhibitor,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
1261,Tetrabenazine,2D6-Substrate,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
1262,Thebacon,2D6-Substrate,COC1=CC=C2C[C@@H]3[C@H]4CC=C(OC(C)=O)[C@@H]5OC1=C2[C@]45CCN3C
1263,Theophylline,2D6-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
1264,Thiamazole,2D6-Inhibitor,CN1C=CNC1=S
1265,Thioridazine,2D6-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
1266,Thioridazine,2D6-Substrate,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
1267,Ticlopidine,2D6-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
1268,Timolol,2D6-Substrate,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
1269,Timolol,2D6-Inhibitor,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
1270,Tiotixene,2D6-Inhibitor,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1
1271,Tiotropium Bromide,2D6-Substrate,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5
1272,Tolperisone,2D6-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
1273,Tolterodine,2D6-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
1274,Trabectedin,2D6-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
1275,Tramadol,2D6-Inhibitor,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1276,Tramadol,2D6-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1277,Tranylcypromine,2D6-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
1278,Trazodone,2D6-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
1279,Trifluperidol,2D6-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC(=CC=C3)C(F)(F)F
1280,Trimipramine,2D6-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
1281,Tripelennamine,2D6-Inhibitor,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2
1282,Triprolidine,2D6-Inhibitor,CC1=CC=C(C=C1)C(=C/CN2CCCC2)C3=CC=CC=N3
1283,Tropisetron,2D6-Substrate,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
1284,Tropisetron,2D6-Inhibitor,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
1285,Trospium,2D6-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
1286,Venlafaxine,2D6-Inhibitor,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
1287,Venlafaxine,2D6-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
1288,Verapamil,2D6-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
1289,Vernakalant,2D6-Substrate,COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1
1290,Vinblastine,2D6-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1291,Vinblastine,2D6-Inhibitor,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1292,Vincamine,2D6-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
1293,Vinorelbine,2D6-Substrate,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
1294,Vinorelbine,2D6-Inhibitor,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
1295,Yohimbin,2D6-Inhibitor,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
1296,Yohimbin,2D6-Substrate,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
1297,Zafirlukast,2D6-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
1298,Zalcitabine,2D6-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
1299,Ziprasidone,2D6-Inhibitor,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
1300,Zolpidem,2D6-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
1301,Zolpidem,2D6-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
1302,Zotepine,2D6-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
1303,Zuclopenthixol,2D6-Substrate,OCCN1CCN(CCC=C2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1
1304,1_PP,2D6-Substrate,C1CN(CCN1)C2=NC=CC=N2
1305,11_oxo_delta_8_tetrahydro_cannabinol,2D6-Substrate,CCCCCC1=CC2=C([C@@H]3CC(=CC[C@H]3C(C)(C)O2)C=O)C(=C1)O
1306,12_methoxy_ibogamine,2D6-Substrate,CCC1CC2CC3C1N(CCC4=C3[NH]C5=C4C=C(OC)C=C5)C2
1307,13_cis_retinoic_acid,2D6-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
1308,2_acetylbenzothiophene,2D6-Substrate,CC(=O)C1=CC2=CC=CC=C2S1
1309,2_oxo_ticlopidine,2D6-Substrate,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2
1310,4_methoxy_N_butylamphetamine,2D6-Substrate,CCCCNC(C)CC1=CC=C(OC)C=C1
1311,5_methylchrysene,2D6-Substrate,CC1=CC2=CC=CC=C2C3=CC=C4C=CC=CC4=C13
1312,7_ethoxy_coumarin,2D6-Substrate,CCOC1=CC=C2C=C[C](=O)OC2=C1
1313,ABT_761,2D6-Substrate,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O
1314,acetaminophen,2D6-Substrate,CC(=O)NC1=CC=C(O)C=C1
1315,almotriptan,2D6-Substrate,CN(C)CCC1=C[NH]C2=CC=C(C[S](=O)(=O)N3CCCC3)C=C12
1316,amiodarone,2D6-Substrate,CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3
1317,amitriptyline,2D6-Substrate,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13
1318,amodiaquine,2D6-Substrate,CCN(CC)CC1=CC(=CC=C1O)NC2=CC=NC3=CC(=CC=C23)Cl
1319,amphetamine,2D6-Substrate,CC(N)CC1=CC=CC=C1
1320,antipyrine,2D6-Substrate,C[N]1[N]([C](=O)C=C1C)C2=CC=CC=C2
1321,astemizole,2D6-Substrate,COC1=CC=C(CCN2CCC(CC2)NC3=NC4=CC=CC=C4[N]3CC5=CC=C(F)C=C5)C=C1
1322,azelastine,2D6-Substrate,CN1CCC[C@@H](CC1)[N]2N=C(CC3=CC=C(Cl)C=C3)C4=C(C=CC=C4)[C]2=O
1323,barnidipine,2D6-Substrate,COC(=O)C1=C(C)NC(=C([C@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4)C
1324,BDB,2D6-Substrate,CCC(N)CC1=CC=C2OCOC2=C1
1325,benzoyl_phenyl_urea,2D6-Substrate,CN(C)C1=CC=CC=C1C(=O)NC(=O)NC2=CC=C(OC3=NC=C(Br)C=N3)C(=C2)C
1326,benzyl_oxy_resorufin,2D6-Substrate,O=[C]1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1
1327,bortezomib,2D6-Substrate,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
1328,BPR_0L075,2D6-Substrate,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC
1329,bufuralol_R,2D6-Substrate,CCC1=C2OC(=CC2=CC=C1)[C@H](O)CNC(C)(C)C
1330,bupivacaine_R,2D6-Substrate,CCCCN1CCCC[C@@H]1C(=O)NC2=C(C)C=CC=C2C
1331,carbaryl,2D6-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
1332,carbofuran,2D6-Substrate,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1
1333,carvedilol_S,2D6-Substrate,COC1=CC=CC=C1OCCNC[C@H](O)COC2=C3C(=CC=C2)[NH]C4=C3C=CC=C4
1334,catechol_methoxychlor,2D6-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C(=C2)O)C(Cl)(Cl)Cl
1335,celecoxib,2D6-Substrate,CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S](N)(=O)=O)C(F)(F)F
1336,chloroquine_R,2D6-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=CC(=CC2=NC=C1)Cl
1337,chlorpyrifos,2D6-Substrate,CCO[P](=S)(OCC)OC1=NC(=C(Cl)C=C1Cl)Cl
1338,chlorzoxazone,2D6-Substrate,ClC1=CC2=C(O[C](=O)[NH]2)C=C1
1339,cinnarizine,2D6-Substrate,C1CN(CCN1C\C=C\C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
1340,citalopram_R,2D6-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
1341,clobazam,2D6-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
1342,clozapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
1343,compound_A,2D6-Substrate,COC1=NC=C(C=C1)[C@H](CC(O)=O)N2CCN(CCCC3=NC4=C(CCCN4)C=C3)C2=O
1344,cp_122_721,2D6-Substrate,COC1=C(CN[C@H]2CCCN[C@H]2C3=CC=CC=C3)C=C(OC(F)(F)F)C=C1
1345,cp_677_623,2D6-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
1346,curcumin,2D6-Substrate,COC1=CC(=CC=C1O)\C=C\C(=O)CC(=O)\C=C\C2=CC=C(O)C(=C2)OC
1347,DDTC_Me,2D6-Substrate,CCN(CC)C(=S)SC
1348,debrisoquine,2D6-Substrate,NC(=N)N1CCC2=CC=CC=C2C1
1349,delavirdine,2D6-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(=CC=C4[NH]3)N[S](C)(=O)=O
1350,delta_3_carene,2D6-Substrate,CC1=CC[C@H]2[C@H](C2(C)C)C1
1351,DETC_Me,2D6-Substrate,CCN(CC)C(=O)SC
1352,dexfenfluramine,2D6-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
1353,diallylsulfide,2D6-Substrate,C=CCSSCC=C
1354,diazinion,2D6-Substrate,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C
1355,dibenzyl_fluorescein,2D6-Substrate,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17
1356,diethyl_meta_toluamide,2D6-Substrate,CCN(CC)C(=O)C1=CC(=CC=C1)C
1357,dimemorfan,2D6-Substrate,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C)C=C4
1358,diphenhydramine,2D6-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
1359,disulfoton,2D6-Substrate,CCO[P](=S)(OCC)SCCSCC
1360,diuron,2D6-Substrate,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl
1361,domperidone,2D6-Substrate,ClC1=CC=C2[N](C3CCN(CCC[N]4[C](=O)[NH]C5=CC=CC=C45)CC3)[C](=O)[NH]C2=C1
1362,DY_9760e,2D6-Substrate,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl
1363,ellipticine,2D6-Substrate,CC1=C2[NH]C3=CC=CC=C3C2=C(C)C4=CN=CC=C14
1364,ethanol,2D6-Substrate,CCO
1365,ethinyl_estradiol,2D6-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@]2(O)C#C
1366,eupatilin,2D6-Substrate,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC
1367,ezlopitant_alkene_CJ_12_458,2D6-Substrate,COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)=C
1368,fluoxetine_R,2D6-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
1369,fluvastatin,2D6-Substrate,CC(C)[N]1C2=CC=CC=C2C(=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3
1370,fluvoxamine,2D6-Substrate,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
1371,foxy,2D6-Substrate,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1
1372,gefitinib,2D6-Substrate,COC1=CC2=NC=NC(=C2C=C1OCCCN3CCOCC3)NC4=CC=C(F)C(=C4)Cl
1373,gepirone,2D6-Substrate,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
1374,harmaline,2D6-Substrate,COC1=CC2=C(C=C1)C3=C([NH]2)C(=NCC3)C
1375,harmine,2D6-Substrate,COC1=CC=C2C(=C1)[NH]C3=C2C=CN=C3C
1376,iloperidone,2D6-Substrate,COC1=CC(=CC=C1OCCCN2CCC(CC2)C3=NOC4=CC(=CC=C34)F)C(C)=O
1377,imidacloprid,2D6-Substrate,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1
1378,imipramine,2D6-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13
1379,indomethacin_phenethylamide,2D6-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCCC3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
1380,isoprene,2D6-Substrate,CC(=C)C=C
1381,K11777,2D6-Substrate,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4
1382,licofelone,2D6-Substrate,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O
1383,linalool,2D6-Substrate,CC(C)=CCCC(C)(O)C=C
1384,LU_2509,2D6-Substrate,CC[N]1N=NC(=N1)C2=CCCN(C)C2
1385,Lu_AA21004,2D6-Substrate,CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C
1386,MDPPP,2D6-Substrate,CC(N1CCCC1)C(=O)C2=CC=C3OCOC3=C2
1387,MeAMFC,2D6-Substrate,CC[N+](C)(CC)CCC1=C(C2=CC=C(OC)C=C2O[C]1=O)C(F)(F)F
1388,meperidine,2D6-Substrate,CCOC(=O)C1(CCN(C)CC1)C2=CC=CC=C2
1389,mequitazine,2D6-Substrate,C1CN2CCC1[C@@H](C2)CN3C4=CC=CC=C4SC5=CC=CC=C35
1390,methadone_R,2D6-Substrate,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1391,methiocarb,2D6-Substrate,CNC(=S)OC1=CC(=C(SC)C(=C1)C)C
1392,metoclopramide,2D6-Substrate,CCN(CC)CCNC(=O)C1=CC(=C(N)C=C1OC)Cl
1393,mianserin_R,2D6-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CC=C24
1394,MK_0457_tozasertib,2D6-Substrate,CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)SC4=CC=C(NC(=O)C5CC5)C=C4
1395,ML_3403,2D6-Substrate,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4
1396,MMPyrC,2D6-Substrate,COC1=CC2=C(C=C1)C(=C[C](=O)O2)C[N+]3=CC=CC=C3
1397,montelukast,2D6-Substrate,CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC2(CC2)CC(O)=O)C3=CC=CC(=C3)\C=C\C4=CC=C5C=CC(=CC5=N4)Cl
1398,morphine,2D6-Substrate,CN1CC[C@@]23[C@H]4OC5=C(O)C=CC(=C25)C[C@@H]1[C@@H]3C=C[C@@H]4O
1399,MPBP,2D6-Substrate,CCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
1400,muraglitazar,2D6-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
1401,nabumetone,2D6-Substrate,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
1402,NE_100,2D6-Substrate,CCCN(CCC)CCC1=CC=C(OC)C(=C1)OCCC2=CC=CC=C2
1403,nevirapine,2D6-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2C4CC4
1404,nicardipine_R,2D6-Substrate,COC(=O)C1=C(C)NC(=C([C@@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)OCCN(C)CC3=CC=CC=C3)C
1405,nicotine,2D6-Substrate,CN1CCCC1C2=CC=CN=C2
1406,NN_diamyl_nitrosoamine,2D6-Substrate,CCCCCN(CCCCC)N=O
1407,NN_diethyl_nitrosoamine,2D6-Substrate,CCN(CC)N=O
1408,NN_dimethyl_nitrosoamine,2D6-Substrate,CN(C)N=O
1409,NN_methyl_butyl_nitrosoamine,2D6-Substrate,CCCCN(C)N=O
1410,NN_methyl_ethyl_nitrosoamine,2D6-Substrate,CCN(C)N=O
1411,NNK,2D6-Substrate,CN(CCCC(=O)C1=CC=CN=C1)N=O
1412,norLAAM,2D6-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2
1413,O_phenylphenol,2D6-Substrate,OC1=C(C=CC=C1)C2=CC=CC=C2
1414,olanzapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(C)S4
1415,ondansetron,2D6-Substrate,C[N]1C2=C(C(=O)[C@@H](CC2)C[N]3C=CN=C3C)C4=CC=CC=C14
1416,OSU_6162,2D6-Substrate,CCCN1CCC[C@H](C1)C2=CC(=CC=C2)[S](C)(=O)=O
1417,p_cresol,2D6-Substrate,CC1=CC=C(O)C=C1
1418,perhexiline,2D6-Substrate,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
1419,phenytoin,2D6-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
1420,pregnenolone,2D6-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
1421,progesterone,2D6-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1422,promazine,2D6-Substrate,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13
1423,propafenone_R,2D6-Substrate,CCCNC[C@@H](O)COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2
1424,R_95913,2D6-Substrate,FC1=CC=CC=C1C(N2CCC3SC(=O)C=C3C2)C(=O)C4CC4
1425,rabeprazole_thioether,2D6-Substrate,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2
1426,ranitidine,2D6-Substrate,CN\C(NCCSCC1=CC=C(CN(C)C)O1)=C/[N](=O)=O
1427,roxatidine_m5,2D6-Substrate,OCCCOC1=CC=CC(=C1)CN2CCCCC2
1428,rutaecarpine,2D6-Substrate,O=[C]1[N]2CCC3=C([NH]C4=CC=CC=C34)C2=NC5=C1C=CC=C5
1429,safrole,2D6-Substrate,C=CCC1=CC=C2OCOC2=C1
1430,selegiline,2D6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
1431,sertraline,2D6-Substrate,CN[C@H]1CC[C@@H](C2=CC(=C(Cl)C=C2)Cl)C3=C1C=CC=C3
1432,SNI_2011_R_R,2D6-Substrate,C[C@@H]1O[C@@]2(CS1)CN3CCC2CC3
1433,sulprofos,2D6-Substrate,CCCS[P](=S)(OCC)OC1=CC=C(SC)C=C1
1434,tamsulosin,2D6-Substrate,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC=C(OC)C(=C2)[S](N)(=O)=O
1435,tauromustine,2D6-Substrate,CN(C)[S](=O)(=O)CCNC(=O)N(CCCl)N=O
1436,territrem_A,2D6-Substrate,COC1=CC(=CC2=C1OCO2)C3=CC4=C(C[C@]5(O)[C@](C)(CC[C@@]6(O)C(C)(C)C=CC(=O)[C@]56C)O4)[C](=O)O3
1437,tert_butyl_propranolol,2D6-Substrate,CC(NCC(O)COC1=CC=CC2=CC=CC=C12)C(C)(C)C
1438,theophylline,2D6-Substrate,C[N]1[C](=O)[N](C)C2=C([NH]C=N2)[C]1=O
1439,ticlopidine,2D6-Substrate,ClC1=CC=CC=C1CN2CCC3=C(C2)C=CS3
1440,tolperisone_R,2D6-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
1441,tolterodine,2D6-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C2=CC(=CC=C2O)C)C(C)C
1442,tramadol,2D6-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
1443,trans_stilbene,2D6-Substrate,C1=CC=C(C=C1)\C=C\C2=CC=CC=C2
1444,tropisetron,2D6-Substrate,CN1[C@H]2CCC1CC(C2)OC(=O)C3=C[NH]C4=CC=CC=C34
1445,V_11294,2D6-Substrate,CCNC1=C2N=C(N=C2[N](CC3=CC=C(OC)C(=C3)OC4CCCC4)C=N1)C(C)C
1446,venlafaxine_R,2D6-Substrate,COC1=CC=C(C=C1)[C@H](CN(C)C)C2(O)CCCCC2
1447,yohimbine,2D6-Substrate,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C([NH]C5=CC=CC=C45)[C@@H]3C[C@H]12
1448,zileuton_R,2D6-Substrate,C[C@@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1
1449,zopiclone_R,2D6-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4
1450,zotepine,2D6-Substrate,CN(C)CCOC1=CC2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
1451,18_methoxy_coronaridine,2D6-Substrate,COCC[C@H]1CC2CN3CCC4=C([NH]C5=CC=CC=C45)[C@](C2)(C13)C(=O)OC
1452,2_hydroxy_indomethacin_phenethylamide,2D6-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCC(O)C3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
1453,2_oxo_clopidogrel,2D6-Substrate,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3
1454,3_methylindole,2D6-Substrate,CC1=C[NH]C2=CC=CC=C12
1455,4_methoxy_amphetamine,2D6-Substrate,COC1=CC=C(CC(C)N)C=C1
1456,4_methoxy_N_ethylamphetamine,2D6-Substrate,CCNC(C)CC1=CC=C(OC)C=C1
1457,6_methylchrysene,2D6-Substrate,CC1=CC2=C3C=CC=CC3=CC=C2C4=CC=CC=C14
1458,7_methoxy_3_cyano_coumarin,2D6-Substrate,COC1=CC=C2C=C(C#N)[C](=O)OC2=C1
1459,7_methoxy_4_trifluoro_methyl_coumarin,2D6-Substrate,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
1460,ABT_438,2D6-Substrate,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1
1461,ABT_66193,2D6-Substrate,CC(NC(N)=O)C1=CC2=CC=CC=C2S1
1462,all_trans_retinal,2D6-Substrate,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
1463,AMMC,2D6-Substrate,CC[N+](C)(CC)CCC1=C(C)C2=CC=C(OC)C=C2O[C]1=O
1464,atomoxetine,2D6-Substrate,CNCC[C@@H](OC1=C(C)C=CC=C1)C2=CC=CC=C2
1465,BMAMC,2D6-Substrate,CCCCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
1466,clomipramine,2D6-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
1467,deshydroxy_propranolol,2D6-Substrate,CC(C)NCCCOC1=CC=CC2=CC=CC=C12
1468,deshydroxy_trifluoro_propranolol,2D6-Substrate,CC(NCCCOC1=CC=CC2=CC=CC=C12)C(F)(F)F
1469,desmethyl_citalopram,2D6-Substrate,CNCCCC1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
1470,difluoro_propranolol,2D6-Substrate,CC(NCC(O)COC1=CC=CC2=CC=CC=C12)C(F)F
1471,DiMMAMC,2D6-Substrate,COC1=CC=C2C(=C[C](=O)OC2=C1)CN(C)C
1472,EMAMC,2D6-Substrate,CCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
1473,ethyl_morphine,2D6-Substrate,CCOC1=C2O[C@H]3[C@@H](O)C=C[C@H]4[C@H]5CC(=C2[C@@]34CCN5C)C=C1
1474,ezlopitant,2D6-Substrate,COC1=C(CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C=C(C=C1)C(C)C
1475,flunarizine,2D6-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)C\C=C\C3=CC=CC=C3)C4=CC=C(F)C=C4
1476,fluoro_propranolol,2D6-Substrate,CC(CF)NCC(O)COC1=CC=CC2=CC=CC=C12
1477,isopropyl_propranolol,2D6-Substrate,CC(C)C(C)NCC(O)COC1=CC=CC2=CC=CC=C12
1478,lidocaine,2D6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
1479,MAMC,2D6-Substrate,COC1=CC=C2C(=C[C](=O)OC2=C1)CN
1480,MBDB,2D6-Substrate,CC[C@H](CC1=CC=C2OCOC2=C1)NC
1481,MDA_tenamfetamine,2D6-Substrate,CC(N)CC1=CC=C2OCOC2=C1
1482,MDE_R,2D6-Substrate,CCN[C@H](C)CC1=CC=C2OCOC2=C1
1483,MDMA_R,2D6-Substrate,CN[C@H](C)CC1=CC=C2OCOC2=C1
1484,mesoridazine,2D6-Substrate,CN1CCCCC1CCN2C3=CC=CC=C3SC4=CC=C(C=C24)[S](C)=O
1485,methamphetamine_R,2D6-Substrate,CN[C@H](C)CC1=CC=CC=C1
1486,methamphetamine_S,2D6-Substrate,CN[C@@H](C)CC1=CC=CC=C1
1487,methyl_eugenol,2D6-Substrate,COC1=C(OC)C=C(CC=C)C=C1
1488,mirtazapine_R,2D6-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CN=C24
1489,ML_3603,2D6-Substrate,CC(NC1=NC=CC(=C1)C2=C(N=C([NH]2)[S](C)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4
1490,MMAMC,2D6-Substrate,CNCC1=C[C](=O)OC2=C1C=CC(=C2)OC
1491,mono_OH_methoxychlor,2D6-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
1492,MOPPP_R,2D6-Substrate,COC1=CC=C(C=C1)C(=O)[C@@H](C)N2CCCC2
1493,N_butyl_amphetamine,2D6-Substrate,CCCCNC(C)CC1=CC=CC=C1
1494,N_desmethyl_clomipramine,2D6-Substrate,CNCCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
1495,N_ethyl_amphetamine,2D6-Substrate,CCNC(C)CC1=CC=CC=C1
1496,N_trifluoro_ethyl_desisopropyl_propranolol,2D6-Substrate,OC(CNCC(F)(F)F)COC1=CC=CC2=CC=CC=C12
1497,oxycodone,2D6-Substrate,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(=C2[C@@]34CCN5C)C=C1
1498,perazine,2D6-Substrate,CN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=CC=C4)CC1
1499,perphenazine,2D6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
1500,PMAMC,2D6-Substrate,CCCNCC1=C[C](=O)OC2=C1C=CC(=C2)OC
1501,propranolol_R,2D6-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
1502,propranolol_S,2D6-Substrate,CC(C)NC[C@H](O)COC1=C2C=CC=CC2=CC=C1
1503,retinol,2D6-Substrate,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
1504,tangeretin,2D6-Substrate,COC1=CC=C(C=C1)C2=C[C](=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC
1505,thioridazine_R,2D6-Substrate,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1
1506,trifluoro_propranolol,2D6-Substrate,CC(NCC(O)COC1=CC=CC2=CC=CC=C12)C(F)(F)F
1507,Albendazole,2D6-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
1508,Amiflamine,2D6-Substrate,CC1=C(C=CC(=C1)N(C)C)CC(C)N
1509,Aminopyrine,2D6-Substrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
1510,Amodiaquine,2D6-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
1511,Amoxapine,2D6-Substrate,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
1512,Artemisinin,2D6-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
1513,Avitriptan,2D6-Substrate,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC
1514,Brofaromine,2D6-Substrate,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br
1515,Carbaril,2D6-Substrate,CNC(=O)OC1=CC=CC2=CC=CC=C21
1516,Celecoxib,2D6-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
1517,Chlorpyrifos,2D6-Substrate,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
1518,Cisapride,2D6-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
1519,Cyclophosphamide,2D6-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
1520,Dapsone,2D6-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
1521,Dextrorphan,2D6-Substrate,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
1522,Diphenhydramine,2D6-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
1523,Diprafenone,2D6-Substrate,CCC(C)(C)NCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
1524,Estradiol,2D6-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
1525,Etoperidone,2D6-Substrate,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
1526,Etoricoxib,2D6-Substrate,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
1527,Ezlopitant,2D6-Substrate,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
1528,Fenfluramine,2D6-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
1529,Hydrocortisone,2D6-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
1530,Iloperidone,2D6-Substrate,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
1531,Ketamine,2D6-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
1532,Levacetylmethadol,2D6-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
1533,Lidocaine,2D6-Substrate,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
1534,m-Chlorophenylpiperazine,2D6-Substrate,C1CN(CCN1)C2=CC(=CC=C2)Cl
1535,Methiocarb,2D6-Substrate,CC1=CC(=CC(=C1SC)C)OC(=O)NC
1536,Milameline,2D6-Substrate,CN1CCC=C(C1)C=NOC
1537,Mizolastine,2D6-Substrate,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
1538,Molindone,2D6-Substrate,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C
1539,Nelfinavir,2D6-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
1540,Norcodeine,2D6-Substrate,COC1=C2C3=C(CC4C5C3(CCN4)C(O2)C(C=C5)O)C=C1
1541,Omeprazole,2D6-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
1542,Orphenadrine,2D6-Substrate,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
1543,Papaverine,2D6-Substrate,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
1544,Parathion,2D6-Substrate,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
1545,Penbutolol,2D6-Substrate,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O
1546,Pentazocine,2D6-Substrate,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
1547,Pethidine,2D6-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
1548,Phenytoin,2D6-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
1549,Pinacidil,2D6-Substrate,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C
1550,Praziquantel,2D6-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
1551,Pregnenolone,2D6-Substrate,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
1552,Primaquine,2D6-Substrate,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
1553,Promazine,2D6-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
1554,Tauromustine,2D6-Substrate,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
1555,Terguride,2D6-Substrate,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C
1556,Testosterone,2D6-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1557,Tiagabine,2D6-Substrate,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3
1558,Trichloromethane,2D6-Substrate,C(Cl)(Cl)Cl
1559,Troglitazone,2D6-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
1560,Valdecoxib,2D6-Substrate,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
1561,Warfarin,2D6-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
1562,Yohimbine,2D6-Substrate,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
1563,Abacavir,-,NC1=NC2=C(N=CN2[C@H]3C[C@@H](CO)C=C3)C(N[C@H]4CC4)=N1
1564,Abecarnil,-,CC(C)OC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4
1565,Acebutolol,-,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1
1566,Aceclofenac,-,OC(=O)COC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
1567,Acenocoumarol,-,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
1568,Acetanilide,-,CC(=O)NC1=CC=CC=C1
1569,Acetazolamide,-,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
1570,Acetone,-,CC(=O)C
1571,Acetylsalicylic acid,-,CC(=O)OC1=CC=CC=C1C(=O)O
1572,Adinazolam,-,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
1573,Ajmaline,-,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
1574,Alosetron,-,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
1575,Alpidem,-,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl
1576,Alprazolam,-,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
1577,Ambroxol,-,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
1578,Aminoglutethimide,-,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
1579,Amlodipine,-,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
1580,Anastrozole,-,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
1581,Aniline,-,C1=CC=C(C=C1)N
1582,Anthraquinone,-,C1=CC=C2C(=C1)C(=O)C3=CC=CC=C3C2=O
1583,Apomorphine,-,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
1584,Aprepitant,-,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
1585,Argatroban,-,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
1586,Artesunate,-,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O
1587,Atazanavir,-,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
1588,Atorvastatin,-,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
1589,Atovaquone,-,OC1=C([C@H]2CC[C@@H](CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O
1590,Avasimibe,-,CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
1591,Azacyclonol,-,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O
1592,Azamulin,-,CCC1(CC(C2(C(CCC3(C2C(=O)CC3)C(C1O)C)C)C)OC(=O)CSC4=NNC(=N4)N)C
1593,Azapropazone,-,CCC[C@H]1C(=O)N2N(C1=O)C(=NC3=C2C=C(C)C=C3)N(C)C
1594,Azatadine,-,CN1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=CC=C3
1595,Azimilide,-,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl
1596,Azithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
1597,Barnidipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
1598,Benzbromarone,-,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1
1599,Benzene,-,C1=CC=CC=C1
1600,Benzfetamine,-,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
1601,Bepridil,-,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
1602,Betamethasone,-,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
1603,Bexarotene,-,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
1604,Bezafibrate,-,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
1605,Bifluranol,-,CCC(C1=CC(=C(C=C1)O)F)C(C)C2=CC(=C(C=C2)O)F
1606,Bifonazole,-,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
1607,Biperiden,-,O[C@](CCN1CCCCC1)([C@@H]2C[C@H]3C[C@@H]2C=C3)C4=CC=CC=C4
1608,Boldenone,-,CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C
1609,Bosentan,-,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
1610,Brinzolamide,-,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
1611,Bromazepam,-,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
1612,Bromocriptine,-,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
1613,Bropirimine,-,C1=CC=C(C=C1)C2=C(C(=O)NC(=N2)N)Br
1614,Brotizolam,-,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(SC(Br)=C4)N12
1615,Budesonide,-,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
1616,Budipine,-,CC(C)(C)N1CC[C@](CC1)(C2=CC=CC=C2)C3=CC=CC=C3
1617,Bupropion,-,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
1618,Busulfan,-,CS(=O)(=O)OCCCCOS(C)(=O)=O
1619,Calcium folinate,-,C1C(N(C2=C(N1)N=C(N=C2[O-])N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)O.[Ca+2]
1620,Candesartan,-,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
1621,Capravirine,-,CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl
1622,Carbimazole,-,CCOC(=O)N1C=CN(C1=S)C
1623,Carisoprodol,-,CCC[C@@](C)(COC(N)=O)COC(=O)NC(C)C
1624,Cathinone,-,CC(C(=O)C1=CC=CC=C1)N
1625,Cerivastatin,-,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
1626,Chenodeoxycholic acid,-,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
1627,Chloral hydrate,-,C(C(Cl)(Cl)Cl)(O)O
1628,Chloramphenicol,-,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
1629,Chlordiazepoxide,-,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1
1630,Chlormadinone,-,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
1631,Ciclosporin,-,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
1632,Cilnidipine,-,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3
1633,Cilostazol,-,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
1634,Cimetidine,-,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
1635,Ciprofibrate,-,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
1636,Clemastine,-,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
1637,Clindamycin,-,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
1638,Clofazimine,-,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5
1639,Clofibrate,-,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
1640,Clofibric acid,-,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
1641,Clomethiazole,-,CC1=C(CCCl)SC=N1
1642,Clopidogrel,-,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
1643,Clotrimazole,-,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
1644,Cocaine,-,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
1645,Colchicine,-,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
1646,Colecalciferol,-,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
1647,Colestyramine,-,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
1648,Cortisol,-,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
1649,Cortisone,-,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
1650,Cotinine,-,CN1C(CCC1=O)C2=CN=CC=C2
1651,Coumarin,-,C1=CC=C2C(=C1)C=CC(=O)O2
1652,Cyproterone,-,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
1653,Dacarbazine,-,CN(C)N=NC1=C(N=CN1)C(N)=O
1654,Dalfopristin,-,CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C
1655,Danazol,-,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
1656,Dantrolene,-,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O
1657,Daunorubicin,-,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
1658,Dazoxiben,-,C1=CC(=CC=C1C(=O)O)OCCN2C=CN=C2
1659,Desogestrel,-,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
1660,Dexloxiglumide,-,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl
1661,Dexmedetomidine,-,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
1662,Dextropropoxyphene,-,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
1663,Dicoumarol,-,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
1664,Dieldrin,-,C1C2C3C(C1C4C2O4)C5(C(=C(C3(C5(Cl)Cl)Cl)Cl)Cl)Cl
1665,Diethylcarbamazine,-,CCN(CC)C(=O)N1CCN(C)CC1
1666,Diethylstilbestrol,-,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
1667,Difloxacin,-,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F
1668,Digitoxin,-,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
1669,Digoxin,-,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
1670,Dihydralazine,-,NNC1=NN=C(NN)C2=C1C=CC=C2
1671,Dihydroergotamine,-,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
1672,Dimethyl sulfoxide,-,CS(=O)C
1673,Diosmin,-,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
1674,Dipotassium clorazepate,-,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O.[OH-].[K+].[K+]
1675,Dirithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O
1676,Disopyramide,-,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C
1677,Disulfamide,-,CC1=CC(=C(C=C1S(=O)(=O)N)S(=O)(=O)N)Cl
1678,Disulfiram,-,CCN(CC)C(=S)SSC(=S)N(CC)CC
1679,Ditiocarb sodium,-,CCN(CC)C(=S)[S-].[Na+]
1680,Docetaxel,-,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
1681,Dofetilide,-,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2
1682,Dorzolamide,-,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
1683,Doxycycline,-,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
1684,Dronabinol,-,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
1685,Drospirenone,-,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
1686,Dutasteride,-,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
1687,Ebastine,-,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
1688,Ebrotidine,-,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br
1689,Ecabapide,-,CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC
1690,Econazole,-,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1691,Efavirenz,-,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
1692,Efonidipine,-,CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5
1693,Eletriptan,-,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
1694,Enalapril,-,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
1695,Enflurane,-,FC(F)OC(F)(F)[C@H](F)Cl
1696,Entacapone,-,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
1697,Epinephrine,-,CNC[C@H](O)C1=CC(O)=C(O)C=C1
1698,Eplerenone,-,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
1699,Eprosartan,-,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
1700,Ergotamine,-,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
1701,Erythromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
1702,Estrone,-,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
1703,Ethanol,-,CCO
1704,Ethinylestradiol,-,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
1705,Ethosuximide,-,CC[C@]1(C)CC(=O)NC1=O
1706,Ethylbenzene,-,CCC1=CC=CC=C1
1707,Etomidate,-,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
1708,Etonogestrel,-,CC[C@@]12CC(=C)[C@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@@H]1CC[C@@]2(O)C#C
1709,Etoposide,-,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
1710,Everolimus,-,CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
1711,Exemestane,-,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
1712,Fadrozole,-,C1CC(N2C=NC=C2C1)C3=CC=C(C=C3)C#N
1713,Famotidine,-,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
1714,Felbamate,-,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
1715,Felodipine,-,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
1716,Fenofibrate,-,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
1717,Fentanyl,-,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
1718,Fexofenadine,-,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
1719,Finasteride,-,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
1720,Flosequinan,-,COSC1=CN(C)C2=C(C=CC(F)=C2)C1=O
1721,Flucloxacillin,-,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
1722,Fluconazole,-,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
1723,Flufenamic acid,-,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F
1724,Flunitrazepam,-,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
1725,Fluorouracil,-,FC1=CNC(=O)NC1=O
1726,Fluparoxan,-,C1C2C(CN1)OC3=C(O2)C=CC=C3F
1727,Flurazepam,-,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
1728,Flurbiprofen,-,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
1729,Flurithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
1730,Flutamide,-,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
1731,Fluticasone,-,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
1732,Fosphenytoin,-,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
1733,Frovatriptan,-,CN[C@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(N)=O
1734,Furafylline,-,CC1=NC2=C(N1)C(=O)N(C(=O)N2CC3=CC=CO3)C
1735,Gallopamil,-,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1
1736,Ganaxolone,-,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C
1737,Gefitinib,-,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
1738,Gemfibrozil,-,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
1739,Gestodene,-,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
1740,Glibenclamide,-,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
1741,Gliclazide,-,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2
1742,Glimepiride,-,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
1743,Glyceryl trinitrate,-,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
1744,Granisetron,-,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
1745,Grepafloxacin,-,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
1746,Griseofulvin,-,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
1747,Guanabenz,-,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl
1748,Hexobarbital,-,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
1749,Homochlorcyclizine,-,CN1CCCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
1750,Hydralazine,-,NN=C1NN=CC2=C1C=CC=C2
1751,Hydroxychloroquine,-,CCN(CCO)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
1752,Hydroxyzine,-,OCCOCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
1753,Ibuprofen,-,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
1754,Ibutilide,-,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
1755,Ifosfamide,-,ClCCN[P@@]1(=O)OCCCN1CCCl
1756,Imatinib,-,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
1757,Imiquimod,-,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
1758,Indometacin,-,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
1759,Ipriflavone,-,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
1760,Irbesartan,-,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
1761,Irinotecan,-,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
1762,Isbogrel,-,C1=CC=C(C=C1)C(=CCCCCC(=O)O)C2=CN=CC=C2
1763,Isoflurane,-,FC(F)O[C@@H](Cl)C(F)(F)F
1764,Isoniazid,-,NNC(=O)C1=CC=NC=C1
1765,Isosorbide dinitrate,-,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
1766,Isradipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
1767,Itraconazole,-,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
1768,Ivermectin,-,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
1769,Josamycin,-,CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(C)=O
1770,Ketoconazole,-,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
1771,Ketoprofen,-,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
1772,Lacidipine,-,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)C=CC(=O)OC(C)(C)C)C(=O)OCC
1773,Leflunomide,-,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
1774,Letrozole,-,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
1775,Levobupivacaine,-,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
1776,Levofloxacin,-,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
1777,Levomepromazine,-,COC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
1778,Levothyroxine sodium,-,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]
1779,Liarozole,-,C1=CC(=CC(=C1)Cl)C(C2=CC3=C(C=C2)N=CN3)N4C=CN=C4
1780,Lilopristone,-,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C
1781,Linezolid,-,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
1782,Liothyronine,-,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O
1783,Lisofylline,-,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O
1784,Litoxetine,-,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2
1785,Lomustine,-,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
1786,Lopinavir,-,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
1787,Losigamone,-,COC1=CC(=O)OC1C(C2=CC=CC=C2Cl)O
1788,Lovastatin,-,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
1789,Lumefantrine,-,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O
1790,Malathion,-,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
1791,Manidipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
1792,Mebendazole,-,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3
1793,Medazepam,-,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
1794,Medifoxamine,-,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
1795,Medroxyprogesterone,-,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
1796,Mefenamic acid,-,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
1797,Mefloquine,-,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
1798,Mepacrine,-,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
1799,Mepyramine,-,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
1800,Methaqualone,-,CC1=C(C=CC=C1)N2C(C)=NC3=C(C=CC=C3)C2=O
1801,Methomyl,-,CC(=NOC(=O)NC)SC
1802,Methoxsalen,-,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
1803,Methoxyflurane,-,COC(F)(F)C(Cl)Cl
1804,Methylergometrine,-,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
1805,Methylphenidate,-,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
1806,Methylprednisolone,-,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14
1807,Metronidazole,-,CC1=NC=C(N1CCO)[N+]([O-])=O
1808,Metyrapone,-,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
1809,Mevastatin,-,CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O
1810,Mexazolam,-,CC1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl
1811,Mibefradil,-,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
1812,Midecamycin,-,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
1813,Mifepristone,-,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
1814,Milnacipran,-,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2
1815,Minoxidil,-,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
1816,Mitoxantrone,-,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
1817,Moclobemide,-,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
1818,Montelukast,-,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
1819,Moracizine,-,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1
1820,Mosapride,-,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
1821,Nafcillin,-,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O
1822,Nalidixic acid,-,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O
1823,Naproxen,-,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
1824,Nateglinide,-,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
1825,Nefazodone,-,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
1826,Nefiracetam,-,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
1827,Niclosamide,-,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O
1828,Niludipine,-,CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOCCC)C)C
1829,Nimodipine,-,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
1830,Nimorazole,-,C1COCCN1CCN2C=NC=C2[N+](=O)[O-]
1831,Nisoldipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
1832,Nitrendipine,-,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
1833,Nitrosamine,-,NN=O
1834,Norethisterone,-,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
1835,Norfloxacin,-,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
1836,Ofloxacin,-,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
1837,Olopatadine,-,CN(C)CCC=C1C2=C(COC3=C1C=C(CC(O)=O)C=C3)C=CC=C2
1838,Oltipraz,-,CC1=C(SSC1=S)C2=NC=CN=C2
1839,Omapatrilat,-,C1CC(N2C(C1)SCCC(C2=O)NC(=O)C(CC3=CC=CC=C3)S)C(=O)O
1840,Oxamniquine,-,CC(C)NC[C@H]1CCC2=C(N1)C=C(C(CO)=C2)[N+]([O-])=O
1841,Oxcarbazepine,-,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
1842,Oxiconazole,-,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1843,Oxodipine,-,CCOC(=O)C1=C(NC(=C(C1C2=C3C(=CC=C2)OCO3)C(=O)OC)C)C
1844,Oxprenolol,-,CC(C)NC[C@@H](O)COC1=C(OCC=C)C=CC=C1
1845,Oxybutynin,-,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
1846,Paclitaxel,-,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
1847,Pantoprazole,-,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
1848,Parecoxib,-,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
1849,Pargyline,-,CN(CC#C)CC1=CC=CC=C1
1850,Pefloxacin,-,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCN(C)CC3)C(F)=C2
1851,Pentamidine,-,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
1852,Pergolide,-,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
1853,Phenazone,-,CN1N(C(=O)C=C1C)C2=CC=CC=C2
1854,Phencyclidine,-,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
1855,Phenobarbital,-,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
1856,Phenol,-,OC1=CC=CC=C1
1857,Phenprocoumon,-,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
1858,Phensuximide,-,CN1C(=O)C[C@@H](C1=O)C2=CC=CC=C2
1859,Phenylbutazone,-,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
1860,Pilocarpine,-,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
1861,Pimozide,-,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
1862,Pipemidic acid,-,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCNCC3)C(=O)O
1863,Piroxicam,-,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
1864,Plomestane,-,CC12CCC3C(C1CCC2=O)CCC4=CC(=O)CCC34CC#C
1865,Pramipexole,-,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
1866,Pranidipine,-,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
1867,Prasterone,-,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
1868,Pravastatin,-,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
1869,Prednisolone,-,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
1870,Primidone,-,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
1871,Proadifen,-,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
1872,Probenecid,-,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
1873,Proguanil,-,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
1874,Propanol,-,CCCO
1875,Pyridostigmine bromide,-,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]
1876,Pyrimethamine,-,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
1877,Quercetin,-,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
1878,Quinelorane,-,CCCN1CCCC2C1CC3=CN=C(N=C3C2)N
1879,Quinine,-,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
1880,Quinupristin,-,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
1881,Rabeprazole,-,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
1882,Raloxifene,-,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
1883,Ranolazine,-,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
1884,Rebamipide,-,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
1885,Remacemide,-,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN
1886,Repaglinide,-,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
1887,Reserpine,-,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
1888,Resiquimod,-,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
1889,Rifabutin,-,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
1890,Rifampicin,-,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1891,Rifamycin,-,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
1892,Rifapentine,-,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
1893,Riluzole,-,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
1894,Rofecoxib,-,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
1895,Rokitamycin,-,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
1896,Ropinirole,-,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
1897,Roquinimex,-,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O
1898,Rosiglitazone,-,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
1899,Rosuvastatin,-,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
1900,Roxatidine,-,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
1901,Roxithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
1902,Rupatadine,-,CC1=CC(CN2CCC(CC2)=C3/C4=C(CCC5=C3N=CC=C5)C=C(Cl)C=C4)=CN=C1
1903,Salbutamol,-,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1
1904,Salicylic acid,-,C1=CC=C(C(=C1)C(=O)O)O
1905,Salmeterol,-,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
1906,Secobarbital,-,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
1907,Seratrodast,-,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
1908,Sevoflurane,-,FCOC(C(F)(F)F)C(F)(F)F
1909,Sibutramine,-,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2
1910,Sirolimus,-,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
1911,Spironolactone,-,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
1912,Sufentanil,-,CCC(=O)N(C1=CC=CC=C1)[C@]2(CCN(CCC3=CC=CS3)CC2)COC
1913,Sulconazole,-,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
1914,Sulfadimethoxine,-,COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
1915,Sulfadimidine,-,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
1916,Sulfafurazole,-,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
1917,Sulfamethoxazole,-,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
1918,Sulfamoxole,-,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1
1919,Sulfanilamide,-,NC1=CC=C(C=C1)S(N)(=O)=O
1920,Sulfaphenazole,-,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
1921,Sulfapyridine,-,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
1922,Sulfasalazine,-,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
1923,Sulfinpyrazone,-,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
1924,Sulpiride,-,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
1925,Tacrine,-,NC1=C2CCCCC2=NC3=C1C=CC=C3
1926,Tacrolimus,-,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
1927,Tadalafil,-,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O
1928,Tasosartan,-,CC1=NC2=C(CCC(=O)N2CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5)C(C)=N1
1929,Tazanolast,-,CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C2=NNN=N2
1930,Tazofelone,-,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NCS2
1931,Tecastemizole,-,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
1932,Tegafur,-,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
1933,Telmisartan,-,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
1934,Temazepam,-,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
1935,Teniposide,-,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
1936,Tenofovir,-,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O
1937,Tenoxicam,-,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O
1938,Terbinafine,-,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
1939,Testolactone,-,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C
1940,Tezosentan,-,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC
1941,Thalidomide,-,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
1942,Theobromine,-,CN1C=NC2=C1C(=O)NC(=O)N2C
1943,Thiamazole,-,CN1C=CNC1=S
1944,Thiotepa,-,S=P(N1CC1)(N2CC2)N3CC3
1945,Tiabendazole,-,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
1946,Tiaramide,-,C1CN(CCN1CCO)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O
1947,Ticlopidine,-,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
1948,Tienilic acid,-,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
1949,Timoprazole,-,C1=CC=C2C(=C1)NC(=N2)S(=O)CC3=CC=CC=N3
1950,Tinidazole,-,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
1951,Tioconazole,-,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
1952,Tiotixene,-,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1
1953,Tipranavir,-,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4
1954,Tirilazad,-,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN5CCN(CC5)C6=CC(=NC(=N6)N7CCCC7)N8CCCC8
1955,Tocainide,-,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C
1956,Tolbutamide,-,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
1957,Tolcapone,-,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
1958,Toluene,-,CC1=CC=CC=C1
1959,Topiramate,-,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1
1960,Torasemide,-,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
1961,Toremifene,-,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
1962,Tranylcypromine,-,N[C@H]1C[C@@H]1C2=CC=CC=C2
1963,Trapidil,-,CCN(CC)C1=CC(=NC2=NC=NN12)C
1964,Tretinoin,-,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
1965,Trichloroethylene,-,ClC=C(Cl)Cl
1966,Trifluoperazine,-,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
1967,Trimetazidine,-,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC
1968,Trimethadione,-,CN1C(=O)OC(C)(C)C1=O
1969,Trimethoprim,-,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
1970,Trimetrexate,-,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC
1971,Tripelennamine,-,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2
1972,Triprolidine,-,CC1=CC=C(C=C1)C(=C/CN2CCCC2)C3=CC=CC=N3
1973,Trofosfamide,-,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl
1974,Troleandomycin,-,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
1975,Trospium chloride,-,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
1976,Valproic acid,-,CCCC(CCC)C(=O)O
1977,Valspodar,-,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
1978,Vanoxerine,-,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
1979,Verapamil,-,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
1980,Vesnarinone,-,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC
1981,Vinblastine,-,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1982,Vincristine,-,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
1983,Vindesine,-,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1
1984,Voriconazole,-,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
1985,Zafirlukast,-,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
1986,Zaleplon,-,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
1987,Zaltoprofen,-,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
1988,Zatosetron,-,CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C
1989,Zidovudine,-,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
1990,Zileuton,-,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
1991,Ziprasidone,-,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
1992,Zolmitriptan,-,CN(C)CCC1=CNC2=C1C=C(C[C@H]3COC(=O)N3)C=C2
1993,Zonisamide,-,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
1994,Zopiclone,-,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
1995,Zoxazolamine,-,C1=CC2=C(C=C1Cl)N=C(O2)N
1996,Bromperidol,2D6-Substrate,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3
1997,Bufuralol,2D6-Substrate,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
1998,Bunitrolol,2D6-Substrate,CC(C)(C)NCC(COC1=CC=CC=C1C#N)O
1999,Carbamazepine,2D6-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2000,Cinnarizine,2D6-Substrate,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
2001,Demethylcitalopram,2D6-Substrate,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
2002,Fluperlapine,2D6-Substrate,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F
2003,Hydroxyamfetamine,2D6-Substrate,CC(CC1=CC=C(C=C1)O)N
2004,Norfluoxetine,2D6-Substrate,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
2005,Perospirone,2D6-Substrate,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54
2006,Abiraterone,-,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O
2007,Alfentanil,-,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
2008,Amifloxacin,-,CNN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O
2009,Aranidipine,-,CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
2010,Atamestane,-,CC1=CC(=O)C=C2C1(C3CCC4(C(C3CC2)CCC4=O)C)C
2011,Beclometasone,-,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2012,Benidipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
2013,Cetirizine,-,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
2014,Chlorproguanil,-,CC(C)N=C(N)N=C(N)NC1=CC(=C(C=C1)Cl)Cl
2015,Ciprofloxacin,-,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
2016,Clarithromycin,-,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
2017,Clonazepam,-,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
2018,Corticosterone,-,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
2019,Delapril,-,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2
2020,Desloratadine,-,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
2021,Dexamethasone,-,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2022,Diazepam,-,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2023,Diclofenac,-,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2024,Domperidone,-,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
2025,Doxorubicin,-,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2026,Emedastine,-,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
2027,Emivirine,-,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2
2028,Enoxacin,-,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2
2029,Ergometrine,-,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
2030,Ethotoin,-,CCN1C(=O)N[C@H](C1=O)C2=CC=CC=C2
2031,Gatifloxacin,-,COC1=C(N2CCN[C@@H](C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)[C@H]4CC4
2032,Glipizide,-,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2033,Hydroquinidine,-,CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OC)O
2034,Isoconazole,-,ClC1=CC(Cl)=C(C=C1)[C@H](CN2C=CN=C2)OCC3=C(Cl)C=CC=C3Cl
2035,Lansoprazole,-,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
2036,Lercanidipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
2037,Levonorgestrel,-,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2038,Lobeline,-,CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O
2039,Lomefloxacin,-,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12
2040,Lornoxicam,-,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O
2041,Losartan,-,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
2042,Meloxicam,-,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
2043,Mephenytoin,-,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
2044,Mestranol,-,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC
2045,Methylphenobarbital,-,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
2046,Miconazole,-,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
2047,Midazolam,-,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2048,Modafinil,-,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2049,Nilutamide,-,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
2050,Nilvadipine,-,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
2051,Nordazepam,-,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
2052,Onapristone,-,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C
2053,Oxomemazine,-,C[C@H](CN(C)C)CN1C2=C(C=CC=C2)S(=O)(=O)C3=C1C=CC=C3
2054,Paraxanthine,-,CN1C=NC2=C1C(=O)N(C(=O)N2)C
2055,Pentobarbital,-,CCC[C@@H](C)[C@@]1(CC)C(=O)NC(=O)NC1=O
2056,Pentoxifylline,-,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
2057,Pilsicainide,-,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
2058,Pimobendan,-,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC
2059,Pioglitazone,-,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
2060,Prednisone,-,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
2061,Reboxetine,-,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
2062,Rogletimide,-,CCC1(CCC(=O)NC1=O)C2=CC=NC=C2
2063,Simvastatin,-,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2064,Stiripentol,-,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
2065,Styrene,-,C=CC1=CC=CC=C1
2066,Sulfadiazine,-,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
2067,Sulfadoxine,-,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N
2068,Sulfamerazine,-,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N
2069,Sulfamethizole,-,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
2070,Sulfatroxazole,-,CC1=C(ON=C1NS(=O)(=O)C2=CC=C(C=C2)N)C
2071,Sulindac,-,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
2072,Suprofen,-,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
2073,Tetracycline,-,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
2074,Triazolam,-,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2075,Valsartan,-,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
2076,Vorozole,-,CN1N=NC2=C1C=C(C=C2)[C@@H](N3C=NC=N3)C4=CC=C(Cl)C=C4
2077,Almotriptan,2D6-Inhibitor,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
2078,Alprenolol,2D6-Inhibitor,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C
2079,Amoxapine,2D6-Inhibitor,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
2080,Astemizole,2D6-Inhibitor,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
2081,Atorvastatin,2D6-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
2082,Azacyclonol,2D6-Inhibitor,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O
2083,Bepridil,2D6-Inhibitor,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
2084,Bufuralol,2D6-Inhibitor,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
2085,Bupranolol,2D6-Inhibitor,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1
2086,Cathinone,2D6-Inhibitor,CC(C(=O)C1=CC=CC=C1)N
2087,Cerivastatin,2D6-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
2088,Chloramphenicol,2D6-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
2089,Debrisoquine,2D6-Inhibitor,NC(=N)N1CCC2=C(C1)C=CC=C2
2090,Dimethyl sulfoxide,2D6-Inhibitor,CS(=O)C
2091,Diphenhydramine,2D6-Inhibitor,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
2092,Erythromycin,2D6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2093,Etoperidone,2D6-Inhibitor,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
2094,Ezlopitant,2D6-Inhibitor,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
2095,Hydroquinidine,2D6-Inhibitor,CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OC)O
2096,Lidocaine,2D6-Inhibitor,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
2097,Maprotiline,2D6-Inhibitor,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
2098,Mepacrine,2D6-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
2099,Methoxsalen,2D6-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
2100,Methylphenidate,2D6-Inhibitor,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
2101,Midazolam,2D6-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2102,Niclosamide,2D6-Inhibitor,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O
2103,Orphenadrine,2D6-Inhibitor,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
2104,Pargyline,2D6-Inhibitor,CN(CC#C)CC1=CC=CC=C1
2105,Pentamidine,2D6-Inhibitor,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
2106,Pramipexole,2D6-Inhibitor,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
2107,Proadifen,2D6-Inhibitor,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
2108,Quercetin,2D6-Inhibitor,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
2109,Riluzole,2D6-Inhibitor,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
2110,Seratrodast,2D6-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
2111,Sertindole,2D6-Inhibitor,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
2112,Stiripentol,2D6-Inhibitor,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
2113,Tioconazole,2D6-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
2114,Tolperisone,2D6-Inhibitor,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
2115,Trimethoprim,2D6-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
2116,Trimipramine,2D6-Inhibitor,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2117,Troglitazone,2D6-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
2118,Trospium chloride,2D6-Inhibitor,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
2119,Valdecoxib,2D6-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
2120,Valproic acid,2D6-Inhibitor,CCCC(CCC)C(=O)O
2121,Vincristine,2D6-Inhibitor,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2122,Yohimbine,2D6-Inhibitor,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
2123,Zileuton,2D6-Inhibitor,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
2124,Albendazole,-,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
2125,Amfetamine,-,C[C@@H](N)CC1=CC=CC=C1
2126,Amiflamine,-,CC1=C(C=CC(=C1)N(C)C)CC(C)N
2127,Aminopyrine,-,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
2128,Amodiaquine,-,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
2129,Amprenavir,-,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2130,Aprindine,-,CCN(CC)CCCN([C@H]1CC2=CC=CC=C2C1)C3=CC=CC=C3
2131,Aripiprazole,-,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
2132,Artemisinin,-,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
2133,Atomoxetine,-,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
2134,Avitriptan,-,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC
2135,Benzydamine,-,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
2136,Bisoprolol,-,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1
2137,Bortezomib,-,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
2138,Brofaromine,-,COC1=CC(=C2C(=C1)C=C(O2)C3CCNCC3)Br
2139,Bromperidol,-,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3
2140,Buflomedil,-,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
2141,Bunitrolol,-,CC(C)(C)NCC(COC1=CC=CC=C1C#N)O
2142,Caffeine,-,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
2143,Captopril,-,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
2144,Carbaril,-,CNC(=O)OC1=CC=CC2=CC=CC=C21
2145,Carteolol,-,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCC(=O)N2
2146,Carvedilol,-,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
2147,Cevimeline,-,CC1O[C@@]2(CS1)CN1CCC2CC1
2148,Chlorpyrifos,-,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
2149,Chlorzoxazone,-,OC1=NC2=C(O1)C=CC(Cl)=C2
2150,Cibenzoline,-,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4
2151,Cyclobenzaprine,-,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2152,Dapsone,-,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
2153,Dextrorphan,-,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
2154,Dihydrocodeine,-,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
2155,Diprafenone,-,CCC(C)(C)NCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
2156,Dolasetron,-,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
2157,Encainide,-,COC1=CC=C(C=C1)C(=O)NC2=C(C=CC=C2)[C@H](C)CN3CCCCC3
2158,Epinastine,-,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
2159,Escitalopram,-,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
2160,Estradiol,-,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2161,Ethylmorphine,-,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
2162,Fenfluramine,-,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
2163,Flunarizine,-,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
2164,Galantamine,-,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24
2165,Gepirone,-,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
2166,Guanoxan,-,NC(=N)NC[C@H]1COC2=C(O1)C=CC=C2
2167,Halothane,-,FC(F)(F)[C@@H](Cl)Br
2168,Hydrocodone,-,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
2169,Hydroxyamfetamine,-,CC(CC1=CC=C(C=C1)O)N
2170,Iloperidone,-,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
2171,Ketamine,-,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
2172,Levacetylmethadol,-,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2173,m-Chlorophenylpiperazine,-,C1CN(CCN1)C2=CC(=CC=C2)Cl
2174,Mequitazine,-,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4
2175,Metamfetamine,-,CN[C@@H](C)CC1=CC=CC=C1
2176,Methiocarb,-,CC1=CC(=CC(=C1SC)C)OC(=O)NC
2177,Milameline,-,CN1CCC=C(C1)C=NOC
2178,Minaprine,-,CC1=CC(=NN=C1NCCN2CCOCC2)C3=CC=CC=C3
2179,Molindone,-,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C
2180,Nevirapine,-,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
2181,Norcodeine,-,COC1=C2C3=C(CC4C5C3(CCN4)C(O2)C(C=C5)O)C=C1
2182,Papaverine,-,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
2183,Parathion,-,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
2184,Penbutolol,-,CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2)O
2185,Pentazocine,-,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O
2186,Perospirone,-,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54
2187,Pethidine,-,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
2188,Phenacetin,-,CCOC1=CC=C(NC(C)=O)C=C1
2189,Phenformin,-,NC(=N)NC(=N)NCCC1=CC=CC=C1
2190,Phenytoin,-,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2191,Pinacidil,-,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C
2192,Pregnenolone,-,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
2193,Procainamide,-,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
2194,Promazine,-,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
2195,Pyrantel,-,CN1CCCN=C1C=CC2=CC=CS2
2196,Quetiapine,-,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
2197,Remoxipride,-,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C(Br)=CC=C2OC
2198,Ropivacaine,-,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
2199,Sildenafil,-,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
2200,Tamsulosin,-,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
2201,Tauromustine,-,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
2202,Terguride,-,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C
2203,Theophylline,-,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2204,Tiagabine,-,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3
2205,Tolterodine,-,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
2206,Tramadol,-,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
2207,Trazodone,-,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
2208,Trichloromethane,-,C(Cl)(Cl)Cl
2209,Trifluperidol,-,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC(=CC=C3)C(F)(F)F
2210,Warfarin,-,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
2211,Zotepine,-,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
2212,Zuclopenthixol,-,OCCN1CCN(CCC=C2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4)CC1
2213,Fluperlapine,2D6-Inhibitor,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F
2214,Lobeline,2D6-Inhibitor,CN1C(CCCC1CC(=O)C2=CC=CC=C2)CC(C3=CC=CC=C3)O
2215,Norfluoxetine,2D6-Inhibitor,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
2216,Quinine,2D6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
2217,Bupivacaine,-,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
2218,Buspirone,-,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
2219,Carbamazepine,-,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2220,Cinnarizine,-,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
2221,Cyclophosphamide,-,ClCCN(CCCl)[P@]1(=O)NCCCO1
2222,Demethylcitalopram,-,CNCCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
2223,Donepezil,-,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1
2224,Doxepin,-,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
2225,Hydrocortisone,-,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2226,Indoramin,-,O=C(N[C@H]1CCN(CC1)CCC2=CNC3=C2C=CC=C3)C4=CC=CC=C4
2227,Lisuride,-,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
2228,Mexiletine,-,C[C@H](N)COC1=C(C)C=CC=C1C
2229,Morphine,-,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
2230,Nicotine,-,CN1CCC[C@H]1C2=CC=CN=C2
2231,Opipramol,-,OCCN1CCN(CCCN2C3=C(C=CC=C3)C=CC4=C2C=CC=C4)CC1
2232,Oxycodone,-,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
2233,Paracetamol,-,CC(=O)NC1=CC=C(O)C=C1
2234,Progesterone,-,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2235,Testosterone,-,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2236,Clofibrate,P450_HP-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2237,Midazolam,P450_HP-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2238,Phenobarbital,P450_HP-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2239,Progesterone,P450_HP-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2240,Sodium Sulfate,P450_HP-Inducer,[O-]S([O-])(=O)=O
2241,Testosterone,P450_HP-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2242,Thiamine (vit B1),P450_HP-Inducer,CC1=NC(N)=C(C[N+]2=CSC(CCO)=C2C)C=N1
2243,Cisplatin,High_affinity_copper_uptake_protein_1-Inhibitor,N[Pt](N)(Cl)Cl
2244,Cisplatin,High_affinity_copper_uptake_protein_1-Substrate,N[Pt](N)(Cl)Cl
2245,Copper Sulfate,High_affinity_copper_uptake_protein_1-Substrate,[O-]S([O-])(=O)=O
2246,Copper Sulfate,High_affinity_copper_uptake_protein_1-Inhibitor,[O-]S([O-])(=O)=O
2247,Estradiol,High_affinity_copper_uptake_protein_1-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2248,Silver,High_affinity_copper_uptake_protein_1-Inhibitor,[Ag]
2249,Silver,High_affinity_copper_uptake_protein_1-Substrate,[Ag]
2250,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1C1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2251,Aldosterone,Steroid_11_beta_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
2252,Aminogluthetimide,Steroid_11_beta_hydroxylase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
2253,Angiotensinamide,Steroid_11_beta_hydroxylase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
2254,Cimetidine,Steroid_11_beta_hydroxylase-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2255,Clotrimazole,Steroid_11_beta_hydroxylase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2256,Corticotropin,Steroid_11_beta_hydroxylase-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
2257,Desoxycortone,Steroid_11_beta_hydroxylase-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
2258,Dexamethasone,Steroid_11_beta_hydroxylase-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2259,Etomidate,Steroid_11_beta_hydroxylase-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
2260,Fluconazole,Steroid_11_beta_hydroxylase-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2261,Hydrocortisone,Steroid_11_beta_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2262,Ketoconazole,Steroid_11_beta_hydroxylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2263,Metoclopramide,Steroid_11_beta_hydroxylase-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
2264,Metyrapone,Steroid_11_beta_hydroxylase-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
2265,Mibefradil,Steroid_11_beta_hydroxylase-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
2266,Miconazole,Steroid_11_beta_hydroxylase-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
2267,Phenytoin,Steroid_11_beta_hydroxylase-Inhibitor,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2268,Spironolactone,Steroid_11_beta_hydroxylase-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
2269,Spironolactone,Steroid_11_beta_hydroxylase-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
2270,Acriflavinium Chloride,1B1-Inducer,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4
2271,Amodiaquine,1B1-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
2272,Arsenic Trioxide,1B1-Inhibitor,O=[As]1=[As](=O)O1
2273,Biotin,1B1-Inducer,OC(=O)CCCC[C@@H]1SC[C@H]2NC(=O)N[C@@H]12
2274,Caffeine,1B1-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
2275,Clozapine,1B1-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
2276,Daunorubicin,1B1-Inhibitor,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
2277,Dibutylphthalate,1B1-Substrate,CCCCOC(=O)C1=C(C=CC=C1)C(=O)OCCCC
2278,Diosmectite,1B1-Inhibitor,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
2279,Docetaxel,1B1-Inducer,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
2280,Docetaxel,1B1-Inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
2281,Docetaxel,1B1-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
2282,Doxorubicin,1B1-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2283,Doxycycline,1B1-Inhibitor,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
2284,Erythromycin,1B1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2285,Estradiol,1B1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2286,Estrone,1B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2287,Flutamide,1B1-Inhibitor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
2288,Flutamide,1B1-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
2289,Hydrocortisone,1B1-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2290,Hydrogen Peroxide,1B1-Substrate,OO
2291,Ketoconazole,1B1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2292,Lansoprazole,1B1-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
2293,Melatonin,1B1-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
2294,Metharbital,1B1-Inducer,CCC1(CC)C(=O)NC(=O)N(C)C1=O
2295,Mitobronitol,1B1-Inducer,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr
2296,Mitoxantrone,1B1-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
2297,Omeprazole,1B1-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2298,Oxaliplatin,1B1-Substrate,N[C@@H]1CCCC[C@H]1N
2299,Oxolamine,1B1-Inducer,CCN(CC)CCC1=NC(=NO1)C2=CC=CC=C2
2300,Paclitaxel,1B1-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
2301,Phenobarbital,1B1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2302,Primaquine,1B1-Inducer,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
2303,Procarbazine,1B1-Substrate,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
2304,Progesterone,1B1-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2305,Retinol (vit A),1B1-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
2306,Rifampicin,1B1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2307,Rosuvastatin,1B1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
2308,Salicylamide,1B1-Inhibitor,NC(=O)C1=C(O)C=CC=C1
2309,Tamoxifen,1B1-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2310,Testosterone,1B1-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2311,Theophylline,1B1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2312,Tryptophan,1B1-Inducer,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
2313,Etoposide,Proton_coupled_folate_transporter-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2314,Folic Acid,Proton_coupled_folate_transporter-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
2315,Methotrexate,Proton_coupled_folate_transporter-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2316,Pemetrexed,Proton_coupled_folate_transporter-Substrate,NC1=NC2=C(C(=O)N1)C(CCC3=CC=C(C=C3)C(=O)N[C@H](CCC(O)=O)C(O)=O)=CN2
2317,Sulfasalazine,Proton_coupled_folate_transporter-Inhibitor,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
2318,Cocaine,CP2AD-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2319,Methoxsalen,CP2AD-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
2320,Nicotine,CP2AD-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2321,Phenacetin,CP2AD-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
2322,Rifampicin,CP2AD-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2323,Testosterone,CP2AD-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2324,Acetylcholin,MET-Inducer,CC(=O)OCC[N+](C)(C)C
2325,Acetylsalicylic Acid,MET-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
2326,Ademetionine,MET-Substrate,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
2327,Angiotensinamide,MET-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
2328,Argatroban,MET-Inducer,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
2329,Ascorbic Acid (vit C),MET-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
2330,Ascorbic Acid (vit C),MET-Substrate,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
2331,Azacitidine,MET-Inhibitor,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
2332,Azathioprine,MET-Substrate,CN1C=NC(=C1SC2=C3NC=NC3=NC=N2)[N+]([O-])=O
2333,Bendroflumethiazide,MET-Inhibitor,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F
2334,Captopril,MET-Substrate,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O
2335,Chlorhexidine,MET-Inhibitor,ClC1=CC=C(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2=CC=C(Cl)C=C2)C=C1
2336,Chloroquine,MET-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
2337,Chlorphenamine,MET-Inducer,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
2338,Cocaine,MET-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2339,Deanol,MET-Substrate,CN(C)CCO
2340,Decitabine,MET-Inhibitor,NC1=NC(=O)N(C=N1)[C@H]1C[C@H](O)[C@@H](CO)O1
2341,Dicycloverine,MET-Inhibitor,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2
2342,Diosmin,MET-Inhibitor,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
2343,Entacapone,MET-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
2344,Entacapone,MET-Inducer,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
2345,Epinephrine,MET-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
2346,Epinephrine,MET-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
2347,Estradiol,MET-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2348,Estradiol,MET-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2349,Folic Acid,MET-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
2350,Fosfocreatine,MET-Inhibitor,CN(CC(O)=O)C(=N)NP(O)(O)=O
2351,Glucagon,MET-Inducer,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
2352,Histamine,MET-Substrate,NCCC1=CNC=N1
2353,Hydralazine,MET-Inducer,NN=C1NN=CC2=C1C=CC=C2
2354,Hydrocortisone,MET-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2355,Imipramine,MET-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2356,Isoprenaline,MET-Substrate,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
2357,Ketoprofen,MET-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
2358,Ketotifen,MET-Inducer,CN1CCC(CC1)=C2C3=C(CC(=O)C4=C2C=CS4)C=CC=C3
2359,Levodopa,MET-Substrate,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
2360,Lidocain,MET-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2361,Mepacrine,MET-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
2362,Mercaptopurine,MET-Substrate,S=C1NC=NC2=C1NC=N2
2363,Mesalazine,MET-Inhibitor,NC1=CC(C(O)=O)=C(O)C=C1
2364,Methotrexate,MET-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2365,Methotrexate,MET-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2366,Methyldopa (levorotatory),MET-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
2367,Methyldopa (levorotatory),MET-Inhibitor,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
2368,Moclobemide,MET-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
2369,Naproxen,MET-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
2370,Olsalazine,MET-Inhibitor,OC(=O)C1=CC(=CC=C1O)N=NC2=CC(C(O)=O)=C(O)C=C2
2371,Pargyline,MET-Inhibitor,CN(CC#C)CC1=CC=CC=C1
2372,Pargyline,MET-Inducer,CN(CC#C)CC1=CC=CC=C1
2373,Physostigmine,MET-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
2374,Plicamycin,MET-Inhibitor,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O
2375,Procaine,MET-Inhibitor,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1
2376,Progesterone,MET-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2377,Progesterone,MET-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2378,Pyridoxine (vit B6),MET-Inhibitor,CC1=C(O)C(CO)=C(CO)C=N1
2379,Ribavirin,MET-Inhibitor,NC(=O)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
2380,Selenium Compounds,MET-Inhibitor,[Se]
2381,Tacrine,MET-Inhibitor,NC1=C2CCCCC2=NC3=C1C=CC=C3
2382,Tamoxifen,MET-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2383,Temozolomide,MET-Inhibitor,CN1N=NC2=C(N=CN2C1=O)C(N)=O
2384,Tioguanine,MET-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
2385,Tioguanine,MET-Inducer,NC1=NC2=C(N=CN2)C(=S)N1
2386,Tolcapone,MET-Inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
2387,Trimethoprim,MET-Inducer,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
2388,Tubocurarine,MET-Inhibitor,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1
2389,Ubidecarenone,MET-Substrate,COC1=C(OC)C(=O)C(CC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)C)=C(C)C1=O
2390,Varenicline,MET-Inhibitor,[H][C@]12C[C@]([H])(CNC1)C1=CC3=NC=CN=C3C=C21
2391,Vecuronium,MET-Inhibitor,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N@@+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6
2392,Virginiamycin,MET-Inhibitor,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
2393,Vorinostat,MET-Inhibitor,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
2394,Biotin,Monocarboxylate_transporter_1-Substrate,OC(=O)CCCC[C@@H]1SC[C@H]2NC(=O)N[C@@H]12
2395,Hydroxybutyric Acid,Monocarboxylate_transporter_1-Substrate,CCCC(O)=O
2396,Mersalyl,Monocarboxylate_transporter_1-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
2397,Milchsure,Monocarboxylate_transporter_1-Substrate,C[C@@H](O)C(O)=O
2398,Nateglinide,Monocarboxylate_transporter_1-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
2399,Nicotine,Monocarboxylate_transporter_1-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
2400,Niflumic Acid,Monocarboxylate_transporter_1-Inhibitor,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1
2401,Nitric Oxide,Monocarboxylate_transporter_1-Inducer,N=O
2402,Testosterone,Monocarboxylate_transporter_1-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2403,Aminohippuric Acid,Solute_carrier_family_22_member_6-Substrate,NC1=CC=C(C=C1)C(=O)NCC(O)=O
2404,Amoxicillin,Solute_carrier_family_22_member_6-Substrate,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O
2405,Amoxicillin,Solute_carrier_family_22_member_6-Inhibitor,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O
2406,Cefaclor,Solute_carrier_family_22_member_6-Inhibitor,N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3
2407,Cefazolin,Solute_carrier_family_22_member_6-Substrate,CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN4C=NN=N4)C3=O)C(O)=O)S1
2408,Cidofovir,Solute_carrier_family_22_member_6-Substrate,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1
2409,Cimetidine,Solute_carrier_family_22_member_6-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2410,Famotidine,Solute_carrier_family_22_member_6-Substrate,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
2411,Fluorescein,Solute_carrier_family_22_member_6-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
2412,Furosemide,Solute_carrier_family_22_member_6-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2413,Indometacin,Solute_carrier_family_22_member_6-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2414,Lumiracoxib,Solute_carrier_family_22_member_6-Inhibitor,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
2415,Meropenem,Solute_carrier_family_22_member_6-Substrate,C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(S[C@H]3CC[C@H](N3)C(=O)N(C)C)=C(N2C1=O)C(O)=O
2416,Methotrexate,Solute_carrier_family_22_member_6-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2417,Mycophenolic Acid,Solute_carrier_family_22_member_6-Substrate,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2
2418,Piroxicam,Solute_carrier_family_22_member_6-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
2419,Probenecid,Solute_carrier_family_22_member_6-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2420,Simvastatin,Solute_carrier_family_22_member_6-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2421,Cocaine,2A13-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2422,Methoxsalen,2A13-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
2423,Nicotine,2A13-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2424,Phenacetin,2A13-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
2425,Rifampicin,2A13-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2426,Testosterone,2A13-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2427,Clofibrate,4B1-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2428,Midazolam,4B1-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2429,Phenobarbital,4B1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2430,Progesterone,4B1-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2431,Sodium Sulfate,4B1-Inducer,[O-]S([O-])(=O)=O
2432,Testosterone,4B1-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2433,Thiamine (vit B1),4B1-Inducer,CC1=NC(N)=C(C[N+]2=CSC(CCO)=C2C)C=N1
2434,Digoxin,Solute_carrier_organic_anion_transporter_family_member_4C1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
2435,Estrone,Solute_carrier_organic_anion_transporter_family_member_4C1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2436,Minoxidil,8A1-Inhibitor,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
2437,Tranylcypromine,8A1-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
2438,Aciclovir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,NC1=NC2=C(N=CN2COCCO)C(=O)N1
2439,Arsenic Trioxide,Canalicular_multispecific_organic_anion_transporter_1-Inducer,O=[As]1=[As](=O)O1
2440,Arsenic Trioxide,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O=[As]1=[As](=O)O1
2441,Azithromycin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
2442,Benzbromarone,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1
2443,Benzylpenicillin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
2444,Bosentan,Canalicular_multispecific_organic_anion_transporter_1-Inducer,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
2445,Carbamazepine,Canalicular_multispecific_organic_anion_transporter_1-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2446,Chenodeoxycholic Acid,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2447,Ciclosporin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2448,Ciclosporin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2449,Cimetidine,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2450,Ciprofloxacin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
2451,Cisplatin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,N[Pt](N)(Cl)Cl
2452,Cisplatin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,N[Pt](N)(Cl)Cl
2453,Cisplatin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,N[Pt](N)(Cl)Cl
2454,Clotrimazole,Canalicular_multispecific_organic_anion_transporter_1-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2455,Dexamethasone,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2456,Diclofenac,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2457,Doxorubicin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2458,Enoxolone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
2459,Eprosartan,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
2460,Erythromycin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2461,Estradiol,Canalicular_multispecific_organic_anion_transporter_1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2462,Estradiol,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2463,Estrone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2464,Etodolac,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
2465,Etoposide,Canalicular_multispecific_organic_anion_transporter_1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2466,Ezetimibe,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
2467,Fluorescein,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
2468,Fluorouracil,Canalicular_multispecific_organic_anion_transporter_1-Substrate,FC1=CNC(=O)NC1=O
2469,Gentamicin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CN[C@H](C)[C@@H]1CC[C@H](N)[C@H](O1)O[C@@H]2[C@@H](N)C[C@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@@H](NC)[C@@H]3O)[C@H]2O
2470,Glibenclamide,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2471,Glutathione,Canalicular_multispecific_organic_anion_transporter_1-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
2472,Grepafloxacin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
2473,Indinavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2474,Indinavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2475,Indometacin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2476,Indometacin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
2477,Irinotecan,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
2478,Ketoconazole,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2479,Levonorgestrel,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2480,Lopinavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2481,Lopinavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2482,Mesalazine,Canalicular_multispecific_organic_anion_transporter_1-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
2483,Methotrexate,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2484,Midecamycin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
2485,Mitoxantrone,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
2486,Montelukast,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
2487,Mycophenolic Acid,Canalicular_multispecific_organic_anion_transporter_1-Substrate,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2
2488,Mycophenolic Acid,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=C(C)C2=C(C(O)=C1CC=C(/C)CCC(O)=O)C(=O)OC2
2489,Octreotide,Canalicular_multispecific_organic_anion_transporter_1-Substrate,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@H](CC3=CC=CC=C3)C(=O)N[C@H](CC4=CNC5=CC=CC=C45)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1
2490,Paclitaxel,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
2491,Paracetamol,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(=O)NC1=CC=C(O)C=C1
2492,Phenobarbital,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2493,Phenobarbital,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2494,Phenolphthalein,Canalicular_multispecific_organic_anion_transporter_1-Substrate,OC1=CC=C(C=C1)[C@@]2(OC(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
2495,Phenytoin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2496,Pravastatin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2497,Pravastatin,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2498,Probenecid,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2499,Rifampicin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2500,Rifampicin,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2501,Ritonavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2502,Ritonavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2503,Saquinavir,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2504,Saquinavir,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2505,Sulfinpyrazon,Canalicular_multispecific_organic_anion_transporter_1-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2506,Sulfinpyrazon,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2507,Talinolol,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
2508,Telithromycin,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
2509,Ursodeoxycholic Acid,Canalicular_multispecific_organic_anion_transporter_1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2510,Valsartan,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
2511,Verapamil,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2512,Vinblastine,Canalicular_multispecific_organic_anion_transporter_1-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2513,Vinblastine,Canalicular_multispecific_organic_anion_transporter_1-Inhibitor,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2514,Vinblastine,Canalicular_multispecific_organic_anion_transporter_1-Inducer,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
2515,Adenosine,Solute_carrier_family_12_member_2-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
2516,Bumetanide,Solute_carrier_family_12_member_2-Inhibitor,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2517,Cisplatin,Solute_carrier_family_12_member_2-Inducer,N[Pt](N)(Cl)Cl
2518,Estradiol,Solute_carrier_family_12_member_2-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2519,Furosemide,Solute_carrier_family_12_member_2-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2520,Glibenclamide,Solute_carrier_family_12_member_2-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2521,Kanamycin,Solute_carrier_family_12_member_2-Inhibitor,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
2522,Lithium,Solute_carrier_family_12_member_2-Inducer,[Li]
2523,Methoxamine,Solute_carrier_family_12_member_2-Inducer,COC1=CC([C@@H](O)[C@@H](C)N)=C(OC)C=C1
2524,Nitric Oxide,Solute_carrier_family_12_member_2-Inhibitor,N=O
2525,Nitroprusside,Solute_carrier_family_12_member_2-Inhibitor,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N
2526,Oxygen,Solute_carrier_family_12_member_2-Inducer,O=O
2527,Oxytocin,Solute_carrier_family_12_member_2-Inducer,CC[C@H](C)[C@H]1NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
2528,Phenylephrine,Solute_carrier_family_12_member_2-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
2529,Potassium Chloride,Solute_carrier_family_12_member_2-Substrate,[Cl-].[K+]
2530,Sodium Chloride,Solute_carrier_family_12_member_2-Substrate,[Na+].[Cl-]
2531,Enflurane,CP2F1-Substrate,FC(F)OC(F)(F)[C@H](F)Cl
2532,Ketoconazole,CP2F1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2533,Phenol,CP2F1-Substrate,OC1=CC=CC=C1
2534,Rifampicin,CP2F1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2535,Aminolevulinic Acid,Solute_carrier_family_15_member_2-Substrate,NCC(=O)CCC(O)=O
2536,Cefadroxil,Solute_carrier_family_15_member_2-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O
2537,Fosinopril,Solute_carrier_family_15_member_2-Substrate,CCC(=O)O[C@@H](O[P@@](=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(O)=O)[C@H]3CCCCC3)C(C)C
2538,Glibenclamide,Solute_carrier_family_15_member_2-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2539,Quinapril,Solute_carrier_family_15_member_2-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=C(C[C@H]2C(O)=O)C=CC=C3
2540,Valaciclovir,Solute_carrier_family_15_member_2-Substrate,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O
2541,Valganciclovir,Solute_carrier_family_15_member_2-Inhibitor,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O
2542,Bumetanide,Solute_carrier_family_22_member_7-Substrate,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2543,Erythromycin,Solute_carrier_family_22_member_7-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2544,Erythromycin,Solute_carrier_family_22_member_7-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2545,Estradiol,Solute_carrier_family_22_member_7-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2546,Methotrexate,Solute_carrier_family_22_member_7-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2547,Probenecid,Solute_carrier_family_22_member_7-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
2548,Ranitidine,Solute_carrier_family_22_member_7-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
2549,Theophylline,Solute_carrier_family_22_member_7-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2550,Theophylline,Solute_carrier_family_22_member_7-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
2551,Amitriptyline,2B6-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2552,Amlodipine,2B6-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
2553,Amprenavir,2B6-Inhibitor,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2554,Aprobarbital,2B6-Inducer,CC(C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
2555,Artemisinin,2B6-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
2556,Artemisinin,2B6-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
2557,Azelastine,2B6-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
2558,Barnidipine,2B6-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
2559,Brompheniramine,2B6-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
2560,Bupropion,2B6-Inhibitor,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
2561,Bupropion,2B6-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
2562,Capsaicin,2B6-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
2563,Carbamazepine,2B6-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2564,Carbamazepine,2B6-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2565,Carbinoxamine,2B6-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
2566,Chlorpromazine,2B6-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
2567,Cinnarizin,2B6-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2568,Cisapride,2B6-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
2569,Cisplatin,2B6-Inhibitor,N[Pt](N)(Cl)Cl
2570,Citalopram,2B6-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
2571,Clobazam,2B6-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2572,Clofibrate,2B6-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
2573,Clomethiazole,2B6-Substrate,CC1=C(CCCl)SC=N1
2574,Clonazepam,2B6-Inducer,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
2575,Clonazepam,2B6-Inhibitor,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
2576,Clopidogrel,2B6-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2577,Clopidogrel,2B6-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2578,Clotiazepam,2B6-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
2579,Clotrimazole,2B6-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2580,Clotrimazole,2B6-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2581,Colchicine,2B6-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
2582,Colecalciferol,2B6-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
2583,Cyclophosphamide,2B6-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
2584,Cyclophosphamide,2B6-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
2585,Desipramine,2B6-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2586,Dexamethasone,2B6-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2587,Dextromethorphan,2B6-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
2588,Diazepam,2B6-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2589,Diclofenac,2B6-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
2590,Diethyltoluamide,2B6-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
2591,Disulfiram,2B6-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
2592,Disulfiram,2B6-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
2593,Domperidone,2B6-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
2594,Doxorubicin,2B6-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2595,Efavirenz,2B6-Inducer,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2596,Efavirenz,2B6-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2597,Efavirenz,2B6-Substrate,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
2598,Epinastine,2B6-Substrate,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
2599,Erythromycin,2B6-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2600,Esketamine,2B6-Substrate,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
2601,Estrone,2B6-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2602,Ethanol,2B6-Inhibitor,CCO
2603,Ethinylestradiol,2B6-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
2604,Ethylmorphine,2B6-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
2605,Flunitrazepam,2B6-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
2606,Fluoxetine,2B6-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
2607,Fluoxetine,2B6-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
2608,Fluvoxamine,2B6-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
2609,Fosphenytoin,2B6-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
2610,Halothane,2B6-Substrate,FC(F)(F)[C@@H](Cl)Br
2611,Ifosfamide,2B6-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
2612,Imipramine,2B6-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2613,Irinotecan,2B6-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
2614,Isoflurane,2B6-Inducer,FC(F)O[C@@H](Cl)C(F)(F)F
2615,Isoflurane,2B6-Inhibitor,FC(F)O[C@@H](Cl)C(F)(F)F
2616,Isoflurane,2B6-Substrate,FC(F)O[C@@H](Cl)C(F)(F)F
2617,Ketamine,2B6-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
2618,Ketobemidone,2B6-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
2619,Ketoconazole,2B6-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2620,Levoverbenone,2B6-Substrate,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C
2621,Lidocain,2B6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2622,Loperamide,2B6-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
2623,Lopinavir,2B6-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
2624,Malathion,2B6-Substrate,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
2625,Memantine,2B6-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
2626,Metamizole Sodium,2B6-Inducer,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
2627,Methadone,2B6-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2628,Methoxyflurane,2B6-Substrate,COC(F)(F)C(Cl)Cl
2629,Methylphenobarbital,2B6-Substrate,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
2630,Methyltestosterone,2B6-Substrate,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
2631,Mexiletine,2B6-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
2632,Mianserin,2B6-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
2633,Miconazole,2B6-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
2634,Midazolam,2B6-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2635,Modafinil,2B6-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2636,Modafinil,2B6-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2637,Nelfinavir,2B6-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2638,Nevirapine,2B6-Inducer,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
2639,Nevirapine,2B6-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
2640,Nicardipine,2B6-Inducer,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
2641,Nicotine,2B6-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
2642,Nifedipine,2B6-Inducer,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
2643,Orphenadrine (citrate),2B6-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
2644,Paroxetine,2B6-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
2645,Perhexiline,2B6-Substrate,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
2646,Permethrin,2B6-Inducer,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2
2647,Permethrin,2B6-Substrate,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2
2648,Perphenazine,2B6-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
2649,Pethidine,2B6-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
2650,Phenazone,2B6-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
2651,Phenazone,2B6-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
2652,Phenobarbital,2B6-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2653,Phenytoin,2B6-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2654,Primidone,2B6-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
2655,Promethazine,2B6-Substrate,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
2656,Propofol,2B6-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
2657,Quinidine,2B6-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
2658,Retinol (vit A),2B6-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
2659,Rifampicin,2B6-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2660,Rifampicin,2B6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2661,Ritonavir,2B6-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2662,Ritonavir,2B6-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2663,Ritonavir,2B6-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2664,Ropivacaine,2B6-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
2665,Roxithromycin,2B6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
2666,Selegiline,2B6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
2667,Sertraline,2B6-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
2668,Sertraline,2B6-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
2669,Sevoflurane,2B6-Substrate,FCOC(C(F)(F)F)C(F)(F)F
2670,Sulconazole,2B6-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
2671,Sulfaphenazole,2B6-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
2672,Sulfinpyrazon,2B6-Inducer,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
2673,Tamoxifen,2B6-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2674,Tamoxifen,2B6-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2675,Temazepam,2B6-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2676,Testosterone,2B6-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2677,Testosterone,2B6-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2678,Thalidomide,2B6-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
2679,Thiamazole,2B6-Inhibitor,CN1C=CNC1=S
2680,Thiotepa,2B6-Inhibitor,S=P(N1CC1)(N2CC2)N3CC3
2681,Thiram,2B6-Inducer,CN(C)C(=S)SSC(=S)N(C)C
2682,Ticlopidine,2B6-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
2683,Tramadol,2B6-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
2684,Tretinoin,2B6-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
2685,Triclosan,2B6-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
2686,Trofosfamide,2B6-Substrate,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl
2687,Troglitazone,2B6-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
2688,Venlafaxine,2B6-Inhibitor,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
2689,Verapamil,2B6-Inducer,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2690,Verapamil,2B6-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2691,Zotepine,2B6-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
2692,Milchsure,Monocarboxylate_transporter_2-Substrate,C[C@@H](O)C(O)=O
2693,Testosterone,Monocarboxylate_transporter_2-Inhibitor,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2694,Acetylcarnitine,Solute_carrier_family_22_member_5-Substrate,CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C
2695,Cefepime,Solute_carrier_family_22_member_5-Inhibitor,CON=C(/C(=O)N[C@H]1[C@H]2SCC(C[N@+]3(C)CCCC3)=C(N2C1=O)C([O-])=O)C4=CSC(N)=N4
2696,Levocarnitine,Solute_carrier_family_22_member_5-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
2697,Mepyramine,Solute_carrier_family_22_member_5-Substrate,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1
2698,Potassium Chloride,Solute_carrier_family_22_member_5-Substrate,[Cl-].[K+]
2699,Verapamil,Solute_carrier_family_22_member_5-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
2700,Bezafibrate,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
2701,Ciprofibrate,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
2702,Colestyramine,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
2703,Ezetimibe,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
2704,Fenofibrate,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
2705,Gemfibrozil,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
2706,Glucose,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inducer,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
2707,Insulin (human),Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2708,Metyrapone,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
2709,Retinol (vit A),Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
2710,Rifampicin,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2711,Ritonavir,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2712,Ursodeoxycholic Acid,Cholesterol_7_alpha_monooxygenase_Cholesterol_7_alpha_hydroxylase-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2713,Atorvastatin,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
2714,Ergoloid Mesylates,Solute_carrier_organic_anion_transporter_family_member_2B1-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](CC5=CNC6=CC=CC4=C56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
2715,Estrone,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2716,Fexofenadine,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
2717,Glibenclamide,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
2718,Montelukast,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
2719,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2720,Ritonavir,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2721,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_2B1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
2722,Testosterone,Solute_carrier_organic_anion_transporter_family_member_2B1-Inhibitor,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2723,Histamine,Chromaffin_granule_amine_transporter-Substrate,NCCC1=CNC=N1
2724,Reserpine,Chromaffin_granule_amine_transporter-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
2725,Reserpine,Chromaffin_granule_amine_transporter-Substrate,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
2726,Tetrabenazine,Chromaffin_granule_amine_transporter-Inhibitor,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
2727,Sodium Bicarbonate,Electroneutral_sodium_bicarbonate_exchanger_1-Substrate,OC([O-])=O
2728,Angiotensinamide,Steroid_21_hydroxylase_21_OHase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
2729,Hydroxyprogesterone,Steroid_21_hydroxylase_21_OHase-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2730,Progesterone,Steroid_21_hydroxylase_21_OHase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2731,Alfacalcidol,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)C[C@@H](O)C3=C
2732,Ciclosporin,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2733,Ciprofibrate,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
2734,Colecalciferol,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
2735,Colestyramine,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
2736,Dexamethasone,Sterol_26_hydroxylase_Sterol_27_hydroxylase_Vitamin_D3_25_hydroxylase_5_beta_cholestane_3_alpha_7_alpha12_alpha_triol_27_hydroxylase-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2737,Ebastine,CP4FB-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
2738,Chenodeoxycholic Acid,Canalicular_multispecific_organic_anion_transporter_2-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2739,Estradiol,Canalicular_multispecific_organic_anion_transporter_2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2740,Etoposide,Canalicular_multispecific_organic_anion_transporter_2-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2741,Etoposide,Canalicular_multispecific_organic_anion_transporter_2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2742,Methotrexate,Canalicular_multispecific_organic_anion_transporter_2-Inhibitor,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
2743,Morphine,Canalicular_multispecific_organic_anion_transporter_2-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
2744,Oxypertine,Canalicular_multispecific_organic_anion_transporter_2-Inducer,COC1=CC2=C(C=C1OC)C(CCN3CCN(CC3)C4=CC=CC=C4)=C(C)N2
2745,Paracetamol,Canalicular_multispecific_organic_anion_transporter_2-Inducer,CC(=O)NC1=CC=C(O)C=C1
2746,Phenobarbital,Canalicular_multispecific_organic_anion_transporter_2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2747,Prasterone,Canalicular_multispecific_organic_anion_transporter_2-Inducer,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
2748,Bumetanide,Solute_carrier_family_12_member_1-Inhibitor,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2749,Bumetanide,Solute_carrier_family_12_member_1-Substrate,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O
2750,Desmopressin,Solute_carrier_family_12_member_1-Inducer,NC(=N)NCCC[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]2CSSCCC(=O)N[C@H](CC3=CC=C(O)C=C3)C(=O)N[C@H](CC4=CC=CC=C4)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H](CC(N)=O)C(=O)N2)C(=O)NCC(N)=O
2751,Furosemide,Solute_carrier_family_12_member_1-Inducer,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2752,Hydrochlorothiazide,Solute_carrier_family_12_member_1-Inducer,NS(=O)(=O)C1=CC2=C(NCNS2(=O)=O)C=C1Cl
2753,Lithium,Solute_carrier_family_12_member_1-Inducer,[Li]
2754,Nitric Oxide,Solute_carrier_family_12_member_1-Inhibitor,N=O
2755,Potassium Chloride,Solute_carrier_family_12_member_1-Substrate,[Cl-].[K+]
2756,Sodium Chloride,Solute_carrier_family_12_member_1-Inducer,[Na+].[Cl-]
2757,Sodium Chloride,Solute_carrier_family_12_member_1-Substrate,[Na+].[Cl-]
2758,Vasopressin,Solute_carrier_family_12_member_1-Inducer,CC[C@H](C)[C@H]1NC(=O)[C@@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](N)CSSC[C@@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O
2759,Aminomethylbenzoic Acid,Solute_carrier_family_15_member_1-Inhibitor,NCC1=CC=C(C=C1)C(O)=O
2760,Cefaclor,Solute_carrier_family_15_member_1-Substrate,N[C@@H](C(=O)N[C@H]1[C@H]2SCC(Cl)=C(N2C1=O)C(O)=O)C3=CC=CC=C3
2761,Cefadroxil,Solute_carrier_family_15_member_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C2=O)C(O)=O
2762,Cefalexin,Solute_carrier_family_15_member_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
2763,Cefixime,Solute_carrier_family_15_member_1-Substrate,NC1=NC(=CS1)C(=N/OCC(O)=O)C(=O)N[C@H]2[C@H]3SCC(C=C)=C(N3C2=O)C(O)=O
2764,Cefradine,Solute_carrier_family_15_member_1-Inhibitor,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(O)=O
2765,Cefradine,Solute_carrier_family_15_member_1-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(O)=O
2766,Ceftibuten,Solute_carrier_family_15_member_1-Substrate,NC1=NC(=CS1)C(=C/CC(O)=O)C(=O)N[C@H]2[C@@H]3SCC=C(N3C2=O)C(O)=O
2767,Cisplatin,Solute_carrier_family_15_member_1-Inducer,N[Pt](N)(Cl)Cl
2768,Deanol,Solute_carrier_family_15_member_1-Substrate,CN(C)CCO
2769,Didanosine,Solute_carrier_family_15_member_1-Substrate,OC[C@@H]1CC[C@@H](O1)N2C=NC3=C2N=CNC3=O
2770,Insulin (human),Solute_carrier_family_15_member_1-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2771,Midodrine,Solute_carrier_family_15_member_1-Substrate,COC1=CC([C@H](O)CNC(=O)CN)=C(OC)C=C1
2772,Nitrogen,Solute_carrier_family_15_member_1-Substrate,N#N
2773,Oseltamivir,Solute_carrier_family_15_member_1-Substrate,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
2774,Pancreozymin (cholecystokinin),Solute_carrier_family_15_member_1-Substrate,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
2775,Quinapril,Solute_carrier_family_15_member_1-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=C(C[C@H]2C(O)=O)C=CC=C3
2776,Sulpiride,Solute_carrier_family_15_member_1-Substrate,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
2777,Talinolol,Solute_carrier_family_15_member_1-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
2778,Valaciclovir,Solute_carrier_family_15_member_1-Substrate,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O
2779,Valganciclovir,Solute_carrier_family_15_member_1-Substrate,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O
2780,Cimetidine,Solute_carrier_family_22_member_4-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2781,Gabapentin,Solute_carrier_family_22_member_4-Substrate,NC[C@@]1(CCCCC1)CC(O)=O
2782,Levocarnitine,Solute_carrier_family_22_member_4-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
2783,Furosemide,Solute_carrier_family_12_member_5-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
2784,Potassium Chloride,Solute_carrier_family_12_member_5-Substrate,[Cl-].[K+]
2785,Candesartan,Solute_carrier_family_22_member_11-Inhibitor,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
2786,Estrone,Solute_carrier_family_22_member_11-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2787,Pranlukast,Solute_carrier_family_22_member_11-Inhibitor,O=C(NC1=CC=C2C(=O)C=C(OC2=C1)C3=NN=NN3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4
2788,Dactinomycin,Solute_carrier_family_12_member_4-Inducer,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
2789,Potassium Chloride,Solute_carrier_family_12_member_4-Substrate,[Cl-].[K+]
2790,Ursodeoxycholic Acid,2W1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2791,Ursodeoxycholic Acid,2W1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
2792,Calcifediol,24A-Substrate,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)CCC3=C
2793,Calcitriol,24A-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
2794,Calcitriol,24A-Substrate,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
2795,Teriparatide,24A-Inhibitor,CC[C@H](C)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC3=CNC4=C3C=CC=C4)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(O)=O
2796,Acetylcholin,Solute_carrier_family_22_member_1-Substrate,CC(=O)OCC[N+](C)(C)C
2797,Amiloride,Solute_carrier_family_22_member_1-Inhibitor,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N
2798,Carvedilol,Solute_carrier_family_22_member_1-Inhibitor,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
2799,Cimetidine,Solute_carrier_family_22_member_1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2800,Cisplatin,Solute_carrier_family_22_member_1-Substrate,N[Pt](N)(Cl)Cl
2801,Dexamethasone,Solute_carrier_family_22_member_1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2802,Dinoprostone,Solute_carrier_family_22_member_1-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
2803,Estradiol,Solute_carrier_family_22_member_1-Inhibitor,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2804,Imatinib,Solute_carrier_family_22_member_1-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2805,Insulin (human),Solute_carrier_family_22_member_1-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2806,Lamivudine,Solute_carrier_family_22_member_1-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
2807,Metformin,Solute_carrier_family_22_member_1-Substrate,CN(C)C(=N)NC(N)=N
2808,Nicotine,Solute_carrier_family_22_member_1-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
2809,Phenformin,Solute_carrier_family_22_member_1-Inhibitor,NC(=N)NC(=N)NCCC1=CC=CC=C1
2810,Pramipexole,Solute_carrier_family_22_member_1-Substrate,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
2811,Prazosin,Solute_carrier_family_22_member_1-Inhibitor,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4
2812,Quinidine,Solute_carrier_family_22_member_1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
2813,Rifampicin,Solute_carrier_family_22_member_1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2814,Tubocurarine,Solute_carrier_family_22_member_1-Inhibitor,COC1=C(O)C2=C3[C@@H](CC4=CC(OC5=CC6=C(CCN(C)[C@H]6CC7=CC=C(O2)C=C7)C=C5OC)=C(O)C=C4)[N+](C)(C)CCC3=C1
2815,Acetylcholin,Solute_carrier_family_22_member_3-Substrate,CC(=O)OCC[N+](C)(C)C
2816,Desipramine,Solute_carrier_family_22_member_3-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
2817,Sodium Chloride,Solute_carrier_family_22_member_3-Substrate,[Na+].[Cl-]
2818,Ebastine,4F11-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
2819,Milchsure,Monocarboxylate_transporter_4-Substrate,C[C@@H](O)C(O)=O
2820,Oxypertine,Sodium_dependent_serotonin_transporter-Substrate,COC1=CC2=C(C=C1OC)C(CCN3CCN(CC3)C4=CC=CC=C4)=C(C)N2
2821,Tryptophan,Monocarboxylate_transporter_10-Substrate,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
2822,Aciclovir,Neutral_amino_acid_transporter_B0-Substrate,NC1=NC2=C(N=CN2COCCO)C(=O)N1
2823,Ganciclovir,Neutral_amino_acid_transporter_B0-Substrate,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
2824,Glycine,Neutral_amino_acid_transporter_B0-Substrate,NCC(O)=O
2825,Insulin (human),Neutral_amino_acid_transporter_B0-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
2826,Levocarnitine,Neutral_amino_acid_transporter_B0-Substrate,C[N+](C)(C)C[C@H](O)CC([O-])=O
2827,Levoglutamide,Neutral_amino_acid_transporter_B0-Substrate,N[C@@H](CCC(N)=O)C(O)=O
2828,Levoglutamide,Neutral_amino_acid_transporter_B0-Inducer,N[C@@H](CCC(N)=O)C(O)=O
2829,Nitric Oxide,Neutral_amino_acid_transporter_B0-Substrate,N=O
2830,Valaciclovir,Neutral_amino_acid_transporter_B0-Substrate,CC(C)[C@H](N)C(=O)OCCOCN1C=NC2=C1N=C(N)NC2=O
2831,Valganciclovir,Neutral_amino_acid_transporter_B0-Substrate,CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1NC(N)=NC2=O
2832,Aldosterone,HLp2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
2833,Alfentanil,HLp2-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
2834,Alprazolam,HLp2-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
2835,Amiodarone,HLp2-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
2836,Amitriptyline,HLp2-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
2837,Amlodipine,HLp2-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
2838,Amprenavir,HLp2-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
2839,Aprepitant,HLp2-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
2840,Argatroban,HLp2-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
2841,Aripiprazole,HLp2-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
2842,Astemizole,HLp2-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
2843,Atazanavir,HLp2-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
2844,Atazanavir,HLp2-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
2845,Atorvastatin,HLp2-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
2846,Aztreonam,HLp2-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
2847,Beclometasone,HLp2-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2848,Buspirone,HLp2-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
2849,Caffeine,HLp2-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
2850,Carbamazepine,HLp2-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2851,Carbamazepine,HLp2-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
2852,Cerivastatin,HLp2-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
2853,Chinin,HLp2-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
2854,Chloroquine,HLp2-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
2855,Chlorphenamine,HLp2-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
2856,Chlorpromazine,HLp2-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
2857,Ciclosporin,HLp2-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2858,Ciclosporin,HLp2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2859,Ciclosporin,HLp2-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
2860,Cimetidine,HLp2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
2861,Cisapride,HLp2-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
2862,Clarithromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
2863,Clopidogrel,HLp2-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
2864,Cocaine,HLp2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2865,Cocaine,HLp2-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
2866,Codeine,HLp2-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
2867,Cortisone,HLp2-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
2868,Cyclobarbital,HLp2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
2869,Dapsone,HLp2-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
2870,Daunorubicin,HLp2-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
2871,Dexamethasone,HLp2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2872,Dexamethasone,HLp2-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
2873,Dextromethorphan,HLp2-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
2874,Diazepam,HLp2-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
2875,Diethyltoluamide,HLp2-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
2876,Diltiazem,HLp2-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
2877,Diltiazem,HLp2-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
2878,Disulfiram,HLp2-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
2879,Docetaxel,HLp2-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
2880,Domperidone,HLp2-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
2881,Doxorubicin,HLp2-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
2882,Doxylamin,HLp2-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
2883,Dutasteride,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
2884,Eplerenone,HLp2-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
2885,Erythromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2886,Erythromycin,HLp2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
2887,Estradiol,HLp2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
2888,Estrone,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
2889,Ethinylestradiol,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
2890,Ethosuximide,HLp2-Substrate,CC[C@]1(C)CC(=O)NC1=O
2891,Etoposide,HLp2-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2892,Etoposide,HLp2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
2893,Felodipine,HLp2-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
2894,Fentanyl,HLp2-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
2895,Finasteride,HLp2-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
2896,Fluconazole,HLp2-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2897,Fluconazole,HLp2-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
2898,Flutamide,HLp2-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
2899,Fluvoxamine,HLp2-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
2900,Glycyrrhizic Acid,HLp2-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
2901,Glycyrrhizic Acid,HLp2-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
2902,Granisetron,HLp2-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
2903,Halofantrine,HLp2-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
2904,Haloperidol,HLp2-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
2905,Hydrocortisone,HLp2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
2906,Ifosfamide,HLp2-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
2907,Imatinib,HLp2-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2908,Imatinib,HLp2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
2909,Indinavir,HLp2-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2910,Indinavir,HLp2-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
2911,Irinotecan,HLp2-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
2912,Ketoconazole,HLp2-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2913,Ketoconazole,HLp2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2914,Ketoconazole,HLp2-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
2915,Lercanidipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
2916,Levacetylmethadol,HLp2-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2917,Lidocain,HLp2-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
2918,Linopirdine,HLp2-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
2919,Losartan,HLp2-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
2920,Lovastatin,HLp2-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2921,Mepacrine,HLp2-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
2922,Mephenytoin,HLp2-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
2923,Methadone,HLp2-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
2924,Mibefradil,HLp2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
2925,Midazolam,HLp2-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
2926,Mifepristone,HLp2-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
2927,Mifepristone,HLp2-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
2928,Modafinil,HLp2-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2929,Modafinil,HLp2-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
2930,Nateglinide,HLp2-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
2931,Nefazodone,HLp2-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
2932,Nelfinavir,HLp2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2933,Nelfinavir,HLp2-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
2934,Neostigmine,HLp2-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
2935,Nicardipine,HLp2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
2936,Nifedipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
2937,Nimodipine,HLp2-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
2938,Nisoldipine,HLp2-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
2939,Nitrendipine,HLp2-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
2940,Norethisterone,HLp2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
2941,Norfloxacin,HLp2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
2942,Octopamine,HLp2-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
2943,Omeprazole,HLp2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2944,Omeprazole,HLp2-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2945,Omeprazole,HLp2-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
2946,Ondansetron,HLp2-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
2947,Ornidazole,HLp2-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
2948,Oxazepam,HLp2-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
2949,Oxcarbazepine,HLp2-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
2950,Oxybutynin,HLp2-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
2951,Oxycodone,HLp2-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
2952,Paclitaxel,HLp2-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
2953,Paracetamol,HLp2-Inducer,CC(=O)NC1=CC=C(O)C=C1
2954,Paracetamol,HLp2-Substrate,CC(=O)NC1=CC=C(O)C=C1
2955,Paraoxon,HLp2-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
2956,Pethidine,HLp2-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
2957,Phenelzine,HLp2-Inhibitor,NNCCC1=CC=CC=C1
2958,Phenelzine,HLp2-Substrate,NNCCC1=CC=CC=C1
2959,Phenobarbital,HLp2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
2960,Phenytoin,HLp2-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
2961,Physostigmine,HLp2-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
2962,Pimozide,HLp2-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
2963,Pleconaril,HLp2-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
2964,Pravastatin,HLp2-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
2965,Praziquantel,HLp2-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
2966,Prednisolone,HLp2-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
2967,Prednisolone,HLp2-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
2968,Progesterone,HLp2-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
2969,Propranolol,HLp2-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
2970,Quetiapine,HLp2-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
2971,Ranitidine,HLp2-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
2972,Reserpine,HLp2-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
2973,Rifampicin,HLp2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2974,Rifampicin,HLp2-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2975,Rifampicin,HLp2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
2976,Rifapentine,HLp2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
2977,Risperidone,HLp2-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
2978,Ritonavir,HLp2-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2979,Ritonavir,HLp2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2980,Ritonavir,HLp2-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
2981,Rosuvastatin,HLp2-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
2982,Salmeterol,HLp2-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
2983,Saquinavir,HLp2-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2984,Saquinavir,HLp2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
2985,Sildenafil,HLp2-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
2986,Simvastatin,HLp2-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
2987,Sirolimus,HLp2-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
2988,Spironolactone,HLp2-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
2989,Sulfasalazine,HLp2-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
2990,Tacrolimus,HLp2-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
2991,Tamoxifen,HLp2-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
2992,Tegafur,HLp2-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
2993,Telithromycin,HLp2-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
2994,Teniposide,HLp2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
2995,Terfenadine,HLp2-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
2996,Testosterone,HLp2-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
2997,Thalidomide,HLp2-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
2998,Tocopherol (vit E),HLp2-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
2999,Trazodone,HLp2-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
3000,Triamcinolone,HLp2-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
3001,Triazolam,HLp2-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
3002,Troglitazone,HLp2-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3003,Troglitazone,HLp2-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3004,Vardenafil,HLp2-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
3005,Verapamil,HLp2-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3006,Verapamil,HLp2-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3007,Vinblastine,HLp2-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
3008,Vincristine,HLp2-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
3009,Zalcitabine,HLp2-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
3010,Zaleplon,HLp2-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
3011,Ziprasidone,HLp2-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
3012,Zolpidem,HLp2-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
3013,Zonisamide,HLp2-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
3014,Zotepine,HLp2-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
3015,Adenosine,Equilibrative_nucleoside_transporter_1-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
3016,Amiloride,Solute_carrier_family_22_member_2-Substrate,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N
3017,Bromides,Solute_carrier_family_22_member_2-Substrate,[Br-]
3018,Budesonide,Solute_carrier_family_22_member_2-Inhibitor,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
3019,Cimetidine,Solute_carrier_family_22_member_2-Substrate,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3020,Cimetidine,Solute_carrier_family_22_member_2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3021,Cisplatin,Solute_carrier_family_22_member_2-Substrate,N[Pt](N)(Cl)Cl
3022,Cisplatin,Solute_carrier_family_22_member_2-Inhibitor,N[Pt](N)(Cl)Cl
3023,Dexamethasone,Solute_carrier_family_22_member_2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3024,Dinoprostone,Solute_carrier_family_22_member_2-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
3025,Dopamine,Solute_carrier_family_22_member_2-Substrate,NCCC1=CC(O)=C(O)C=C1
3026,Epinephrine,Solute_carrier_family_22_member_2-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
3027,Flurazepam,Solute_carrier_family_22_member_2-Inhibitor,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
3028,Gabapentin,Solute_carrier_family_22_member_2-Substrate,NC[C@@]1(CCCCC1)CC(O)=O
3029,Histamine,Solute_carrier_family_22_member_2-Substrate,NCCC1=CNC=N1
3030,Metformin,Solute_carrier_family_22_member_2-Substrate,CN(C)C(=N)NC(N)=N
3031,Mexiletine,Solute_carrier_family_22_member_2-Inhibitor,C[C@H](N)COC1=C(C)C=CC=C1C
3032,Norepinephrine,Solute_carrier_family_22_member_2-Substrate,NC[C@@H](O)C1=CC(O)=C(O)C=C1
3033,Oxaliplatin,Solute_carrier_family_22_member_2-Inhibitor,N[C@@H]1CCCC[C@H]1N
3034,Pramipexole,Solute_carrier_family_22_member_2-Substrate,CCCN[C@@H]1CCC2=C(C1)SC(N)=N2
3035,Propranolol,Solute_carrier_family_22_member_2-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
3036,Quinidine,Solute_carrier_family_22_member_2-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
3037,Dexamethasone,3A43-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3038,Ethosuximide,3A43-Substrate,CC[C@]1(C)CC(=O)NC1=O
3039,Oxazepam,3A43-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
3040,Phenelzine,3A43-Inhibitor,NNCCC1=CC=CC=C1
3041,Praziquantel,3A43-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
3042,Rifampicin,3A43-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3043,Rifapentine,3A43-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
3044,Testosterone,3A43-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3045,Zalcitabine,3A43-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
3046,Estrone,Solute_carrier_organic_anion_transporter_family_member_4A1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
3047,Budesonide,Multidrug_resistance_associated_protein_1-Inhibitor,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
3048,Celecoxib,Multidrug_resistance_associated_protein_1-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
3049,Chlorcyclizine,Multidrug_resistance_associated_protein_1-Substrate,CN1CCN(CC1)[C@@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
3050,Chlorphenamine,Multidrug_resistance_associated_protein_1-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
3051,Cisplatin,Multidrug_resistance_associated_protein_1-Substrate,N[Pt](N)(Cl)Cl
3052,Clotrimazole,Multidrug_resistance_associated_protein_1-Substrate,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3053,Clotrimazole,Multidrug_resistance_associated_protein_1-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3054,Daunorubicin,Multidrug_resistance_associated_protein_1-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
3055,Daunorubicin,Multidrug_resistance_associated_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
3056,Dipyridamole,Multidrug_resistance_associated_protein_1-Inhibitor,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
3057,Disulfiram,Multidrug_resistance_associated_protein_1-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3058,Doxorubicin,Multidrug_resistance_associated_protein_1-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
3059,Doxorubicin,Multidrug_resistance_associated_protein_1-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
3060,Doxorubicin,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
3061,Epirubicin,Multidrug_resistance_associated_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C(=O)C2=CC=C1
3062,Estradiol,Multidrug_resistance_associated_protein_1-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
3063,Estradiol,Multidrug_resistance_associated_protein_1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
3064,Estrone,Multidrug_resistance_associated_protein_1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
3065,Etacrynic Acid,Multidrug_resistance_associated_protein_1-Substrate,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
3066,Ethanol,Multidrug_resistance_associated_protein_1-Inducer,CCO
3067,Etoposide,Multidrug_resistance_associated_protein_1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
3068,Fluorescein,Multidrug_resistance_associated_protein_1-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
3069,G-strophanthin,Multidrug_resistance_associated_protein_1-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
3070,Glibenclamide,Multidrug_resistance_associated_protein_1-Inducer,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3071,Glibenclamide,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3072,Glutathione,Multidrug_resistance_associated_protein_1-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
3073,Indometacin,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3074,Ivermectin,Multidrug_resistance_associated_protein_1-Substrate,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
3075,Ivermectin,Multidrug_resistance_associated_protein_1-Inhibitor,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
3076,Lopinavir,Multidrug_resistance_associated_protein_1-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
3077,Lovastatin,Multidrug_resistance_associated_protein_1-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3078,Menadione,Multidrug_resistance_associated_protein_1-Inducer,CC1=CC(=O)C2=C(C=CC=C2)C1=O
3079,"Mercury, Metallic",Multidrug_resistance_associated_protein_1-Inducer,[Hg]
3080,Paracetamol,Multidrug_resistance_associated_protein_1-Inducer,CC(=O)NC1=CC=C(O)C=C1
3081,Phenytoin,Multidrug_resistance_associated_protein_1-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3082,Probenecid,Multidrug_resistance_associated_protein_1-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3083,Probenecid,Multidrug_resistance_associated_protein_1-Substrate,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3084,Quinidine,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
3085,Ritonavir,Multidrug_resistance_associated_protein_1-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3086,Rofecoxib,Multidrug_resistance_associated_protein_1-Inducer,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
3087,Saquinavir,Multidrug_resistance_associated_protein_1-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3088,Saquinavir,Multidrug_resistance_associated_protein_1-Inducer,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3089,Silymarin,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
3090,Sulfinpyrazon,Multidrug_resistance_associated_protein_1-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
3091,Trastuzumab,Multidrug_resistance_associated_protein_1-Inhibitor,NCC=C
3092,Verapamil,Multidrug_resistance_associated_protein_1-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3093,Vinblastine,Multidrug_resistance_associated_protein_1-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
3094,Vincristine,Multidrug_resistance_associated_protein_1-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
3095,Aminophenazone,2C18-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
3096,Buprenorphine,2C18-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3097,Clobazam,2C18-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3098,Clotiazepam,2C18-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
3099,Cyclophosphamide,2C18-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3100,Dapsone,2C18-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3101,Dexamethasone,2C18-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3102,Diazepam,2C18-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3103,Diclofenac,2C18-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3104,Fluconazole,2C18-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3105,Ifosfamide,2C18-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3106,Imipramine,2C18-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3107,Lansoprazole,2C18-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3108,Lidocain,2C18-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
3109,Mephenytoin,2C18-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3110,Methadone,2C18-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3111,Omeprazole,2C18-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3112,Perphenazine,2C18-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3113,Phenazone,2C18-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3114,Phenobarbital,2C18-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3115,Phenytoin,2C18-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3116,Phenytoin,2C18-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3117,Propofol,2C18-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3118,Rifampicin,2C18-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3119,Thalidomide,2C18-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3120,Tolbutamide,2C18-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
3121,Troleandomycin,2C18-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
3122,Valproic Acid,2C18-Inhibitor,CCCC(CCC)C(O)=O
3123,Warfarin,2C18-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3124,Dextromethorphan,46A-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
3125,Diclofenac,46A-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3126,Phenacetin,46A-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
3127,Progesterone,46A-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3128,Testosterone,46A-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3129,Acetylsalicylic Acid,2C19-Inducer,CC(=O)OC1=C(C=CC=C1)C(O)=O
3130,Adinazolam,2C19-Substrate,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
3131,Aminogluthetimide,2C19-Inducer,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
3132,Aminophenazone,2C19-Inhibitor,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
3133,Aminophenazone,2C19-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
3134,Amiodarone,2C19-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
3135,Amitriptyline,2C19-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3136,Amitriptyline,2C19-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3137,Amoxicillin,2C19-Substrate,CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)C3=CC=C(O)C=C3)C(=O)N2[C@H]1C(O)=O
3138,Amprenavir,2C19-Inhibitor,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3139,Aprepitant,2C19-Inhibitor,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
3140,Aprepitant,2C19-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
3141,Artemether,2C19-Substrate,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
3142,Artemisinin,2C19-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
3143,Atomoxetine,2C19-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
3144,Azelastine,2C19-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3145,Azelastine,2C19-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3146,Barnidipine,2C19-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
3147,Benidipine,2C19-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
3148,Benzatropine,2C19-Substrate,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
3149,Benzethonium,2C19-Substrate,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
3150,Benzydamine,2C19-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
3151,Bicalutamide,2C19-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
3152,Bifonazole,2C19-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
3153,Bortezomib,2C19-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3154,Bortezomib,2C19-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3155,Bromazepam,2C19-Substrate,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
3156,Brompheniramine,2C19-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
3157,Buflomedil,2C19-Substrate,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1
3158,Bupivacaine,2C19-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
3159,Buprenorphine,2C19-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3160,Capsaicin,2C19-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
3161,Carbamazepine,2C19-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3162,Carbamazepine,2C19-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3163,Carbinoxamine,2C19-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
3164,Carisoprodol,2C19-Substrate,CCC[C@@](C)(COC(N)=O)COC(=O)NC(C)C
3165,Chinin,2C19-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
3166,Chinin,2C19-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
3167,Chloramphenicol,2C19-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
3168,Chloramphenicol,2C19-Substrate,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
3169,Chlormadinone,2C19-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3170,Chloroform,2C19-Substrate,ClC(Cl)Cl
3171,Chlorpropamide,2C19-Substrate,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
3172,Ciclosporin,2C19-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
3173,Cilostazol,2C19-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
3174,Cimetidine,2C19-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3175,Cisapride,2C19-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3176,Citalopram,2C19-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
3177,Citalopram,2C19-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
3178,Clarithromycin,2C19-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
3179,Clarithromycin,2C19-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
3180,Clobazam,2C19-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3181,Clomethiazole,2C19-Substrate,CC1=C(CCCl)SC=N1
3182,Clomipramine,2C19-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
3183,Clopidogrel,2C19-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
3184,Clotiazepam,2C19-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
3185,Clotrimazole,2C19-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3186,Clozapine,2C19-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3187,Clozapine,2C19-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3188,Colecalciferol,2C19-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
3189,Cyclophosphamide,2C19-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3190,Dapsone,2C19-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3191,Delavirdine,2C19-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
3192,Desipramine,2C19-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3193,Desipramine,2C19-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3194,Desloratadine,2C19-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
3195,Desogestrel,2C19-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3196,Dexamethasone,2C19-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3197,Dexfenfluramine,2C19-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
3198,Dextromethorphan,2C19-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
3199,Diazepam,2C19-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3200,Diazepam,2C19-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3201,Diclofenac,2C19-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3202,Diethyltoluamide,2C19-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
3203,Dimethyl Sulfoxide,2C19-Inhibitor,CS(C)=O
3204,Dopamine,2C19-Substrate,NCCC1=CC(O)=C(O)C=C1
3205,Doxazosin,2C19-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5
3206,Doxepin,2C19-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
3207,Dronabinol,2C19-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
3208,Efavirenz,2C19-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
3209,Entacapone,2C19-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
3210,Escitalopram,2C19-Substrate,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
3211,Esomeprazole,2C19-Substrate,COC1=CC2=C([N-]C(=N2)S(=O)CC3=NC=C(C)C(OC)=C3C)C=C1
3212,Estradiol,2C19-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
3213,Ethanol,2C19-Inhibitor,CCO
3214,Ethinylestradiol,2C19-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
3215,Ethinylestradiol,2C19-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
3216,Ethotoin,2C19-Inhibitor,CCN1C(=O)N[C@H](C1=O)C2=CC=CC=C2
3217,Etizolam,2C19-Substrate,CCC1=CC2=C(S1)N3C(C)=NN=C3CN=C2C4=C(Cl)C=CC=C4
3218,Etoricoxib,2C19-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
3219,Famotidine,2C19-Substrate,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
3220,Felbamate,2C19-Inhibitor,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
3221,Fenofibrate,2C19-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
3222,Fluconazole,2C19-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3223,Flunitrazepam,2C19-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
3224,Fluoxetine,2C19-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3225,Fluoxetine,2C19-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3226,Flutamide,2C19-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
3227,Fluvoxamine,2C19-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3228,Formoterol,2C19-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
3229,Fosamprenavir,2C19-Inhibitor,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3230,Fosphenytoin,2C19-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3231,Fosphenytoin,2C19-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3232,Gefitinib,2C19-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
3233,Gemfibrozil,2C19-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3234,Glibenclamide,2C19-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3235,Gliclazide,2C19-Inhibitor,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2
3236,Glipizide,2C19-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3237,Glucosamine,2C19-Substrate,N[C@@H]1[C@@H](O)O[C@@H](CO)[C@H](O)[C@H]1O
3238,Haloperidol,2C19-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3239,Hexobarbital,2C19-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
3240,Ibuprofen,2C19-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3241,Ifosfamide,2C19-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3242,Imatinib,2C19-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3243,Imipramine,2C19-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3244,Imipramine,2C19-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3245,Indinavir,2C19-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
3246,Indometacin,2C19-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3247,Indometacin,2C19-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3248,Ipriflavone,2C19-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
3249,Isoniazid,2C19-Inhibitor,NNC(=O)C1=CC=NC=C1
3250,Isopropanol,2C19-Inhibitor,CC(C)O
3251,Ketobemidone,2C19-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
3252,Ketoconazole,2C19-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3253,Lafutidine,2C19-Inhibitor,O=C(CS(=O)CC1=CC=CO1)NCC=C/COC2=NC=CC(CN3CCCCC3)=C2
3254,Lansoprazole,2C19-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3255,Lansoprazole,2C19-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3256,Lopinavir,2C19-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
3257,Loratadine,2C19-Inducer,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3258,Loratadine,2C19-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3259,Losartan,2C19-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3260,Lumiracoxib,2C19-Substrate,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
3261,Lynestrenol,2C19-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3262,Lynestrenol,2C19-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3263,Medazepam,2C19-Substrate,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3264,Medrysone,2C19-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
3265,Melatonin,2C19-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
3266,Memantine,2C19-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
3267,Mephenytoin,2C19-Inhibitor,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3268,Mephenytoin,2C19-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3269,Meprobamate,2C19-Substrate,CCCC(C)(COC(N)=O)COC(N)=O
3270,Mesuximide,2C19-Inhibitor,CN1C(=O)C[C@](C)(C1=O)C2=CC=CC=C2
3271,Mesuximide,2C19-Substrate,CN1C(=O)C[C@](C)(C1=O)C2=CC=CC=C2
3272,Methadone,2C19-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3273,Methazolamide,2C19-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
3274,Methylphenobarbital,2C19-Inhibitor,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
3275,Methylphenobarbital,2C19-Substrate,CC[C@]1(C(=O)NC(=O)N(C)C1=O)C2=CC=CC=C2
3276,Metoprolol,2C19-Substrate,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
3277,Miconazole,2C19-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
3278,Moclobemide,2C19-Substrate,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
3279,Moclobemide,2C19-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
3280,Modafinil,2C19-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
3281,Modafinil,2C19-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
3282,Nelfinavir,2C19-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3283,Nelfinavir,2C19-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3284,Nicardipine,2C19-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3285,Nicotine,2C19-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
3286,Nilutamide,2C19-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
3287,Nilutamide,2C19-Substrate,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
3288,Nilvadipine,2C19-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
3289,Nordazepam,2C19-Substrate,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
3290,Norethisterone,2C19-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3291,Nortriptyline,2C19-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3292,Noscapine,2C19-Inhibitor,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34
3293,Olanzapine,2C19-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
3294,Omeprazole,2C19-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3295,Omeprazole,2C19-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3296,Omeprazole,2C19-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3297,Orphenadrine (citrate),2C19-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
3298,Oxcarbazepine,2C19-Inhibitor,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
3299,Pantoprazole,2C19-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
3300,Pantoprazole,2C19-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
3301,Paroxetine,2C19-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
3302,Pentobarbital,2C19-Substrate,CCC[C@@H](C)[C@@]1(CC)C(=O)NC(=O)NC1=O
3303,Perazine,2C19-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3304,Perazine,2C19-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3305,Perphenazine,2C19-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3306,Pethidine,2C19-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
3307,Phenacetin,2C19-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
3308,Phenazone,2C19-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3309,Phenazone,2C19-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3310,Phenelzine,2C19-Inhibitor,NNCCC1=CC=CC=C1
3311,Phenelzine,2C19-Substrate,NNCCC1=CC=CC=C1
3312,Phenobarbital,2C19-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3313,Phenobarbital,2C19-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3314,Phensuximide,2C19-Inhibitor,CN1C(=O)C[C@@H](C1=O)C2=CC=CC=C2
3315,Phenytoin,2C19-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3316,Phenytoin,2C19-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3317,Pimozide,2C19-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
3318,Pioglitazone,2C19-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3319,Podophyllotoxin,2C19-Substrate,COC1=CC(=CC(OC)=C1OC)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=C2C=C5OCOC5=C4
3320,Praziquantel,2C19-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
3321,Primidone,2C19-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3322,Primidone,2C19-Substrate,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3323,Probenecid,2C19-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3324,Progesterone,2C19-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3325,Progesterone,2C19-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3326,Proguanil,2C19-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
3327,Promazine,2C19-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
3328,Propofol,2C19-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3329,Propranolol,2C19-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
3330,Quazepam,2C19-Substrate,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3
3331,Quetiapine,2C19-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
3332,Rabeprazole,2C19-Inhibitor,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
3333,Rabeprazole,2C19-Substrate,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
3334,Ranitidine,2C19-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
3335,Retinol (vit A),2C19-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
3336,Rifampicin,2C19-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3337,Rifampicin,2C19-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3338,Ritonavir,2C19-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3339,Ritonavir,2C19-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
3340,Rosiglitazone,2C19-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3341,Saquinavir,2C19-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
3342,Selegiline,2C19-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3343,Seratrodast,2C19-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3344,Seratrodast,2C19-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3345,Sertraline,2C19-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
3346,Sertraline,2C19-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
3347,Sildenafil,2C19-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
3348,Sildenafil,2C19-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
3349,Sulconazole,2C19-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
3350,Sulfanilamide,2C19-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
3351,Tamoxifen,2C19-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3352,Telmisartan,2C19-Inhibitor,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
3353,Temazepam,2C19-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3354,Teniposide,2C19-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
3355,Terbinafine,2C19-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
3356,Testosterone,2C19-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3357,Tetrabenazine,2C19-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
3358,Thalidomide,2C19-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3359,Thiamazole,2C19-Inhibitor,CN1C=CNC1=S
3360,Thioridazine,2C19-Substrate,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
3361,Ticlopidine,2C19-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
3362,Timolol,2C19-Substrate,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
3363,Tioconazole,2C19-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
3364,Tolbutamide,2C19-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
3365,Tolperisone,2C19-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
3366,Tolterodine,2C19-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
3367,Topiramate,2C19-Inhibitor,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1
3368,Torasemide,2C19-Inhibitor,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
3369,Trabectedin,2C19-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
3370,Tranylcypromine,2C19-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
3371,Trimethadione,2C19-Substrate,CN1C(=O)OC(C)(C)C1=O
3372,Trimipramine,2C19-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3373,Troglitazone,2C19-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3374,Troglitazone,2C19-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
3375,Troleandomycin,2C19-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
3376,Trospium,2C19-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
3377,Valdecoxib,2C19-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
3378,Valproic Acid,2C19-Inhibitor,CCCC(CCC)C(O)=O
3379,Valproic Acid,2C19-Substrate,CCCC(CCC)C(O)=O
3380,Venlafaxine,2C19-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
3381,Verapamil,2C19-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
3382,Voriconazole,2C19-Inhibitor,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3383,Voriconazole,2C19-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3384,Warfarin,2C19-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3385,Warfarin,2C19-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3386,Zafirlukast,2C19-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
3387,Zidovudine,2C19-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
3388,Zolpidem,2C19-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
3389,Zonisamide,2C19-Inhibitor,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
3390,Zonisamide,2C19-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
3391,Zotepine,2C19-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
3392,11_oxo_delta_8_tetrahydro_cannabinol,2C19-Substrate,CCCCCC1=CC2=C([C@@H]3CC(=CC[C@H]3C(C)(C)O2)C=O)C(=C1)O
3393,18_methoxy_coronaridine,2C19-Substrate,COCC[C@H]1CC2CN3CCC4=C([NH]C5=CC=CC=C45)[C@](C2)(C13)C(=O)OC
3394,2_oxo_ticlopidine,2C19-Substrate,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2
3395,2n_propylquinoline,2C19-Substrate,CCCC1=CC=C2C=CC=CC2=N1
3396,3_O_methyl_fluorescein,2C19-Substrate,COC1=CC=C2C(=C1)OC3=CC(=CC=C3C24OC(=O)C5=CC=CC=C45)O
3397,4_chloro_7_ethoxycoumarin,2C19-Substrate,CCOC1=CC=C2C(=C[C](=O)OC2=C1)Cl
3398,4prime_hydroxy_clobazam,2C19-Substrate,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C3=CC(=CC=C13)Cl
3399,5_hydroxy_tryptamine,2C19-Substrate,NCCC1=C[NH]C2=CC=C(O)C=C12
3400,5beta_cholestane_3alpha_7alpha_12alpha_triol,2C19-Substrate,CC(C)CCC[C@@H](C)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3C[C@H](O)[C@]12C
3401,7_benzyloxy_4_trifluoromethyl_coumarin,2C19-Substrate,FC(F)(F)C1=C[C](=O)OC2=CC(=CC=C12)OCC3=CC=CC=C3
3402,9_anthraldehyde,2C19-Substrate,O=CC1=C2C=CC=CC2=CC3=CC=CC=C13
3403,ABT_438,2C19-Substrate,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1
3404,almotriptan,2C19-Substrate,CN(C)CCC1=C[NH]C2=CC=C(C[S](=O)(=O)N3CCCC3)C=C12
3405,amiodarone,2C19-Substrate,CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3
3406,amitriptyline,2C19-Substrate,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13
3407,amodiaquine,2C19-Substrate,CCN(CC)CC1=CC(=CC=C1O)NC2=CC=NC3=CC(=CC=C23)Cl
3408,atomoxetine,2C19-Substrate,CNCC[C@@H](OC1=C(C)C=CC=C1)C2=CC=CC=C2
3409,atrazine,2C19-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)C
3410,azelastine,2C19-Substrate,CN1CCC[C@@H](CC1)[N]2N=C(CC3=CC=C(Cl)C=C3)C4=C(C=CC=C4)[C]2=O
3411,azinphosmethyl,2C19-Substrate,CO[P](=S)(OC)SC[N]1N=NC2=CC=CC=C2[C]1=O
3412,BDB,2C19-Substrate,CCC(N)CC1=CC=C2OCOC2=C1
3413,BMAMC,2C19-Substrate,CCCCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
3414,bortezomib,2C19-Substrate,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3415,BPR_0L075,2C19-Substrate,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC
3416,bufuralol_R,2C19-Substrate,CCC1=C2OC(=CC2=CC=C1)[C@H](O)CNC(C)(C)C
3417,bupivacaine_R,2C19-Substrate,CCCCN1CCCC[C@@H]1C(=O)NC2=C(C)C=CC=C2C
3418,carbaryl,2C19-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
3419,carbofuran,2C19-Substrate,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1
3420,catechol_methoxychlor,2C19-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C(=C2)O)C(Cl)(Cl)Cl
3421,celecoxib,2C19-Substrate,CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S](N)(=O)=O)C(F)(F)F
3422,chlorpyrifos,2C19-Substrate,CCO[P](=S)(OCC)OC1=NC(=C(Cl)C=C1Cl)Cl
3423,citalopram_R,2C19-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
3424,clomipramine,2C19-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
3425,clopidogrel,2C19-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl
3426,clozapine,2C19-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
3427,cp_677_623,2C19-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
3428,dapsone,2C19-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)C2=CC=C(N)C=C2
3429,deoxy_podophyllotoxin,2C19-Substrate,COC1=C(OC)C(=CC(=C1)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=CC5=C(OCO5)C=C24)OC
3430,desogestrel,2C19-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3431,dextropropoxyphene,2C19-Substrate,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C2=CC=CC=C2
3432,diallylsulfide,2C19-Substrate,C=CCSSCC=C
3433,diazepam,2C19-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
3434,diazinion,2C19-Substrate,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C
3435,diclofenac,2C19-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3436,diethyl_meta_toluamide,2C19-Substrate,CCN(CC)C(=O)C1=CC(=CC=C1)C
3437,dimemorfan,2C19-Substrate,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C)C=C4
3438,DiMMAMC,2C19-Substrate,COC1=CC=C2C(=C[C](=O)OC2=C1)CN(C)C
3439,diphenhydramine,2C19-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
3440,disulfoton,2C19-Substrate,CCO[P](=S)(OCC)SCCSCC
3441,diuron,2C19-Substrate,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl
3442,DMZ,2C19-Substrate,CN(C1=CC=N[N]1C2=CC=CC=C2)[S](=O)(=O)C3=CC=C(C)C=C3
3443,domperidone,2C19-Substrate,ClC1=CC=C2[N](C3CCN(CCC[N]4[C](=O)[NH]C5=CC=CC=C45)CC3)[C](=O)[NH]C2=C1
3444,DY_9760e,2C19-Substrate,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl
3445,EMAMC,2C19-Substrate,CCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
3446,endosulfan,2C19-Substrate,ClC1=C(Cl)C2(Cl)C3CO[S](=O)OCC3C1(Cl)C2(Cl)Cl
3447,ethanol,2C19-Substrate,CCO
3448,ethinyl_estradiol,2C19-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@]2(O)C#C
3449,eupatilin,2C19-Substrate,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC
3450,fipronil,2C19-Substrate,NC1=C(C(=N[N]1C2=C(Cl)C=C(C=C2Cl)C(F)(F)F)C#N)[S@](=O)C(F)(F)F
3451,fluoxetine_R,2C19-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3452,fluticasone_proprionate,2C19-Substrate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
3453,H_259_31_R,2C19-Substrate,FC1=CC=C2N=C([NH]C2=C1)[S@](=O)CC3=NC=CC(=C3)OCC4CC4
3454,haloperidol,2C19-Substrate,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3455,harmaline,2C19-Substrate,COC1=CC2=C(C=C1)C3=C([NH]2)C(=NCC3)C
3456,harmine,2C19-Substrate,COC1=CC=C2C(=C1)[NH]C3=C2C=CN=C3C
3457,hexobarbital_R,2C19-Substrate,CN1C(=O)NC(=O)[C@](C)(C1=O)C2=CCCCC2
3458,imidacloprid,2C19-Substrate,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1
3459,indole,2C19-Substrate,[NH]1C=CC2=CC=CC=C12
3460,indomethacin,2C19-Substrate,COC1=CC=C2[N](C(=C(CC(O)=O)C2=C1)C)C(=O)C3=CC=C(Cl)C=C3
3461,ipriflavone,2C19-Substrate,CC(C)OC1=CC=C2C(=C1)OC=C([C]2=O)C3=CC=CC=C3
3462,licofelone,2C19-Substrate,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O
3463,limonene_S,2C19-Substrate,CC(=C)[C@H]1CCC(=CC1)C
3464,linalool,2C19-Substrate,CC(C)=CCCC(C)(O)C=C
3465,LU_2509,2C19-Substrate,CC[N]1N=NC(=N1)C2=CCCN(C)C2
3466,Lu_AA21004,2C19-Substrate,CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C
3467,MAMC,2C19-Substrate,COC1=CC=C2C(=C[C](=O)OC2=C1)CN
3468,melatonin,2C19-Substrate,COC1=CC=C2[NH]C=C(CCNC(C)=O)C2=C1
3469,meperidine,2C19-Substrate,CCOC(=O)C1(CCN(C)CC1)C2=CC=CC=C2
3470,mephenytoin_S,2C19-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3471,mesoridazine,2C19-Substrate,CN1CCCCC1CCN2C3=CC=CC=C3SC4=CC=C(C=C24)[S](C)=O
3472,methadone_R,2C19-Substrate,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3473,methiocarb,2C19-Substrate,CNC(=S)OC1=CC(=C(SC)C(=C1)C)C
3474,ML_3403,2C19-Substrate,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4
3475,ML_3603,2C19-Substrate,CC(NC1=NC=CC(=C1)C2=C(N=C([NH]2)[S](C)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4
3476,MMAMC,2C19-Substrate,CNCC1=C[C](=O)OC2=C1C=CC(=C2)OC
3477,montelukast,2C19-Substrate,CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC2(CC2)CC(O)=O)C3=CC=CC(=C3)\C=C\C4=CC=C5C=CC(=CC5=N4)Cl
3478,MOPPP_R,2C19-Substrate,COC1=CC=C(C=C1)C(=O)[C@@H](C)N2CCCC2
3479,muraglitazar,2C19-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
3480,nabumetone,2C19-Substrate,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
3481,nelfinavir,2C19-Substrate,CC1=C(O)C=CC=C1C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3482,nicardipine_R,2C19-Substrate,COC(=O)C1=C(C)NC(=C([C@@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)OCCN(C)CC3=CC=CC=C3)C
3483,NN_diamyl_nitrosoamine,2C19-Substrate,CCCCCN(CCCCC)N=O
3484,NN_diethyl_nitrosoamine,2C19-Substrate,CCN(CC)N=O
3485,NN_methyl_butyl_nitrosoamine,2C19-Substrate,CCCCN(C)N=O
3486,NN_methyl_ethyl_nitrosoamine,2C19-Substrate,CCN(C)N=O
3487,nordiazepam,2C19-Substrate,ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1
3488,norLAAM,2C19-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2
3489,OSU_6162,2C19-Substrate,CCCN1CCC[C@H](C1)C2=CC(=CC=C2)[S](C)(=O)=O
3490,p_cresol,2C19-Substrate,CC1=CC=C(O)C=C1
3491,parathion,2C19-Substrate,CCO[P](=S)(OCC)OC1=CC=C(C=C1)[N](=O)=O
3492,phenprocoumon_S,2C19-Substrate,CC[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
3493,phenytoin,2C19-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
3494,phorate,2C19-Substrate,CCO[P](=S)(OCC)SCSCC
3495,PMAMC,2C19-Substrate,CCCNCC1=C[C](=O)OC2=C1C=CC(=C2)OC
3496,pregnenolone,2C19-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
3497,progesterone,2C19-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3498,propofol,2C19-Substrate,CC(C)C1=C(O)C(=CC=C1)C(C)C
3499,quinine,2C19-Substrate,COC1=CC=C2N=CC=C([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)C2=C1
3500,R_95913,2C19-Substrate,FC1=CC=CC=C1C(N2CCC3SC(=O)C=C3C2)C(=O)C4CC4
3501,rabeprazole_thioether,2C19-Substrate,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2
3502,ranitidine,2C19-Substrate,CN\C(NCCSCC1=CC=C(CN(C)C)O1)=C/[N](=O)=O
3503,retinol,2C19-Substrate,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
3504,selegiline,2C19-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3505,seratrodast_R,2C19-Substrate,CC1=C(C)C(=O)C(=C(C)C1=O)[C@H](CCCCCC(O)=O)C2=CC=CC=C2
3506,sertraline,2C19-Substrate,CN[C@H]1CC[C@@H](C2=CC(=C(Cl)C=C2)Cl)C3=C1C=CC=C3
3507,sibutramine,2C19-Substrate,CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2
3508,sulfadiazine,2C19-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CC=N2
3509,sulprofos,2C19-Substrate,CCCS[P](=S)(OCC)OC1=CC=C(SC)C=C1
3510,tauromustine,2C19-Substrate,CN(C)[S](=O)(=O)CCNC(=O)N(CCCl)N=O
3511,tegafur,2C19-Substrate,FC1=C[N](C2CCCO2)[C](=O)[NH][C]1=O
3512,temazepam,2C19-Substrate,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C3=C1C=CC(=C3)Cl
3513,terbinafine,2C19-Substrate,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12
3514,terbutryn,2C19-Substrate,CCNC1=NC(=NC(=N1)SC)NC(C)(C)C
3515,thalidomide,2C19-Substrate,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3516,tienilic_acid_deriv_3,2C19-Substrate,OCCCOC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CC=CS2
3517,tolbutamide,2C19-Substrate,CCCCNC(=O)N[S](=O)(=O)C1=CC=C(C)C=C1
3518,tolperisone_R,2C19-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
3519,tolterodine,2C19-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C2=CC(=CC=C2O)C)C(C)C
3520,tramadol,2C19-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
3521,V_11294,2C19-Substrate,CCNC1=C2N=C(N=C2[N](CC3=CC=C(OC)C(=C3)OC4CCCC4)C=N1)C(C)C
3522,venlafaxine_R,2C19-Substrate,COC1=CC=C(C=C1)[C@H](CN(C)C)C2(O)CCCCC2
3523,voriconazole,2C19-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F
3524,zonisamide,2C19-Substrate,N[S](=O)(=O)CC1=NOC2=C1C=CC=C2
3525,zopiclone_R,2C19-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4
3526,zotepine,2C19-Substrate,CN(C)CCOC1=CC2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
3527,13_cis_retinoic_acid,2C19-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
3528,2_hydroxy_indomethacin_phenethylamide,2C19-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCC(O)C3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
3529,2_oxo_clopidogrel,2C19-Substrate,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3
3530,3_cyano_7_ethoxycoumarin,2C19-Substrate,CCOC1=CC=C2C=C(C#N)[C](=O)OC2=C1
3531,3_methylether_estradiol,2C19-Substrate,COC1=CC=C2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2=C1
3532,7_ethoxy_4_trifluoro_methyl_coumarin,2C19-Substrate,CCOC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
3533,7_methoxy_3_cyano_coumarin,2C19-Substrate,COC1=CC=C2C=C(C#N)[C](=O)OC2=C1
3534,7_methoxy_4_trifluoro_methyl_coumarin,2C19-Substrate,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
3535,9_cis_retinal,2C19-Substrate,CC(=C\C=O)/C=C/C=C(C)\C=C\C1=C(C)CCCC1(C)C
3536,ABT_761,2C19-Substrate,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O
3537,acenocoumarol_R,2C19-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N](=O)=O)C2=C(O)C3=C(O[C]2=O)C=CC=C3
3538,all_trans_retinal,2C19-Substrate,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
3539,ametryne,2C19-Substrate,CCNC1=NC(=NC(=N1)SC)NC(C)C
3540,bortezomib_M1_M2,2C19-Substrate,CC(C)CC(O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2
3541,clobazam,2C19-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
3542,delta_3_carene,2C19-Substrate,CC1=CC[C@H]2[C@H](C2(C)C)C1
3543,dibenzyl_fluorescein,2C19-Substrate,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17
3544,diclofenac_deriv_2,2C19-Substrate,OCCC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3545,flunitrazepam,2C19-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N](=O)=O
3546,flutamide,2C19-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N](=O)=O)C(F)(F)F
3547,foxy,2C19-Substrate,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1
3548,imipramine,2C19-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13
3549,indomethacin_phenethylamide,2C19-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCCC3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
3550,LAAM,2C19-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3551,lansoprazole_R,2C19-Substrate,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3[NH]2
3552,MBDB,2C19-Substrate,CC[C@H](CC1=CC=C2OCOC2=C1)NC
3553,MDPPP,2C19-Substrate,CC(N1CCCC1)C(=O)C2=CC=C3OCOC3=C2
3554,methoxychlor,2C19-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(OC)C=C2)C(Cl)(Cl)Cl
3555,methyl_eugenol,2C19-Substrate,COC1=C(OC)C=C(CC=C)C=C1
3556,mianserin_R,2C19-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CC=C24
3557,mono_OH_methoxychlor,2C19-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
3558,morphine,2C19-Substrate,CN1CC[C@@]23[C@H]4OC5=C(O)C=CC(=C25)C[C@@H]1[C@@H]3C=C[C@@H]4O
3559,MPBP,2C19-Substrate,CCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
3560,N_desmethyl_clobazapam,2C19-Substrate,ClC1=CC=C2NC(=O)CC(=O)N(C3=CC=CC=C3)C2=C1
3561,N_desmethyl_clomipramine,2C19-Substrate,CNCCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
3562,omeprazole_R,2C19-Substrate,COC1=CC=C2[NH]C(=NC2=C1)[S@](=O)CC3=NC=C(C)C(=C3C)OC
3563,omeprazole_S,2C19-Substrate,COC1=CC=C2[NH]C(=NC2=C1)[S@@](=O)CC3=NC=C(C)C(=C3C)OC
3564,org_30659_tosagestin,2C19-Substrate,C[C@]12CC(=C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C
3565,perazine,2C19-Substrate,CN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=CC=C4)CC1
3566,perphenazine,2C19-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3567,phenprocoumon_R,2C19-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
3568,promazine,2C19-Substrate,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13
3569,quazepam,2C19-Substrate,FC1=CC=CC=C1C2=NCC(=S)N(CC(F)(F)F)C3=CC=C(Cl)C=C23
3570,terbutylazine,2C19-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C
3571,testosterone,2C19-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
3572,thioridazine_R,2C19-Substrate,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1
3573,ticlopidine,2C19-Substrate,ClC1=CC=CC=C1CN2CCC3=C(C2)C=CS3
3574,warfarin_R,2C19-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(O[C]2=O)C=CC=C3
3575,warfarin_S,2C19-Substrate,CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
3576,Oxaliplatin,Copper_transporting_ATPase_1-Substrate,N[C@@H]1CCCC[C@H]1N
3577,Amfetamine,Coumarin_7_hydroxylase-Inhibitor,C[C@@H](N)CC1=CC=CC=C1
3578,Amlodipine,Coumarin_7_hydroxylase-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
3579,Amobarbital,Coumarin_7_hydroxylase-Inducer,CC[C@@]1(CCC(C)C)C(=O)NC(=O)NC1=O
3580,Artemisinin,Coumarin_7_hydroxylase-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
3581,Artesunate,Coumarin_7_hydroxylase-Substrate,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O
3582,Azelastine,Coumarin_7_hydroxylase-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3583,Azithromycin,Coumarin_7_hydroxylase-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
3584,Buprenorphine,Coumarin_7_hydroxylase-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
3585,Bupropion,Coumarin_7_hydroxylase-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
3586,Carbamazepine,Coumarin_7_hydroxylase-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3587,Chloroform,Coumarin_7_hydroxylase-Substrate,ClC(Cl)Cl
3588,Chloroxylenol,Coumarin_7_hydroxylase-Substrate,CC1=CC(O)=CC(C)=C1Cl
3589,Chlorzoxazone,Coumarin_7_hydroxylase-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
3590,Cinnarizin,Coumarin_7_hydroxylase-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3591,Cisapride,Coumarin_7_hydroxylase-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3592,Clofibrate,Coumarin_7_hydroxylase-Inhibitor,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3593,Clomethiazole,Coumarin_7_hydroxylase-Substrate,CC1=C(CCCl)SC=N1
3594,Clomifene,Coumarin_7_hydroxylase-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
3595,Clotrimazole,Coumarin_7_hydroxylase-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3596,Clotrimazole,Coumarin_7_hydroxylase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3597,Clozapine,Coumarin_7_hydroxylase-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3598,Cocaine,Coumarin_7_hydroxylase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3599,Cyclophosphamide,Coumarin_7_hydroxylase-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3600,Desipramine,Coumarin_7_hydroxylase-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3601,Dexfenfluramine,Coumarin_7_hydroxylase-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
3602,Dexmedetomidine,Coumarin_7_hydroxylase-Substrate,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
3603,Diethyl Ether,Coumarin_7_hydroxylase-Substrate,CCOCC
3604,Diethyltoluamide,Coumarin_7_hydroxylase-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
3605,Disulfiram,Coumarin_7_hydroxylase-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3606,Disulfiram,Coumarin_7_hydroxylase-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
3607,Dronabinol,Coumarin_7_hydroxylase-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
3608,Eletriptan,Coumarin_7_hydroxylase-Inducer,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
3609,Entacapone,Coumarin_7_hydroxylase-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
3610,Flunarizine,Coumarin_7_hydroxylase-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
3611,Flunitrazepam,Coumarin_7_hydroxylase-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
3612,Fluorouracil,Coumarin_7_hydroxylase-Substrate,FC1=CNC(=O)NC1=O
3613,Fomepizole,Coumarin_7_hydroxylase-Inhibitor,CC1=CNN=C1
3614,Formoterol,Coumarin_7_hydroxylase-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
3615,Halothane,Coumarin_7_hydroxylase-Substrate,FC(F)(F)[C@@H](Cl)Br
3616,Histamine,Coumarin_7_hydroxylase-Inhibitor,NCCC1=CNC=N1
3617,Ifosfamide,Coumarin_7_hydroxylase-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3618,Indigo Carmine,Coumarin_7_hydroxylase-Inhibitor,[O-]S(=O)(=O)C1=CC=C2NC(C(=O)C2=C1)=C3NC4=CC=C(C=C4C3=O)S([O-])(=O)=O
3619,Isoniazid,Coumarin_7_hydroxylase-Inhibitor,NNC(=O)C1=CC=NC=C1
3620,Isopropanol,Coumarin_7_hydroxylase-Inhibitor,CC(C)O
3621,Ketoconazole,Coumarin_7_hydroxylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3622,Letrozole,Coumarin_7_hydroxylase-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
3623,Letrozole,Coumarin_7_hydroxylase-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
3624,Levoverbenone,Coumarin_7_hydroxylase-Substrate,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C
3625,Lidocain,Coumarin_7_hydroxylase-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
3626,Medifoxamine,Coumarin_7_hydroxylase-Substrate,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
3627,Memantine,Coumarin_7_hydroxylase-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
3628,Menadione,Coumarin_7_hydroxylase-Inhibitor,CC1=CC(=O)C2=C(C=CC=C2)C1=O
3629,Methoxsalen,Coumarin_7_hydroxylase-Substrate,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
3630,Methoxsalen,Coumarin_7_hydroxylase-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
3631,Methoxyflurane,Coumarin_7_hydroxylase-Substrate,COC(F)(F)C(Cl)Cl
3632,Metyrapone,Coumarin_7_hydroxylase-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
3633,Miconazole,Coumarin_7_hydroxylase-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
3634,Nicotine,Coumarin_7_hydroxylase-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
3635,Nicotine,Coumarin_7_hydroxylase-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
3636,Nicotinyl Alcohol (pyridylcarbinol),Coumarin_7_hydroxylase-Substrate,OCC1=CC=CN=C1
3637,Nilvadipine,Coumarin_7_hydroxylase-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
3638,Norfloxacin,Coumarin_7_hydroxylase-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
3639,Orphenadrine (citrate),Coumarin_7_hydroxylase-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
3640,Paracetamol,Coumarin_7_hydroxylase-Substrate,CC(=O)NC1=CC=C(O)C=C1
3641,Perazine,Coumarin_7_hydroxylase-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3642,Phenacetin,Coumarin_7_hydroxylase-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
3643,Phenazone,Coumarin_7_hydroxylase-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3644,Phenobarbital,Coumarin_7_hydroxylase-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3645,Phenobarbital,Coumarin_7_hydroxylase-Inhibitor,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3646,Pilocarpine,Coumarin_7_hydroxylase-Inhibitor,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
3647,Pilocarpine,Coumarin_7_hydroxylase-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
3648,Prednisolone,Coumarin_7_hydroxylase-Inhibitor,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
3649,Progesterone,Coumarin_7_hydroxylase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3650,Propofol,Coumarin_7_hydroxylase-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
3651,Rifampicin,Coumarin_7_hydroxylase-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3652,Rifampicin,Coumarin_7_hydroxylase-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3653,Rifampicin,Coumarin_7_hydroxylase-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
3654,Rosiglitazone,Coumarin_7_hydroxylase-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
3655,Roxatidine,Coumarin_7_hydroxylase-Substrate,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
3656,Selegiline,Coumarin_7_hydroxylase-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
3657,Seratrodast,Coumarin_7_hydroxylase-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
3658,Sevoflurane,Coumarin_7_hydroxylase-Substrate,FCOC(C(F)(F)F)C(F)(F)F
3659,Sulconazole,Coumarin_7_hydroxylase-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
3660,Sulfaphenazole,Coumarin_7_hydroxylase-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
3661,Tamoxifen,Coumarin_7_hydroxylase-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3662,Tegafur,Coumarin_7_hydroxylase-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
3663,Thalidomide,Coumarin_7_hydroxylase-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
3664,Thiamazole,Coumarin_7_hydroxylase-Inhibitor,CN1C=CNC1=S
3665,Tranylcypromine,Coumarin_7_hydroxylase-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
3666,Tretinoin,Coumarin_7_hydroxylase-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
3667,Troleandomycin,Coumarin_7_hydroxylase-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
3668,Trospium,Coumarin_7_hydroxylase-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
3669,Valproic Acid,Coumarin_7_hydroxylase-Substrate,CCCC(CCC)C(O)=O
3670,Zidovudine,Coumarin_7_hydroxylase-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
3671,Calcitriol,27B-Inhibitor,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
3672,Acetylcholin,N_acetyltransferase-Inhibitor,CC(=O)OCC[N+](C)(C)C
3673,Acetylsalicylic Acid,N_acetyltransferase-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
3674,Adenosine,N_acetyltransferase-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
3675,Allopurinol,N_acetyltransferase-Substrate,OC1=NC=NC2=C1C=NN2
3676,Amfetamine,N_acetyltransferase-Inducer,C[C@@H](N)CC1=CC=CC=C1
3677,Aminobenzoic Acid,N_acetyltransferase-Substrate,NC1=CC=C(C=C1)C(O)=O
3678,Aminobenzoic Acid,N_acetyltransferase-Inhibitor,NC1=CC=C(C=C1)C(O)=O
3679,Aminophylline,N_acetyltransferase-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
3680,Androstanolone,N_acetyltransferase-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
3681,Apomorphine,N_acetyltransferase-Inhibitor,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
3682,Arbekacin,N_acetyltransferase-Substrate,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
3683,Ascorbic Acid (vit C),N_acetyltransferase-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
3684,Bergapten,N_acetyltransferase-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
3685,Bromocriptine,N_acetyltransferase-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
3686,Bucladesine,N_acetyltransferase-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
3687,Caffeine,N_acetyltransferase-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
3688,Carbachol,N_acetyltransferase-Inhibitor,C[N+](C)(C)CCOC(N)=O
3689,Carmustine,N_acetyltransferase-Inhibitor,ClCCNC(=O)N(CCCl)N=O
3690,Cimetidine,N_acetyltransferase-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3691,Clonazepam,N_acetyltransferase-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
3692,Clonidine,N_acetyltransferase-Inhibitor,ClC1=CC=CC(Cl)=C1NC2=NCCN2
3693,Clozapine,N_acetyltransferase-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3694,Cocaine,N_acetyltransferase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3695,Cocaine,N_acetyltransferase-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3696,Dactinomycin,N_acetyltransferase-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
3697,Desipramine,N_acetyltransferase-Inducer,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3698,Desipramine,N_acetyltransferase-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3699,Dexamfetamine,N_acetyltransferase-Inducer,C[C@H](N)CC1=CC=CC=C1
3700,Diazepam,N_acetyltransferase-Inducer,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3701,Dihydralazine,N_acetyltransferase-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
3702,Dinoprostone,N_acetyltransferase-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
3703,Disulfiram,N_acetyltransferase-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3704,Esketamine,N_acetyltransferase-Inducer,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3705,Fluoxetine,N_acetyltransferase-Inducer,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3706,Folic Acid,N_acetyltransferase-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
3707,Folic Acid,N_acetyltransferase-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
3708,G-strophanthin,N_acetyltransferase-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
3709,Glycyrrhizic Acid,N_acetyltransferase-Inhibitor,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
3710,Haloperidol,N_acetyltransferase-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3711,Hydralazine,N_acetyltransferase-Substrate,NN=C1NN=CC2=C1C=CC=C2
3712,Hydrocortisone,N_acetyltransferase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
3713,Ibuprofen,N_acetyltransferase-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3714,Ibuprofen,N_acetyltransferase-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3715,Imipramine,N_acetyltransferase-Inducer,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
3716,Indometacin,N_acetyltransferase-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3717,Indometacin,N_acetyltransferase-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3718,Insulin (human),N_acetyltransferase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
3719,Iproniazide,N_acetyltransferase-Inhibitor,CC(C)NNC(=O)C1=CC=NC=C1
3720,Isoprenaline,N_acetyltransferase-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
3721,Ketamine,N_acetyltransferase-Inducer,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3722,Ketoprofen,N_acetyltransferase-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
3723,Levodopa,N_acetyltransferase-Inducer,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
3724,Lindane,N_acetyltransferase-Inducer,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
3725,Melatonin,N_acetyltransferase-Inducer,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
3726,Melatonin,N_acetyltransferase-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
3727,Mercaptamine,N_acetyltransferase-Inhibitor,NCCS
3728,Mesalazine,N_acetyltransferase-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
3729,Metamizole Sodium,N_acetyltransferase-Substrate,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
3730,Methotrexate,N_acetyltransferase-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
3731,Metoclopramide,N_acetyltransferase-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
3732,Netilmicin,N_acetyltransferase-Substrate,CCN[C@@H]1C[C@H](N)[C@@H](O[C@@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O
3733,Nicotine,N_acetyltransferase-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
3734,Norepinephrine,N_acetyltransferase-Inducer,NC[C@@H](O)C1=CC(O)=C(O)C=C1
3735,Octopamine,N_acetyltransferase-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
3736,Oxedrine,N_acetyltransferase-Inhibitor,CNC[C@@H](O)C1=CC=C(O)C=C1
3737,Paclitaxel,N_acetyltransferase-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
3738,Pargyline,N_acetyltransferase-Inducer,CN(CC#C)CC1=CC=CC=C1
3739,Phenazone,N_acetyltransferase-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3740,Procainamide,N_acetyltransferase-Substrate,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
3741,Salicylamide,N_acetyltransferase-Inhibitor,NC(=O)C1=C(O)C=CC=C1
3742,Sulfadiazine,N_acetyltransferase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
3743,Sulfamethoxazole,N_acetyltransferase-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
3744,Sulfapyridine,N_acetyltransferase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
3745,Sulindac,N_acetyltransferase-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
3746,Sultiame,N_acetyltransferase-Inducer,NS(=O)(=O)C1=CC=C(C=C1)N2CCCCS2(=O)=O
3747,Tamoxifen,N_acetyltransferase-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
3748,Testosterone,N_acetyltransferase-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
3749,Theophylline,N_acetyltransferase-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
3750,Tobramycin,N_acetyltransferase-Substrate,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
3751,Trichloroethylene,N_acetyltransferase-Substrate,ClC=C(Cl)Cl
3752,Warfarin,N_acetyltransferase-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3753,Lovastatin,4F22-Inducer,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3754,Aceclofenac,2C9-Substrate,OC(=O)COC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3755,Acenocoumarol,2C9-Inhibitor,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
3756,Acenocoumarol,2C9-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
3757,Acetylsalicylic Acid,2C9-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
3758,Adefovir Dipivoxil,2C9-Inhibitor,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C
3759,Alosetron,2C9-Substrate,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
3760,Aminophenazone,2C9-Inhibitor,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
3761,Amiodarone,2C9-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
3762,Amitriptyline,2C9-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
3763,Amlodipine,2C9-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
3764,Amodiaquine,2C9-Inhibitor,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
3765,Amprenavir,2C9-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3766,Anastrozole,2C9-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
3767,Aprepitant,2C9-Inducer,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
3768,Aprepitant,2C9-Inhibitor,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
3769,Atovaquone,2C9-Inhibitor,OC1=C([C@H]2CC[C@@H](CC2)C3=CC=C(Cl)C=C3)C(=O)C4=C(C=CC=C4)C1=O
3770,Azapropazone,2C9-Inhibitor,CCC[C@H]1C(=O)N2N(C1=O)C(=NC3=C2C=C(C)C=C3)N(C)C
3771,Azelastine,2C9-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
3772,Barnidipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
3773,Benidipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
3774,Benzbromarone,2C9-Inhibitor,CCC1=C(C(=O)C2=CC(Br)=C(O)C(Br)=C2)C3=CC=CC=C3O1
3775,Benzethonium,2C9-Inhibitor,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
3776,Bexarotene,2C9-Substrate,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
3777,Bicalutamide,2C9-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
3778,Bortezomib,2C9-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3779,Bortezomib,2C9-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
3780,Bosentan,2C9-Inducer,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
3781,Bosentan,2C9-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
3782,Brompheniramine,2C9-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
3783,Bupropion,2C9-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
3784,Caffeine,2C9-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
3785,Candesartan,2C9-Inhibitor,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
3786,Candesartan,2C9-Substrate,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
3787,Capecitabine,2C9-Inhibitor,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O
3788,Capsaicin,2C9-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
3789,Carbamazepine,2C9-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
3790,Carbinoxamine,2C9-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
3791,Carvedilol,2C9-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
3792,Celecoxib,2C9-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
3793,Chinin,2C9-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
3794,Chloramphenicol,2C9-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
3795,Chlorpropamide,2C9-Substrate,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1
3796,Ciclosporin,2C9-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
3797,Cimetidine,2C9-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
3798,Cinnarizin,2C9-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
3799,Cisapride,2C9-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
3800,Clevidipine,2C9-Inhibitor,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC
3801,Clopidogrel,2C9-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
3802,Clopidogrel,2C9-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
3803,Clotrimazole,2C9-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
3804,Clozapine,2C9-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3805,Clozapine,2C9-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
3806,Cocaine,2C9-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
3807,Colchicine,2C9-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
3808,Colchicine,2C9-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
3809,Colecalciferol,2C9-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
3810,Cyamemazine,2C9-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
3811,Cyclizine,2C9-Inhibitor,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
3812,Cyclophosphamide,2C9-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
3813,Cyclophosphamide,2C9-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
3814,Dapsone,2C9-Inducer,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3815,Dapsone,2C9-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
3816,Delavirdine,2C9-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
3817,Desloratadine,2C9-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
3818,Desogestrel,2C9-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3819,Dexamethasone,2C9-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
3820,Dexfenfluramine,2C9-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
3821,Dexibuprofen,2C9-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3822,Dexmedetomidine,2C9-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
3823,Dextromethorphan,2C9-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
3824,Dextropropoxyphene,2C9-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
3825,Diazepam,2C9-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3826,Diazepam,2C9-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
3827,Diclofenac,2C9-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3828,Diclofenac,2C9-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
3829,Diclofenamide,2C9-Inducer,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O
3830,Dicoumarol,2C9-Inhibitor,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
3831,Dicoumarol,2C9-Substrate,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC4=C1C=CC=C4
3832,Diltiazem,2C9-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
3833,Diltiazem,2C9-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
3834,Disulfiram,2C9-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
3835,Dolasetron,2C9-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
3836,Dopamine,2C9-Substrate,NCCC1=CC(O)=C(O)C=C1
3837,Dorzolamide,2C9-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
3838,Doxepin,2C9-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
3839,Dronabinol,2C9-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
3840,Efavirenz,2C9-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
3841,Enoxolone,2C9-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
3842,Entacapone,2C9-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
3843,Epinephrine,2C9-Inhibitor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
3844,Epoprostenol,2C9-Substrate,CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@@H]2OC(C[C@H]12)=C/CCCC(O)=O
3845,Eprosartan,2C9-Inhibitor,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
3846,Esketamine,2C9-Substrate,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3847,Estradiol,2C9-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
3848,Estrone,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
3849,Ethanol,2C9-Inhibitor,CCO
3850,Ethinylestradiol,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
3851,Etodolac,2C9-Substrate,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
3852,Etodolac,2C9-Inhibitor,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
3853,Etoposide,2C9-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
3854,Etoricoxib,2C9-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
3855,Felodipine,2C9-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
3856,Fenofibrate,2C9-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
3857,Flecainide,2C9-Inhibitor,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
3858,Fluconazole,2C9-Substrate,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3859,Fluconazole,2C9-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
3860,Flunarizine,2C9-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
3861,Flunitrazepam,2C9-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
3862,Fluorouracil,2C9-Inhibitor,FC1=CNC(=O)NC1=O
3863,Fluoxetine,2C9-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3864,Fluoxetine,2C9-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
3865,Fluphenazine,2C9-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
3866,Flurbiprofen,2C9-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
3867,Flurbiprofen,2C9-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
3868,Fluvastatin,2C9-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
3869,Fluvastatin,2C9-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
3870,Fluvoxamine,2C9-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
3871,Formoterol,2C9-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
3872,Fosamprenavir,2C9-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
3873,Fosphenytoin,2C9-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3874,Fosphenytoin,2C9-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
3875,Gemfibrozil,2C9-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
3876,Glibenclamide,2C9-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3877,Glibenclamide,2C9-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3878,Glimepiride,2C9-Substrate,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
3879,Glipizide,2C9-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
3880,Griseofulvin,2C9-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
3881,Halofantrine,2C9-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
3882,Haloperidol,2C9-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
3883,Halothane,2C9-Substrate,FC(F)(F)[C@@H](Cl)Br
3884,Hexobarbital,2C9-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
3885,Histamine,2C9-Substrate,NCCC1=CNC=N1
3886,Histamine,2C9-Inhibitor,NCCC1=CNC=N1
3887,Hydrochloric Acid,2C9-Inhibitor,Cl
3888,Hydromorphone,2C9-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
3889,Ibuprofen,2C9-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3890,Ibuprofen,2C9-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
3891,Idarubicin,2C9-Substrate,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(CC3=C2C(O)=C4C(=O)C5=CC=CC=C5C(=O)C4=C3O)C(C)=O
3892,Ifosfamide,2C9-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
3893,Ifosfamide,2C9-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
3894,Imatinib,2C9-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3895,Imatinib,2C9-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
3896,Indinavir,2C9-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
3897,Indometacin,2C9-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3898,Indometacin,2C9-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
3899,Ipriflavone,2C9-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
3900,Irbesartan,2C9-Substrate,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
3901,Irbesartan,2C9-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
3902,Isoniazid,2C9-Inhibitor,NNC(=O)C1=CC=NC=C1
3903,Ketamine,2C9-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
3904,Ketobemidone,2C9-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
3905,Ketoconazole,2C9-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
3906,Ketoprofen,2C9-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
3907,Lansoprazole,2C9-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3908,Lansoprazole,2C9-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3909,Lansoprazole,2C9-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
3910,Leflunomide,2C9-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
3911,Leflunomide,2C9-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
3912,Lidocain,2C9-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
3913,Lopinavir,2C9-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
3914,Loratadine,2C9-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3915,Loratadine,2C9-Substrate,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
3916,Lornoxicam,2C9-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O
3917,Lornoxicam,2C9-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=C(Cl)S3)S1(=O)=O
3918,Losartan,2C9-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3919,Losartan,2C9-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
3920,Lovastatin,2C9-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3921,Lovastatin,2C9-Inducer,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
3922,Lumiracoxib,2C9-Substrate,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
3923,Lynestrenol,2C9-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
3924,Manidipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
3925,Medroxyprogesterone,2C9-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
3926,Medrysone,2C9-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
3927,Mefenamic Acid,2C9-Substrate,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
3928,Mefenamic Acid,2C9-Inhibitor,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
3929,Meloxicam,2C9-Inhibitor,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
3930,Meloxicam,2C9-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
3931,Mephenytoin,2C9-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
3932,Methadone,2C9-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
3933,Methazolamide,2C9-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
3934,Methoxyflurane,2C9-Substrate,COC(F)(F)C(Cl)Cl
3935,Metronidazole,2C9-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
3936,Metronidazole,2C9-Substrate,CC1=NC=C(N1CCO)[N+]([O-])=O
3937,Miconazole,2C9-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
3938,Mirtazapine,2C9-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
3939,Mizolastine,2C9-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
3940,Moclobemide,2C9-Substrate,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
3941,Moclobemide,2C9-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
3942,Modafinil,2C9-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
3943,Modafinil,2C9-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
3944,Naproxen,2C9-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
3945,Nateglinide,2C9-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
3946,Nelfinavir,2C9-Inducer,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3947,Nelfinavir,2C9-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
3948,Nevirapine,2C9-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
3949,Nevirapine,2C9-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
3950,Nicardipine,2C9-Inducer,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3951,Nicardipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
3952,Nicotine,2C9-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
3953,Nifedipine,2C9-Inducer,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
3954,Nifedipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
3955,Nilutamide,2C9-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
3956,Nilvadipine,2C9-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
3957,Nimesulide,2C9-Inhibitor,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
3958,Nimesulide,2C9-Substrate,CS(=O)(=O)NC1=C(OC2=CC=CC=C2)C=C(C=C1)[N+]([O-])=O
3959,Noscapine,2C9-Inhibitor,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34
3960,Olanzapine,2C9-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
3961,Omeprazole,2C9-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3962,Omeprazole,2C9-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
3963,Ondansetron,2C9-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
3964,Orphenadrine (citrate),2C9-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
3965,Oxaprozin,2C9-Substrate,OC(=O)CCC1=NC(=C(O1)C2=CC=CC=C2)C3=CC=CC=C3
3966,Paclitaxel,2C9-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
3967,Pancreozymin (cholecystokinin),2C9-Inhibitor,CC[C@H](C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H]2CCCN2C(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]3CCCN3C(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN)[C@H](C)CC)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC6=CC=CC=C6)C(N)=O)C7=CC=C(OS(O)(=O)=O)C=C7
3968,Pantoprazole,2C9-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
3969,Paracetamol,2C9-Substrate,CC(=O)NC1=CC=C(O)C=C1
3970,Parecoxib,2C9-Inhibitor,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
3971,Paroxetine,2C9-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
3972,Perazine,2C9-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3973,Perazine,2C9-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
3974,Perphenazine,2C9-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
3975,Phenacetin,2C9-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
3976,Phenazone,2C9-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
3977,Phenobarbital,2C9-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3978,Phenobarbital,2C9-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
3979,Phenprocoumon,2C9-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
3980,Phentermine,2C9-Inducer,CC(C)(N)CC1=CC=CC=C1
3981,Phentermine,2C9-Inhibitor,CC(C)(N)CC1=CC=CC=C1
3982,Phenylbutazone,2C9-Inhibitor,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
3983,Phenylbutazone,2C9-Substrate,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
3984,Phenytoin,2C9-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3985,Phenytoin,2C9-Inhibitor,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3986,Phenytoin,2C9-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
3987,Pioglitazone,2C9-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3988,Pioglitazone,2C9-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
3989,Piroxicam,2C9-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
3990,Piroxicam,2C9-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
3991,Pranlukast,2C9-Inhibitor,O=C(NC1=CC=C2C(=O)C=C(OC2=C1)C3=NN=NN3)C4=CC=C(OCCCCC5=CC=CC=C5)C=C4
3992,Pravastatin,2C9-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
3993,Pravastatin,2C9-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
3994,Primidone,2C9-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
3995,Probenecid,2C9-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
3996,Progesterone,2C9-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3997,Progesterone,2C9-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
3998,Proguanil,2C9-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
3999,Promethazine,2C9-Inhibitor,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
4000,Propafenone,2C9-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
4001,Propanol,2C9-Inhibitor,CCCO
4002,Propofol,2C9-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
4003,Propofol,2C9-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
4004,Pyrimethamine,2C9-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
4005,Quazepam,2C9-Substrate,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3
4006,Quinidine,2C9-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
4007,Quinidine,2C9-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
4008,Retinol (vit A),2C9-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4009,Rifampicin,2C9-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4010,Rifampicin,2C9-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4011,Rifapentine,2C9-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
4012,Ritonavir,2C9-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4013,Ritonavir,2C9-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4014,Rofecoxib,2C9-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
4015,Rosiglitazone,2C9-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4016,Rosiglitazone,2C9-Substrate,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4017,Rosuvastatin,2C9-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
4018,Rosuvastatin,2C9-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
4019,Rutoside,2C9-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
4020,Saquinavir,2C9-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4021,Secobarbital,2C9-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
4022,Selegiline,2C9-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4023,Selegiline,2C9-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4024,Seratrodast,2C9-Inducer,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
4025,Seratrodast,2C9-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
4026,Seratrodast,2C9-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
4027,Sertraline,2C9-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
4028,Sertraline,2C9-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
4029,Sildenafil,2C9-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
4030,Silymarin,2C9-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
4031,Simvastatin,2C9-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4032,Ezetimibe,2C9-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
4033,Sulconazole,2C9-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
4034,Sulfadiazine,2C9-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
4035,Sulfadiazine,2C9-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
4036,Sulfadimethoxine,2C9-Inhibitor,COC1=NC(OC)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1
4037,Sulfadimidine,2C9-Inhibitor,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
4038,Sulfafurazole,2C9-Substrate,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
4039,Sulfafurazole,2C9-Inhibitor,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
4040,Sulfamethizole,2C9-Inhibitor,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
4041,Sulfamethoxazole,2C9-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
4042,Sulfamethoxazole,2C9-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
4043,Trimethoprim,2C9-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
4044,Trimethoprim,2C9-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
4045,Sulfamoxole,2C9-Inhibitor,CC1=C(C)N=C(NS(=O)(=O)C2=CC=C(N)C=C2)O1
4046,Sulfanilamide,2C9-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
4047,Sulfaphenazole,2C9-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
4048,Sulfapyridine,2C9-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
4049,Sulfinpyrazon,2C9-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
4050,Sulfinpyrazon,2C9-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
4051,Suprofen,2C9-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
4052,Suprofen,2C9-Substrate,C[C@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
4053,Tamoxifen,2C9-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4054,Tamoxifen,2C9-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4055,Tegaserod,2C9-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
4056,Telmisartan,2C9-Inhibitor,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
4057,Temazepam,2C9-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4058,Teniposide,2C9-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
4059,Tenofovir Disoproxil,2C9-Inhibitor,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C
4060,Tenoxicam,2C9-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O
4061,Terbinafine,2C9-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
4062,Terfenadine,2C9-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
4063,Testosterone,2C9-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4064,Tetrabenazine,2C9-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
4065,Thalidomide,2C9-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
4066,Theophylline,2C9-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
4067,Thiamazole,2C9-Inhibitor,CN1C=CNC1=S
4068,Thioridazine,2C9-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
4069,Tibolone,2C9-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
4070,Ticlopidine,2C9-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
4071,Tienilic Acid,2C9-Inducer,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2
4072,Tienilic Acid,2C9-Substrate,OC(=O)COC1=C(Cl)C(Cl)=C(C=C1)C(=O)C2=CC=CS2
4073,Tioconazole,2C9-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
4074,Tolbutamide,2C9-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
4075,Tolbutamide,2C9-Inhibitor,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
4076,Tolcapone,2C9-Inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
4077,Tolterodine,2C9-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
4078,Torasemide,2C9-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
4079,Trabectedin,2C9-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
4080,Tranylcypromine,2C9-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
4081,Tretinoin,2C9-Inhibitor,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4082,Tretinoin,2C9-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4083,Triazolam,2C9-Inhibitor,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
4084,Trimethadione,2C9-Substrate,CN1C(=O)OC(C)(C)C1=O
4085,Trimipramine,2C9-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4086,Troglitazone,2C9-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4087,Troglitazone,2C9-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4088,Tropisetron,2C9-Substrate,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
4089,Trospium,2C9-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
4090,Valdecoxib,2C9-Substrate,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
4091,Valdecoxib,2C9-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
4092,Valproic Acid,2C9-Inhibitor,CCCC(CCC)C(O)=O
4093,Valproic Acid,2C9-Substrate,CCCC(CCC)C(O)=O
4094,Valsartan,2C9-Inhibitor,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
4095,Valsartan,2C9-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
4096,Venlafaxine,2C9-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
4097,Verapamil,2C9-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4098,Verapamil,2C9-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4099,Voriconazole,2C9-Inhibitor,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4100,Voriconazole,2C9-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4101,Warfarin,2C9-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4102,Warfarin,2C9-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4103,Ximelagatran,2C9-Substrate,CCOC(=O)CN[C@H]([C@H]1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)C=NNO
4104,Zafirlukast,2C9-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4105,Zafirlukast,2C9-Substrate,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4106,Zalcitabine,2C9-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
4107,Zidovudine,2C9-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
4108,Zolpidem,2C9-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
4109,Zolpidem,2C9-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
4110,Zopiclone,2C9-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
4111,11_oxo_delta_8_tetrahydro_cannabinol,2C9-Substrate,CCCCCC1=CC2=C([C@@H]3CC(=CC[C@H]3C(C)(C)O2)C=O)C(=C1)O
4112,17_beta_estradiol,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O
4113,18_methoxy_coronaridine,2C9-Substrate,COCC[C@H]1CC2CN3CCC4=C([NH]C5=CC=CC=C45)[C@](C2)(C13)C(=O)OC
4114,2_acetylbenzothiophene,2C9-Substrate,CC(=O)C1=CC2=CC=CC=C2S1
4115,2_oxo_ticlopidine,2C9-Substrate,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2
4116,2n_propylquinoline,2C9-Substrate,CCCC1=CC=C2C=CC=CC2=N1
4117,3_O_methyl_fluorescein,2C9-Substrate,COC1=CC=C2C(=C1)OC3=CC(=CC=C3C24OC(=O)C5=CC=CC=C45)O
4118,5_hydroxy_tryptamine,2C9-Substrate,NCCC1=C[NH]C2=CC=C(O)C=C12
4119,58C80_tautomer_1,2C9-Substrate,CC(C)(C)C1CCC(CC1)C2=C(O)C3=CC=CC=C3C(=O)C2=O
4120,7_benzyloxy_4_trifluoromethyl_coumarin,2C9-Substrate,FC(F)(F)C1=C[C](=O)OC2=CC(=CC=C12)OCC3=CC=CC=C3
4121,7_ethoxy_coumarin,2C9-Substrate,CCOC1=CC=C2C=C[C](=O)OC2=C1
4122,ABT_438,2C9-Substrate,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1
4123,acetaminophen,2C9-Substrate,CC(=O)NC1=CC=C(O)C=C1
4124,amitriptyline,2C9-Substrate,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13
4125,antipyrine,2C9-Substrate,C[N]1[N]([C](=O)C=C1C)C2=CC=CC=C2
4126,atomoxetine,2C9-Substrate,CNCC[C@@H](OC1=C(C)C=CC=C1)C2=CC=CC=C2
4127,BMAMC,2C9-Substrate,CCCCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
4128,bortezomib,2C9-Substrate,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
4129,BPR_0L075,2C9-Substrate,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC
4130,butadienemonoxide,2C9-Substrate,C=CC1CO1
4131,carbaryl,2C9-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
4132,carbofuran,2C9-Substrate,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1
4133,carvedilol_S,2C9-Substrate,COC1=CC=CC=C1OCCNC[C@H](O)COC2=C3C(=CC=C2)[NH]C4=C3C=CC=C4
4134,catechol_methoxychlor,2C9-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C(=C2)O)C(Cl)(Cl)Cl
4135,celecoxib,2C9-Substrate,CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S](N)(=O)=O)C(F)(F)F
4136,chlorpyrifos,2C9-Substrate,CCO[P](=S)(OCC)OC1=NC(=C(Cl)C=C1Cl)Cl
4137,cinnarizine,2C9-Substrate,C1CN(CCN1C\C=C\C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
4138,clobazam,2C9-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
4139,clozapine,2C9-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
4140,CMV_423,2C9-Substrate,NC(=O)C1=C2CCCC[N]2C(=C1Cl)C3=CC=CN=C3
4141,cp_677_623,2C9-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
4142,dapsone,2C9-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)C2=CC=C(N)C=C2
4143,DDB_aka_BDD,2C9-Substrate,COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3C(=O)OC)OC
4144,DDTC_Me,2C9-Substrate,CCN(CC)C(=S)SC
4145,deoxy_podophyllotoxin,2C9-Substrate,COC1=C(OC)C(=CC(=C1)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=CC5=C(OCO5)C=C24)OC
4146,desogestrel,2C9-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
4147,DETC_Me,2C9-Substrate,CCN(CC)C(=O)SC
4148,diallylsulfide,2C9-Substrate,C=CCSSCC=C
4149,diazepam,2C9-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
4150,diclofenac_deriv_2,2C9-Substrate,OCCC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4151,diltiazem,2C9-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
4152,dimemorfan,2C9-Substrate,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C)C=C4
4153,disulfoton,2C9-Substrate,CCO[P](=S)(OCC)SCCSCC
4154,diuron,2C9-Substrate,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl
4155,DMBA,2C9-Substrate,CC1=C2C=CC=CC2=C(C)C3=C4C=CC=CC4=CC=C13
4156,DMZ,2C9-Substrate,CN(C1=CC=N[N]1C2=CC=CC=C2)[S](=O)(=O)C3=CC=C(C)C=C3
4157,DY_9760e,2C9-Substrate,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl
4158,endosulfan,2C9-Substrate,ClC1=C(Cl)C2(Cl)C3CO[S](=O)OCC3C1(Cl)C2(Cl)Cl
4159,estrone,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CCC2=O
4160,ethanol,2C9-Substrate,CCO
4161,ethinyl_estradiol,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@]2(O)C#C
4162,etodolac_R,2C9-Substrate,CCC1=C2[NH]C3=C(CCO[C@]3(CC)CC(O)=O)C2=CC=C1
4163,FLU,2C9-Substrate,NC1=CC=C(C(=C1)C(F)(F)F)[N](=O)=O
4164,fluoxetine_R,2C9-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
4165,flurbiprofen_R,2C9-Substrate,C[C@@H](C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2
4166,fluvastatin,2C9-Substrate,CC(C)[N]1C2=CC=CC=C2C(=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3
4167,galangin,2C9-Substrate,OC1=CC(=C2[C](=O)C(=C(OC2=C1)C3=CC=CC=C3)O)O
4168,H_259_31_R,2C9-Substrate,FC1=CC=C2N=C([NH]C2=C1)[S@](=O)CC3=NC=CC(=C3)OCC4CC4
4169,haloperidol,2C9-Substrate,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
4170,harmaline,2C9-Substrate,COC1=CC2=C(C=C1)C3=C([NH]2)C(=NCC3)C
4171,harmine,2C9-Substrate,COC1=CC=C2C(=C1)[NH]C3=C2C=CN=C3C
4172,ibuprofen_R,2C9-Substrate,CC(C)CC1=CC=C(C=C1)[C@@H](C)C(O)=O
4173,imidacloprid,2C9-Substrate,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1
4174,imipramine,2C9-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13
4175,indomethacin,2C9-Substrate,COC1=CC=C2[N](C(=C(CC(O)=O)C2=C1)C)C(=O)C3=CC=C(Cl)C=C3
4176,ipriflavone,2C9-Substrate,CC(C)OC1=CC=C2C(=C1)OC=C([C]2=O)C3=CC=CC=C3
4177,K11777,2C9-Substrate,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4
4178,ketamine_R,2C9-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
4179,ketobemidone,2C9-Substrate,CCC(=O)C1(CCN(C)CC1)C2=CC=CC(=C2)O
4180,lauric_acid,2C9-Substrate,CCCCCCCCCCCC(O)=O
4181,licofelone,2C9-Substrate,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O
4182,lidocaine,2C9-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4183,limonene_S,2C9-Substrate,CC(=C)[C@H]1CCC(=CC1)C
4184,losartan,2C9-Substrate,CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)Cl
4185,Lu_AA21004,2C9-Substrate,CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C
4186,MDE_R,2C9-Substrate,CCN[C@H](C)CC1=CC=C2OCOC2=C1
4187,mephenytoin_S,2C9-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
4188,methiocarb,2C9-Substrate,CNC(=S)OC1=CC(=C(SC)C(=C1)C)C
4189,mirtazapine_R,2C9-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CN=C24
4190,ML_3403,2C9-Substrate,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4
4191,montelukast,2C9-Substrate,CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC2(CC2)CC(O)=O)C3=CC=CC(=C3)\C=C\C4=CC=C5C=CC(=CC5=N4)Cl
4192,morphine,2C9-Substrate,CN1CC[C@@]23[C@H]4OC5=C(O)C=CC(=C25)C[C@@H]1[C@@H]3C=C[C@@H]4O
4193,muraglitazar,2C9-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
4194,N_desmethyl_clomipramine,2C9-Substrate,CNCCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4195,naproxen_S,2C9-Substrate,COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
4196,NE_100,2C9-Substrate,CCCN(CCC)CCC1=CC=C(OC)C(=C1)OCCC2=CC=CC=C2
4197,nicardipine_R,2C9-Substrate,COC(=O)C1=C(C)NC(=C([C@@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)OCCN(C)CC3=CC=CC=C3)C
4198,NN_diamyl_nitrosoamine,2C9-Substrate,CCCCCN(CCCCC)N=O
4199,NN_diethyl_nitrosoamine,2C9-Substrate,CCN(CC)N=O
4200,NN_dimethyl_nitrosoamine,2C9-Substrate,CN(C)N=O
4201,NN_methyl_butyl_nitrosoamine,2C9-Substrate,CCCCN(C)N=O
4202,NN_methyl_ethyl_nitrosoamine,2C9-Substrate,CCN(C)N=O
4203,NNK,2C9-Substrate,CN(CCCC(=O)C1=CC=CN=C1)N=O
4204,norLAAM,2C9-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2
4205,ochratoxin_A,2C9-Substrate,C[C@@H]1CC2=C(C(=C(C=C2Cl)C(=O)N[C@@H](CC3=CC=CC=C3)C(O)=O)O)C(=O)O1
4206,perazine,2C9-Substrate,CN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=CC=C4)CC1
4207,phenytoin,2C9-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
4208,phorate,2C9-Substrate,CCO[P](=S)(OCC)SCSCC
4209,piroxicam,2C9-Substrate,CN1C(=C(O)C2=CC=CC=C2[S]1(=O)=O)C(=O)NC3=NC=CC=C3
4210,progesterone,2C9-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4211,promazine,2C9-Substrate,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13
4212,propofol,2C9-Substrate,CC(C)C1=C(O)C(=CC=C1)C(C)C
4213,quinidine,2C9-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
4214,R_95913,2C9-Substrate,FC1=CC=CC=C1C(N2CCC3SC(=O)C=C3C2)C(=O)C4CC4
4215,rabeprazole_thioether,2C9-Substrate,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2
4216,retinol,2C9-Substrate,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
4217,rosiglitazone_R,2C9-Substrate,CN(CCOC1=CC=C(C[C@H]2SC(=O)NC2=O)C=C1)C3=CC=CC=N3
4218,rutaecarpine,2C9-Substrate,O=[C]1[N]2CCC3=C([NH]C4=CC=CC=C34)C2=NC5=C1C=CC=C5
4219,S_145,2C9-Substrate,OC(=O)CCC\C=C/C[C@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3
4220,S_MTPPA,2C9-Substrate,C[C@H](C(O)=O)C1=CC=C(C=C1)C2=C(C)C=CS2
4221,selegiline,2C9-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4222,seratrodast_R,2C9-Substrate,CC1=C(C)C(=O)C(=C(C)C1=O)[C@H](CCCCCC(O)=O)C2=CC=CC=C2
4223,sertraline,2C9-Substrate,CN[C@H]1CC[C@@H](C2=CC(=C(Cl)C=C2)Cl)C3=C1C=CC=C3
4224,sildenafil,2C9-Substrate,CCCC1=N[N](C)C2=C1N=C([NH][C]2=O)C3=CC(=CC=C3OCC)[S](=O)(=O)N4CCN(C)CC4
4225,SNI_2011_R_R,2C9-Substrate,C[C@@H]1O[C@@]2(CS1)CN3CCC2CC3
4226,sulfadiazine,2C9-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CC=N2
4227,sulfamethoxazole,2C9-Substrate,CC1=CC(=NO1)N[S](=O)(=O)C2=CC=C(N)C=C2
4228,sulfinpyrazone_sulfide,2C9-Substrate,O=C1C(CCSC2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
4229,sulprofos,2C9-Substrate,CCCS[P](=S)(OCC)OC1=CC=C(SC)C=C1
4230,suprofen_R,2C9-Substrate,C[C@@H](C(O)=O)C1=CC=C(C=C1)C(=O)C2=CC=CS2
4231,tegafur,2C9-Substrate,FC1=C[N](C2CCCO2)[C](=O)[NH][C]1=O
4232,temazepam,2C9-Substrate,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C3=C1C=CC(=C3)Cl
4233,tenoxicam,2C9-Substrate,CN1\C(=C(\O)NC2=CC=CC=N2)C(=O)C3=C(C=CS3)[S]1(=O)=O
4234,terbinafine,2C9-Substrate,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12
4235,territrem_A,2C9-Substrate,COC1=CC(=CC2=C1OCO2)C3=CC4=C(C[C@]5(O)[C@](C)(CC[C@@]6(O)C(C)(C)C=CC(=O)[C@]56C)O4)[C](=O)O3
4236,tetranor,2C9-Substrate,OC(=O)CC[C@@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3
4237,thalidomide,2C9-Substrate,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
4238,tienilic_acid_deriv_3_isomer,2C9-Substrate,OC(=O)COC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CSC=C2
4239,tolbutamide,2C9-Substrate,CCCCNC(=O)N[S](=O)(=O)C1=CC=C(C)C=C1
4240,tolterodine,2C9-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C2=CC(=CC=C2O)C)C(C)C
4241,torasemide,2C9-Substrate,CC(C)NC(=O)N[S](=O)(=O)C1=CN=CC=C1NC2=CC=CC(=C2)C
4242,TR_14035,2C9-Substrate,COC1=C(C(=CC=C1)OC)C2=CC=C(C[C@H](NC(=O)C3=C(Cl)C=CC=C3Cl)C(O)=O)C=C2
4243,tramadol,2C9-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
4244,trimethadione,2C9-Substrate,CN1C(=O)OC(C)(C)C1=O
4245,V_11294,2C9-Substrate,CCNC1=C2N=C(N=C2[N](CC3=CC=C(OC)C(=C3)OC4CCCC4)C=N1)C(C)C
4246,valdecoxib,2C9-Substrate,CC1=C(C2=CC=C(C=C2)[S](N)(=O)=O)C(=NO1)C3=CC=CC=C3
4247,valproic_acid,2C9-Substrate,CCCC(CCC)C(O)=O
4248,valsartan,2C9-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NN=N[NH]3)[C@@H](C(C)C)C(O)=O
4249,venlafaxine_R,2C9-Substrate,COC1=CC=C(C=C1)[C@H](CN(C)C)C2(O)CCCCC2
4250,vicriviroc,2C9-Substrate,COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F
4251,voriconazole,2C9-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F
4252,warfarin_S,2C9-Substrate,CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
4253,zileuton_R,2C9-Substrate,C[C@@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1
4254,zopiclone_R,2C9-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4
4255,zotepine,2C9-Substrate,CN(C)CCOC1=CC2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4256,13_cis_retinoic_acid,2C9-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
4257,2_oxo_clopidogrel,2C9-Substrate,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3
4258,2_oxo_quazepam,2C9-Substrate,FC1=CC=CC=C1C2=NCC(=O)N(CC(F)(F)F)C3=CC=C(Cl)C=C23
4259,3_methylether_estradiol,2C9-Substrate,COC1=CC=C2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2=C1
4260,4prime_hydroxy_clobazam,2C9-Substrate,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C3=CC(=CC=C13)Cl
4261,5_hydroxy_diclofenac,2C9-Substrate,OC(=O)CC1=CC(=CC=C1NC2=C(Cl)C=CC=C2Cl)O
4262,7_methoxy_3_cyano_coumarin,2C9-Substrate,COC1=CC=C2C=C(C#N)[C](=O)OC2=C1
4263,7_methoxy_4_trifluoro_methyl_coumarin,2C9-Substrate,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
4264,9_cis_retinoic_acid,2C9-Substrate,CC1=C(\C=C\C(C)=C/C=C/C(C)=C/C(O)=O)C(C)(C)CCC1
4265,ABT_66193,2C9-Substrate,CC(NC(N)=O)C1=CC2=CC=CC=C2S1
4266,ABT_761,2C9-Substrate,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O
4267,aceclofenac,2C9-Substrate,OC(=O)COC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4268,acenocoumarol_R,2C9-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N](=O)=O)C2=C(O)C3=C(O[C]2=O)C=CC=C3
4269,all_trans_retinal,2C9-Substrate,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
4270,all_trans_retinoic_acid,2C9-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1
4271,clomipramine,2C9-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4272,delta_9_tetrahydrocannabinol,2C9-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(=C1)O
4273,dextromethorphan,2C9-Substrate,COC1=CC2=C(C[C@@H]3[C@@H]4CCCC[C@]24CCN3C)C=C1
4274,dibenzyl_fluorescein,2C9-Substrate,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17
4275,diclofenac,2C9-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4276,eupatilin,2C9-Substrate,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC
4277,flunarizine,2C9-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)C\C=C\C3=CC=CC=C3)C4=CC=C(F)C=C4
4278,flunitrazepam,2C9-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N](=O)=O
4279,flurbiprofen_S,2C9-Substrate,C[C@H](C(O)=O)C1=CC=C(C(=C1)F)C2=CC=CC=C2
4280,flutamide,2C9-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N](=O)=O)C(F)(F)F
4281,foxy,2C9-Substrate,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1
4282,indomethacin_phenethylamide,2C9-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCCC3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
4283,kaempferide,2C9-Substrate,COC1=CC=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O
4284,LAAM,2C9-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4285,lansoprazole_R,2C9-Substrate,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3[NH]2
4286,losartan_carboxaldehyde_EXP_3179,2C9-Substrate,CCCCC1=NC(=C(C=O)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)Cl
4287,meloxicam,2C9-Substrate,CN1C(=C(O)C2=CC=CC=C2[S]1(=O)=O)C(=O)NC3=NC=C(C)S3
4288,methoxychlor,2C9-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(OC)C=C2)C(Cl)(Cl)Cl
4289,methyl_eugenol,2C9-Substrate,COC1=C(OC)C=C(CC=C)C=C1
4290,mono_OH_methoxychlor,2C9-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
4291,omeprazole_S,2C9-Substrate,COC1=CC=C2[NH]C(=NC2=C1)[S@@](=O)CC3=NC=C(C)C(=C3C)OC
4292,perphenazine,2C9-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
4293,phenprocoumon_R,2C9-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
4294,phenprocoumon_S,2C9-Substrate,CC[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
4295,quazepam,2C9-Substrate,FC1=CC=CC=C1C2=NCC(=S)N(CC(F)(F)F)C3=CC=C(Cl)C=C23
4296,safrole,2C9-Substrate,C=CCC1=CC=C2OCOC2=C1
4297,suprofen_desmethyl,2C9-Substrate,OC(=O)COC1=CC=C(C=C1)C(=O)C2=CC=CS2
4298,tamarixetin,2C9-Substrate,COC1=C(O)C=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O
4299,testosterone,2C9-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4300,thioridazine_R,2C9-Substrate,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1
4301,tienilic_acid,2C9-Substrate,OC(=O)COC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CC=CS2
4302,tienilic_acid_deriv_1,2C9-Substrate,OC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CC=CS2
4303,tienilic_acid_newderiv_9,2C9-Substrate,ClC1=C(Cl)C(=CC=C1OCC2=NN=N[NH]2)C(=O)C3=CC=CS3
4304,warfarin_R,2C9-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(O[C]2=O)C=CC=C3
4305,Acetylsalicylic acid,2C9-Substrate,CC(=O)OC1=CC=CC=C1C(=O)O
4306,Albendazole,2C9-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
4307,Aminopyrine,2C9-Substrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
4308,Amiodarone,2C9-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
4309,Amoxapine,2C9-Substrate,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
4310,Atomoxetine,2C9-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
4311,Bufuralol,2C9-Substrate,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
4312,Carbaril,2C9-Substrate,CNC(=O)OC1=CC=CC2=CC=CC=C21
4313,Chlorpyrifos,2C9-Substrate,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
4314,Clomipramine,2C9-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4315,Delavirdine,2C9-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
4316,Disopyramide,2C9-Substrate,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C
4317,Eletriptan,2C9-Substrate,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
4318,Etoperidone,2C9-Substrate,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
4319,Etoricoxib,2C9-Substrate,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
4320,Gliclazide,2C9-Substrate,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2C[C@@H]3CCC[C@@H]3C2
4321,Imipramine,2C9-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4322,Indinavir,2C9-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
4323,Levacetylmethadol,2C9-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4324,Lidocaine,2C9-Substrate,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
4325,Mefenamic acid,2C9-Substrate,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
4326,Mestranol,2C9-Substrate,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC
4327,Midazolam,2C9-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
4328,Montelukast,2C9-Substrate,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
4329,Morphine,2C9-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
4330,Nelfinavir,2C9-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
4331,Praziquantel,2C9-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
4332,Promazine,2C9-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
4333,Pyrantel,2C9-Substrate,CN1CCCN=C1C=CC2=CC=CS2
4334,Quetiapine,2C9-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
4335,Repaglinide,2C9-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
4336,Ritonavir,2C9-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4337,Sulfinpyrazone,2C9-Substrate,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
4338,Tauromustine,2C9-Substrate,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
4339,Tegafur,2C9-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
4340,Tiaramide,2C9-Substrate,C1CN(CCN1CCO)C(=O)CN2C3=C(C=CC(=C3)Cl)SC2=O
4341,Tienilic acid,2C9-Substrate,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
4342,Toremifene,2C9-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
4343,Trichloromethane,2C9-Substrate,C(Cl)(Cl)Cl
4344,Valproic acid,2C9-Substrate,CCCC(CCC)C(=O)O
4345,Zaltoprofen,2C9-Substrate,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
4346,Zileuton,2C9-Substrate,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
4347,Alprenolol,-,CC(C)NC[C@H](O)COC1=CC=CC=C1CC=C
4348,Astemizole,-,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
4349,Azelastine,-,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
4350,Betaxolol,-,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
4351,Buprenorphine,-,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4352,Chlorphenamine,-,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
4353,Chlorpromazine,-,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4354,Citalopram,-,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
4355,Codeine,-,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
4356,Debrisoquine,-,NC(=N)N1CCC2=C(C1)C=CC=C2
4357,Desipramine,-,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4358,Diphenhydramine,-,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
4359,Ezlopitant,-,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
4360,Flecainide,-,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
4361,Fluperlapine,-,CN1CCN(CC1)C2=NC3=C(CC4=CC=CC=C42)C=CC(=C3)F
4362,Fluphenazine,-,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
4363,Fluvoxamine,-,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
4364,Halofantrine,-,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
4365,Labetalol,-,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
4366,Loratadine,-,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
4367,Maprotiline,-,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
4368,Mizolastine,-,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
4369,Norfluoxetine,-,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
4370,Nortriptyline,-,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4371,Olanzapine,-,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
4372,Paroxetine,-,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
4373,Perhexiline,-,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
4374,Primaquine,-,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
4375,Promethazine,-,C[C@@H](CN1C2=C(SC3=C1C=CC=C3)C=CC=C2)N(C)C
4376,Propafenone,-,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
4377,Propranolol,-,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
4378,Ranitidine,-,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4379,Risperidone,-,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
4380,Saquinavir,-,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4381,Sertindole,-,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
4382,Sparteine,-,C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1
4383,Tegaserod,-,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
4384,Terfenadine,-,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
4385,Thioridazine,-,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
4386,Timolol,-,CC(C)(C)NC[C@H](O)COC1=NSN=C1N2CCOCC2
4387,Tolperisone,-,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
4388,Trimipramine,-,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4389,Yohimbine,-,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
4390,Carbamazepine,2C9-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4391,Cinnarizine,2C9-Substrate,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
4392,Mianserin,2C9-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
4393,Almotriptan,-,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
4394,Bupranolol,-,CC1=CC(OC[C@@H](O)CNC(C)(C)C)=C(Cl)C=C1
4395,Chloroquine,-,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
4396,Haloperidol,-,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
4397,Metoclopramide,-,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4398,Metoprolol,-,COCCC1=CC=C(OC[C@H](O)CNC(C)C)C=C1
4399,Nicardipine,-,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
4400,Nifedipine,-,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
4401,Orphenadrine,-,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
4402,Pindolol,-,CC(C)NC[C@@H](O)COC1=CC=CC2=C1C=CN2
4403,Vinorelbine,-,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
4404,Amitriptyline,2C9-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4405,Astemizole,2C9-Inhibitor,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
4406,Atazanavir,2C9-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
4407,Atorvastatin,2C9-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
4408,Buprenorphine,2C9-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4409,Cerivastatin,2C9-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
4410,Chlorpromazine,2C9-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4411,Cilnidipine,2C9-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3
4412,Citalopram,2C9-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
4413,Dexloxiglumide,2C9-Inhibitor,CCCCCN(CCCOC)C(=O)C(CCC(=O)O)NC(=O)C1=CC(=C(C=C1)Cl)Cl
4414,Dimethyl sulfoxide,2C9-Inhibitor,CS(=O)C
4415,Drospirenone,2C9-Inhibitor,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
4416,Escitalopram,2C9-Inhibitor,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
4417,Irinotecan,2C9-Inhibitor,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4418,Isradipine,2C9-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
4419,Itraconazole,2C9-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
4420,Mefenamic acid,2C9-Inhibitor,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
4421,Mephenytoin,2C9-Inhibitor,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
4422,Methoxsalen,2C9-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
4423,Midazolam,2C9-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
4424,Nateglinide,2C9-Inhibitor,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
4425,Nimodipine,2C9-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
4426,Nitrendipine,2C9-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
4427,Ondansetron,2C9-Inhibitor,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
4428,Orphenadrine,2C9-Inhibitor,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
4429,Parathion,2C9-Inhibitor,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
4430,Perphenazine,2C9-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
4431,Phenprocoumon,2C9-Inhibitor,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4432,Proadifen,2C9-Inhibitor,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
4433,Quercetin,2C9-Inhibitor,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
4434,Quetiapine,2C9-Inhibitor,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
4435,Rabeprazole,2C9-Inhibitor,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
4436,Rebamipide,2C9-Inhibitor,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
4437,Sildenafil,2C9-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
4438,Sulfinpyrazone,2C9-Inhibitor,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
4439,Tenoxicam,2C9-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CS3)S1(=O)=O
4440,Terfenadine,2C9-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
4441,Tezosentan,2C9-Inhibitor,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC
4442,Tiabendazole,2C9-Inhibitor,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
4443,Tienilic acid,2C9-Inhibitor,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
4444,Valproic acid,2C9-Inhibitor,CCCC(CCC)C(=O)O
4445,Zaltoprofen,2C9-Inhibitor,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
4446,Zileuton,2C9-Inhibitor,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
4447,Amoxapine,-,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
4448,Bufuralol,-,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
4449,Celecoxib,-,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4450,Clomipramine,-,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4451,Dextromethorphan,-,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
4452,Etoperidone,-,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
4453,Imipramine,-,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4454,Lidocaine,-,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
4455,Mirtazapine,-,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
4456,Praziquantel,-,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
4457,Venlafaxine,-,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
4458,Carbamazepine,2C9-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4459,Norfluoxetine,2C9-Inhibitor,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
4460,Stiripentol,2C9-Inhibitor,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
4461,Sulfadoxine,2C9-Inhibitor,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N
4462,Sulfamerazine,2C9-Inhibitor,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N
4463,Sulfatroxazole,2C9-Inhibitor,CC1=C(ON=C1NS(=O)(=O)C2=CC=C(C=C2)N)C
4464,Sulindac,2C9-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
4465,Cisapride,-,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
4466,Methadone,-,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4467,Mianserin,-,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
4468,Tropisetron,-,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
4469,Ketoconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4470,Meglutol,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,CC(O)(CC(O)=O)CC(O)=O
4471,Sertaconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl
4472,Terconazole,Sterol_14_alpha_demethylase_Lanosterol_14_alpha_demethylase-Inhibitor,CC(C)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4473,Sodium Bicarbonate,Electrogenic_sodium_bicarbonate_cotransporter_1-Substrate,OC([O-])=O
4474,Tenidap,Electrogenic_sodium_bicarbonate_cotransporter_1-Inhibitor,NC(=O)N1C(=O)C(=C(/O)C2=CC=CS2)C3=C1C=CC(Cl)=C3
4475,Cisplatin,Copper_transporting_ATPase_2-Substrate,N[Pt](N)(Cl)Cl
4476,Cisplatin,Copper_transporting_ATPase_2-Inducer,N[Pt](N)(Cl)Cl
4477,Aminosalicylic Acid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NC1=CC(O)=C(C=C1)C(O)=O
4478,Cisplatin,Sodium_coupled_neutral_amino_acid_transporter_3-Inhibitor,N[Pt](N)(Cl)Cl
4479,Dexamethasone,Sodium_coupled_neutral_amino_acid_transporter_3-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4480,Folic Acid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
4481,Isoniazid,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NNC(=O)C1=CC=NC=C1
4482,Levoglutamide,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,N[C@@H](CCC(N)=O)C(O)=O
4483,"Mercury, Metallic",Sodium_coupled_neutral_amino_acid_transporter_3-Inhibitor,[Hg]
4484,Mesalazine,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
4485,Paclitaxel,Sodium_coupled_neutral_amino_acid_transporter_3-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4486,Sulfadimidine,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
4487,Sulfamethoxazole,Sodium_coupled_neutral_amino_acid_transporter_3-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
4488,Alfacalcidol,27A-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@H](O)C[C@@H](O)C3=C
4489,Ciclosporin,27A-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
4490,Ciprofibrate,27A-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
4491,Colecalciferol,27A-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
4492,Colestyramine,27A-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
4493,Dexamethasone,27A-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4494,Acetylsalicylic Acid,2C8-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
4495,Aminophenazone,2C8-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
4496,Amiodarone,2C8-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
4497,Amitriptyline,2C8-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4498,Amitriptyline,2C8-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4499,Amlodipine,2C8-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
4500,Amodiaquine,2C8-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
4501,Amprenavir,2C8-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
4502,Atorvastatin,2C8-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
4503,Bezafibrate,2C8-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
4504,Bortezomib,2C8-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
4505,Brompheniramine,2C8-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
4506,Buprenorphine,2C8-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4507,Bupropion,2C8-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
4508,Caffeine,2C8-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
4509,Capsaicin,2C8-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
4510,Carbamazepine,2C8-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4511,Carbamazepine,2C8-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4512,Carbinoxamine,2C8-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
4513,Cefaloridine,2C8-Substrate,[O-]C(=O)C1=C(CS[C@@H]2[C@H](NC(=O)CC3=CC=CS3)C(=O)N12)C[N+]4=CC=CC=C4
4514,Cerivastatin,2C8-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
4515,Cerivastatin,2C8-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
4516,Chinin,2C8-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
4517,Chloramphenicol,2C8-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
4518,Chloroquine,2C8-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
4519,Ciclosporin,2C8-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
4520,Cimetidine,2C8-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
4521,Cisapride,2C8-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
4522,Clopidogrel,2C8-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
4523,Clotrimazole,2C8-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4524,Clozapine,2C8-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
4525,Cocaine,2C8-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
4526,Colchicine,2C8-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
4527,Colchicine,2C8-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
4528,Colecalciferol,2C8-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
4529,Cyamemazine,2C8-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
4530,Cyclophosphamide,2C8-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
4531,Cyclophosphamide,2C8-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
4532,Dapsone,2C8-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
4533,Delavirdine,2C8-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
4534,Dexamethasone,2C8-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4535,Dexmedetomidine,2C8-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
4536,Dextromethorphan,2C8-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
4537,Dextropropoxyphene,2C8-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
4538,Diazepam,2C8-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4539,Diclofenac,2C8-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4540,Diclofenac,2C8-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4541,Diltiazem,2C8-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
4542,Diltiazem,2C8-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
4543,Disulfiram,2C8-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
4544,Dolasetron,2C8-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
4545,Domperidone,2C8-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
4546,Dorzolamide,2C8-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
4547,Efavirenz,2C8-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
4548,Entacapone,2C8-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
4549,Eprosartan,2C8-Inhibitor,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
4550,Estradiol,2C8-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4551,Etoposide,2C8-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
4552,Felodipine,2C8-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
4553,Fenofibrate,2C8-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
4554,Fluconazole,2C8-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4555,Fluorouracil,2C8-Substrate,FC1=CNC(=O)NC1=O
4556,Fluoxetine,2C8-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
4557,Fluoxetine,2C8-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
4558,Fluphenazine,2C8-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
4559,Flurbiprofen,2C8-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
4560,Flurbiprofen,2C8-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
4561,Fluvastatin,2C8-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
4562,Fluvastatin,2C8-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
4563,Fluvoxamine,2C8-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
4564,Formoterol,2C8-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
4565,Fosamprenavir,2C8-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
4566,Fosphenytoin,2C8-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
4567,Fosphenytoin,2C8-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
4568,Gemfibrozil,2C8-Inducer,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
4569,Gemfibrozil,2C8-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
4570,Glimepiride,2C8-Substrate,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
4571,Glipizide,2C8-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
4572,Griseofulvin,2C8-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
4573,Halofantrine,2C8-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
4574,Halothane,2C8-Substrate,FC(F)(F)[C@@H](Cl)Br
4575,Hydrocortisone,2C8-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4576,Ibuprofen,2C8-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
4577,Ibuprofen,2C8-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
4578,Ifosfamide,2C8-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
4579,Ifosfamide,2C8-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
4580,Imatinib,2C8-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4581,Imatinib,2C8-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
4582,Indinavir,2C8-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
4583,Indometacin,2C8-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4584,Indometacin,2C8-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4585,Ipriflavone,2C8-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
4586,Irbesartan,2C8-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
4587,Irbesartan,2C8-Substrate,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
4588,Isoniazid,2C8-Inhibitor,NNC(=O)C1=CC=NC=C1
4589,Ketamine,2C8-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
4590,Ketobemidone,2C8-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
4591,Ketoconazole,2C8-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
4592,Ketoprofen,2C8-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
4593,Lansoprazole,2C8-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4594,Lansoprazole,2C8-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
4595,Leflunomide,2C8-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
4596,Leflunomide,2C8-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
4597,Lidocain,2C8-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4598,Loperamide,2C8-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
4599,Loratadine,2C8-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
4600,Losartan,2C8-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
4601,Losartan,2C8-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
4602,Lovastatin,2C8-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4603,Medroxyprogesterone,2C8-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
4604,Mefenamic Acid,2C8-Inhibitor,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4605,Mefenamic Acid,2C8-Substrate,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
4606,Meloxicam,2C8-Inhibitor,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
4607,Meloxicam,2C8-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
4608,Mephenytoin,2C8-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
4609,Methadone,2C8-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4610,Metronidazole,2C8-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
4611,Mirtazapine,2C8-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
4612,Mometasone,2C8-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
4613,Montelukast,2C8-Inhibitor,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
4614,Morphine,2C8-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
4615,Naloxone,2C8-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
4616,Naproxen,2C8-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
4617,Nicardipine,2C8-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
4618,Nicardipine,2C8-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
4619,Nicotine,2C8-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
4620,Nifedipine,2C8-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
4621,Nilutamide,2C8-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
4622,Nilvadipine,2C8-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
4623,Omeprazole,2C8-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
4624,Oxybutynin,2C8-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
4625,Paclitaxel,2C8-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4626,Paracetamol,2C8-Substrate,CC(=O)NC1=CC=C(O)C=C1
4627,Paraoxon,2C8-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
4628,Paroxetine,2C8-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
4629,Pentamidine Isethionate,2C8-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
4630,Perphenazine,2C8-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
4631,Phenazone,2C8-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
4632,Phenelzine,2C8-Inhibitor,NNCCC1=CC=CC=C1
4633,Phenobarbital,2C8-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4634,Phenobarbital,2C8-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4635,Phenprocoumon,2C8-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4636,Phenytoin,2C8-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
4637,Phenytoin,2C8-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
4638,Pioglitazone,2C8-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
4639,Pioglitazone,2C8-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
4640,Piroxicam,2C8-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
4641,Piroxicam,2C8-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
4642,Pravastatin,2C8-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
4643,Primidone,2C8-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
4644,Probenecid,2C8-Inducer,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4645,Progesterone,2C8-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
4646,Propafenone,2C8-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
4647,Propofol,2C8-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
4648,Pyrimethamine,2C8-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
4649,Quinidine,2C8-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
4650,Raloxifene,2C8-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
4651,Repaglinide,2C8-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
4652,Retinol (vit A),2C8-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4653,Retinol (vit A),2C8-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
4654,Rifampicin,2C8-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4655,Rifampicin,2C8-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4656,Rifampicin,2C8-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
4657,Rifapentine,2C8-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
4658,Ritonavir,2C8-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4659,Ritonavir,2C8-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4660,Rofecoxib,2C8-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
4661,Rosiglitazone,2C8-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4662,Rosiglitazone,2C8-Substrate,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
4663,Rutoside,2C8-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
4664,Salmeterol,2C8-Inhibitor,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
4665,Saquinavir,2C8-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4666,Secobarbital,2C8-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
4667,Selegiline,2C8-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
4668,Seratrodast,2C8-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
4669,Simvastatin,2C8-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4670,Simvastatin,2C8-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4671,Ezetimibe,2C8-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
4672,Spironolactone,2C8-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
4673,Sulfadiazine,2C8-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
4674,Sulfafurazole,2C8-Substrate,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
4675,Sulfafurazole,2C8-Inhibitor,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
4676,Sulfamethoxazole,2C8-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
4677,Sulfaphenazole,2C8-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
4678,Sulfinpyrazon,2C8-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
4679,Tamoxifen,2C8-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4680,Tazarotene,2C8-Substrate,CCOC(=O)C1=CC=C(N=C1)C#CC2=CC3=C(SCCC3(C)C)C=C2
4681,Tegafur,2C8-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
4682,Tegaserod,2C8-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
4683,Temazepam,2C8-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4684,Terbinafine,2C8-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
4685,Terfenadine,2C8-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
4686,Testosterone,2C8-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4687,Tetrabenazine,2C8-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
4688,Thalidomide,2C8-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
4689,Theophylline,2C8-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
4690,Thioridazine,2C8-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
4691,Ticlopidine,2C8-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
4692,Tioconazole,2C8-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
4693,Tolbutamide,2C8-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
4694,Tolbutamide,2C8-Inhibitor,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
4695,Torasemide,2C8-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
4696,Tretinoin,2C8-Inhibitor,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4697,Tretinoin,2C8-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
4698,Triazolam,2C8-Inhibitor,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
4699,Trimethadione,2C8-Substrate,CN1C(=O)OC(C)(C)C1=O
4700,Trimethoprim,2C8-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
4701,Trimethoprim,2C8-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
4702,Troglitazone,2C8-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4703,Troglitazone,2C8-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4704,Troleandomycin,2C8-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
4705,Valproic Acid,2C8-Inhibitor,CCCC(CCC)C(O)=O
4706,Verapamil,2C8-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
4707,Warfarin,2C8-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4708,Warfarin,2C8-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4709,Zafirlukast,2C8-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4710,Zafirlukast,2C8-Substrate,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
4711,Zidovudine,2C8-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
4712,Zopiclone,2C8-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
4713,11_oxo_delta_8_tetrahydro_cannabinol,2C8-Substrate,CCCCCC1=CC2=C([C@@H]3CC(=CC[C@H]3C(C)(C)O2)C=O)C(=C1)O
4714,2_acetylbenzothiophene,2C8-Substrate,CC(=O)C1=CC2=CC=CC=C2S1
4715,2_oxo_ticlopidine,2C8-Substrate,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2
4716,3_O_methyl_fluorescein,2C8-Substrate,COC1=CC=C2C(=C1)OC3=CC(=CC=C3C24OC(=O)C5=CC=CC=C45)O
4717,7_benzyloxy_4_trifluoromethyl_coumarin,2C8-Substrate,FC(F)(F)C1=C[C](=O)OC2=CC(=CC=C12)OCC3=CC=CC=C3
4718,all_trans_retinal,2C8-Substrate,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
4719,almotriptan,2C8-Substrate,CN(C)CCC1=C[NH]C2=CC=C(C[S](=O)(=O)N3CCCC3)C=C12
4720,amiodarone,2C8-Substrate,CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3
4721,amodiaquine,2C8-Substrate,CCN(CC)CC1=CC(=CC=C1O)NC2=CC=NC3=CC(=CC=C23)Cl
4722,antipyrine,2C8-Substrate,C[N]1[N]([C](=O)C=C1C)C2=CC=CC=C2
4723,benzoyl_phenyl_urea,2C8-Substrate,CN(C)C1=CC=CC=C1C(=O)NC(=O)NC2=CC=C(OC3=NC=C(Br)C=N3)C(=C2)C
4724,benzyl_oxy_resorufin,2C8-Substrate,O=[C]1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1
4725,carbamazepine,2C8-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4726,carbaryl,2C8-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
4727,carbofuran,2C8-Substrate,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1
4728,catechol_methoxychlor,2C8-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C(=C2)O)C(Cl)(Cl)Cl
4729,cisapride,2C8-Substrate,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(=C(N)C=C3OC)Cl
4730,clobazam,2C8-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
4731,clomipramine,2C8-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4732,clozapine,2C8-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
4733,cp_677_623,2C8-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
4734,dapsone,2C8-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)C2=CC=C(N)C=C2
4735,diallylsulfide,2C8-Substrate,C=CCSSCC=C
4736,diazinion,2C8-Substrate,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C
4737,diclofenac_deriv_2,2C8-Substrate,OCCC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4738,diltiazem,2C8-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
4739,DMBA,2C8-Substrate,CC1=C2C=CC=CC2=C(C)C3=C4C=CC=CC4=CC=C13
4740,DMZ,2C8-Substrate,CN(C1=CC=N[N]1C2=CC=CC=C2)[S](=O)(=O)C3=CC=C(C)C=C3
4741,domperidone,2C8-Substrate,ClC1=CC=C2[N](C3CCN(CCC[N]4[C](=O)[NH]C5=CC=CC=C45)CC3)[C](=O)[NH]C2=C1
4742,DY_9760e,2C8-Substrate,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl
4743,ethanol,2C8-Substrate,CCO
4744,ethinyl_estradiol,2C8-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@]2(O)C#C
4745,eupatilin,2C8-Substrate,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC
4746,fluvastatin,2C8-Substrate,CC(C)[N]1C2=CC=CC=C2C(=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3
4747,halofantrine_R,2C8-Substrate,CCCCN(CCCC)CC[C@@H](O)C1=CC2=C(Cl)C=C(Cl)C=C2C3=C1C=CC(=C3)C(F)(F)F
4748,haloperidol,2C8-Substrate,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
4749,ibuprofen_R,2C8-Substrate,CC(C)CC1=CC=C(C=C1)[C@@H](C)C(O)=O
4750,imipramine,2C8-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13
4751,K11777,2C8-Substrate,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4
4752,L_775_606,2C8-Substrate,FC1=CC=CC(=C1)CCN2CCN(CCCC3=C[NH]C4=CC=C(C=C34)[N]5C=NN=C5)CC2
4753,lauric_acid,2C8-Substrate,CCCCCCCCCCCC(O)=O
4754,licofelone,2C8-Substrate,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O
4755,lidocaine,2C8-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
4756,limonene_S,2C8-Substrate,CC(=C)[C@H]1CCC(=CC1)C
4757,MDE_R,2C8-Substrate,CCN[C@H](C)CC1=CC=C2OCOC2=C1
4758,mirtazapine_R,2C8-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CN=C24
4759,MK_0457_tozasertib,2C8-Substrate,CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)SC4=CC=C(NC(=O)C5CC5)C=C4
4760,ML_3403,2C8-Substrate,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4
4761,muraglitazar,2C8-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
4762,nicardipine_R,2C8-Substrate,COC(=O)C1=C(C)NC(=C([C@@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)OCCN(C)CC3=CC=CC=C3)C
4763,NN_diethyl_nitrosoamine,2C8-Substrate,CCN(CC)N=O
4764,NN_dimethyl_nitrosoamine,2C8-Substrate,CN(C)N=O
4765,NN_methyl_butyl_nitrosoamine,2C8-Substrate,CCCCN(C)N=O
4766,NN_methyl_ethyl_nitrosoamine,2C8-Substrate,CCN(C)N=O
4767,NNK,2C8-Substrate,CN(CCCC(=O)C1=CC=CN=C1)N=O
4768,NO_1886,2C8-Substrate,CCO[P](=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(Br)C=C2)C#N)OCC
4769,norLAAM,2C8-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2
4770,norverapamil_R,2C8-Substrate,COC1=C(OC)C=C(CCNCCC[C@@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
4771,omeprazole_R,2C8-Substrate,COC1=CC=C2[NH]C(=NC2=C1)[S@](=O)CC3=NC=C(C)C(=C3C)OC
4772,parathion,2C8-Substrate,CCO[P](=S)(OCC)OC1=CC=C(C=C1)[N](=O)=O
4773,perphenazine,2C8-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
4774,phenprocoumon_S,2C8-Substrate,CC[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
4775,phenytoin,2C8-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
4776,repaglinide,2C8-Substrate,CCOC1=CC(=CC=C1C(O)=O)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3
4777,retinol,2C8-Substrate,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
4778,rosiglitazone_R,2C8-Substrate,CN(CCOC1=CC=C(C[C@H]2SC(=O)NC2=O)C=C1)C3=CC=CC=N3
4779,seratrodast_R,2C8-Substrate,CC1=C(C)C(=O)C(=C(C)C1=O)[C@H](CCCCCC(O)=O)C2=CC=CC=C2
4780,sertraline,2C8-Substrate,CN[C@H]1CC[C@@H](C2=CC(=C(Cl)C=C2)Cl)C3=C1C=CC=C3
4781,simvastatin_hydroxy_acid,2C8-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
4782,sulfadiazine,2C8-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)NC2=NC=CC=N2
4783,taxol,2C8-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(=C1C5(C)C)C
4784,tegafur,2C8-Substrate,FC1=C[N](C2CCCO2)[C](=O)[NH][C]1=O
4785,temazepam,2C8-Substrate,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C3=C1C=CC(=C3)Cl
4786,terbinafine,2C8-Substrate,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12
4787,tienilic_acid,2C8-Substrate,OC(=O)COC1=CC=C(C(=C1Cl)Cl)C(=O)C2=CC=CS2
4788,tolbutamide,2C8-Substrate,CCCCNC(=O)N[S](=O)(=O)C1=CC=C(C)C=C1
4789,toluene,2C8-Substrate,CC1=CC=CC=C1
4790,troglitazone,2C8-Substrate,CC1=C(O)C(=C2CC[C@](C)(COC3=CC=C(C[C@H]4SC(=O)NC4=O)C=C3)OC2=C1C)C
4791,zopiclone_R,2C8-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4
4792,zotepine,2C8-Substrate,CN(C)CCOC1=CC2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
4793,13_cis_retinoic_acid,2C8-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
4794,2_oxo_clopidogrel,2C8-Substrate,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3
4795,4_chloro_7_ethoxycoumarin,2C8-Substrate,CCOC1=CC=C2C(=C[C](=O)OC2=C1)Cl
4796,4prime_hydroxy_clobazam,2C8-Substrate,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C3=CC(=CC=C13)Cl
4797,7_ethoxy_coumarin,2C8-Substrate,CCOC1=CC=C2C=C[C](=O)OC2=C1
4798,7_methoxy_4_trifluoro_methyl_coumarin,2C8-Substrate,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
4799,9_cis_retinoic_acid,2C8-Substrate,CC1=C(\C=C\C(C)=C/C=C/C(C)=C/C(O)=O)C(C)(C)CCC1
4800,acetaminophen,2C8-Substrate,CC(=O)NC1=CC=C(O)C=C1
4801,all_trans_retinoic_acid,2C8-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1
4802,buprenorphine,2C8-Substrate,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4CC5=C6C(=C(O)C=C5)O[C@@H]2[C@@]36CCN4CC7CC7
4803,chloroquine_R,2C8-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=CC(=CC2=NC=C1)Cl
4804,delta_9_tetrahydrocannabinol,2C8-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(=C1)O
4805,diazepam,2C8-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
4806,dibenzyl_fluorescein,2C8-Substrate,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17
4807,diclofenac,2C8-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4808,foxy,2C8-Substrate,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1
4809,LAAM,2C8-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4810,licofelone_M1,2C8-Substrate,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(=O)O[C@@H]5O[C@@H]([C@@H](O)[C@H](O)[C@H]5O)C(O)=O
4811,methadone_R,2C8-Substrate,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
4812,methoxychlor,2C8-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(OC)C=C2)C(Cl)(Cl)Cl
4813,mono_OH_methoxychlor,2C8-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
4814,morphine,2C8-Substrate,CN1CC[C@@]23[C@H]4OC5=C(O)C=CC(=C25)C[C@@H]1[C@@H]3C=C[C@@H]4O
4815,norverapamil_S,2C8-Substrate,COC1=C(OC)C=C(CCNCCC[C@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
4816,verapamil_R,2C8-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
4817,verapamil_S,2C8-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
4818,warfarin_R,2C8-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(O[C]2=O)C=CC=C3
4819,warfarin_S,2C8-Substrate,CC(=O)C[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
4820,Latanoprost,Solute_carrier_organic_anion_transporter_family_member_2A1-Inhibitor,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2
4821,Latanoprost,Solute_carrier_organic_anion_transporter_family_member_2A1-Substrate,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC2=CC=CC=C2
4822,Aldosterone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
4823,Aminogluthetimide,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
4824,Aminosalicylic Acid,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inducer,NC1=CC(O)=C(C=C1)C(O)=O
4825,Angiotensinamide,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4826,Benazepril,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(CC(O)=O)C2=O
4827,Desoxycortone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
4828,Eplerenone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
4829,Etomidate,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
4830,Glucose,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
4831,Hydrocortisone,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4832,Insulin (human),Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
4833,Metoclopramide,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
4834,Mibefradil,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
4835,Valsartan,Aldosterone_synthase_ALDOS_Aldosterone_synthesizing_enzyme_Steroid_18_hydroxylase-Inhibitor,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
4836,Doxorubicin,Multidrug_resistance_associated_protein_7-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
4837,Paclitaxel,Multidrug_resistance_associated_protein_7-Inducer,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
4838,Sulfinpyrazon,Multidrug_resistance_associated_protein_7-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
4839,Calcitriol,Calcidiol_1_monooxygenase_25_OHD_1_alpha_hydroxylase_25_hydroxyvitamin_D3_1_alpha_hydroxylase_VD3_1A_hydroxylase_P450C1_alpha_50VD1_alpha-Inhibitor,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
4840,Lovastatin,CP4FN-Inducer,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4841,Minoxidil,Prostacyclin_synthase_Prostaglandin_I2_synthase_PTGIS-Inhibitor,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
4842,Tranylcypromine,Prostacyclin_synthase_Prostaglandin_I2_synthase_PTGIS-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
4843,Androstanolone,Solute_carrier_family_22_member_8-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4844,Angiotensinamide,Solute_carrier_family_22_member_8-Inhibitor,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
4845,Benzylpenicillin,Solute_carrier_family_22_member_8-Substrate,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
4846,Benzylpenicillin,Solute_carrier_family_22_member_8-Inhibitor,CC1(C)S[C@@H]2[C@H](NC(=O)CC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
4847,Cefazolin,Solute_carrier_family_22_member_8-Substrate,CC1=NN=C(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CN4C=NN=N4)C3=O)C(O)=O)S1
4848,Cefotiam,Solute_carrier_family_22_member_8-Substrate,CN(C)CCN1N=NN=C1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)CC4=CSC(N)=N4)C3=O)C(O)=O
4849,Celecoxib,Solute_carrier_family_22_member_8-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
4850,Chlorothiazide,Solute_carrier_family_22_member_8-Substrate,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
4851,Cidofovir,Solute_carrier_family_22_member_8-Substrate,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1
4852,Ciprofloxacin,Solute_carrier_family_22_member_8-Inhibitor,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4853,Ciprofloxacin,Solute_carrier_family_22_member_8-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
4854,Estrone,Solute_carrier_family_22_member_8-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
4855,Etoricoxib,Solute_carrier_family_22_member_8-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
4856,Famotidine,Solute_carrier_family_22_member_8-Substrate,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
4857,Fluvastatin,Solute_carrier_family_22_member_8-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
4858,Furosemide,Solute_carrier_family_22_member_8-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
4859,Gatifloxacin,Solute_carrier_family_22_member_8-Inhibitor,COC1=C(N2CCN[C@@H](C)C2)C(F)=CC3=C1N(C=C(C(O)=O)C3=O)[C@H]4CC4
4860,Glutathione,Solute_carrier_family_22_member_8-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
4861,Hydrocortisone,Solute_carrier_family_22_member_8-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4862,Ibuprofen,Solute_carrier_family_22_member_8-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
4863,Mercaptopurine,Solute_carrier_family_22_member_8-Substrate,S=C1NC=NC2=C1NC=N2
4864,Methotrexate,Solute_carrier_family_22_member_8-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
4865,Phenolsulfonphthalein,Solute_carrier_family_22_member_8-Substrate,OC1=CC=C(C=C1)[C@@]2(OS(=O)(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
4866,Prasterone,Solute_carrier_family_22_member_8-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
4867,Pravastatin,Solute_carrier_family_22_member_8-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
4868,Probenecid,Solute_carrier_family_22_member_8-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4869,Ranitidine,Solute_carrier_family_22_member_8-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4870,Rofecoxib,Solute_carrier_family_22_member_8-Inhibitor,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
4871,Rosuvastatin,Solute_carrier_family_22_member_8-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
4872,Simvastatin,Solute_carrier_family_22_member_8-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
4873,Sulfasalazine,Solute_carrier_family_22_member_8-Inhibitor,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
4874,Torasemide,Solute_carrier_family_22_member_8-Inhibitor,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
4875,Tryptophan,Solute_carrier_family_22_member_8-Substrate,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
4876,Valdecoxib,Solute_carrier_family_22_member_8-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
4877,Etretinate,26B-Substrate,CCOC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)C(C)=C(OC)C=C1C
4878,Abacavir,UGT-Substrate,NC1=NC2=C(N=CN2[C@H]3C[C@@H](CO)C=C3)C(N[C@H]4CC4)=N1
4879,Acarbose,UGT-Inhibitor,C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O
4880,Acetylsalicylic Acid,UGT-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
4881,Amitriptyline,UGT-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4882,Amitriptyline,UGT-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
4883,Anastrozole,UGT-Substrate,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
4884,Androstanolone,UGT-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
4885,Atazanavir,UGT-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
4886,Atazanavir,UGT-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
4887,Atorvastatin,UGT-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
4888,Benfluorex,UGT-Inducer,C[C@@H](CC1=CC(=CC=C1)C(F)(F)F)NCCOC(=O)C2=CC=CC=C2
4889,Bucladesine,UGT-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
4890,Buprenorphine,UGT-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
4891,Bupropion,UGT-Inhibitor,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
4892,Candesartan,UGT-Substrate,CCOC1=NC2=CC=CC(C(O)=O)=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NN=NN5
4893,Canrenone,UGT-Inhibitor,C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@@]4(C)[C@H]3CC[C@@]45CCC(=O)O5
4894,Carbamazepine,UGT-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4895,Carbamazepine,UGT-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
4896,Chenodeoxycholic Acid,UGT-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
4897,Cicletanine,UGT-Substrate,CC1=NC=C2[C@H](OCC2=C1O)C3=CC=C(Cl)C=C3
4898,Cisplatin,UGT-Inducer,N[Pt](N)(Cl)Cl
4899,Clofibrate,UGT-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
4900,Clomipramine,UGT-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
4901,Codeine,UGT-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
4902,Cyproheptadin,UGT-Substrate,CN1CCC(CC1)=C2/C3=C(C=CC=C3)C=CC4=C2C=CC=C4
4903,Dactinomycin,UGT-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
4904,Dasatinib,UGT-Inhibitor,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
4905,Dexamethasone,UGT-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4906,Diazepam,UGT-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
4907,Diclofenac,UGT-Inducer,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
4908,Diflunisal,UGT-Substrate,OC(=O)C1=C(O)C=CC(=C1)C2=C(F)C=C(F)C=C2
4909,Digitoxin,UGT-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
4910,Disulfiram,UGT-Inducer,CCN(CC)C(=S)SSC(=S)N(CC)CC
4911,Enoxolone,UGT-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
4912,Epinephrine,UGT-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
4913,Erlotinib,UGT-Inhibitor,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
4914,Esketamine,UGT-Inducer,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
4915,Eslicarbazepine,UGT-Substrate,NC(=O)N1C2=C(C[C@H](O)C3=C1C=CC=C3)C=CC=C2
4916,Estradiol,UGT-Inhibitor,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4917,Estradiol,UGT-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
4918,Estriol,UGT-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
4919,Estriol,UGT-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
4920,Ethanol,UGT-Inducer,CCO
4921,Etodolac,UGT-Substrate,CCC1=CC=CC2=C1NC3=C2CCO[C@@]3(CC)CC(O)=O
4922,Ezetimibe,UGT-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
4923,Febuxostat,UGT-Substrate,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N
4924,Fluconazole,UGT-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
4925,Flurbiprofen,UGT-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
4926,Gefitinib,UGT-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
4927,Gemfibrozil,UGT-Substrate,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
4928,Hydrocodone,UGT-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
4929,Hydrocortisone,UGT-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
4930,Hydromorphone,UGT-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
4931,Hydroxyprogesterone,UGT-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
4932,Hymecromone,UGT-Inhibitor,CC1=CC(=O)OC2=C1C=CC(O)=C2
4933,Hymecromone,UGT-Inducer,CC1=CC(=O)OC2=C1C=CC(O)=C2
4934,Hymecromone,UGT-Substrate,CC1=CC(=O)OC2=C1C=CC(O)=C2
4935,Imipramine,UGT-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4936,Imipramine,UGT-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4937,Indinavir,UGT-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
4938,Indometacin,UGT-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4939,Indometacin,UGT-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
4940,Irinotecan,UGT-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
4941,Itraconazole,UGT-Substrate,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
4942,Ketamine,UGT-Inducer,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
4943,Labetalol,UGT-Substrate,C[C@@H](CCC1=CC=CC=C1)NC[C@H](O)C2=CC=C(O)C(=C2)C(N)=O
4944,Lopinavir,UGT-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
4945,Losartan,UGT-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
4946,Medroxyprogesterone,UGT-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
4947,Meprobamate,UGT-Substrate,CCCC(C)(COC(N)=O)COC(N)=O
4948,Mercaptopurine,UGT-Substrate,S=C1NC=NC2=C1NC=N2
4949,Mitiglinide,UGT-Substrate,[H][C@@](CC(=O)N1C[C@@]2([H])CCCC[C@@]2([H])C1)(CC1=CC=CC=C1)C(O)=O
4950,Naloxone,UGT-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
4951,Naproxen,UGT-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
4952,Nicotine,UGT-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
4953,Nicotine,UGT-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
4954,Niflumic Acid,UGT-Substrate,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1
4955,Niflumic Acid,UGT-Inhibitor,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1
4956,Nilotinib,UGT-Inhibitor,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F
4957,Oleandomycin,UGT-Substrate,CO[C@@H]1C[C@@H](O[C@@H](C)[C@H]1O)O[C@H]2[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
4958,Oxazepam,UGT-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
4959,Oxymetazoline,UGT-Substrate,CC1=CC(=C(O)C(C)=C1CC2=NCCN2)C(C)(C)C
4960,Paracetamol,UGT-Substrate,CC(=O)NC1=CC=C(O)C=C1
4961,Phenobarbital,UGT-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
4962,Phenol,UGT-Substrate,OC1=CC=CC=C1
4963,Phenolphthalein,UGT-Substrate,OC1=CC=C(C=C1)[C@@]2(OC(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
4964,Phenolsulfonphthalein,UGT-Substrate,OC1=CC=C(C=C1)[C@@]2(OS(=O)(=O)C3=C2C=CC=C3)C4=CC=C(O)C=C4
4965,Phenylbutazone,UGT-Substrate,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
4966,Phenylbutazone,UGT-Inhibitor,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
4967,Phenytoin,UGT-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
4968,Pirprofen,UGT-Substrate,C[C@H](C(O)=O)C1=CC(Cl)=C(C=C1)N2CC=CC2
4969,Pitavastatin,UGT-Inhibitor,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O
4970,Pitavastatin,UGT-Substrate,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O
4971,Posaconazole,UGT-Substrate,[H][C@@](C)(O)[C@]([H])(CC)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@]2([H])CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1
4972,Probenecid,UGT-Substrate,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4973,Probenecid,UGT-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
4974,Raltegravir,UGT-Substrate,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
4975,Ranitidine,UGT-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
4976,Repaglinide,UGT-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
4977,Riluzole,UGT-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
4978,Ritonavir,UGT-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
4979,Saquinavir,UGT-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
4980,Silymarin,UGT-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
4981,Sorafenib,UGT-Inhibitor,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1
4982,Spironolactone,UGT-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
4983,Tamoxifen,UGT-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
4984,Telmisartan,UGT-Substrate,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
4985,Telmisartan,UGT-Inducer,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
4986,Tiadenol,UGT-Inducer,OCCSCCCCCCCCCCSCCO
4987,Triclosan,UGT-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
4988,Trimipramine,UGT-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
4989,Troglitazone,UGT-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
4990,Valproic Acid,UGT-Substrate,CCCC(CCC)C(O)=O
4991,Valproic Acid,UGT-Inhibitor,CCCC(CCC)C(O)=O
4992,Vorinostat,UGT-Substrate,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
4993,Warfarin,UGT-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
4994,Zidovudine,UGT-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
4995,Dexamethasone,CP343-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
4996,Ethosuximide,CP343-Substrate,CC[C@]1(C)CC(=O)NC1=O
4997,Oxazepam,CP343-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
4998,Phenelzine,CP343-Inhibitor,NNCCC1=CC=CC=C1
4999,Praziquantel,CP343-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
5000,Rifampicin,CP343-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5001,Rifapentine,CP343-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
5002,Testosterone,CP343-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5003,Zalcitabine,CP343-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
5004,Alprostadil,Multidrug_resistance_associated_protein_4-Substrate,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
5005,Androstanolone,Multidrug_resistance_associated_protein_4-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
5006,Cefmetazole,Multidrug_resistance_associated_protein_4-Inhibitor,CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(CSC3=NN=NN3C)=C(N2C1=O)C(O)=O
5007,Celecoxib,Multidrug_resistance_associated_protein_4-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
5008,Chlorothiazide,Multidrug_resistance_associated_protein_4-Inhibitor,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
5009,Ciprofloxacin,Multidrug_resistance_associated_protein_4-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
5010,Cyclophosphamide,Multidrug_resistance_associated_protein_4-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
5011,Diclofenac,Multidrug_resistance_associated_protein_4-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5012,Dinoprostone,Multidrug_resistance_associated_protein_4-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
5013,Folic Acid,Multidrug_resistance_associated_protein_4-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
5014,Furosemide,Multidrug_resistance_associated_protein_4-Inhibitor,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl
5015,Indometacin,Multidrug_resistance_associated_protein_4-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
5016,Irinotecan,Multidrug_resistance_associated_protein_4-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5017,Ketoprofen,Multidrug_resistance_associated_protein_4-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
5018,Mercaptopurine,Multidrug_resistance_associated_protein_4-Substrate,S=C1NC=NC2=C1NC=N2
5019,Methotrexate,Multidrug_resistance_associated_protein_4-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
5020,Oseltamivir,Multidrug_resistance_associated_protein_4-Substrate,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1
5021,Paracetamol,Multidrug_resistance_associated_protein_4-Inducer,CC(=O)NC1=CC=C(O)C=C1
5022,Prasterone,Multidrug_resistance_associated_protein_4-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
5023,Sulindac,Multidrug_resistance_associated_protein_4-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
5024,Telmisartan,Multidrug_resistance_associated_protein_4-Inhibitor,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
5025,Tioguanine,Multidrug_resistance_associated_protein_4-Substrate,NC1=NC2=C(N=CN2)C(=S)N1
5026,Adenosine,Multidrug_resistance_associated_protein_5-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
5027,Fluorescein,Multidrug_resistance_associated_protein_5-Substrate,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
5028,Fluorouracil,Multidrug_resistance_associated_protein_5-Inducer,FC1=CNC(=O)NC1=O
5029,Gemcitabine,Multidrug_resistance_associated_protein_5-Inducer,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F
5030,Gemcitabine,Multidrug_resistance_associated_protein_5-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2(F)F
5031,Irinotecan,Multidrug_resistance_associated_protein_5-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5032,Probenecid,Multidrug_resistance_associated_protein_5-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
5033,Colestyramine,8B1-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
5034,Insulin (human),8B1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5035,Dextromethorphan,Cholesterol_24_hydroxylase-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
5036,Diclofenac,Cholesterol_24_hydroxylase-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5037,Phenacetin,Cholesterol_24_hydroxylase-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
5038,Progesterone,Cholesterol_24_hydroxylase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5039,Testosterone,Cholesterol_24_hydroxylase-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5040,Amfetamine,2A6-Inhibitor,C[C@@H](N)CC1=CC=CC=C1
5041,Amlodipine,2A6-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
5042,Amobarbital,2A6-Inducer,CC[C@@]1(CCC(C)C)C(=O)NC(=O)NC1=O
5043,Artemisinin,2A6-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
5044,Artesunate,2A6-Substrate,C[C@H]1CC[C@H]2[C@H](C)[C@H](O[C@H]3O[C@]4(C)CC[C@H]1[C@]23OO4)OC(=O)CCC(O)=O
5045,Azelastine,2A6-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
5046,Azithromycin,2A6-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
5047,Buprenorphine,2A6-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
5048,Bupropion,2A6-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
5049,Carbamazepine,2A6-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5050,Chloroform,2A6-Substrate,ClC(Cl)Cl
5051,Chloroxylenol,2A6-Substrate,CC1=CC(O)=CC(C)=C1Cl
5052,Chlorzoxazone,2A6-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
5053,Cinnarizin,2A6-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5054,Cisapride,2A6-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
5055,Clofibrate,2A6-Inhibitor,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5056,Clomethiazole,2A6-Substrate,CC1=C(CCCl)SC=N1
5057,Clomifene,2A6-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
5058,Clotrimazole,2A6-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5059,Clotrimazole,2A6-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5060,Clozapine,2A6-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5061,Cocaine,2A6-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5062,Cyclophosphamide,2A6-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
5063,Desipramine,2A6-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5064,Dexfenfluramine,2A6-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
5065,Dexmedetomidine,2A6-Substrate,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
5066,Diethyl Ether,2A6-Substrate,CCOCC
5067,Diethyltoluamide,2A6-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
5068,Disulfiram,2A6-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
5069,Disulfiram,2A6-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
5070,Dronabinol,2A6-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
5071,Eletriptan,2A6-Inducer,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
5072,Entacapone,2A6-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
5073,Flunarizine,2A6-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
5074,Flunitrazepam,2A6-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
5075,Fluorouracil,2A6-Substrate,FC1=CNC(=O)NC1=O
5076,Fomepizole,2A6-Inhibitor,CC1=CNN=C1
5077,Formoterol,2A6-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
5078,Halothane,2A6-Substrate,FC(F)(F)[C@@H](Cl)Br
5079,Histamine,2A6-Inhibitor,NCCC1=CNC=N1
5080,Ifosfamide,2A6-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
5081,Indigo Carmine,2A6-Inhibitor,[O-]S(=O)(=O)C1=CC=C2NC(C(=O)C2=C1)=C3NC4=CC=C(C=C4C3=O)S([O-])(=O)=O
5082,Isoniazid,2A6-Inhibitor,NNC(=O)C1=CC=NC=C1
5083,Isopropanol,2A6-Inhibitor,CC(C)O
5084,Ketoconazole,2A6-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5085,Letrozole,2A6-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
5086,Letrozole,2A6-Inhibitor,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
5087,Levoverbenone,2A6-Substrate,CC1=CC(=O)[C@@H]2C[C@H]1C2(C)C
5088,Lidocain,2A6-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5089,Medifoxamine,2A6-Substrate,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
5090,Memantine,2A6-Inhibitor,C[C@]12C[C@@H]3C[C@](C)(C1)C[C@@](N)(C3)C2
5091,Menadione,2A6-Inhibitor,CC1=CC(=O)C2=C(C=CC=C2)C1=O
5092,Methoxsalen,2A6-Substrate,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
5093,Methoxsalen,2A6-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
5094,Methoxyflurane,2A6-Substrate,COC(F)(F)C(Cl)Cl
5095,Metyrapone,2A6-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
5096,Miconazole,2A6-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
5097,Nicotine,2A6-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
5098,Nicotine,2A6-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
5099,Nicotinyl Alcohol (pyridylcarbinol),2A6-Substrate,OCC1=CC=CN=C1
5100,Nilvadipine,2A6-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
5101,Norfloxacin,2A6-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
5102,Orphenadrine (citrate),2A6-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
5103,Paracetamol,2A6-Substrate,CC(=O)NC1=CC=C(O)C=C1
5104,Perazine,2A6-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
5105,Phenacetin,2A6-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
5106,Phenazone,2A6-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
5107,Phenobarbital,2A6-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5108,Phenobarbital,2A6-Inhibitor,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5109,Pilocarpine,2A6-Inhibitor,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
5110,Pilocarpine,2A6-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
5111,Prednisolone,2A6-Inhibitor,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5112,Progesterone,2A6-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5113,Propofol,2A6-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
5114,Rifampicin,2A6-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5115,Rifampicin,2A6-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5116,Rifampicin,2A6-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5117,Rosiglitazone,2A6-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
5118,Roxatidine,2A6-Substrate,OCC(=O)NCCCOC1=CC=CC(CN2CCCCC2)=C1
5119,Selegiline,2A6-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
5120,Seratrodast,2A6-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
5121,Sevoflurane,2A6-Substrate,FCOC(C(F)(F)F)C(F)(F)F
5122,Sulconazole,2A6-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
5123,Sulfaphenazole,2A6-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
5124,Tamoxifen,2A6-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5125,Tegafur,2A6-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
5126,Thalidomide,2A6-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
5127,Thiamazole,2A6-Inhibitor,CN1C=CNC1=S
5128,Tranylcypromine,2A6-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
5129,Tretinoin,2A6-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
5130,Troleandomycin,2A6-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
5131,Trospium,2A6-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
5132,Valproic Acid,2A6-Substrate,CCCC(CCC)C(O)=O
5133,Zidovudine,2A6-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
5134,Ketoconazole,51A-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5135,Meglutol,51A-Inhibitor,CC(O)(CC(O)=O)CC(O)=O
5136,Sertaconazole,51A-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=CSC4=C3C=CC=C4Cl
5137,Terconazole,51A-Inhibitor,CC(C)N1CCN(CC1)C2=CC=C(OC[C@H]3CO[C@](CN4C=NC=N4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5138,Bupropion,ATP_binding_cassette_sub_family_G_member_2-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
5139,Ciclosporin,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5140,Cimetidine,ATP_binding_cassette_sub_family_G_member_2-Substrate,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
5141,Ciprofloxacin,ATP_binding_cassette_sub_family_G_member_2-Substrate,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
5142,Cladribine,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1
5143,Daunorubicin,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5144,Dexamethasone,ATP_binding_cassette_sub_family_G_member_2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5145,Diclofenac,ATP_binding_cassette_sub_family_G_member_2-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5146,Dipyridamole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
5147,Dipyridamole,ATP_binding_cassette_sub_family_G_member_2-Substrate,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
5148,Doxorubicin,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5149,Doxycycline,ATP_binding_cassette_sub_family_G_member_2-Inducer,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
5150,Estradiol,ATP_binding_cassette_sub_family_G_member_2-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5151,Estrone,ATP_binding_cassette_sub_family_G_member_2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
5152,Etoposide,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5153,Fluorouracil,ATP_binding_cassette_sub_family_G_member_2-Substrate,FC1=CNC(=O)NC1=O
5154,Folic Acid,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
5155,Folic Acid,ATP_binding_cassette_sub_family_G_member_2-Inducer,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
5156,Ganciclovir,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1
5157,Gefitinib,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
5158,Gefitinib,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
5159,Glafenine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,OC[C@@H](O)COC(=O)C1=C(NC2=C3C=CC(Cl)=CC3=NC=C2)C=CC=C1
5160,Glibenclamide,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
5161,Glutathione,ATP_binding_cassette_sub_family_G_member_2-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
5162,Grepafloxacin,ATP_binding_cassette_sub_family_G_member_2-Substrate,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
5163,Imatinib,ATP_binding_cassette_sub_family_G_member_2-Inducer,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5164,Imatinib,ATP_binding_cassette_sub_family_G_member_2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5165,Imatinib,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5166,Insulin (human),ATP_binding_cassette_sub_family_G_member_2-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5167,Irinotecan,ATP_binding_cassette_sub_family_G_member_2-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5168,Itraconazole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
5169,Ketoconazole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5170,Lamivudine,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2
5171,Leflunomide,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
5172,Lopinavir,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
5173,Menadione,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
5174,Metformin,ATP_binding_cassette_sub_family_G_member_2-Substrate,CN(C)C(=N)NC(N)=N
5175,Methotrexate,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
5176,Methotrexate,ATP_binding_cassette_sub_family_G_member_2-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
5177,Mitoxantrone,ATP_binding_cassette_sub_family_G_member_2-Substrate,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
5178,Mitoxantrone,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
5179,Nelfinavir,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5180,Nicardipine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
5181,Nimodipine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
5182,Nitrofurantoin,ATP_binding_cassette_sub_family_G_member_2-Substrate,[O-][N+](=O)C1=CC=C(O1)C=NN2CC(=O)NC2=O
5183,Norfloxacin,ATP_binding_cassette_sub_family_G_member_2-Substrate,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
5184,Omeprazole,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5185,Oxycodone,ATP_binding_cassette_sub_family_G_member_2-Inducer,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
5186,Oxygen,ATP_binding_cassette_sub_family_G_member_2-Inducer,O=O
5187,Pantoprazole,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5188,Pantoprazole,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5189,Plicamycin,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@@H]([C@@H]1CC2=C(C(O)=C3C(O)=C(C)C(O[C@H]4C[C@@H](O[C@H]5C[C@@H](O)[C@H](O)[C@@H](C)O5)[C@H](O)[C@@H](C)O4)=CC3=C2)C(=O)[C@H]1O[C@H]6C[C@@H](O[C@H]7C[C@@H](O[C@H]8C[C@](C)(O)[C@H](O)[C@@H](C)O8)[C@H](O)[C@@H](C)O7)[C@H](O)[C@@H](C)O6)C(=O)[C@@H](O)[C@@H](C)O
5190,Prazosin,ATP_binding_cassette_sub_family_G_member_2-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4
5191,Progesterone,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5192,Progesterone,ATP_binding_cassette_sub_family_G_member_2-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5193,Propafenone,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
5194,Rabeprazole,ATP_binding_cassette_sub_family_G_member_2-Substrate,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
5195,Reserpine,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
5196,Riboflavin (vit B2),ATP_binding_cassette_sub_family_G_member_2-Substrate,CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2
5197,Riluzole,ATP_binding_cassette_sub_family_G_member_2-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
5198,Ritonavir,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5199,Rosiglitazone,ATP_binding_cassette_sub_family_G_member_2-Inducer,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
5200,Rosuvastatin,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
5201,Rutoside,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
5202,Saquinavir,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
5203,Sirolimus,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
5204,Sulfasalazine,ATP_binding_cassette_sub_family_G_member_2-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
5205,Tacrolimus,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
5206,Topotecan,ATP_binding_cassette_sub_family_G_member_2-Substrate,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
5207,Topotecan,ATP_binding_cassette_sub_family_G_member_2-Inducer,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
5208,Toremifene,ATP_binding_cassette_sub_family_G_member_2-Inhibitor,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
5209,Alprazolam,Ileal_sodiumbile_acid_cotransporter-Inducer,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
5210,Budesonide,Ileal_sodiumbile_acid_cotransporter-Inducer,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
5211,Ciprofibrate,Ileal_sodiumbile_acid_cotransporter-Inducer,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
5212,Colestyramine,Ileal_sodiumbile_acid_cotransporter-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
5213,Dexamethasone,Ileal_sodiumbile_acid_cotransporter-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5214,Secretin,Ileal_sodiumbile_acid_cotransporter-Inducer,CC(C)C[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC2=NC=CN2)[C@H](C)O)[C@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O
5215,Tretinoin,Ileal_sodiumbile_acid_cotransporter-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
5216,Acetylsalicylic Acid,Sulfotransferase-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
5217,Acetylsalicylic Acid,Sulfotransferase-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
5218,Adenosine,Sulfotransferase-Substrate,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
5219,Aminobenzoic Acid,Sulfotransferase-Substrate,NC1=CC=C(C=C1)C(O)=O
5220,Apomorphine,Sulfotransferase-Substrate,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
5221,Bemiparin,Sulfotransferase-Substrate,C1=CC=C(C=C1)C=CC(=O)O
5222,Betamethason,Sulfotransferase-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5223,Budesonide,Sulfotransferase-Substrate,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
5224,Calcitriol,Sulfotransferase-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
5225,Celecoxib,Sulfotransferase-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
5226,Celecoxib,Sulfotransferase-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
5227,Cholic Acid,Sulfotransferase-Substrate,[H][C@@](C)(CCC(O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@]([H])(O)C[C@]4([H])C[C@]([H])(O)CC[C@]4(C)[C@@]3([H])C[C@]([H])(O)[C@]12C
5228,Clioquinol,Sulfotransferase-Inhibitor,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
5229,Clioquinol,Sulfotransferase-Substrate,OC1=C(I)C=C(Cl)C2=C1N=CC=C2
5230,Corticotropin,Sulfotransferase-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
5231,Cortisone,Sulfotransferase-Inhibitor,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
5232,Diethyl Ether,Sulfotransferase-Inducer,CCOCC
5233,Digitoxin,Sulfotransferase-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
5234,Ephedrin,Sulfotransferase-Substrate,CN[C@@H](C)[C@H](O)C1=CC=CC=C1
5235,Epinephrine,Sulfotransferase-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
5236,Epinephrine,Sulfotransferase-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
5237,Estradiol,Sulfotransferase-Inducer,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5238,Estradiol,Sulfotransferase-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5239,Fluphenazine,Sulfotransferase-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
5240,Galactose,Sulfotransferase-Substrate,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O
5241,Hydrocortisone,Sulfotransferase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5242,Hydrocortisone,Sulfotransferase-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5243,Ibuprofen,Sulfotransferase-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
5244,Insulin (human),Sulfotransferase-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5245,Methotrexate,Sulfotransferase-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
5246,Methyldopa (levorotatory),Sulfotransferase-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
5247,Minoxidil,Sulfotransferase-Substrate,NC1=[N+]([O-])C(N)=NC(=C1)N2CCCCC2
5248,Naproxen,Sulfotransferase-Inhibitor,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
5249,Paclitaxel,Sulfotransferase-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5250,Pantoprazole,Sulfotransferase-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5251,Paracetamol,Sulfotransferase-Substrate,CC(=O)NC1=CC=C(O)C=C1
5252,Pipamperone,Sulfotransferase-Inhibitor,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
5253,Progesterone,Sulfotransferase-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5254,Progesterone,Sulfotransferase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5255,Promegestone,Sulfotransferase-Inducer,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C
5256,Pseudoephedrine,Sulfotransferase-Substrate,CN[C@@H](C)[C@@H](O)C1=CC=CC=C1
5257,Pyridoxal Phosphate,Sulfotransferase-Inhibitor,CC1=C(O)C(C=O)=C(COP(O)(O)=O)C=N1
5258,Ritodrine,Sulfotransferase-Substrate,C[C@H](NCCC1=CC=C(O)C=C1)[C@H](O)C2=CC=C(O)C=C2
5259,Salicylic Acid,Sulfotransferase-Inhibitor,OC(=O)C1=C(O)C=CC=C1
5260,Sodium Citrate,Sulfotransferase-Inhibitor,OC(=O)CC(O)(CC(O)=O)C([O-])=O
5261,Sodium Salicylate,Sulfotransferase-Inhibitor,CO[C@@H](CNC(=O)C1=C(OCC([O-])=O)C=CC=C1)C[Hg]O
5262,Sulindac,Sulfotransferase-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
5263,Tamoxifen,Sulfotransferase-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5264,Tamoxifen,Sulfotransferase-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5265,Teicoplanin,Sulfotransferase-Substrate,CC(=O)N[C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H]3NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]5NC(=O)[C@@H](Cc6ccc(Oc7cc4cc(Oc8ccc2cc8Cl)c7O[C@@H]9O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]9NC(=O)C)c(Cl)c6)NC(=O)[C@H](N)c%10ccc(O)c(Oc%11cc(O)cc5c%11)c%10)c%12ccc(O)c(c%12)c%13c(O[C@H]%14O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]%14O)cc(O)cc%13[C@H](NC3=O)C(=O)O
5266,Testosterone,Sulfotransferase-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5267,Tibolone,Sulfotransferase-Substrate,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
5268,Tibolone,Sulfotransferase-Inducer,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
5269,Triamcinolone,Sulfotransferase-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
5270,Triclosan,Sulfotransferase-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
5271,Warfarin,Sulfotransferase-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
5272,Warfarin,Sulfotransferase-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
5273,Astemizole,Arachidonic_acid_epoxygenase-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
5274,Cocaine,Arachidonic_acid_epoxygenase-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5275,Ebastine,Arachidonic_acid_epoxygenase-Inhibitor,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
5276,Ebastine,Arachidonic_acid_epoxygenase-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
5277,Ergocalciferol,Arachidonic_acid_epoxygenase-Substrate,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
5278,Masoprocol,Arachidonic_acid_epoxygenase-Inhibitor,C[C@H](CC1=CC=C(O)C(O)=C1)[C@@H](C)CC2=CC(O)=C(O)C=C2
5279,Terfenadine,Arachidonic_acid_epoxygenase-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
5280,Alprostadil,4F3-Substrate,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
5281,Aldosterone,11B1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
5282,Aminogluthetimide,11B1-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
5283,Angiotensinamide,11B1-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
5284,Cimetidine,11B1-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
5285,Clotrimazole,11B1-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5286,Corticotropin,11B1-Inducer,CSCC[C@H](NC(=O)[C@@H](N)CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C45)C(=O)NCC(O)=O
5287,Desoxycortone,11B1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
5288,Dexamethasone,11B1-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5289,Etomidate,11B1-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
5290,Fluconazole,11B1-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
5291,Hydrocortisone,11B1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5292,Ketoconazole,11B1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5293,Metoclopramide,11B1-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
5294,Metyrapone,11B1-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
5295,Mibefradil,11B1-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5296,Miconazole,11B1-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
5297,Phenytoin,11B1-Inhibitor,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
5298,Spironolactone,11B1-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
5299,Spironolactone,11B1-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
5300,Dinoprostone,4F2-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
5301,Ebastine,4F2-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
5302,Fingolimod,4F2-Substrate,CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1
5303,Ketoconazole,4F2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5304,Retinol (vit A),4F2-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5305,Tocopherol (vit E),4F2-Substrate,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
5306,Acriflavinium Chloride,1A2-Substrate,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4
5307,Albendazole,1A2-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
5308,Albendazole,1A2-Inhibitor,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
5309,Albendazole,1A2-Inducer,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
5310,Alitretinoin,1A2-Inhibitor,CC1=C(C=CC(C)=C/C=C/C(C)=C/C(O)=O)C(C)(C)CCC1
5311,Alosetron,1A2-Substrate,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
5312,Aminogluthetimide,1A2-Inducer,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
5313,Aminophenazone,1A2-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
5314,Aminophylline,1A2-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5315,Amiodarone,1A2-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
5316,Amiodarone,1A2-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
5317,Amitriptyline,1A2-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5318,Amitriptyline,1A2-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5319,Amlodipine,1A2-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
5320,Anagrelide,1A2-Substrate,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl
5321,Anastrozole,1A2-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
5322,Aprepitant,1A2-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
5323,Artemisinin,1A2-Inhibitor,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
5324,Ascorbic Acid (vit C),1A2-Inducer,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
5325,Atropine,1A2-Inhibitor,CN1[C@@H]2CC[C@H]1C[C@H](C2)OC(=O)[C@@H](CO)C3=CC=CC=C3
5326,Azelastine,1A2-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
5327,Benoxaprofen,1A2-Inducer,C[C@H](C(O)=O)C1=CC2=C(OC(=N2)C3=CC=C(Cl)C=C3)C=C1
5328,Benzydamine,1A2-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
5329,Bergapten,1A2-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
5330,Betacarotene,1A2-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1
5331,Betaxolol,1A2-Substrate,CC(C)NC[C@H](O)COC1=CC=C(CCOC[C@H]2CC2)C=C1
5332,Bortezomib,1A2-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
5333,Bromazepam,1A2-Substrate,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
5334,Bromocriptine,1A2-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
5335,Bupivacaine,1A2-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5336,Buprenorphine,1A2-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
5337,Bupropion,1A2-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
5338,Caffeine,1A2-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5339,Caffeine,1A2-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
5340,Capsaicin,1A2-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
5341,Carbamazepine,1A2-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5342,Carbamazepine,1A2-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5343,Carbamazepine,1A2-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5344,Carmustine,1A2-Substrate,ClCCNC(=O)N(CCCl)N=O
5345,Carvedilol,1A2-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
5346,Chinin,1A2-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5347,Chinin,1A2-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5348,Chinin,1A2-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
5349,Chlorothiazide,1A2-Inducer,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
5350,Chlorpromazine,1A2-Substrate,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5351,Chlorpromazine,1A2-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5352,Chlorpromazine,1A2-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5353,Chlorzoxazone,1A2-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
5354,Cilostazol,1A2-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
5355,Cimetidine,1A2-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
5356,Cinacalcet,1A2-Substrate,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
5357,Cinnarizin,1A2-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
5358,Ciprofloxacin,1A2-Inhibitor,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
5359,Cisapride,1A2-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
5360,Citalopram,1A2-Inhibitor,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
5361,Clarithromycin,1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
5362,Clenbuterol,1A2-Substrate,CC(C)(C)NC[C@H](O)C1=CC(Cl)=C(N)C(Cl)=C1
5363,Clobetasol,1A2-Inhibitor,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
5364,Clomifene,1A2-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
5365,Clomipramine,1A2-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
5366,Clopidogrel,1A2-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
5367,Clotrimazole,1A2-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5368,Clozapine,1A2-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5369,Clozapine,1A2-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
5370,Cocaine,1A2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5371,Cyamemazine,1A2-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
5372,Cyclobarbital,1A2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
5373,Cyclobenzaprine,1A2-Substrate,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5374,Cypermethrin,1A2-Substrate,CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2
5375,Dacarbazine,1A2-Inhibitor,CN(C)N=NC1=C(N=CN1)C(N)=O
5376,Dacarbazine,1A2-Substrate,CN(C)N=NC1=C(N=CN1)C(N)=O
5377,Dactinomycin,1A2-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
5378,Daunorubicin,1A2-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5379,Deanol,1A2-Substrate,CN(C)CCO
5380,Decamethrin,1A2-Substrate,CC1(C)[C@@H](C=C(/Br)Br)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2
5381,Delavirdine,1A2-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
5382,Desipramine,1A2-Substrate,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5383,Desloratadine,1A2-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
5384,Dexamethasone,1A2-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5385,Dexfenfluramine,1A2-Inhibitor,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
5386,Dexfenfluramine,1A2-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
5387,Dexmedetomidine,1A2-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
5388,Diazepam,1A2-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5389,Diazepam,1A2-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
5390,Diclofenac,1A2-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5391,Diclofenac,1A2-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5392,Diethyltoluamide,1A2-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
5393,Dihydralazine,1A2-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
5394,Dihydralazine,1A2-Inhibitor,NNC1=NN=C(NN)C2=C1C=CC=C2
5395,Dinoprostone,1A2-Substrate,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
5396,Disulfiram,1A2-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
5397,Disulfiram,1A2-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
5398,Domperidone,1A2-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
5399,Dopamine,1A2-Inhibitor,NCCC1=CC(O)=C(O)C=C1
5400,Dopamine,1A2-Substrate,NCCC1=CC(O)=C(O)C=C1
5401,Doxepin,1A2-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
5402,Doxorubicin,1A2-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5403,Duloxetine,1A2-Substrate,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
5404,Efavirenz,1A2-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
5405,Enoxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2
5406,Enoxolone,1A2-Inhibitor,CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O
5407,Entacapone,1A2-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
5408,Epinephrine,1A2-Inhibitor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
5409,Ergotamine,1A2-Substrate,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
5410,Erlotinib,1A2-Substrate,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
5411,Erythromycin,1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5412,Erythromycin,1A2-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5413,Estradiol,1A2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
5414,Estriol,1A2-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
5415,Estrone,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
5416,Ethanol,1A2-Substrate,CCO
5417,Ethinylestradiol,1A2-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5418,Ethinylestradiol,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
5419,Etoposide,1A2-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5420,Etoricoxib,1A2-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
5421,Fenbendazole,1A2-Inducer,COC(=O)NC1=NC2=C(N1)C=CC(SC3=CC=CC=C3)=C2
5422,Flecainide,1A2-Substrate,FC(F)(F)COC1=CC(C(=O)NC[C@@H]2CCCCN2)=C(OCC(F)(F)F)C=C1
5423,Fluconazole,1A2-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
5424,Flunarizine,1A2-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
5425,Flunitrazepam,1A2-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
5426,Fluorouracil,1A2-Substrate,FC1=CNC(=O)NC1=O
5427,Fluoxetine,1A2-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
5428,Fluoxetine,1A2-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
5429,Fluphenazine,1A2-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
5430,Flutamide,1A2-Inhibitor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
5431,Flutamide,1A2-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
5432,Fluvastatin,1A2-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
5433,Fluvoxamine,1A2-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
5434,Fluvoxamine,1A2-Substrate,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
5435,Frovatriptan,1A2-Substrate,CN[C@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(N)=O
5436,Gemfibrozil,1A2-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
5437,Granisetron,1A2-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
5438,Griseofulvin,1A2-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
5439,Griseofulvin,1A2-Substrate,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
5440,Guajazulen,1A2-Substrate,CC(C)C1=CC2=C(C)C=CC2=C(C)C=C1
5441,Haloperidol,1A2-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5442,Hexobarbital,1A2-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
5443,Hydrochloric Acid,1A2-Inhibitor,Cl
5444,Idebenone,1A2-Substrate,COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
5445,Imatinib,1A2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5446,Imipramine,1A2-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5447,Imipramine,1A2-Inhibitor,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5448,Imipramine Oxide,1A2-Substrate,C[N+](C)([O-])CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5449,Imiquimod,1A2-Substrate,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
5450,Insulin (human),1A2-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5451,Ipriflavone,1A2-Substrate,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
5452,Ipriflavone,1A2-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
5453,Irbesartan,1A2-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
5454,Isoniazid,1A2-Inhibitor,NNC(=O)C1=CC=NC=C1
5455,Ketoconazole,1A2-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5456,Lansoprazole,1A2-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
5457,Levobupivacaine,1A2-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5458,Levofloxacin,1A2-Inhibitor,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
5459,Lidocain,1A2-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5460,Lidocain,1A2-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5461,Lomefloxacin,1A2-Substrate,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12
5462,Lomefloxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(N3CCN[C@H](C)C3)C(F)=C12
5463,Lopinavir,1A2-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
5464,Losartan,1A2-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
5465,Lumiracoxib,1A2-Substrate,CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=CC=C2F)C=C1
5466,Malathion,1A2-Substrate,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
5467,Maprotiline,1A2-Substrate,CNCCC[C@@]12CC[C@@H](C3=C1C=CC=C3)C4=C2C=CC=C4
5468,Meclozin,1A2-Inhibitor,CC1=CC(CN2CCN(CC2)[C@@H](C3=CC=CC=C3)C4=CC=C(Cl)C=C4)=CC=C1
5469,Medrysone,1A2-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
5470,Melatonin,1A2-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
5471,Menadione,1A2-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
5472,Methadone,1A2-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5473,Methoxsalen,1A2-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
5474,Methoxyflurane,1A2-Substrate,COC(F)(F)C(Cl)Cl
5475,Methyldopa (levorotatory),1A2-Substrate,C[C@@](N)(CC1=CC(O)=C(O)C=C1)C(O)=O
5476,Mexiletine,1A2-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
5477,Mexiletine,1A2-Inhibitor,C[C@H](N)COC1=C(C)C=CC=C1C
5478,Mianserin,1A2-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
5479,Mibefradil,1A2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5480,Miconazole,1A2-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
5481,Mirtazapine,1A2-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
5482,Mitobronitol,1A2-Inducer,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr
5483,Mitomycin,1A2-Inducer,CO[C@@]12[C@H](COC(N)=O)C3=C(N1C[C@@H]4N[C@H]24)C(=O)C(C)=C(N)C3=O
5484,Moclobemide,1A2-Inhibitor,ClC1=CC=C(C=C1)C(=O)NCCN2CCOCC2
5485,Modafinil,1A2-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
5486,Modafinil,1A2-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
5487,Moracizine,1A2-Inhibitor,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1
5488,Nabumetone,1A2-Substrate,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2
5489,Naproxen,1A2-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
5490,Nelfinavir,1A2-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5491,Nevirapine,1A2-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
5492,Niclosamide,1A2-Inhibitor,OC1=C(C=C(Cl)C=C1)C(=O)NC2=C(Cl)C=C(C=C2)[N+]([O-])=O
5493,Nicotinamide,1A2-Inducer,NC(=O)C1=CC=CN=C1
5494,Nicotine,1A2-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
5495,Nicotine,1A2-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
5496,Nifedipine,1A2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
5497,Nilvadipine,1A2-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
5498,Nisoldipine,1A2-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
5499,Nitrazepam,1A2-Inducer,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
5500,Nitroprusside,1A2-Inhibitor,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N
5501,Norepinephrine,1A2-Inhibitor,NC[C@@H](O)C1=CC(O)=C(O)C=C1
5502,Norfloxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
5503,Nortriptyline,1A2-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5504,Ofloxacin,1A2-Inhibitor,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
5505,Olanzapine,1A2-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
5506,Omeprazole,1A2-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5507,Omeprazole,1A2-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5508,Omeprazole,1A2-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
5509,Ondansetron,1A2-Inhibitor,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
5510,Ondansetron,1A2-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
5511,Orphenadrine (citrate),1A2-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
5512,Oxaliplatin,1A2-Substrate,N[C@@H]1CCCC[C@H]1N
5513,Palonosetron,1A2-Substrate,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
5514,Pantoprazole,1A2-Inducer,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5515,Pantoprazole,1A2-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
5516,Paracetamol,1A2-Substrate,CC(=O)NC1=CC=C(O)C=C1
5517,Paraoxon,1A2-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
5518,Paroxetine,1A2-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
5519,Pefloxacin,1A2-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCN(C)CC3)C(F)=C2
5520,Pentamidine Isethionate,1A2-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
5521,Pentoxifylline,1A2-Substrate,CN1C=NC2=C1C(=O)N(CCCCC(C)=O)C(=O)N2C
5522,Perazine,1A2-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
5523,Perazine,1A2-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
5524,Perphenazine,1A2-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
5525,Perphenazine,1A2-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
5526,Pethidine,1A2-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
5527,Phenacetin,1A2-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
5528,Phenazone,1A2-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
5529,Phenobarbital,1A2-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5530,Phentermine,1A2-Inhibitor,CC(C)(N)CC1=CC=CC=C1
5531,Phenylephrine,1A2-Inducer,CNC[C@H](O)C1=CC(O)=CC=C1
5532,Phenylpropanolamine,1A2-Inhibitor,C[C@@H](N)[C@@H](O)C1=CC=CC=C1
5533,Pimozide,1A2-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
5534,Pipamperone,1A2-Inducer,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
5535,Pirfenidone,1A2-Substrate,CC1=CN(C(=O)C=C1)C1=CC=CC=C1
5536,Prasterone,1A2-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
5537,Praziquantel,1A2-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
5538,Prednisone,1A2-Inducer,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5539,Primaquine,1A2-Inducer,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
5540,Primaquine,1A2-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
5541,Primaquine,1A2-Substrate,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
5542,Primidone,1A2-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
5543,Procarbazine,1A2-Substrate,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
5544,Progesterone,1A2-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5545,Proguanil,1A2-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
5546,Promazine,1A2-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
5547,Propafenone,1A2-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
5548,Propafenone,1A2-Substrate,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
5549,Propofol,1A2-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
5550,Propofol,1A2-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
5551,Propranolol,1A2-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
5552,Propranolol,1A2-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
5553,Pyrazinamide,1A2-Substrate,NC(=O)C1=CN=CC=N1
5554,Quinidine,1A2-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5555,Rabeprazole,1A2-Inducer,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
5556,Ranitidine,1A2-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
5557,Ranitidine,1A2-Substrate,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
5558,Rasagiline,1A2-Substrate,C#CCNC1CCC2=CC=CC=C12
5559,Retinol (vit A),1A2-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5560,Retinol (vit A),1A2-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5561,Rifabutin,1A2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
5562,Rifampicin,1A2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5563,Rifampicin,1A2-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5564,Riluzole,1A2-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
5565,Ritonavir,1A2-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5566,Ritonavir,1A2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5567,Ritonavir,1A2-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
5568,Rofecoxib,1A2-Inhibitor,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
5569,Rofecoxib,1A2-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
5570,Ropinirole,1A2-Inhibitor,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
5571,Ropinirole,1A2-Substrate,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
5572,Ropivacaine,1A2-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5573,Rosiglitazone,1A2-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
5574,Roxithromycin,1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
5575,Salicylamide,1A2-Inhibitor,NC(=O)C1=C(O)C=CC=C1
5576,Secobarbital,1A2-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
5577,Selegiline,1A2-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
5578,Selegiline,1A2-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
5579,Sertraline,1A2-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
5580,Sorbitol,1A2-Inhibitor,OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)CO
5581,Streptozocin,1A2-Inducer,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
5582,Sulconazole,1A2-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
5583,Sulindac,1A2-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
5584,Sulpiride,1A2-Inhibitor,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
5585,Tacrine,1A2-Substrate,NC1=C2CCCCC2=NC3=C1C=CC=C3
5586,Tegafur,1A2-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
5587,Tegaserod,1A2-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
5588,Telithromycin,1A2-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
5589,Temafloxacin,1A2-Substrate,C[C@@H]1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=C(F)C=C(F)C=C4)C(O)=O
5590,Temafloxacin,1A2-Inhibitor,C[C@@H]1CN(CCN1)C2=CC3=C(C=C2F)C(=O)C(=CN3C4=C(F)C=C(F)C=C4)C(O)=O
5591,Tenofovir Disoproxil,1A2-Inhibitor,CC(C)OC(=O)OCOP(=O)(CO[C@H](C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C
5592,Terbinafine,1A2-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
5593,Tetrabenazine,1A2-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
5594,Theobromine,1A2-Substrate,CN1C=NC2=C1C(=O)NC(=O)N2C
5595,Theophylline,1A2-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5596,Theophylline,1A2-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
5597,Thiamazole,1A2-Inhibitor,CN1C=CNC1=S
5598,Thioridazine,1A2-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
5599,Thioridazine,1A2-Substrate,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
5600,Tiabendazole,1A2-Inhibitor,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
5601,Tiabendazole,1A2-Substrate,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
5602,Tibolone,1A2-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
5603,Ticlopidine,1A2-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
5604,Tioconazole,1A2-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
5605,Tiotixene,1A2-Substrate,CN1CCN(CCC=C2C3=C(SC4=C2C=C(C=C4)S(=O)(=O)N(C)C)C=CC=C3)CC1
5606,Tizanidine,1A2-Substrate,ClC1=C(NC2=NCCN2)C3=NSN=C3C=C1
5607,Tocainide,1A2-Inhibitor,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C
5608,Tolperisone,1A2-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
5609,Toremifene,1A2-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
5610,Tranylcypromine,1A2-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
5611,Treosulfan,1A2-Inhibitor,CS(=O)(=O)OC[C@H](O)[C@H](O)COS(C)(=O)=O
5612,Triamterene,1A2-Inhibitor,NC1=NC2=C(N=C(C3=CC=CC=C3)C(N)=N2)C(N)=N1
5613,Triamterene,1A2-Substrate,NC1=NC2=C(N=C(C3=CC=CC=C3)C(N)=N2)C(N)=N1
5614,Trichloroethylene,1A2-Substrate,ClC=C(Cl)Cl
5615,Trifluoperazine,1A2-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
5616,Trospium,1A2-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
5617,Tryptophan,1A2-Inducer,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
5618,Valproic Acid,1A2-Inhibitor,CCCC(CCC)C(O)=O
5619,Verapamil,1A2-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
5620,Vincamine,1A2-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
5621,Warfarin,1A2-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
5622,Zafirlukast,1A2-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
5623,Ziprasidone,1A2-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
5624,Zolmitriptan,1A2-Substrate,CN(C)CCC1=CNC2=C1C=C(C[C@H]3COC(=O)N3)C=C2
5625,Zolpidem,1A2-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
5626,Zolpidem,1A2-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
5627,Zotepine,1A2-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
5628,17_beta_estradiol,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O
5629,2_acetylamino_fluorene,1A2-Substrate,CC(=O)NC1=CC=C2C(=C1)CC3=CC=CC=C23
5630,2_acetylbenzothiophene,1A2-Substrate,CC(=O)C1=CC2=CC=CC=C2S1
5631,2_amino_1_methyl_6_phenylimidazo_4_5_b_pyridine,1A2-Substrate,C[N]1C(=NC2=NC=C(C=C12)C3=CC=CC=C3)N
5632,2_amino_3_8_dimethylimidazo_4_5_f_quinoxaline,1A2-Substrate,C[N]1C(=NC2=C1C=CC3=NC=C(C)N=C23)N
5633,2_amino_3_methylimidazo_4_5_f_quinoline,1A2-Substrate,C[N]1C(=NC2=C1C=CC3=NC=CC=C23)N
5634,2_oxo_clopidogrel,1A2-Substrate,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3
5635,2_oxo_ticlopidine,1A2-Substrate,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2
5636,3_cyano_7_ethoxycoumarin,1A2-Substrate,CCOC1=CC=C2C=C(C#N)[C](=O)OC2=C1
5637,3_methylindole,1A2-Substrate,CC1=C[NH]C2=CC=CC=C12
5638,3_O_methyl_fluorescein,1A2-Substrate,COC1=CC=C2C(=C1)OC3=CC(=CC=C3C24OC(=O)C5=CC=CC=C45)O
5639,4_aminobiphenyl,1A2-Substrate,NC1=CC=C(C=C1)C2=CC=CC=C2
5640,5_methylchrysene,1A2-Substrate,CC1=CC2=CC=CC=C2C3=CC=C4C=CC=CC4=C13
5641,7_benzyloxy_4_trifluoromethyl_coumarin,1A2-Substrate,FC(F)(F)C1=C[C](=O)OC2=CC(=CC=C12)OCC3=CC=CC=C3
5642,7_benzyloxy_quinoline,1A2-Substrate,C(OC1=CC=C2C=CC=NC2=C1)C3=CC=CC=C3
5643,7_ethoxy_resorufin,1A2-Substrate,CCOC1=CC=C2N=C3C=C[C](=O)C=C3OC2=C1
5644,7_methoxy_coumarin,1A2-Substrate,COC1=CC=C2C=C[C](=O)OC2=C1
5645,ABT_438,1A2-Substrate,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1
5646,acenocoumarol_R,1A2-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N](=O)=O)C2=C(O)C3=C(O[C]2=O)C=CC=C3
5647,aflatoxin_B1,1A2-Substrate,COC1=CC2=C([C@@H]3C=CO[C@@H]3O2)C4=C1C5=C(C(=O)CC5)[C](=O)O4
5648,all_trans_retinal,1A2-Substrate,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
5649,almotriptan,1A2-Substrate,CN(C)CCC1=C[NH]C2=CC=C(C[S](=O)(=O)N3CCCC3)C=C12
5650,amiodarone,1A2-Substrate,CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3
5651,amitriptyline,1A2-Substrate,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13
5652,antipyrine,1A2-Substrate,C[N]1[N]([C](=O)C=C1C)C2=CC=CC=C2
5653,apigenin,1A2-Substrate,OC1=CC=C(C=C1)C2=C[C](=O)C3=C(O2)C=C(O)C=C3O
5654,atomoxetine,1A2-Substrate,CNCC[C@@H](OC1=C(C)C=CC=C1)C2=CC=CC=C2
5655,atrazine,1A2-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)C
5656,azelastine,1A2-Substrate,CN1CCC[C@@H](CC1)[N]2N=C(CC3=CC=C(Cl)C=C3)C4=C(C=CC=C4)[C]2=O
5657,azinphosmethyl,1A2-Substrate,CO[P](=S)(OC)SC[N]1N=NC2=CC=CC=C2[C]1=O
5658,BMAMC,1A2-Substrate,CCCCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
5659,bortezomib,1A2-Substrate,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
5660,BPR_0L075,1A2-Substrate,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC
5661,BRN_4201400,1A2-Substrate,C[N]1[C](=O)[N](CC2CCCCC2)C3=C([NH]C(=N3)C)[C]1=O
5662,bropirimine,1A2-Substrate,NC1=N[C](=O)C(=C([NH]1)C2=CC=CC=C2)Br
5663,bufuralol_R,1A2-Substrate,CCC1=C2OC(=CC2=CC=C1)[C@H](O)CNC(C)(C)C
5664,carbaryl,1A2-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
5665,carbofuran,1A2-Substrate,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1
5666,carvedilol_S,1A2-Substrate,COC1=CC=CC=C1OCCNC[C@H](O)COC2=C3C(=CC=C2)[NH]C4=C3C=CC=C4
5667,celecoxib,1A2-Substrate,CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S](N)(=O)=O)C(F)(F)F
5668,chlorpyrifos,1A2-Substrate,CCO[P](=S)(OCC)OC1=NC(=C(Cl)C=C1Cl)Cl
5669,chlorzoxazone,1A2-Substrate,ClC1=CC2=C(O[C](=O)[NH]2)C=C1
5670,cinnarizine,1A2-Substrate,C1CN(CCN1C\C=C\C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
5671,cisapride,1A2-Substrate,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(=C(N)C=C3OC)Cl
5672,clobazam,1A2-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
5673,clopidogrel,1A2-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl
5674,clozapine,1A2-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
5675,CMV_423,1A2-Substrate,NC(=O)C1=C2CCCC[N]2C(=C1Cl)C3=CC=CN=C3
5676,cp_677_623,1A2-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
5677,curcumin,1A2-Substrate,COC1=CC(=CC=C1O)\C=C\C(=O)CC(=O)\C=C\C2=CC=C(O)C(=C2)OC
5678,dacarbazine,1A2-Substrate,CN(C)N\N=C1/N=CN=C1C(N)=O
5679,DDB_aka_BDD,1A2-Substrate,COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3C(=O)OC)OC
5680,DDTC_Me,1A2-Substrate,CCN(CC)C(=S)SC
5681,delta_3_carene,1A2-Substrate,CC1=CC[C@H]2[C@H](C2(C)C)C1
5682,DETC_Me,1A2-Substrate,CCN(CC)C(=O)SC
5683,dexfenfluramine,1A2-Substrate,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F
5684,diazinion,1A2-Substrate,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C
5685,dibenzacridine,1A2-Substrate,C1=CC=C2C(=C1)C=CC3=NC4=CC=C5C=CC=CC5=C4C=C23
5686,diclofenac,1A2-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5687,diethyl_meta_toluamide,1A2-Substrate,CCN(CC)C(=O)C1=CC(=CC=C1)C
5688,diphenhydramine,1A2-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
5689,disulfoton,1A2-Substrate,CCO[P](=S)(OCC)SCCSCC
5690,diuron,1A2-Substrate,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl
5691,DMXAA,1A2-Substrate,CC1=CC=C2[C](=O)C3=C(OC2=C1C)C(=CC=C3)CC(O)=O
5692,domperidone,1A2-Substrate,ClC1=CC=C2[N](C3CCN(CCC[N]4[C](=O)[NH]C5=CC=CC=C45)CC3)[C](=O)[NH]C2=C1
5693,DY_9760e,1A2-Substrate,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl
5694,efavirenz,1A2-Substrate,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC3CC3
5695,ellipticine,1A2-Substrate,CC1=C2[NH]C3=CC=CC=C3C2=C(C)C4=CN=CC=C14
5696,ethanol,1A2-Substrate,CCO
5697,etoposide,1A2-Substrate,COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4OC5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC
5698,FLU,1A2-Substrate,NC1=CC=C(C(=C1)C(F)(F)F)[N](=O)=O
5699,furafylline,1A2-Substrate,C[N]1[C](=O)[N](CC2=CC=CO2)C3=C([NH]C(=N3)C)[C]1=O
5700,H_259_31_R,1A2-Substrate,FC1=CC=C2N=C([NH]C2=C1)[S@](=O)CC3=NC=CC(=C3)OCC4CC4
5701,haloperidol,1A2-Substrate,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
5702,harmaline,1A2-Substrate,COC1=CC2=C(C=C1)C3=C([NH]2)C(=NCC3)C
5703,harmine,1A2-Substrate,COC1=CC=C2C(=C1)[NH]C3=C2C=CN=C3C
5704,hesperetin,1A2-Substrate,COC1=CC=C(C=C1O)[C@@H]2CC(=O)C3=C(O)C=C(O)C=C3O2
5705,imidacloprid,1A2-Substrate,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1
5706,imipramine,1A2-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13
5707,indiplon,1A2-Substrate,CN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=N[N]23)C(=O)C4=CC=CS4
5708,ipriflavone_M4,1A2-Substrate,CC(CO)OC1=CC=C2[C](=O)C(=COC2=C1)C3=CC=CC=C3
5709,K11777,1A2-Substrate,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4
5710,lidocaine,1A2-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
5711,LU_2509,1A2-Substrate,CC[N]1N=NC(=N1)C2=CCCN(C)C2
5712,MBDB,1A2-Substrate,CC[C@H](CC1=CC=C2OCOC2=C1)NC
5713,MeAMFC,1A2-Substrate,CC[N+](C)(CC)CCC1=C(C2=CC=C(OC)C=C2O[C]1=O)C(F)(F)F
5714,melatonin,1A2-Substrate,COC1=CC=C2[NH]C=C(CCNC(C)=O)C2=C1
5715,methiocarb,1A2-Substrate,CNC(=S)OC1=CC(=C(SC)C(=C1)C)C
5716,methoxychlor,1A2-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(OC)C=C2)C(Cl)(Cl)Cl
5717,metoclopramide,1A2-Substrate,CCN(CC)CCNC(=O)C1=CC(=C(N)C=C1OC)Cl
5718,mirtazapine_R,1A2-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CN=C24
5719,ML_3403,1A2-Substrate,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4
5720,MPBP,1A2-Substrate,CCC(N1CCCC1)C(=O)C2=CC=C(C)C=C2
5721,muraglitazar,1A2-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
5722,myristicin,1A2-Substrate,COC1=C2OCOC2=CC(=C1)CC=C
5723,N_desmethyl_clomipramine,1A2-Substrate,CNCCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
5724,nabumetone,1A2-Substrate,COC1=CC=C2C=C(CCC(C)=O)C=CC2=C1
5725,naproxen_S,1A2-Substrate,COC1=CC=C2C=C(C=CC2=C1)[C@H](C)C(O)=O
5726,NN_diamyl_nitrosoamine,1A2-Substrate,CCCCCN(CCCCC)N=O
5727,NN_methyl_butyl_nitrosoamine,1A2-Substrate,CCCCN(C)N=O
5728,NNK,1A2-Substrate,CN(CCCC(=O)C1=CC=CN=C1)N=O
5729,nonane,1A2-Substrate,CCCCCCCCC
5730,O_methyl_acetaminophen,1A2-Substrate,COC1=CC=C(NC(C)=O)C=C1
5731,O_phenylphenol,1A2-Substrate,OC1=C(C=CC=C1)C2=CC=CC=C2
5732,O6_benzylguanine,1A2-Substrate,NC1=NC2=C(N=C[NH]2)C(=N1)OCC3=CC=CC=C3
5733,ochratoxin_A,1A2-Substrate,C[C@@H]1CC2=C(C(=C(C=C2Cl)C(=O)N[C@@H](CC3=CC=CC=C3)C(O)=O)O)C(=O)O1
5734,olanzapine,1A2-Substrate,CN1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(C)S4
5735,ondansetron,1A2-Substrate,C[N]1C2=C(C(=O)[C@@H](CC2)C[N]3C=CN=C3C)C4=CC=CC=C14
5736,p_cresol,1A2-Substrate,CC1=CC=C(O)C=C1
5737,parathion,1A2-Substrate,CCO[P](=S)(OCC)OC1=CC=C(C=C1)[N](=O)=O
5738,phenanthrene,1A2-Substrate,C1=CC=C2C(=C1)C=CC3=CC=CC=C23
5739,phenytoin,1A2-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
5740,phorate,1A2-Substrate,CCO[P](=S)(OCC)SCSCC
5741,promazine,1A2-Substrate,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13
5742,propafenone_R,1A2-Substrate,CCCNC[C@@H](O)COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2
5743,propofol,1A2-Substrate,CC(C)C1=C(O)C(=CC=C1)C(C)C
5744,propranolol_R,1A2-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
5745,pyrazolo_acridine,1A2-Substrate,COC1=CC2=C(NC3=C(C=CC4=C3C2=N[N]4CCCN(C)C)[N](=O)=O)C=C1
5746,rabeprazole_thioether,1A2-Substrate,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2
5747,ranitidine,1A2-Substrate,CN\C(NCCSCC1=CC=C(CN(C)C)O1)=C/[N](=O)=O
5748,RHP+,1A2-Substrate,OC(CCC[N+]1=CC=C(C=C1)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3
5749,riluzole,1A2-Substrate,NC1=NC2=CC=C(OC(F)(F)F)C=C2S1
5750,ropinirole,1A2-Substrate,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
5751,ropivacaine,1A2-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
5752,rutaecarpine,1A2-Substrate,O=[C]1[N]2CCC3=C([NH]C4=CC=CC=C34)C2=NC5=C1C=CC=C5
5753,selegiline,1A2-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
5754,sulprofos,1A2-Substrate,CCCS[P](=S)(OCC)OC1=CC=C(SC)C=C1
5755,tacrine,1A2-Substrate,NC1=C2CCCCC2=NC3=C1C=CC=C3
5756,tangeretin,1A2-Substrate,COC1=CC=C(C=C1)C2=C[C](=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC
5757,tauromustine,1A2-Substrate,CN(C)[S](=O)(=O)CCNC(=O)N(CCCl)N=O
5758,tegafur,1A2-Substrate,FC1=C[N](C2CCCO2)[C](=O)[NH][C]1=O
5759,terbinafine,1A2-Substrate,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12
5760,terbutryn,1A2-Substrate,CCNC1=NC(=NC(=N1)SC)NC(C)(C)C
5761,theophylline,1A2-Substrate,C[N]1[C](=O)[N](C)C2=C([NH]C=N2)[C]1=O
5762,thiabendazole,1A2-Substrate,[NH]1C2=CC=CC=C2N=C1C3=CSC=N3
5763,ticlopidine,1A2-Substrate,ClC1=CC=CC=C1CN2CCC3=C(C2)C=CS3
5764,tolperisone_R,1A2-Substrate,C[C@H](CN1CCCCC1)C(=O)C2=CC=C(C)C=C2
5765,trans_stilbene,1A2-Substrate,C1=CC=C(C=C1)\C=C\C2=CC=CC=C2
5766,xylene_meta,1A2-Substrate,CC1=CC=CC(=C1)C
5767,xylene_ortho,1A2-Substrate,CC1=CC=CC=C1C
5768,xylene_para,1A2-Substrate,CC1=CC=C(C)C=C1
5769,zileuton_R,1A2-Substrate,C[C@@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1
5770,zolmitriptan,1A2-Substrate,CN(C)CCC1=C[NH]C2=C1C=C(C[C@H]3COC(=O)N3)C=C2
5771,zotepine,1A2-Substrate,CN(C)CCOC1=CC2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
5772,13_cis_retinoic_acid,1A2-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
5773,3_methylether_estradiol,1A2-Substrate,COC1=CC=C2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2=C1
5774,4_chloro_7_ethoxycoumarin,1A2-Substrate,CCOC1=CC=C2C(=C[C](=O)OC2=C1)Cl
5775,6_methylchrysene,1A2-Substrate,CC1=CC2=C3C=CC=CC3=CC=C2C4=CC=CC=C14
5776,7_ethoxy_4_trifluoro_methyl_coumarin,1A2-Substrate,CCOC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
5777,7_ethoxy_coumarin,1A2-Substrate,CCOC1=CC=C2C=C[C](=O)OC2=C1
5778,7_methoxy_3_cyano_coumarin,1A2-Substrate,COC1=CC=C2C=C(C#N)[C](=O)OC2=C1
5779,7_methoxy_4_trifluoro_methyl_coumarin,1A2-Substrate,COC1=CC=C2C(=C1)O[C](=O)C=C2C(F)(F)F
5780,7_methyl_benzacridine,1A2-Substrate,CC1=C2C=CC3=C(C=CC=C3)C2=NC4=CC=CC=C14
5781,9_cis_retinal,1A2-Substrate,CC(=C\C=O)/C=C/C=C(C)\C=C\C1=C(C)CCCC1(C)C
5782,ABT_66193,1A2-Substrate,CC(NC(N)=O)C1=CC2=CC=CC=C2S1
5783,ABT_761,1A2-Substrate,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O
5784,acetaminophen,1A2-Substrate,CC(=O)NC1=CC=C(O)C=C1
5785,all_trans_retinoic_acid,1A2-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1
5786,ametryne,1A2-Substrate,CCNC1=NC(=NC(=N1)SC)NC(C)C
5787,AMMC,1A2-Substrate,CC[N+](C)(CC)CCC1=C(C)C2=CC=C(OC)C=C2O[C]1=O
5788,benzyl_oxy_resorufin,1A2-Substrate,O=[C]1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1
5789,caffeine,1A2-Substrate,C[N]1C=NC2=C1[C](=O)[N](C)[C](=O)[N]2C
5790,catechol_methoxychlor,1A2-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C(=C2)O)C(Cl)(Cl)Cl
5791,clomipramine,1A2-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
5792,dibenzyl_fluorescein,1A2-Substrate,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17
5793,diclofenac_deriv_2,1A2-Substrate,OCCC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5794,DiMMAMC,1A2-Substrate,COC1=CC=C2C(=C[C](=O)OC2=C1)CN(C)C
5795,DMBA,1A2-Substrate,CC1=C2C=CC=CC2=C(C)C3=C4C=CC=CC4=CC=C13
5796,EMAMC,1A2-Substrate,CCNCC1=C[C](=O)OC2=CC(=CC=C12)OC
5797,estrone,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CCC2=O
5798,ethinyl_estradiol,1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@]2(O)C#C
5799,eupatilin,1A2-Substrate,COC1=CC=C(C=C1OC)C2=C[C](=O)C3=C(O)C(=C(O)C=C3O2)OC
5800,flutamide,1A2-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N](=O)=O)C(F)(F)F
5801,foxy,1A2-Substrate,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1
5802,galangin,1A2-Substrate,OC1=CC(=C2[C](=O)C(=C(OC2=C1)C3=CC=CC=C3)O)O
5803,genistein,1A2-Substrate,OC1=CC=C(C=C1)C2=COC3=CC(=CC(=C3[C]2=O)O)O
5804,ipriflavone,1A2-Substrate,CC(C)OC1=CC=C2C(=C1)OC=C([C]2=O)C3=CC=CC=C3
5805,kaempferide,1A2-Substrate,COC1=CC=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O
5806,kaempferol,1A2-Substrate,OC1=CC=C(C=C1)C2=C(O)[C](=O)C3=C(O)C=C(O)C=C3O2
5807,MAMC,1A2-Substrate,COC1=CC=C2C(=C[C](=O)OC2=C1)CN
5808,MDE_R,1A2-Substrate,CCN[C@H](C)CC1=CC=C2OCOC2=C1
5809,MDMA_R,1A2-Substrate,CN[C@H](C)CC1=CC=C2OCOC2=C1
5810,methyl_eugenol,1A2-Substrate,COC1=C(OC)C=C(CC=C)C=C1
5811,mianserin_R,1A2-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CC=C24
5812,ML_3603,1A2-Substrate,CC(NC1=NC=CC(=C1)C2=C(N=C([NH]2)[S](C)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4
5813,MMAMC,1A2-Substrate,CNCC1=C[C](=O)OC2=C1C=CC(=C2)OC
5814,mono_OH_methoxychlor,1A2-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
5815,naringenin,1A2-Substrate,OC1=CC=C(C=C1)[C@H]2CC(=O)C3=C(O)C=C(O)C=C3O2
5816,O_isopropyl_acetaminophen,1A2-Substrate,CC(C)OC1=CC=C(NC(C)=O)C=C1
5817,perazine,1A2-Substrate,CN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=CC=C4)CC1
5818,perphenazine,1A2-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
5819,phenacetin,1A2-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
5820,PMAMC,1A2-Substrate,CCCNCC1=C[C](=O)OC2=C1C=CC(=C2)OC
5821,propranolol_S,1A2-Substrate,CC(C)NC[C@H](O)COC1=C2C=CC=CC2=CC=C1
5822,quinoline,1A2-Substrate,C1=CC=C2N=CC=CC2=C1
5823,retinol,1A2-Substrate,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
5824,tamarixetin,1A2-Substrate,COC1=C(O)C=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O
5825,terbutylazine,1A2-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C
5826,thioridazine_R,1A2-Substrate,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1
5827,toluene,1A2-Substrate,CC1=CC=CC=C1
5828,trans_phenylpropene,1A2-Substrate,C\C=C\C1=CC=CC=C1
5829,Amitriptyline,Sodium_dependent_noradrenaline_transporter-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
5830,Atomoxetine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
5831,Cocaine,Sodium_dependent_noradrenaline_transporter-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
5832,Desipramine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
5833,Dopamine,Sodium_dependent_noradrenaline_transporter-Substrate,NCCC1=CC(O)=C(O)C=C1
5834,Duloxetine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1
5835,Metaraminol,Sodium_dependent_noradrenaline_transporter-Substrate,C[C@H](N)[C@H](O)C1=CC(O)=CC=C1
5836,Methylphenidate,Sodium_dependent_noradrenaline_transporter-Substrate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
5837,Norepinephrine,Sodium_dependent_noradrenaline_transporter-Substrate,NC[C@@H](O)C1=CC(O)=C(O)C=C1
5838,Reboxetine,Sodium_dependent_noradrenaline_transporter-Inducer,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
5839,Sibutramine,Sodium_dependent_noradrenaline_transporter-Inhibitor,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2
5840,Sodium Chloride,Sodium_dependent_noradrenaline_transporter-Inducer,[Na+].[Cl-]
5841,Tramadol,Sodium_dependent_noradrenaline_transporter-Inhibitor,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
5842,Vorinostat,Sodium_dependent_noradrenaline_transporter-Inducer,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1
5843,Angiotensinamide,21A-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
5844,Hydroxyprogesterone,21A-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
5845,Progesterone,21A-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5846,Acetylcysteine,Multidrug_resistance_protein_1-Inducer,CC(=O)N[C@H](CS)C(O)=O
5847,Ajmaline,Multidrug_resistance_protein_1-Substrate,CCC1C(O)N2C3CC1C4C(O)C5(CC24)C3N(C)C6=C5C=CC=C6
5848,Aldosterone,Multidrug_resistance_protein_1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
5849,Arsenic Trioxide,Multidrug_resistance_protein_1-Inhibitor,O=[As]1=[As](=O)O1
5850,Arsenic Trioxide,Multidrug_resistance_protein_1-Inducer,O=[As]1=[As](=O)O1
5851,Artemisinin,Multidrug_resistance_protein_1-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
5852,Atorvastatin,Multidrug_resistance_protein_1-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
5853,Atorvastatin,Multidrug_resistance_protein_1-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
5854,Bromocriptine,Multidrug_resistance_protein_1-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
5855,Budesonide,Multidrug_resistance_protein_1-Inducer,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
5856,Carbamazepine,Multidrug_resistance_protein_1-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
5857,Celecoxib,Multidrug_resistance_protein_1-Inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
5858,Ciclosporin,Multidrug_resistance_protein_1-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5859,Ciclosporin,Multidrug_resistance_protein_1-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5860,Ciclosporin,Multidrug_resistance_protein_1-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
5861,Cisplatin,Multidrug_resistance_protein_1-Inducer,N[Pt](N)(Cl)Cl
5862,Clopidogrel,Multidrug_resistance_protein_1-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
5863,Colchicine,Multidrug_resistance_protein_1-Substrate,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
5864,Cytarabine,Multidrug_resistance_protein_1-Inducer,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
5865,Cytarabine,Multidrug_resistance_protein_1-Inhibitor,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
5866,Dactinomycin,Multidrug_resistance_protein_1-Inducer,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
5867,Daunorubicin,Multidrug_resistance_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5868,Daunorubicin,Multidrug_resistance_protein_1-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
5869,Dexamethasone,Multidrug_resistance_protein_1-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5870,Dexamethasone,Multidrug_resistance_protein_1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5871,Diclofenac,Multidrug_resistance_protein_1-Inducer,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
5872,Dicloxacillin,Multidrug_resistance_protein_1-Substrate,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4Cl
5873,Digitoxin,Multidrug_resistance_protein_1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
5874,Digoxin,Multidrug_resistance_protein_1-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
5875,Digoxin,Multidrug_resistance_protein_1-Inducer,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
5876,Diltiazem,Multidrug_resistance_protein_1-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
5877,Dimethyl Sulfoxide,Multidrug_resistance_protein_1-Inducer,CS(C)=O
5878,Dinoprostone,Multidrug_resistance_protein_1-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
5879,Dipyridamole,Multidrug_resistance_protein_1-Inhibitor,OCCN(CCO)C1=NC2=C(N=C(N=C2N3CCCCC3)N(CCO)CCO)C(=N1)N4CCCCC4
5880,Docetaxel,Multidrug_resistance_protein_1-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
5881,Docetaxel,Multidrug_resistance_protein_1-Inducer,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
5882,Doxorubicin,Multidrug_resistance_protein_1-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5883,Doxorubicin,Multidrug_resistance_protein_1-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5884,Doxorubicin,Multidrug_resistance_protein_1-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5885,Epinephrine,Multidrug_resistance_protein_1-Inducer,CNC[C@H](O)C1=CC(O)=C(O)C=C1
5886,Epinephrine,Multidrug_resistance_protein_1-Substrate,CNC[C@H](O)C1=CC(O)=C(O)C=C1
5887,Epirubicin,Multidrug_resistance_protein_1-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C(=O)C2=CC=C1
5888,Erythromycin,Multidrug_resistance_protein_1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
5889,Etoposide,Multidrug_resistance_protein_1-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5890,Etoposide,Multidrug_resistance_protein_1-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
5891,Ezetimibe,Multidrug_resistance_protein_1-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
5892,Fenbufen,Multidrug_resistance_protein_1-Inducer,OC(=O)CCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2
5893,Fexofenadine,Multidrug_resistance_protein_1-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
5894,Flucloxacillin,Multidrug_resistance_protein_1-Inducer,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
5895,Fluorouracil,Multidrug_resistance_protein_1-Inducer,FC1=CNC(=O)NC1=O
5896,Folic Acid,Multidrug_resistance_protein_1-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
5897,G-strophanthin,Multidrug_resistance_protein_1-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
5898,Glutathione,Multidrug_resistance_protein_1-Substrate,N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O
5899,Hydrocortisone,Multidrug_resistance_protein_1-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5900,Hydroxycarbamide,Multidrug_resistance_protein_1-Inducer,NC(=O)NO
5901,Imatinib,Multidrug_resistance_protein_1-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
5902,Indometacin,Multidrug_resistance_protein_1-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
5903,Indometacin,Multidrug_resistance_protein_1-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
5904,Indometacin,Multidrug_resistance_protein_1-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
5905,Insulin (human),Multidrug_resistance_protein_1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5906,Irinotecan,Multidrug_resistance_protein_1-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
5907,Ivermectin,Multidrug_resistance_protein_1-Substrate,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
5908,Ketoconazole,Multidrug_resistance_protein_1-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
5909,Loperamide,Multidrug_resistance_protein_1-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
5910,Lopinavir,Multidrug_resistance_protein_1-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
5911,Losartan,Multidrug_resistance_protein_1-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
5912,Metformin,Multidrug_resistance_protein_1-Inhibitor,CN(C)C(=N)NC(N)=N
5913,Methadone,Multidrug_resistance_protein_1-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
5914,Mitomycin,Multidrug_resistance_protein_1-Substrate,CO[C@@]12[C@H](COC(N)=O)C3=C(N1C[C@@H]4N[C@H]24)C(=O)C(C)=C(N)C3=O
5915,Mitoxantrone,Multidrug_resistance_protein_1-Inducer,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
5916,Morphine,Multidrug_resistance_protein_1-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
5917,Nelfinavir,Multidrug_resistance_protein_1-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
5918,Oxycodone,Multidrug_resistance_protein_1-Inducer,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
5919,Paclitaxel,Multidrug_resistance_protein_1-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5920,Paclitaxel,Multidrug_resistance_protein_1-Inducer,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
5921,Paracetamol,Multidrug_resistance_protein_1-Inducer,CC(=O)NC1=CC=C(O)C=C1
5922,Prednisolone,Multidrug_resistance_protein_1-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
5923,Probenecid,Multidrug_resistance_protein_1-Inhibitor,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
5924,Quinidine,Multidrug_resistance_protein_1-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
5925,Rescinnamine,Multidrug_resistance_protein_1-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C=CC6=CC(OC)=C(OC)C(OC)=C6
5926,Reserpine,Multidrug_resistance_protein_1-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
5927,Reserpine,Multidrug_resistance_protein_1-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
5928,Retinol,Multidrug_resistance_protein_1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5929,Rifampicin,Multidrug_resistance_protein_1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
5930,Risperidone,Multidrug_resistance_protein_1-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
5931,Rosuvastatin,Multidrug_resistance_protein_1-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
5932,Saquinavir,Multidrug_resistance_protein_1-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
5933,Saquinavir,Multidrug_resistance_protein_1-Inducer,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
5934,Sirolimus,Multidrug_resistance_protein_1-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
5935,Tacrolimus,Multidrug_resistance_protein_1-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
5936,Talinolol,Multidrug_resistance_protein_1-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
5937,Tamoxifen,Multidrug_resistance_protein_1-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
5938,Trabectedin,Multidrug_resistance_protein_1-Inhibitor,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
5939,Tretinoin,Multidrug_resistance_protein_1-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
5940,Trifluoperazine,Multidrug_resistance_protein_1-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
5941,Tryptophan,Multidrug_resistance_protein_1-Substrate,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
5942,Ursodeoxycholic Acid,Multidrug_resistance_protein_1-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
5943,Valproic Acid,Multidrug_resistance_protein_1-Inducer,CCCC(CCC)C(O)=O
5944,Venlafaxine,Multidrug_resistance_protein_1-Inducer,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
5945,Verapamil,Multidrug_resistance_protein_1-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
5946,Verapamil,Multidrug_resistance_protein_1-Inducer,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
5947,Verapamil,Multidrug_resistance_protein_1-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
5948,Vinblastine,Multidrug_resistance_protein_1-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
5949,Vincamine,Multidrug_resistance_protein_1-Inhibitor,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
5950,Vincristine,Multidrug_resistance_protein_1-Inducer,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
5951,Vincristine,Multidrug_resistance_protein_1-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
5952,Yohimbin,Multidrug_resistance_protein_1-Inducer,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
5953,Bezafibrate,Multidrug_resistance_protein_3-Inducer,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
5954,Doxorubicin,Multidrug_resistance_protein_3-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
5955,Morphine,Multidrug_resistance_protein_3-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
5956,Phenobarbital,Multidrug_resistance_protein_3-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
5957,Retinol,Multidrug_resistance_protein_3-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
5958,Simvastatin,Multidrug_resistance_protein_3-Inducer,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
5959,Aldosterone,17A-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
5960,Aminogluthetimide,17A-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
5961,Aminophenazone,17A-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
5962,Androstanolone,17A-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
5963,Dexamethasone,17A-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
5964,Insulin (human),17A-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5965,Metoclopramide,17A-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
5966,Progesterone,17A-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
5967,[32P]Natriumphosphat,17A-Substrate,OP([O-])([O-])=O
5968,Aldosterone,11B2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
5969,Aminogluthetimide,11B2-Inhibitor,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
5970,Aminosalicylic Acid,11B2-Inducer,NC1=CC(O)=C(C=C1)C(O)=O
5971,Angiotensinamide,11B2-Inducer,CC(C)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(O)=O
5972,Benazepril,11B2-Inhibitor,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(CC(O)=O)C2=O
5973,Desoxycortone,11B2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO
5974,Eplerenone,11B2-Inhibitor,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
5975,Etomidate,11B2-Inhibitor,CCOC(=O)C1=CN=CN1[C@@H](C)C2=CC=CC=C2
5976,Glucose,11B2-Inhibitor,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
5977,Hydrocortisone,11B2-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
5978,Insulin (human),11B2-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
5979,Metoclopramide,11B2-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
5980,Mibefradil,11B2-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
5981,Valsartan,11B2-Inhibitor,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
5982,Acriflavinium Chloride,1A1-Substrate,Cl.[Cl-].C[n+]1c2cc(N)ccc2cc3ccc(N)cc13.Nc4ccc5cc6ccc(N)cc6nc5c4
5983,Albendazole,1A1-Inducer,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
5984,Alum,1A1-Substrate,[O-]S([O-])(=O)=O
5985,Alum,1A1-Inducer,[O-]S([O-])(=O)=O
5986,Amiloride,1A1-Inhibitor,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N
5987,Amiodarone,1A1-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
5988,Amlodipine,1A1-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
5989,Amodiaquine,1A1-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
5990,Arsenic Trioxide,1A1-Inhibitor,O=[As]1=[As](=O)O1
5991,Ascorbic Acid (vit C),1A1-Inducer,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
5992,Atazanavir,1A1-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
5993,Benidipine,1A1-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
5994,Benoxaprofen,1A1-Inducer,C[C@H](C(O)=O)C1=CC2=C(OC(=N2)C3=CC=C(Cl)C=C3)C=C1
5995,Benzydamine,1A1-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
5996,Betacarotene,1A1-Inducer,CC1=C(C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC2=C(C)CCCC2(C)C)C(C)(C)CCC1
5997,Bezafibrate,1A1-Inducer,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
5998,Bortezomib,1A1-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
5999,Caffeine,1A1-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6000,Capsaicin,1A1-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
6001,Chinin,1A1-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6002,Chinin,1A1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6003,Chloroquine,1A1-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
6004,Chlorothiazide,1A1-Inducer,NS(=O)(=O)C1=CC2=C(C=C1Cl)N=CNS2(=O)=O
6005,Chlorpromazine,1A1-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
6006,Cinnarizin,1A1-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
6007,Clenbuterol,1A1-Substrate,CC(C)(C)NC[C@H](O)C1=CC(Cl)=C(N)C(Cl)=C1
6008,Clobetasol,1A1-Inhibitor,C[C@@H]1C[C@H]2[C@H]3CCC4=CC(=O)C=C[C@@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
6009,Clofibrate,1A1-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
6010,Clomifene,1A1-Inducer,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
6011,Clozapine,1A1-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
6012,Cocaine,1A1-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6013,Colchicine,1A1-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6014,Colecalciferol,1A1-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
6015,Dacarbazine,1A1-Inhibitor,CN(C)N=NC1=C(N=CN1)C(N)=O
6016,Dacarbazine,1A1-Substrate,CN(C)N=NC1=C(N=CN1)C(N)=O
6017,Dactinomycin,1A1-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
6018,Dantrolene,1A1-Inhibitor,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O
6019,Daunorubicin,1A1-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
6020,Debrisoquine,1A1-Substrate,NC(=N)N1CCC2=C(C1)C=CC=C2
6021,Decamethrin,1A1-Substrate,CC1(C)[C@@H](C=C(/Br)Br)[C@H]1C(=O)O[C@H](C#N)C2=CC(OC3=CC=CC=C3)=CC=C2
6022,Deferoxamine,1A1-Inhibitor,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN
6023,Dexamethasone,1A1-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6024,Diclofenac,1A1-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
6025,Dicycloverine,1A1-Inducer,CCN(CC)CCOC(=O)[C@@]1(CCCCC1)[C@H]2CCCCC2
6026,Diethylstilbestrol,1A1-Inducer,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
6027,Diosmectite,1A1-Inducer,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
6028,Diosmectite,1A1-Inhibitor,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
6029,Diosmin,1A1-Inhibitor,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
6030,Diosmin,1A1-Inducer,COC1=CC=C(C=C1O)C2=CC(=O)C3=C(O2)C=C(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@@H]5O)[C@H](O)[C@H](O)[C@H]4O)C=C3O
6031,Doxorubicin,1A1-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
6032,Dronabinol,1A1-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
6033,Enoxacin,1A1-Inducer,CCN1C=C(C(O)=O)C(=O)C2=C1N=C(N3CCNCC3)C(F)=C2
6034,Ergometrine,1A1-Inhibitor,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
6035,Erythromycin,1A1-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6036,Estradiol,1A1-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6037,Estriol,1A1-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
6038,Estriol,1A1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
6039,Estrone,1A1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
6040,Etacrynic Acid,1A1-Substrate,CCC(=C)C(=O)C1=CC=C(OCC(O)=O)C(Cl)=C1Cl
6041,Ethanol,1A1-Inhibitor,CCO
6042,Ethinylestradiol,1A1-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
6043,Fluconazole,1A1-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6044,Flunarizine,1A1-Substrate,FC1=CC=C(C=C1)C(N2CCN(CC2)CC=CC3=CC=CC=C3)C4=CC=C(F)C=C4
6045,Fluorescein,1A1-Inducer,OC1=CC2=C(C=C1)[C@]3(OC(=O)C4=C3C=CC=C4)C5=C(O2)C=C(O)C=C5
6046,Flutamide,1A1-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
6047,Fluvastatin,1A1-Inducer,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6048,Fluvastatin,1A1-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6049,Fluvoxamine,1A1-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
6050,G-strophanthin,1A1-Inhibitor,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
6051,Granisetron,1A1-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
6052,Haloperidol,1A1-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
6053,Histamine,1A1-Inducer,NCCC1=CNC=N1
6054,Ipriflavone,1A1-Substrate,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
6055,Isoprenaline,1A1-Inhibitor,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
6056,Itraconazole,1A1-Inducer,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
6057,Ketoconazole,1A1-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6058,Ketoconazole,1A1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6059,Lansoprazole,1A1-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
6060,Lentinan,1A1-Inhibitor,OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](O)[C@H](O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O[C@@H]5O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]5O)[C@H]4O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
6061,Lindane,1A1-Inducer,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
6062,Mebendazole,1A1-Inducer,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3
6063,Mecamylamine,1A1-Inducer,CN[C@@]1(C)[C@H]2CC[C@H](C2)C1(C)C
6064,Melatonin,1A1-Substrate,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
6065,Menadione,1A1-Substrate,CC1=CC(=O)C2=C(C=CC=C2)C1=O
6066,Mercaptopurine,1A1-Substrate,S=C1NC=NC2=C1NC=N2
6067,"Mercury, Metallic",1A1-Inducer,[Hg]
6068,Methoxsalen,1A1-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
6069,Mibefradil,1A1-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
6070,Mitobronitol,1A1-Inducer,O[C@H](CBr)[C@@H](O)[C@H](O)[C@H](O)CBr
6071,Moracizine,1A1-Inhibitor,CCOC(=O)NC1=CC2=C(SC3=C(C=CC=C3)N2C(=O)CCN4CCOCC4)C=C1
6072,Nicotine,1A1-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
6073,Nicotine,1A1-Inducer,CN1CCC[C@H]1C2=CC=CN=C2
6074,Nifedipine,1A1-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6075,Nitrofurantoin,1A1-Substrate,[O-][N+](=O)C1=CC=C(O1)C=NN2CC(=O)NC2=O
6076,Nitroprusside,1A1-Inhibitor,O=N[Fe](C#N)(C#N)(C#N)(C#N)C#N
6077,Norfloxacin,1A1-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
6078,Omeprazole,1A1-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6079,Omeprazole,1A1-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6080,Omeprazole,1A1-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6081,Oxaliplatin,1A1-Substrate,N[C@@H]1CCCC[C@H]1N
6082,Paracetamol,1A1-Substrate,CC(=O)NC1=CC=C(O)C=C1
6083,Perazine,1A1-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
6084,Phenacetin,1A1-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
6085,Phenobarbital,1A1-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
6086,Pipamperone,1A1-Inducer,NC(=O)[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)N3CCCCC3
6087,Prasterone,1A1-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
6088,Prazosin,1A1-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4
6089,Prednisone,1A1-Inducer,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6090,Primaquine,1A1-Inducer,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
6091,Procarbazine,1A1-Substrate,CNNCC1=CC=C(C=C1)C(=O)NC(C)C
6092,Progesterone,1A1-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6093,Propofol,1A1-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
6094,Propranolol,1A1-Inhibitor,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
6095,Propylthiouracil,1A1-Inducer,CCCC1=CC(=O)NC(=S)N1
6096,Pyridoxine (vit B6),1A1-Inducer,CC1=C(O)C(CO)=C(CO)C=N1
6097,Quassia,1A1-Inhibitor,COC1=C[C@@H](C)[C@@H]2C[C@@H]3OC(=O)C[C@H]4C(C)=C(OC)C(=O)[C@@H]([C@]34C)[C@@]2(C)C1=O
6098,Quinidine,1A1-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
6099,Rabeprazole,1A1-Inducer,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
6100,Raltegravir,1A1-Substrate,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1
6101,Retigabine,1A1-Substrate,CCOC(=O)NC1=C(N)C=C(NCC2=CC=C(F)C=C2)C=C1
6102,Retinol,1A1-Inducer,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6103,Retinol,1A1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6104,Retinol (vit A),1A1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6105,Riboflavin (vit B2),1A1-Substrate,CC1=CC2=C(C=C1C)N(C[C@@H](O)[C@@H](O)[C@@H](O)CO)C3=NC(=O)NC(=O)C3=N2
6106,Rifampicin,1A1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6107,Riluzole,1A1-Substrate,NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2
6108,Salicylamide,1A1-Inhibitor,NC(=O)C1=C(O)C=CC=C1
6109,Sildenafil,1A1-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
6110,Streptozocin,1A1-Inducer,CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O
6111,Sulindac,1A1-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
6112,Tamoxifen,1A1-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6113,Testosterone,1A1-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6114,Tetrabenazine,1A1-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
6115,Thalidomide,1A1-Inducer,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
6116,Theophylline,1A1-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6117,Theophylline,1A1-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6118,Tiabendazole,1A1-Inducer,N1C2=C(C=CC=C2)N=C1C3=CSC=N3
6119,Ticlopidine,1A1-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
6120,Tocainide,1A1-Inhibitor,C[C@H](N)C(=O)NC1=C(C)C=CC=C1C
6121,Toremifene,1A1-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
6122,Triclosan,1A1-Inhibitor,OC1=C(OC2=C(Cl)C=C(Cl)C=C2)C=CC(Cl)=C1
6123,Troglitazone,1A1-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6124,Tryptophan,1A1-Inducer,N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O
6125,Zotepine,1A1-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
6126,Acetylcholin,NAT-Inhibitor,CC(=O)OCC[N+](C)(C)C
6127,Acetylsalicylic Acid,NAT-Inhibitor,CC(=O)OC1=C(C=CC=C1)C(O)=O
6128,Adenosine,NAT-Inducer,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
6129,Allopurinol,NAT-Substrate,OC1=NC=NC2=C1C=NN2
6130,Amfetamine,NAT-Inducer,C[C@@H](N)CC1=CC=CC=C1
6131,Aminobenzoic Acid,NAT-Substrate,NC1=CC=C(C=C1)C(O)=O
6132,Aminobenzoic Acid,NAT-Inhibitor,NC1=CC=C(C=C1)C(O)=O
6133,Aminophylline,NAT-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6134,Androstanolone,NAT-Inducer,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
6135,Apomorphine,NAT-Inhibitor,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
6136,Arbekacin,NAT-Substrate,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O
6137,Ascorbic Acid (vit C),NAT-Inhibitor,OC[C@H](O)[C@H]1OC(=O)C(O)=C1O
6138,Bergapten,NAT-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
6139,Bromocriptine,NAT-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
6140,Bucladesine,NAT-Inducer,CCCC(=O)NC1=C2N=CN([C@@H]3O[C@@H]4CO[P@](O)(=O)O[C@H]4[C@H]3OC(=O)CCC)C2=NC=N1
6141,Caffeine,NAT-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6142,Carbachol,NAT-Inhibitor,C[N+](C)(C)CCOC(N)=O
6143,Carmustine,NAT-Inhibitor,ClCCNC(=O)N(CCCl)N=O
6144,Cimetidine,NAT-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
6145,Clonazepam,NAT-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
6146,Clonidine,NAT-Inhibitor,ClC1=CC=CC(Cl)=C1NC2=NCCN2
6147,Clozapine,NAT-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
6148,Cocaine,NAT-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6149,Cocaine,NAT-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6150,Dactinomycin,NAT-Inhibitor,CC(C)[C@@H]1NC(=O)[C@H](NC(=O)C2=C3N=C4C(OC3=C(C)C=C2)=C(C)C(=O)C(N)=C4C(=O)N[C@@H]5[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]6CCCN6C(=O)[C@@H](NC5=O)C(C)C)[C@H](C)OC(=O)[C@@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@H]7CCCN7C1=O
6151,Desipramine,NAT-Inducer,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6152,Desipramine,NAT-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6153,Dexamfetamine,NAT-Inducer,C[C@H](N)CC1=CC=CC=C1
6154,Diazepam,NAT-Inducer,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6155,Dihydralazine,NAT-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
6156,Dinoprostone,NAT-Inducer,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
6157,Disulfiram,NAT-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
6158,Esketamine,NAT-Inducer,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
6159,Fluoxetine,NAT-Inducer,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
6160,Folic Acid,NAT-Inhibitor,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
6161,Folic Acid,NAT-Substrate,NC1=NC(=O)C2=C(N1)N=CC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=N2
6162,G-strophanthin,NAT-Inducer,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
6163,Glycyrrhizic Acid,NAT-Inhibitor,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6164,Haloperidol,NAT-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
6165,Hydralazine,NAT-Substrate,NN=C1NN=CC2=C1C=CC=C2
6166,Hydrocortisone,NAT-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6167,Ibuprofen,NAT-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
6168,Ibuprofen,NAT-Inducer,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
6169,Imipramine,NAT-Inducer,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6170,Indometacin,NAT-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
6171,Indometacin,NAT-Inducer,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
6172,Insulin (human),NAT-Inducer,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
6173,Iproniazide,NAT-Inhibitor,CC(C)NNC(=O)C1=CC=NC=C1
6174,Isoprenaline,NAT-Inducer,CC(C)NC[C@H](O)C1=CC(O)=C(O)C=C1
6175,Ketamine,NAT-Inducer,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
6176,Ketoprofen,NAT-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
6177,Levodopa,NAT-Inducer,N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
6178,Lindane,NAT-Inducer,Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl
6179,Melatonin,NAT-Inducer,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
6180,Melatonin,NAT-Inhibitor,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1
6181,Mercaptamine,NAT-Inhibitor,NCCS
6182,Mesalazine,NAT-Substrate,NC1=CC(C(O)=O)=C(O)C=C1
6183,Metamizole Sodium,NAT-Substrate,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
6184,Methotrexate,NAT-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
6185,Metoclopramide,NAT-Inducer,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
6186,Netilmicin,NAT-Substrate,CCN[C@@H]1C[C@H](N)[C@@H](O[C@@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O
6187,Nicotine,NAT-Inhibitor,CN1CCC[C@H]1C2=CC=CN=C2
6188,Norepinephrine,NAT-Inducer,NC[C@@H](O)C1=CC(O)=C(O)C=C1
6189,Octopamine,NAT-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
6190,Oxedrine,NAT-Inhibitor,CNC[C@@H](O)C1=CC=C(O)C=C1
6191,Paclitaxel,NAT-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6192,Pargyline,NAT-Inducer,CN(CC#C)CC1=CC=CC=C1
6193,Phenazone,NAT-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
6194,Procainamide,NAT-Substrate,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1
6195,Salicylamide,NAT-Inhibitor,NC(=O)C1=C(O)C=CC=C1
6196,Sulfadiazine,NAT-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
6197,Sulfamethoxazole,NAT-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
6198,Sulfapyridine,NAT-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=N2
6199,Sulindac,NAT-Inhibitor,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)C1=C/C3=CC=C(C=C3)S(C)=O
6200,Sultiame,NAT-Inducer,NS(=O)(=O)C1=CC=C(C=C1)N2CCCCS2(=O)=O
6201,Tamoxifen,NAT-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6202,Testosterone,NAT-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6203,Theophylline,NAT-Inducer,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6204,Tobramycin,NAT-Substrate,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O
6205,Trichloroethylene,NAT-Substrate,ClC=C(Cl)Cl
6206,Warfarin,NAT-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
6207,Doxorubicin,ATP_binding_cassette_sub_family_A_member_3-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
6208,Imatinib,ATP_binding_cassette_sub_family_A_member_3-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6209,Methotrexate,ATP_binding_cassette_sub_family_A_member_3-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
6210,Mitoxantrone,ATP_binding_cassette_sub_family_A_member_3-Substrate,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
6211,Alfentanil,3A7-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
6212,Alprazolam,3A7-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
6213,Aminophenazone,3A7-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
6214,Amiodarone,3A7-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
6215,Amlodipine,3A7-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
6216,Aprepitant,3A7-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
6217,Aripiprazole,3A7-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
6218,Astemizole,3A7-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
6219,Atazanavir,3A7-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
6220,Atazanavir,3A7-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
6221,Atorvastatin,3A7-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
6222,Aztreonam,3A7-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
6223,Buspirone,3A7-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
6224,Caffeine,3A7-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6225,Carbamazepine,3A7-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6226,Cerivastatin,3A7-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
6227,Chinin,3A7-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6228,Chlorphenamine,3A7-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
6229,Ciclosporin,3A7-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6230,Ciclosporin,3A7-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6231,Cimetidine,3A7-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
6232,Cisapride,3A7-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
6233,Clarithromycin,3A7-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
6234,Clotiapine,3A7-Substrate,CN1CCN(CC1)C2=NC3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3
6235,Clotrimazole,3A7-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6236,Cocaine,3A7-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6237,Codeine,3A7-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
6238,Cortisone,3A7-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
6239,Cyclophosphamide,3A7-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
6240,Dapsone,3A7-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
6241,Dexamethasone,3A7-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6242,Dexamethasone,3A7-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6243,Dextromethorphan,3A7-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
6244,Dextropropoxyphene,3A7-Inducer,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
6245,Diazepam,3A7-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6246,Diltiazem,3A7-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6247,Docetaxel,3A7-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
6248,Domperidone,3A7-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
6249,Doxylamin,3A7-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
6250,Eplerenone,3A7-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
6251,Erythromycin,3A7-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6252,Estradiol,3A7-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6253,Estriol,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O
6254,Ethinylestradiol,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
6255,Ethosuximide,3A7-Substrate,CC[C@]1(C)CC(=O)NC1=O
6256,Ethylmorphine,3A7-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
6257,Felodipine,3A7-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
6258,Fentanyl,3A7-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
6259,Finasteride,3A7-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
6260,Fluvoxamine,3A7-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
6261,Glycyrrhizic Acid,3A7-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6262,Glycyrrhizic Acid,3A7-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6263,Haloperidol,3A7-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
6264,Hydrocortisone,3A7-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6265,Ifosfamide,3A7-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
6266,Imatinib,3A7-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6267,Imipramine,3A7-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6268,Indinavir,3A7-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6269,Indinavir,3A7-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6270,Irinotecan,3A7-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
6271,Ketoconazole,3A7-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6272,Lercanidipine,3A7-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
6273,Levacetylmethadol,3A7-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6274,Lidocain,3A7-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
6275,Linopirdine,3A7-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
6276,Lovastatin,3A7-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6277,Methadone,3A7-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6278,Mibefradil,3A7-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
6279,Midazolam,3A7-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6280,Midazolam,3A7-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6281,Mifepristone,3A7-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6282,Nateglinide,3A7-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
6283,Nefazodone,3A7-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
6284,Nelfinavir,3A7-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
6285,Nelfinavir,3A7-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
6286,Neostigmine,3A7-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
6287,Nifedipine,3A7-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6288,Nisoldipine,3A7-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
6289,Nitrendipine,3A7-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
6290,Norethisterone,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
6291,Norfloxacin,3A7-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
6292,Ondansetron,3A7-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
6293,Ornidazole,3A7-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
6294,Oxazepam,3A7-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
6295,Oxycodone,3A7-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
6296,Paclitaxel,3A7-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6297,Phenelzine,3A7-Inhibitor,NNCCC1=CC=CC=C1
6298,Phenobarbital,3A7-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
6299,Phenytoin,3A7-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
6300,Pimozide,3A7-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
6301,Pleconaril,3A7-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
6302,Prasterone,3A7-Inhibitor,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
6303,Prasterone,3A7-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
6304,Praziquantel,3A7-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
6305,Progesterone,3A7-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6306,Progesterone,3A7-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6307,Propranolol,3A7-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
6308,Quetiapine,3A7-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
6309,Quinidine,3A7-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
6310,Rifampicin,3A7-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6311,Rifapentine,3A7-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
6312,Risperidone,3A7-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
6313,Ritonavir,3A7-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6314,Ritonavir,3A7-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6315,Salmeterol,3A7-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
6316,Saquinavir,3A7-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6317,Sildenafil,3A7-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
6318,Simvastatin,3A7-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6319,Sirolimus,3A7-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
6320,Tacrolimus,3A7-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
6321,Tamoxifen,3A7-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
6322,Telithromycin,3A7-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
6323,Terfenadine,3A7-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6324,Testosterone,3A7-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6325,Trazodone,3A7-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
6326,Triamcinolone,3A7-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
6327,Triazolam,3A7-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6328,Troglitazone,3A7-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6329,Troglitazone,3A7-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6330,Verapamil,3A7-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6331,Verapamil,3A7-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
6332,Vincristine,3A7-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
6333,Zalcitabine,3A7-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
6334,Zaleplon,3A7-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
6335,Ziprasidone,3A7-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
6336,Zolpidem,3A7-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
6337,Caffeine,Proton_coupled_amino_acid_transporter_1-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6338,Cycloserine,Proton_coupled_amino_acid_transporter_1-Substrate,N[C@@H]1CONC1=O
6339,Glycine,Proton_coupled_amino_acid_transporter_1-Substrate,NCC(O)=O
6340,Oxitriptan,Proton_coupled_amino_acid_transporter_1-Inhibitor,N[C@@H](CC1=CNC2=C1C=C(O)C=C2)C(O)=O
6341,Vigabatrin,Proton_coupled_amino_acid_transporter_1-Substrate,N[C@@H](CCC(O)=O)C=C
6342,Retinol (vit A),2S1-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6343,Bosentan,Bile_salt_export_pump-Inhibitor,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
6344,Bosentan,Bile_salt_export_pump-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
6345,Chenodeoxycholic Acid,Bile_salt_export_pump-Inducer,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
6346,Ciclosporin,Bile_salt_export_pump-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6347,Colchicine,Bile_salt_export_pump-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6348,Estradiol,Bile_salt_export_pump-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6349,Glibenclamide,Bile_salt_export_pump-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
6350,Midecamycin,Bile_salt_export_pump-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
6351,Pravastatin,Bile_salt_export_pump-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6352,Pravastatin,Bile_salt_export_pump-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6353,Rifamycin,Bile_salt_export_pump-Inhibitor,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6354,Troglitazone,Bile_salt_export_pump-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
6355,Alprostadil,Solute_carrier_organic_anion_transporter_family_member_3A1-Substrate,CCCCC[C@H](O)C=C[C@@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O
6356,Acetazolamide,3A4-Inhibitor,CC(=O)NC1=NN=C(S1)S(N)(=O)=O
6357,Adefovir Dipivoxil,3A4-Inhibitor,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C
6358,Ademetionine,3A4-Inhibitor,C[S+](CC[C@H](N)C([O-])=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C(N)N=CN=C23
6359,Adinazolam,3A4-Substrate,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
6360,Albendazole,3A4-Substrate,CCCSC1=CC2=C(NC(NC(=O)OC)=N2)C=C1
6361,Alfentanil,3A4-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
6362,Alfuzosin,3A4-Substrate,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N(C)CCCNC(=O)[C@H]3CCCO3
6363,Allylestrenol,3A4-Substrate,C[C@@]12CC[C@@H]3[C@H](CCC4=CCCC[C@@H]34)[C@@H]1CC[C@@]2(O)CC=C
6364,Almotriptan,3A4-Substrate,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
6365,Alosetron,3A4-Substrate,CN1C2=C(C(=O)N(CC2)CC3=C(C)N=CN3)C4=C1C=CC=C4
6366,Alprazolam,3A4-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
6367,Ambroxol,3A4-Inhibitor,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
6368,Ambroxol,3A4-Substrate,NC1=C(CN[C@H]2CC[C@H](O)CC2)C=C(Br)C=C1Br
6369,Aminogluthetimide,3A4-Inducer,CC[C@]1(CCC(=O)NC1=O)C2=CC=C(N)C=C2
6370,Aminophenazone,3A4-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
6371,Aminophylline,3A4-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
6372,Amiodarone,3A4-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
6373,Amiodarone,3A4-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
6374,Amitriptyline,3A4-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
6375,Amitriptyline,3A4-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
6376,Amlodipine,3A4-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
6377,Amlodipine,3A4-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
6378,Amprenavir,3A4-Inhibitor,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6379,Amprenavir,3A4-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6380,Anastrozole,3A4-Inhibitor,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
6381,Aprepitant,3A4-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
6382,Aprepitant,3A4-Inducer,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
6383,Aprepitant,3A4-Inhibitor,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
6384,Argatroban,3A4-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
6385,Aripiprazole,3A4-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
6386,Arsenic Trioxide,3A4-Inhibitor,O=[As]1=[As](=O)O1
6387,Artemether,3A4-Substrate,CO[C@@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
6388,Artemisinin,3A4-Inducer,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
6389,Artemisinin,3A4-Substrate,C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4
6390,Astemizole,3A4-Inhibitor,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
6391,Astemizole,3A4-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
6392,Atazanavir,3A4-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
6393,Atazanavir,3A4-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
6394,Atenolol,3A4-Substrate,CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1
6395,Atomoxetine,3A4-Inhibitor,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
6396,Atorvastatin,3A4-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
6397,Atorvastatin,3A4-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
6398,Azatadine,3A4-Inducer,CN1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=CC=C3
6399,Azelastine,3A4-Inhibitor,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
6400,Azelastine,3A4-Substrate,CN1CCC[C@@H](CC1)N2N=C(CC3=CC=C(Cl)C=C3)C4=CC=CC=C4C2=O
6401,Azithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
6402,Azithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O
6403,Aztreonam,3A4-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
6404,Barnidipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
6405,Barnidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
6406,Benidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)O[C@@H]3CCCN(C3)CC4=CC=CC=C4
6407,Benzethonium,3A4-Inhibitor,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1
6408,Benzocaine,3A4-Inhibitor,CCOC(=O)C1=CC=C(N)C=C1
6409,Benzydamine,3A4-Substrate,CN(C)CCCOC1=NN(CC2=CC=CC=C2)C3=C1C=CC=C3
6410,Bergapten,3A4-Inhibitor,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3
6411,Betamethason,3A4-Inhibitor,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6412,Bexarotene,3A4-Substrate,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
6413,Bexarotene,3A4-Inducer,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(O)=O)C(C)(C)CCC2(C)C
6414,Bezafibrate,3A4-Substrate,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
6415,Bicalutamide,3A4-Substrate,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
6416,Bicalutamide,3A4-Inhibitor,C[C@](O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F
6417,Bifonazole,3A4-Inhibitor,C1=CC=C(C=C1)[C@H](N2C=CN=C2)C3=CC=C(C=C3)C4=CC=CC=C4
6418,Bisoprolol,3A4-Substrate,CC(C)NC[C@@H](O)COC1=CC=C(COCCOC(C)C)C=C1
6419,Bortezomib,3A4-Substrate,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
6420,Bortezomib,3A4-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
6421,Bosentan,3A4-Substrate,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
6422,Bosentan,3A4-Inducer,COC1=CC=CC=C1OC2=C(NS(=O)(=O)C3=CC=C(C=C3)C(C)(C)C)N=C(N=C2OCCO)C4=NC=CC=N4
6423,Brinzolamide,3A4-Substrate,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
6424,Bromazepam,3A4-Substrate,BrC1=CC2=C(NC(=O)CN=C2C3=CC=CC=N3)C=C1
6425,Bromocriptine,3A4-Substrate,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
6426,Bromocriptine,3A4-Inhibitor,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=C(Br)NC6=CC=CC(C4=C3)=C56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C
6427,Bromperidol,3A4-Substrate,O[C@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Br)C=C3
6428,Brompheniramine,3A4-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
6429,Brotizolam,3A4-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(SC(Br)=C4)N12
6430,Budesonide,3A4-Substrate,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
6431,Bupivacaine,3A4-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
6432,Buprenorphine,3A4-Inhibitor,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
6433,Buprenorphine,3A4-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
6434,Bupropion,3A4-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
6435,Buspirone,3A4-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
6436,Busulfan,3A4-Substrate,CS(=O)(=O)OCCCCOS(C)(=O)=O
6437,Caffeine,3A4-Inhibitor,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6438,Caffeine,3A4-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
6439,Calcitriol,3A4-Inducer,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)C[C@H](O)C3=C
6440,Capsaicin,3A4-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
6441,Carbamazepine,3A4-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6442,Carbamazepine,3A4-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6443,Carbinoxamine,3A4-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
6444,Carboplatin,3A4-Inducer,N.N.O=C1O[Pt]OC(=O)C12CCC2
6445,Carvedilol,3A4-Substrate,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
6446,Caspofungin,3A4-Inhibitor,CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@@H](O)[C@H](NCCN)NC(=O)[C@@H]2[C@@H](O)CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@@H](O)CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)[C@H](O)[C@@H](O)C4=CC=C(O)C=C4)[C@H](O)CCN
6447,Cefalexin,3A4-Substrate,CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CC=CC=C3)C2=O)C(O)=O
6448,Celecoxib,3A4-Substrate,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(N)(=O)=O)C(F)(F)F
6449,Cerivastatin,3A4-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
6450,Cerivastatin,3A4-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
6451,Cetirizine,3A4-Substrate,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
6452,Cevimeline,3A4-Substrate,CC1O[C@@]2(CS1)CN1CCC2CC1
6453,Chinin,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6454,Chinin,3A4-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6455,Chinin,3A4-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
6456,Chloramphenicol,3A4-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
6457,Chlordiazepoxide,3A4-Substrate,CNC1=NC2=C(C=C(Cl)C=C2)C(C3=CC=CC=C3)=[N+]([O-])C1
6458,Chlormadinone,3A4-Inhibitor,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
6459,Chloroquine,3A4-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
6460,Chlorphenamine,3A4-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
6461,Chlorpromazine,3A4-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
6462,Chlorpromazine,3A4-Substrate,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
6463,Chlorprothixene,3A4-Substrate,CN(C)CCC=C1/C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
6464,Chlorzoxazone,3A4-Inhibitor,OC1=NC2=C(O1)C=CC(Cl)=C2
6465,Chlorzoxazone,3A4-Substrate,OC1=NC2=C(O1)C=CC(Cl)=C2
6466,Cibenzoline,3A4-Substrate,C1CN=C(N1)[C@@H]2C[C@]2(C3=CC=CC=C3)C4=CC=CC=C4
6467,Ciclesonide,3A4-Substrate,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@@H]3[C@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@H]4[C@@H](O)C[C@@]23C)[C@H]6CCCCC6
6468,Ciclosporin,3A4-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6469,Ciclosporin,3A4-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6470,Ciclosporin,3A4-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
6471,Cilnidipine,3A4-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCC=CC3=CC=CC=C3
6472,Cilostazol,3A4-Substrate,O=C1CCC2=C(N1)C=CC(OCCCCC1=NN=NN1C1CCCCC1)=C2
6473,Cimetidine,3A4-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
6474,Cinacalcet,3A4-Substrate,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12
6475,Ciprofibrate,3A4-Substrate,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
6476,Ciprofloxacin,3A4-Inhibitor,OC(=O)C1=CN([C@H]2CC2)C3=CC(N4CCNCC4)=C(F)C=C3C1=O
6477,Cisapride,3A4-Inhibitor,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
6478,Cisapride,3A4-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
6479,Citalopram,3A4-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
6480,Clarithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
6481,Clarithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
6482,Clemastine,3A4-Inhibitor,CN1CCC[C@@H]1CCO[C@](C)(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
6483,Clindamycin,3A4-Inhibitor,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
6484,Clindamycin,3A4-Substrate,CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O
6485,Clobazam,3A4-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6486,Clofazimine,3A4-Inhibitor,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5
6487,Clofazimine,3A4-Substrate,CC(C)N=C1/C=C2N(C3=CC=C(Cl)C=C3)C4=C(C=CC=C4)N=C2C=C1NC5=CC=C(Cl)C=C5
6488,Clofenotane,3A4-Inducer,ClC1=CC=C(C=C1)C(C2=CC=C(Cl)C=C2)C(Cl)(Cl)Cl
6489,Clofibrate,3A4-Substrate,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
6490,Clofibrate,3A4-Inducer,CCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1
6491,Clomethiazole,3A4-Substrate,CC1=C(CCCl)SC=N1
6492,Clomifene,3A4-Inhibitor,CCN(CC)CCOC1=CC=C(C=C1)C(=C(/Cl)C2=CC=CC=C2)C3=CC=CC=C3
6493,Clomipramine,3A4-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
6494,Clonazepam,3A4-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=C(Cl)C=CC=C3)C=C1
6495,Clopidogrel,3A4-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
6496,Clotiazepam,3A4-Substrate,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
6497,Clotiazepam,3A4-Inhibitor,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C3=C(Cl)C=CC=C3
6498,Clotrimazole,3A4-Inducer,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6499,Clotrimazole,3A4-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6500,Clozapine,3A4-Inducer,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
6501,Clozapine,3A4-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
6502,Clozapine,3A4-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
6503,Cocaine,3A4-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6504,Cocaine,3A4-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6505,Cocaine,3A4-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
6506,Codeine,3A4-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
6507,Colchicine,3A4-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6508,Colchicine,3A4-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6509,Colchicine,3A4-Substrate,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
6510,Cortisone,3A4-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
6511,Cyamemazine,3A4-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
6512,Cyclobarbital,3A4-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
6513,Cyclobenzaprine,3A4-Substrate,CN(C)CCC=C1/C2=C(C=CC=C2)C=CC3=C1C=CC=C3
6514,Cyclophosphamide,3A4-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
6515,Cyclophosphamide,3A4-Inhibitor,ClCCN(CCCl)[P@]1(=O)NCCCO1
6516,Cyclophosphamide,3A4-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
6517,Cytarabine,3A4-Substrate,NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O
6518,Danazol,3A4-Inhibitor,C[C@]12CC3=C(ON=C3)C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C
6519,Dantrolene,3A4-Substrate,[O-][N+](=O)C1=CC=C(C=C1)C2=CC=C(O2)C=NN3CC(=O)NC3=O
6520,Dapsone,3A4-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
6521,Daunorubicin,3A4-Inhibitor,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
6522,Daunorubicin,3A4-Substrate,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
6523,Delavirdine,3A4-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
6524,Delavirdine,3A4-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
6525,Desipramine,3A4-Inhibitor,CNCCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6526,Desogestrel,3A4-Substrate,CC[C@]12CC(=C)[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
6527,Desvenlafaxine,3A4-Substrate,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
6528,Dexamethasone,3A4-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6529,Dexamethasone,3A4-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6530,Dexamethasone,3A4-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
6531,Dexmedetomidine,3A4-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
6532,Dextromethorphan,3A4-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
6533,Dextropropoxyphene,3A4-Substrate,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
6534,Dextropropoxyphene,3A4-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
6535,Diazepam,3A4-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6536,Diazepam,3A4-Inhibitor,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6537,Diclofenac,3A4-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
6538,Diclofenac,3A4-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
6539,Dicloxacillin,3A4-Inducer,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4Cl
6540,Diethyltoluamide,3A4-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
6541,Digitoxin,3A4-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5CC[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
6542,Digoxin,3A4-Substrate,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
6543,Dihydralazine,3A4-Inhibitor,NNC1=NN=C(NN)C2=C1C=CC=C2
6544,Dihydralazine,3A4-Substrate,NNC1=NN=C(NN)C2=C1C=CC=C2
6545,Dihydrocodeine,3A4-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CC[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
6546,Dihydroergotamine,3A4-Inhibitor,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
6547,Dihydroergotamine,3A4-Substrate,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
6548,Dihydrostreptomycin,3A4-Substrate,CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@@H](O[C@@H](C)[C@]2(O)CO)O[C@@H]3[C@H](O)[C@@H](O)[C@H](NC(N)=N)[C@@H](O)[C@@H]3NC(N)=N
6549,Diltiazem,3A4-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6550,Diltiazem,3A4-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
6551,Dimethyl Sulfoxide,3A4-Inhibitor,CS(C)=O
6552,Dimetotiazine,3A4-Inhibitor,C[C@@H](CN1C2=C(SC3=CC=C(C=C13)S(=O)(=O)N(C)C)C=CC=C2)N(C)C
6553,Diosmectite,3A4-Inhibitor,COC1=C(O)C=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
6554,Diphenhydramine Methylbromide,3A4-Substrate,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
6555,Dirithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O
6556,Disopyramide,3A4-Substrate,CC(C)N(CC[C@](C(N)=O)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C
6557,Disulfiram,3A4-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
6558,Disulfiram,3A4-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
6559,Docetaxel,3A4-Inhibitor,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
6560,Docetaxel,3A4-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
6561,Dofetilide,3A4-Substrate,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC2=CC=C(NS(C)(=O)=O)C=C2
6562,Dolasetron,3A4-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
6563,Domperidone,3A4-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
6564,Donepezil,3A4-Substrate,COC1=C(OC)C=C2C(=O)[C@H](C[C@H]3CCN(CC3)CC4=CC=CC=C4)CC2=C1
6565,Dorzolamide,3A4-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
6566,Doxazosin,3A4-Substrate,COC1=CC2=C(C=C1OC)C(N)=NC(=N2)N3CCN(CC3)C(=O)[C@@H]4COC5=C(O4)C=CC=C5
6567,Doxepin,3A4-Substrate,CN(C)CCC=C1/C2=C(COC3=C1C=CC=C3)C=CC=C2
6568,Doxorubicin,3A4-Inducer,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
6569,Doxorubicin,3A4-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
6570,Doxorubicin,3A4-Inhibitor,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
6571,Doxycycline,3A4-Substrate,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
6572,Doxycycline,3A4-Inhibitor,C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]3(O)C(O)=C2C(=O)C4=C(O)C=CC=C14
6573,Doxylamin,3A4-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
6574,Dutasteride,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
6575,Ebastine,3A4-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
6576,Econazole,3A4-Inhibitor,ClC1=CC=C(CO[C@@H](C[C@H]2C=NC=N2)C3=C(Cl)C=C(Cl)C=C3)C=C1
6577,Efavirenz,3A4-Inducer,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
6578,Efavirenz,3A4-Substrate,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
6579,Efavirenz,3A4-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
6580,Eletriptan,3A4-Substrate,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
6581,Eletriptan,3A4-Inducer,CN1CCC[C@@H]1CC2=CNC3=C2C=C(CCS(=O)(=O)C4=CC=CC=C4)C=C3
6582,Emetine,3A4-Substrate,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
6583,Emetine,3A4-Inhibitor,CC[C@H]1CN2CCC3=CC(OC)=C(OC)C=C3[C@@H]2C[C@@H]1C[C@H]4NCCC5=C4C=C(OC)C(OC)=C5
6584,Enalapril,3A4-Substrate,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
6585,Entacapone,3A4-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
6586,Epinastine,3A4-Substrate,NC1=NC[C@H]2N1C3=C(CC4=C2C=CC=C4)C=CC=C3
6587,Epinephrine,3A4-Inhibitor,CNC[C@H](O)C1=CC(O)=C(O)C=C1
6588,Eplerenone,3A4-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
6589,Ergocalciferol,3A4-Substrate,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
6590,Ergocalciferol,3A4-Inducer,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
6591,Ergometrine,3A4-Inhibitor,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
6592,Ergotamine,3A4-Substrate,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
6593,Ergotamine,3A4-Inhibitor,CN1C[C@@H](C=C2[C@H]1CC3=CNC4=C3C2=CC=C4)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](CC8=CC=CC=C8)N6C5=O
6594,Erlotinib,3A4-Substrate,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2
6595,Erythromycin,3A4-Inducer,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6596,Erythromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6597,Erythromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6598,Escitalopram,3A4-Substrate,CN(C)CCC[C@]1(OCC2=CC(=CC=C12)C#N)C3=CC=C(F)C=C3
6599,Esketamine,3A4-Substrate,CN[C@@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
6600,Esomeprazole,3A4-Substrate,COC1=CC2=C([N-]C(=N2)S(=O)CC3=NC=C(C)C(OC)=C3C)C=C1
6601,Estazolam,3A4-Substrate,ClC1=CC2=C(C=C1)N3C=NN=C3CN=C2C4=CC=CC=C4
6602,Estradiol,3A4-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
6603,Estramustine,3A4-Substrate,C[C@@]12CC[C@@H]3[C@H](CCC4=C3C=CC(OC(=O)N(CCCl)CCCl)=C4)[C@@H]1CC[C@@H]2O
6604,Estrone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
6605,Eszopiclone,3A4-Substrate,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1
6606,Ethanol,3A4-Substrate,CCO
6607,Ethanol,3A4-Inhibitor,CCO
6608,Ethanol,3A4-Inducer,CCO
6609,Ethinylestradiol,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
6610,Ethinylestradiol,3A4-Inhibitor,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
6611,Ethinylestradiol,3A4-Inducer,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
6612,Ethosuximide,3A4-Substrate,CC[C@]1(C)CC(=O)NC1=O
6613,Ethylmorphine,3A4-Substrate,CCOC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
6614,Etizolam,3A4-Substrate,CCC1=CC2=C(S1)N3C(C)=NN=C3CN=C2C4=C(Cl)C=CC=C4
6615,Etonogestrel,3A4-Substrate,CC[C@@]12CC(=C)[C@H]3[C@H](CCC4=CC(=O)CC[C@@H]34)[C@@H]1CC[C@@]2(O)C#C
6616,Etoperidone,3A4-Substrate,CCN1C(=O)N(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)N=C1CC
6617,Etoposide,3A4-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
6618,Etoposide,3A4-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
6619,Etoposide,3A4-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
6620,Etoricoxib,3A4-Inhibitor,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
6621,Etoricoxib,3A4-Substrate,CC1=NC=C(C=C1)C2=C(C=C(Cl)C=N2)C3=CC=C(C=C3)S(C)(=O)=O
6622,Everolimus,3A4-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1OCCO)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
6623,Exemestane,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
6624,Famciclovir,3A4-Substrate,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O
6625,Felbamate,3A4-Inducer,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
6626,Felbamate,3A4-Substrate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1
6627,Felodipine,3A4-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
6628,Felodipine,3A4-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
6629,Fenofibrate,3A4-Substrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
6630,Fentanyl,3A4-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
6631,Fentanyl,3A4-Inhibitor,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
6632,Fesoterodine,3A4-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C
6633,Fexofenadine,3A4-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
6634,Finasteride,3A4-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
6635,Flosequinan,3A4-Substrate,COSC1=CN(C)C2=C(C=CC(F)=C2)C1=O
6636,Flucloxacillin,3A4-Inducer,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
6637,Fluconazole,3A4-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6638,Fluconazole,3A4-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
6639,Flunitrazepam,3A4-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N+]([O-])=O
6640,Fluoxetine,3A4-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
6641,Fluoxetine,3A4-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
6642,Flurazepam,3A4-Substrate,CCN(CC)CCN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(Cl)=C3
6643,Flurithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@](C)(F)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
6644,Flutamide,3A4-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
6645,Fluticasone,3A4-Substrate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
6646,Fluvastatin,3A4-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6647,Fluvastatin,3A4-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
6648,Fluvoxamine,3A4-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
6649,Fosamprenavir,3A4-Inhibitor,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6650,Fosamprenavir,3A4-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
6651,Fosphenytoin,3A4-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
6652,Fosphenytoin,3A4-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
6653,Fulvestrant,3A4-Substrate,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC4=CC(O)=CC=C34)[C@@H]1CC[C@@H]2O
6654,Galantamine,3A4-Substrate,COC1=CC=C2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3OC1=C24
6655,Gallopamil,3A4-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1
6656,Gefitinib,3A4-Substrate,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN4CCOCC4
6657,Gemfibrozil,3A4-Inducer,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
6658,Gemfibrozil,3A4-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
6659,Gemfibrozil,3A4-Substrate,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
6660,Gepirone,3A4-Substrate,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
6661,Glibenclamide,3A4-Inhibitor,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
6662,Glibenclamide,3A4-Substrate,COC1=C(C=C(Cl)C=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
6663,Glipizide,3A4-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
6664,Glycyrrhizic Acid,3A4-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6665,Glycyrrhizic Acid,3A4-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
6666,Granisetron,3A4-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
6667,Griseofulvin,3A4-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
6668,Guanethidine,3A4-Inducer,NC(=N)NCCN1CCCCCCC1
6669,Halofantrine,3A4-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
6670,Haloperidol,3A4-Inhibitor,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
6671,Haloperidol,3A4-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
6672,Halothane,3A4-Substrate,FC(F)(F)[C@@H](Cl)Br
6673,Hexobarbital,3A4-Substrate,CN1C(O)=NC(=O)[C@@](C)(C2=CCCCC2)C1=O
6674,Histamine,3A4-Inhibitor,NCCC1=CNC=N1
6675,Histamine,3A4-Substrate,NCCC1=CNC=N1
6676,Hydralazine,3A4-Inhibitor,NN=C1NN=CC2=C1C=CC=C2
6677,Hydrocodone,3A4-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4CCC(=O)[C@@H]5OC1=C2[C@]45CCN3C
6678,Hydrocortisone,3A4-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6679,Hydrocortisone,3A4-Inhibitor,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6680,Hydrocortisone,3A4-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
6681,Hydrocortisone Aceponate,3A4-Substrate,[H][C@@]12CC[C@](OC(=O)CC)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6682,Hydromorphone,3A4-Substrate,CN1CC[C@@]23[C@H]4CCC(=O)[C@@H]2OC5=C3C(C[C@@H]14)=CC=C5O
6683,Hydroquinone,3A4-Substrate,OC1=CC=C(O)C=C1
6684,Ifosfamide,3A4-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
6685,Ifosfamide,3A4-Inhibitor,ClCCN[P@@]1(=O)OCCCN1CCCl
6686,Ifosfamide,3A4-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
6687,Imatinib,3A4-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6688,Imatinib,3A4-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
6689,Imipramine,3A4-Substrate,CN(C)CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6690,Imipramine Oxide,3A4-Substrate,C[N+](C)([O-])CCCN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
6691,Imiquimod,3A4-Substrate,CC(C)CN1C=NC2=C(N)N=C3C=CC=CC3=C12
6692,Indinavir,3A4-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6693,Indinavir,3A4-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
6694,Ipriflavone,3A4-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
6695,Ipriflavone,3A4-Substrate,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
6696,Irbesartan,3A4-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
6697,Irinotecan,3A4-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
6698,Irinotecan,3A4-Inhibitor,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
6699,Isoniazid,3A4-Inhibitor,NNC(=O)C1=CC=NC=C1
6700,Isopropanol,3A4-Inhibitor,CC(C)O
6701,Isosorbide Dinitrate,3A4-Substrate,[O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+]([O-])=O
6702,Isosorbide Mononitrate,3A4-Substrate,O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+]([O-])=O
6703,Isotretinoin,3A4-Substrate,CC1=C(C=CC(C)=CC=CC(C)=C/C(O)=O)C(C)(C)CCC1
6704,Isradipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
6705,Isradipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC3=NON=C23)C(=O)OC(C)C
6706,Itraconazole,3A4-Inhibitor,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
6707,Itraconazole,3A4-Substrate,CC[C@H](C)N1N=CN(C1=O)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(OC[C@H]5CO[C@@](CN6C=NC=N6)(O5)C7=C(Cl)C=C(Cl)C=C7)C=C4
6708,Ivabradine,3A4-Substrate,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1
6709,Ivermectin,3A4-Substrate,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](CC=C(C)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)C=CC=C6/CO[C@@H]7[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]67O)O2
6710,Josamycin,3A4-Inhibitor,CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(C)=O
6711,Ketamine,3A4-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
6712,Ketobemidone,3A4-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
6713,Ketoconazole,3A4-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6714,Ketoconazole,3A4-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6715,Ketoconazole,3A4-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
6716,Lacidipine,3A4-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)C=CC(=O)OC(C)(C)C)C(=O)OCC
6717,Lansoprazole,3A4-Inducer,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
6718,Lansoprazole,3A4-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
6719,Lansoprazole,3A4-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
6720,Lercanidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
6721,Lercanidipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
6722,Letrozole,3A4-Substrate,N#CC1=CC=C(C=C1)C(N2C=NC=N2)C3=CC=C(C=C3)C#N
6723,Levacetylmethadol,3A4-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6724,Levobupivacaine,3A4-Substrate,CCCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
6725,Levofloxacin,3A4-Inhibitor,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
6726,Levonorgestrel,3A4-Substrate,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
6727,Levothyroxine Sodium,3A4-Substrate,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O
6728,Lidocain,3A4-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
6729,Lidocain,3A4-Inhibitor,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
6730,Linopirdine,3A4-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
6731,Lisuride,3A4-Substrate,CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
6732,Lomustine,3A4-Inhibitor,ClCCN(N=O)C(=O)N[C@H]1CCCCC1
6733,Loperamide,3A4-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6734,Loperamide,3A4-Inhibitor,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
6735,Lopinavir,3A4-Substrate,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
6736,Lopinavir,3A4-Inhibitor,CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=C(C)C=CC=C3C)CC4=CC=CC=C4
6737,Loratadine,3A4-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
6738,Loratadine,3A4-Substrate,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
6739,Loratadine,3A4-Inducer,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
6740,Losartan,3A4-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
6741,Losartan,3A4-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
6742,Lovastatin,3A4-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6743,Lovastatin,3A4-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6744,Lynestrenol,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
6745,Manidipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
6746,Mebendazole,3A4-Substrate,COC(=O)NC1=NC2=C(N1)C=CC(=C2)C(=O)C3=CC=CC=C3
6747,Medazepam,3A4-Substrate,CN1CCN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
6748,Medifoxamine,3A4-Substrate,CN(C)CC(OC1=CC=CC=C1)OC2=CC=CC=C2
6749,Medrogestone,3A4-Substrate,CC(=O)[C@@]1(C)CC[C@H]2[C@H]3C=C(C)C4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@@]12C
6750,Medroxyprogesterone,3A4-Inducer,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
6751,Medroxyprogesterone,3A4-Substrate,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
6752,Medrysone,3A4-Inhibitor,C[C@H]1C[C@@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@@H](O)[C@H]2[C@@]4(C)CCC(=O)C=C14
6753,Mefloquine,3A4-Inhibitor,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
6754,Mefloquine,3A4-Substrate,O[C@H]([C@H]1CCCCN1)C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F
6755,Meloxicam,3A4-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
6756,Mepacrine,3A4-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
6757,Mephenytoin,3A4-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
6758,Mequitazine,3A4-Inhibitor,C1CN2CC[C@H]1[C@H](C2)CN3C4=C(SC5=C3C=CC=C5)C=CC=C4
6759,Metamizole Sodium,3A4-Inducer,CN(CS([O-])(=O)=O)C1=C(C)N(C)N(C1=O)C2=CC=CC=C2
6760,Metandienone,3A4-Substrate,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
6761,Metformin,3A4-Inhibitor,CN(C)C(=N)NC(N)=N
6762,Methadone,3A4-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6763,Methadone,3A4-Inhibitor,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6764,Methadone,3A4-Inducer,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
6765,Methaqualone,3A4-Substrate,CC1=C(C=CC=C1)N2C(C)=NC3=C(C=CC=C3)C2=O
6766,Methazolamide,3A4-Inhibitor,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O
6767,Methoxsalen,3A4-Substrate,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
6768,Methoxyflurane,3A4-Substrate,COC(F)(F)C(Cl)Cl
6769,Methylergometrine,3A4-Substrate,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
6770,Methylprednisolone,3A4-Substrate,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14
6771,Methylprednisolone,3A4-Inhibitor,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14
6772,Methylprednisolone Aceponate,3A4-Inducer,CCC(=O)O[C@@]1(CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)COC(C)=O
6773,Methyltestosterone,3A4-Substrate,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C
6774,Metronidazole,3A4-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
6775,Metronidazole,3A4-Substrate,CC1=NC=C(N1CCO)[N+]([O-])=O
6776,Metyrapone,3A4-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
6777,Metyrapone,3A4-Inducer,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
6778,Mexiletine,3A4-Substrate,C[C@H](N)COC1=C(C)C=CC=C1C
6779,Mianserin,3A4-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2C=CC=C4)C=CC=C3
6780,Mibefradil,3A4-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
6781,Mibefradil,3A4-Substrate,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
6782,Miconazole,3A4-Inhibitor,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
6783,Miconazole,3A4-Substrate,ClC1=CC=C(CO[C@H](CN2C=CN=C2)C3=CC=C(Cl)C=C3Cl)C(Cl)=C1
6784,Midazolam,3A4-Inhibitor,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6785,Midazolam,3A4-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
6786,Midecamycin,3A4-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@@H](C)CC=CC=C[C@@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@H](OC(=O)CC)[C@@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H]1OC
6787,Mifepristone,3A4-Inducer,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6788,Mifepristone,3A4-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6789,Mifepristone,3A4-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
6790,Miocamycin,3A4-Inhibitor,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(C)=O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
6791,Miocamycin,3A4-Substrate,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)CC=CC=C[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(C)=O)[C@@H](OC(=O)CC)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
6792,Mirtazapine,3A4-Inhibitor,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
6793,Mirtazapine,3A4-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
6794,Mitoxantrone,3A4-Inhibitor,OCCNCCNC1=CC=C(NCCNCCO)C2=C1C(=O)C3=C(O)C=CC(O)=C3C2=O
6795,Mizolastine,3A4-Inhibitor,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
6796,Modafinil,3A4-Substrate,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
6797,Modafinil,3A4-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
6798,Modafinil,3A4-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
6799,Morphine,3A4-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
6800,Naloxone,3A4-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
6801,Nateglinide,3A4-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
6802,Nefazodone,3A4-Substrate,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
6803,Nefazodone,3A4-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
6804,Nelfinavir,3A4-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
6805,Nelfinavir,3A4-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
6806,Neostigmine,3A4-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
6807,Nevirapine,3A4-Inhibitor,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
6808,Nevirapine,3A4-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
6809,Nevirapine,3A4-Inducer,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2[C@H]4CC4
6810,Nicardipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
6811,Nicardipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
6812,Nicardipine,3A4-Inducer,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
6813,Nicotinamide,3A4-Inhibitor,NC(=O)C1=CC=CN=C1
6814,Nicotine,3A4-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
6815,Nifedipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6816,Nifedipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6817,Nifedipine,3A4-Inducer,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
6818,Nilvadipine,3A4-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
6819,Nimodipine,3A4-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
6820,Nisoldipine,3A4-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
6821,Nisoldipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
6822,Nitrazepam,3A4-Substrate,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
6823,Nitrazepam,3A4-Inducer,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
6824,Nitrendipine,3A4-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
6825,Nitrendipine,3A4-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
6826,Nitric Oxide,3A4-Inhibitor,N=O
6827,Nordazepam,3A4-Substrate,ClC1=CC2=C(NC(=O)CN=C2C3=CC=CC=C3)C=C1
6828,Norethisterone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
6829,Norfloxacin,3A4-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
6830,Nortriptyline,3A4-Substrate,CNCCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
6831,Noscapine,3A4-Inhibitor,COC1=C(OC)C2=C(C=C1)[C@@H](OC2=O)[C@@H]3N(C)CCC4=CC5=C(OCO5)C(OC)=C34
6832,Octopamine,3A4-Inhibitor,NC[C@H](O)C1=CC=C(O)C=C1
6833,Octopamine,3A4-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
6834,Olanzapine,3A4-Inhibitor,CN1CCN(CC1)C2=NC3=C(NC4=C2C=C(C)S4)C=CC=C3
6835,Oleandomycin,3A4-Inhibitor,CO[C@@H]1C[C@@H](O[C@@H](C)[C@H]1O)O[C@H]2[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
6836,Olopatadine,3A4-Substrate,CN(C)CCC=C1C2=C(COC3=C1C=C(CC(O)=O)C=C3)C=CC=C2
6837,Omeprazole,3A4-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6838,Omeprazole,3A4-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6839,Omeprazole,3A4-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
6840,Ondansetron,3A4-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
6841,Ondansetron,3A4-Inducer,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
6842,Ornidazole,3A4-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
6843,Orphenadrine (citrate),3A4-Inhibitor,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
6844,Orphenadrine (citrate),3A4-Substrate,CN(C)CCO[C@H](C1=CC=CC=C1)C2=C(C)C=CC=C2
6845,Oxatomide,3A4-Substrate,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
6846,Oxatomide,3A4-Inhibitor,C[C@@H](C(=O)NC1=CC(C)=CC=N1)C2=CC=CC(=C2)C(=O)C3=CC=CC=C3
6847,Oxazepam,3A4-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
6848,Oxcarbazepine,3A4-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
6849,Oxiconazole,3A4-Inducer,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
6850,Oxomemazine,3A4-Inducer,C[C@H](CN(C)C)CN1C2=C(C=CC=C2)S(=O)(=O)C3=C1C=CC=C3
6851,Oxybutynin,3A4-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
6852,Oxybutynin,3A4-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
6853,Oxycodone,3A4-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
6854,Paclitaxel,3A4-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6855,Paclitaxel,3A4-Inhibitor,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6856,Paclitaxel,3A4-Inducer,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
6857,Palonosetron,3A4-Substrate,[H][C@]12CCCC3=C1C(=CC=C3)C(=O)N(C2)[C@@H]1CN2CCC1CC2
6858,Pantoprazole,3A4-Substrate,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
6859,Pantoprazole,3A4-Inducer,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
6860,Paracetamol,3A4-Inhibitor,CC(=O)NC1=CC=C(O)C=C1
6861,Paracetamol,3A4-Substrate,CC(=O)NC1=CC=C(O)C=C1
6862,Paracetamol,3A4-Inducer,CC(=O)NC1=CC=C(O)C=C1
6863,Paraoxon,3A4-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
6864,Parecoxib,3A4-Substrate,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(C)ON=C2C3=CC=CC=C3
6865,Paroxetine,3A4-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
6866,Pazopanib,3A4-Inhibitor,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1
6867,Pentamidine Isethionate,3A4-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
6868,Pentoxyverine,3A4-Substrate,CCN(CC)CCOCCOC(=O)[C@]1(CCCC1)C2=CC=CC=C2
6869,Perazine,3A4-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
6870,Perazine,3A4-Inhibitor,CN1CCN(CCCN2C3=C(SC4=C2C=CC=C4)C=CC=C3)CC1
6871,Pergolide,3A4-Substrate,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
6872,Pergolide,3A4-Inhibitor,CCCN1C[C@H](CSC)C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34
6873,Perhexiline,3A4-Substrate,C1CC[C@H](CC1)C(C[C@H]2CCCCN2)[C@H]3CCCCC3
6874,Permethrin,3A4-Substrate,CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)OCC2=CC(OC3=CC=CC=C3)=CC=C2
6875,Perphenazine,3A4-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
6876,Pethidine,3A4-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
6877,Pethidine,3A4-Substrate,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
6878,Phenacetin,3A4-Substrate,CCOC1=CC=C(NC(C)=O)C=C1
6879,Phenazone,3A4-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
6880,Phenazone,3A4-Inhibitor,CN1N(C(=O)C=C1C)C2=CC=CC=C2
6881,Phenelzine,3A4-Substrate,NNCCC1=CC=CC=C1
6882,Phenelzine,3A4-Inhibitor,NNCCC1=CC=CC=C1
6883,Phenobarbital,3A4-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
6884,Phenoxybenzamine,3A4-Substrate,C[C@H](COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2
6885,Phenoxymethylpenicillin,3A4-Inducer,CC1(C)S[C@@H]2[C@H](NC(=O)COC3=CC=CC=C3)C(=O)N2[C@H]1C(O)=O
6886,Phenprocoumon,3A4-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
6887,Phenylbutazone,3A4-Inducer,CCCC[C@H]1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
6888,Phenytoin,3A4-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
6889,Phenytoin,3A4-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
6890,Physostigmine,3A4-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
6891,Pilocarpine,3A4-Inhibitor,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
6892,Pilocarpine,3A4-Substrate,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
6893,Pimecrolimus,3A4-Substrate,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC
6894,Pimozide,3A4-Inhibitor,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
6895,Pimozide,3A4-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
6896,Pinacidil,3A4-Substrate,C[C@@H](NC(NC#N)=NC1=CC=NC=C1)C(C)(C)C
6897,Pioglitazone,3A4-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
6898,Pioglitazone,3A4-Inducer,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
6899,Pleconaril,3A4-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
6900,Podophyllotoxin,3A4-Substrate,COC1=CC(=CC(OC)=C1OC)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=C2C=C5OCOC5=C4
6901,Prasterone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
6902,Pravastatin,3A4-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6903,Pravastatin,3A4-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
6904,Prazepam,3A4-Substrate,ClC1=CC2=C(C=C1)N(C[C@H]3CC3)C(=O)CN=C2C4=CC=CC=C4
6905,Praziquantel,3A4-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
6906,Prednisolone,3A4-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6907,Prednisolone,3A4-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6908,Prednisone,3A4-Inducer,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6909,Prednisone,3A4-Inhibitor,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6910,Prednisone,3A4-Substrate,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
6911,Primaquine,3A4-Substrate,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
6912,Primaquine,3A4-Inhibitor,COC1=CC(N[C@H](C)CCCN)=C2N=CC=CC2=C1
6913,Primidone,3A4-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
6914,Probenecid,3A4-Inducer,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
6915,Prochlorperazine,3A4-Substrate,CN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
6916,Progesterone,3A4-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6917,Progesterone,3A4-Inhibitor,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6918,Progesterone,3A4-Inducer,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
6919,Proguanil,3A4-Substrate,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1
6920,Promazine,3A4-Substrate,CN(C)CCCN1C2=C(SC3=C1C=CC=C3)C=CC=C2
6921,Propafenone,3A4-Substrate,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
6922,Propiverine,3A4-Inhibitor,CCCCC(C(=O)O[C@H]1CCN(C)CC1)(C2=CC=CC=C2)C3=CC=CC=C3
6923,Propofol,3A4-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
6924,Propofol,3A4-Inhibitor,CC(C)C1=CC=CC(C(C)C)=C1O
6925,Propranolol,3A4-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
6926,Pyrazinamide,3A4-Substrate,NC(=O)C1=CN=CC=N1
6927,Pyridostigmine,3A4-Inducer,CN(C)C(=O)OC1=C[N+](C)=CC=C1
6928,Quazepam,3A4-Substrate,FC1=C(C=CC=C1)C2=NCC(=S)N(CC(F)(F)F)C3=C2C=C(Cl)C=C3
6929,Quetiapine,3A4-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
6930,Quinidine,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
6931,Quinidine,3A4-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
6932,Quinidine,3A4-Inducer,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
6933,Quinupristin/dalfopristin,3A4-Inhibitor,CC[C@H]1NC(=O)[C@@H](NC(=O)C2=NC=CC=C2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@H]3CC(=O)[C@H](CS[C@@H]4CN5CC[C@@H]4CC5)CN3C(=O)[C@H](CC6=CC=C(C=C6)N(C)C)N(C)C(=O)[C@@H]7CCCN7C1=O)C8=CC=CC=C8
6934,Rabeprazole,3A4-Substrate,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
6935,Rabeprazole,3A4-Inhibitor,COCCCOC1=C(C)C(CC(=O)C2=NC3=C(N2)C=CC=C3)=NC=C1
6936,Raloxifene,3A4-Substrate,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
6937,Raloxifene,3A4-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
6938,Ranitidine,3A4-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
6939,Reboxetine,3A4-Substrate,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
6940,Repaglinide,3A4-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
6941,Repaglinide,3A4-Inhibitor,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
6942,Retinol (vit A),3A4-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
6943,Rifabutin,3A4-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
6944,Rifabutin,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(=O)C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C5N[C@]6(CCN(CC6)CC(C)C)N=C5C4=C3C2=O
6945,Rifampicin,3A4-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6946,Rifampicin,3A4-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6947,Rifampicin,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
6948,Rifapentine,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
6949,Rifaximin,3A4-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(C(O)=C3C)C(O)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C5=C4N=C6C=C(C)C=CN56
6950,Risperidone,3A4-Inhibitor,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
6951,Risperidone,3A4-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
6952,Ritonavir,3A4-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6953,Ritonavir,3A4-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6954,Ritonavir,3A4-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
6955,Rivastigmine,3A4-Inhibitor,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
6956,Rofecoxib,3A4-Inducer,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
6957,Rokitamycin,3A4-Inhibitor,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
6958,Rokitamycin,3A4-Substrate,CCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)OC(=O)CC)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@@H](O)C=CC=CC[C@@H](C)OC(=O)C[C@@H](O)[C@@H]3OC)[C@H](O)[C@H]2N(C)C
6959,Ropinirole,3A4-Substrate,CCCN(CCC)CCC1=CC=CC2=C1CC(=O)N2
6960,Ropivacaine,3A4-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
6961,Roquinimex,3A4-Substrate,CN(C1=CC=CC=C1)C(=O)C2=C(O)C3=C(C=CC=C3)N(C)C2=O
6962,Rosuvastatin,3A4-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
6963,Rosuvastatin,3A4-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
6964,Roxithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
6965,Roxithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=N/OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O
6966,Rufinamide,3A4-Inducer,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1
6967,Rupatadine,3A4-Substrate,CC1=CC(CN2CCC(CC2)=C3/C4=C(CCC5=C3N=CC=C5)C=C(Cl)C=C4)=CN=C1
6968,Rutoside,3A4-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
6969,Salbutamol,3A4-Inhibitor,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1
6970,Salbutamol,3A4-Substrate,CC(C)(C)NC[C@@H](O)C1=CC=C(O)C(CO)=C1
6971,Salmeterol,3A4-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
6972,Saquinavir,3A4-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6973,Saquinavir,3A4-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
6974,Saxagliptin,3A4-Substrate,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2
6975,Selegiline,3A4-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
6976,Seratrodast,3A4-Inducer,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
6977,Seratrodast,3A4-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
6978,Sertindole,3A4-Substrate,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
6979,Sertraline,3A4-Inhibitor,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
6980,Sertraline,3A4-Substrate,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C3=C1C=CC=C3
6981,Sevoflurane,3A4-Substrate,FCOC(C(F)(F)F)C(F)(F)F
6982,Sibutramine,3A4-Substrate,CC(C)C[C@@H](N(C)C)[C@]1(CCC1)C2=CC=C(Cl)C=C2
6983,Sildenafil,3A4-Inhibitor,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
6984,Sildenafil,3A4-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
6985,Silymarin,3A4-Inhibitor,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
6986,Silymarin,3A4-Inducer,COC1=CC(=CC=C1O)[C@H]2OC3=C(O[C@@H]2CO)C=CC(=C3)[C@H]4OC5=CC(O)=CC(O)=C5C(=O)[C@@H]4O
6987,Simvastatin,3A4-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6988,Simvastatin,3A4-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
6989,Ezetimibe,3A4-Substrate,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
6990,Sirolimus,3A4-Inhibitor,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
6991,Sirolimus,3A4-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
6992,Sodium Edetate,3A4-Substrate,[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
6993,Somatostatin,3A4-Inhibitor,C[C@H](N)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@H](NC(=O)[C@@H](CCCCN)NC(=O)[C@@H](CC3=CNC4=C3C=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)[C@@H](CC6=CC=CC=C6)NC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O
6994,Spiramycin,3A4-Substrate,CO[C@H]1[C@H](O)CC(=O)O[C@H](C)CC=CC=C[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C
6995,Spironolactone,3A4-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
6996,Sufentanil,3A4-Substrate,CCC(=O)N(C1=CC=CC=C1)[C@]2(CCN(CCC3=CC=CS3)CC2)COC
6997,Sulconazole,3A4-Inhibitor,ClC1=CC=C(CS[C@H](CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
6998,Sulfadiazine,3A4-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
6999,Sulfadimidine,3A4-Inducer,CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1
7000,Sulfamethoxazole,3A4-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
7001,Sulfamethoxazole,3A4-Substrate,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
7002,Sulfanilamide,3A4-Inhibitor,NC1=CC=C(C=C1)S(N)(=O)=O
7003,Sulfinpyrazon,3A4-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
7004,Sulfinpyrazon,3A4-Inhibitor,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
7005,Sulfinpyrazon,3A4-Inducer,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
7006,Tacrolimus,3A4-Inhibitor,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
7007,Tacrolimus,3A4-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
7008,Tadalafil,3A4-Substrate,CN1CC(=O)N2[C@H](CC3=C(NC4=CC=CC=C34)[C@H]2C5=CC=C6OCOC6=C5)C1=O
7009,Talinolol,3A4-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
7010,Tamoxifen,3A4-Inducer,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
7011,Tamoxifen,3A4-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
7012,Tamoxifen,3A4-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
7013,Tamsulosin,3A4-Substrate,CCOC1=C(OCCN[C@H](C)CC2=CC(=C(OC)C=C2)S(N)(=O)=O)C=CC=C1
7014,Tasosartan,3A4-Substrate,CC1=NC2=C(CCC(=O)N2CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5)C(C)=N1
7015,Telithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
7016,Telithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
7017,Temazepam,3A4-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
7018,Temozolomide,3A4-Inducer,CN1N=NC2=C(N=CN2C1=O)C(N)=O
7019,Teniposide,3A4-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
7020,Teniposide,3A4-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
7021,Terbinafine,3A4-Inducer,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
7022,Terbinafine,3A4-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
7023,Terfenadine,3A4-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
7024,Terfenadine,3A4-Inducer,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
7025,Terfenadine,3A4-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
7026,Testosterone,3A4-Inducer,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
7027,Testosterone,3A4-Inhibitor,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
7028,Testosterone,3A4-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
7029,Tetracycline,3A4-Inhibitor,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
7030,Tetracycline,3A4-Substrate,CN(C)[C@H]1[C@@H]2C[C@@H]3C(=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)C4=C(O)C=CC=C4[C@@]3(C)O
7031,Tetramethrin,3A4-Inducer,CC(C)=C/[C@@H]1[C@@H](C(=O)OCN2C(=O)C3=C(CCCC3)C2=O)C1(C)C
7032,Theophylline,3A4-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
7033,Thiamazole,3A4-Inhibitor,CN1C=CNC1=S
7034,Thiopental,3A4-Inhibitor,CCC[C@@H](C)[C@]1(CC)C(=O)NC(S)=NC1=O
7035,Thiotepa,3A4-Substrate,S=P(N1CC1)(N2CC2)N3CC3
7036,Tiagabine,3A4-Substrate,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(O)=O)C3=C(C)C=CS3
7037,Tibolone,3A4-Inhibitor,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13
7038,Ticlopidine,3A4-Substrate,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7039,Tinidazole,3A4-Substrate,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O
7040,Tioconazole,3A4-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
7041,Tiotropium Bromide,3A4-Substrate,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@@H]23)OC(=O)C(O)(C4=CC=CS4)C5=CC=CS5
7042,Tirilazad,3A4-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN5CCN(CC5)C6=CC(=NC(=N6)N7CCCC7)N8CCCC8
7043,Tocopherol (vit E),3A4-Substrate,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
7044,Tocopherol (vit E),3A4-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
7045,Tofisopam,3A4-Inhibitor,CC[C@@H]1C(C)=NN=C(C2=CC(OC)=C(OC)C=C2)C3=C1C=C(OC)C(OC)=C3
7046,Tolterodine,3A4-Substrate,CC(C)N(CC[C@@H](C1=CC=CC=C1)C2=CC(C)=CC=C2O)C(C)C
7047,Topiramate,3A4-Inducer,CC1(C)O[C@H]2CO[C@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@H]2O1
7048,Topotecan,3A4-Inhibitor,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
7049,Topotecan,3A4-Inducer,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(CC4=C3N=C5C=CC(O)=C(CN(C)C)C5=C4)C2=O
7050,Toremifene,3A4-Substrate,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3
7051,Trabectedin,3A4-Substrate,COC1=C(O)C=C2CCN[C@]3(CS[C@H]4[C@H]5[C@@H]6N(C)[C@@H](CC7=CC(C)=C(OC)C(O)=C67)[C@H](O)N5[C@@H](COC3=O)C8=C4C(OC(C)=O)=C(C)C9=C8OCO9)C2=C1
7052,Tramadol,3A4-Inhibitor,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
7053,Tramadol,3A4-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
7054,Tranylcypromine,3A4-Inhibitor,N[C@H]1C[C@@H]1C2=CC=CC=C2
7055,Trazodone,3A4-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
7056,Treosulfan,3A4-Inhibitor,CS(=O)(=O)OC[C@H](O)[C@H](O)COS(C)(=O)=O
7057,Triamcinolone,3A4-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
7058,Triazolam,3A4-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
7059,Trichloroethylene,3A4-Substrate,ClC=C(Cl)Cl
7060,Trimethadione,3A4-Substrate,CN1C(=O)OC(C)(C)C1=O
7061,Trimethoprim,3A4-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
7062,Trimipramine,3A4-Substrate,C[C@H](CN(C)C)CN1C2=C(CCC3=C1C=CC=C3)C=CC=C2
7063,Trofosfamide,3A4-Substrate,ClCCN(CCCl)[P@]1(=O)OCCCN1CCCl
7064,Troglitazone,3A4-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
7065,Troglitazone,3A4-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
7066,Troglitazone,3A4-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
7067,Troleandomycin,3A4-Substrate,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
7068,Troleandomycin,3A4-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
7069,Tropisetron,3A4-Substrate,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=C3C=CC=C4
7070,Trospium,3A4-Inhibitor,OC(C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N@@]23CCCC3)(C4=CC=CC=C4)C5=CC=CC=C5
7071,Valdecoxib,3A4-Substrate,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
7072,Valproic Acid,3A4-Inhibitor,CCCC(CCC)C(O)=O
7073,Vardenafil,3A4-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
7074,Venlafaxine,3A4-Inhibitor,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
7075,Venlafaxine,3A4-Substrate,COC1=CC=C(C=C1)[C@@H](CN(C)C)[C@@]2(O)CCCCC2
7076,Verapamil,3A4-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
7077,Verapamil,3A4-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
7078,Vinblastine,3A4-Inducer,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
7079,Vinblastine,3A4-Inhibitor,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
7080,Vinblastine,3A4-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
7081,Vincamine,3A4-Substrate,CC[C@@]12CCCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)[C@](O)(C2)C(=O)OC
7082,Vincristine,3A4-Inhibitor,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
7083,Vincristine,3A4-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
7084,Vindesine,3A4-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1
7085,Vinorelbine,3A4-Inhibitor,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
7086,Vinorelbine,3A4-Substrate,CCC1=C[C@@H]2CN(C1)CC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=C(OC)C=C6N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]7([C@H]89)C6=C5)C(=O)OC
7087,Virginiamycin,3A4-Inducer,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
7088,Virginiamycin,3A4-Inhibitor,C[C@@H]1OC(=O)[C@H](NC(=O)[C@H]2CC(=O)CCN2C(=O)[C@H](CC3=CC=C(C=C3)N(C)C)N(C)C(=O)[C@H]4CCCN4C(=O)[C@H](C)NC(=O)[C@@H]1NC(=O)C5=C(O)C=CC=N5)C6=CC=CC=C6
7089,Voriconazole,3A4-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
7090,Voriconazole,3A4-Inhibitor,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
7091,Warfarin,3A4-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
7092,Yohimbin,3A4-Substrate,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C(NC5=C4C=CC=C5)[C@@H]3C[C@H]12
7093,Zafirlukast,3A4-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
7094,Zalcitabine,3A4-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
7095,Zaleplon,3A4-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
7096,Zidovudine,3A4-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
7097,Ziprasidone,3A4-Inhibitor,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
7098,Ziprasidone,3A4-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
7099,Zolpidem,3A4-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
7100,Zomepirac,3A4-Substrate,CN1C(CC(O)=O)=CC(C)=C1C(=O)C2=CC=C(Cl)C=C2
7101,Zonisamide,3A4-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
7102,Zopiclone,3A4-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
7103,Zotepine,3A4-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
7104,1_alpha_hydroxy_vitamin_D2,3A4-Substrate,CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C
7105,11_oxo_delta_8_tetrahydro_cannabinol,3A4-Substrate,CCCCCC1=CC2=C([C@@H]3CC(=CC[C@H]3C(C)(C)O2)C=O)C(=C1)O
7106,18_methoxy_coronaridine,3A4-Substrate,COCC[C@H]1CC2CN3CCC4=C([NH]C5=CC=CC=C45)[C@](C2)(C13)C(=O)OC
7107,2_acetylbenzothiophene,3A4-Substrate,CC(=O)C1=CC2=CC=CC=C2S1
7108,2_oxo_clopidogrel,3A4-Substrate,COC(=O)[C@@H](N1CCC2SC(=O)C=C2C1)C3=C(Cl)C=CC=C3
7109,2_oxo_ticlopidine,3A4-Substrate,ClC1=CC=CC=C1CN2CCC3SC(=O)C=C3C2
7110,2n_propylquinoline,3A4-Substrate,CCCC1=CC=C2C=CC=CC2=N1
7111,4_chloro_7_ethoxycoumarin,3A4-Substrate,CCOC1=CC=C2C(=C[C](=O)OC2=C1)Cl
7112,5_methylchrysene,3A4-Substrate,CC1=CC2=CC=CC=C2C3=CC=C4C=CC=CC4=C13
7113,7_benzyloxy_4_trifluoromethyl_coumarin,3A4-Substrate,FC(F)(F)C1=C[C](=O)OC2=CC(=CC=C12)OCC3=CC=CC=C3
7114,7_benzyloxy_quinoline,3A4-Substrate,C(OC1=CC=C2C=CC=NC2=C1)C3=CC=CC=C3
7115,9_alpha_fluoro_androstadienedione,3A4-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)C1=O
7116,ABT_761,3A4-Substrate,C[C@H](C#CC1=CC=C(CC2=CC=C(F)C=C2)S1)N(O)C(N)=O
7117,acetaminophen,3A4-Substrate,CC(=O)NC1=CC=C(O)C=C1
7118,aflatoxin_B1,3A4-Substrate,COC1=CC2=C([C@@H]3C=CO[C@@H]3O2)C4=C1C5=C(C(=O)CC5)[C](=O)O4
7119,alfentanil,3A4-Substrate,CC[N]1N=N[N](CCN2CCC(CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)[C]1=O
7120,all_trans_retinal,3A4-Substrate,CC(=C\C=O)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
7121,almotriptan,3A4-Substrate,CN(C)CCC1=C[NH]C2=CC=C(C[S](=O)(=O)N3CCCC3)C=C12
7122,alpha_thujone,3A4-Substrate,CC(C)[C@@]12C[C@@H]1[C@@H](C)C(=O)C2
7123,amiodarone,3A4-Substrate,CCCCC1=C(C(=O)C2=CC(=C(OCCN(CC)CC)C(=C2)I)I)C3=C(O1)C=CC=C3
7124,amitriptyline,3A4-Substrate,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C13
7125,amodiaquine,3A4-Substrate,CCN(CC)CC1=CC(=CC=C1O)NC2=CC=NC3=CC(=CC=C23)Cl
7126,androstenedione,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O
7127,antipyrine,3A4-Substrate,C[N]1[N]([C](=O)C=C1C)C2=CC=CC=C2
7128,astemizole,3A4-Substrate,COC1=CC=C(CCN2CCC(CC2)NC3=NC4=CC=CC=C4[N]3CC5=CC=C(F)C=C5)C=C1
7129,atomoxetine,3A4-Substrate,CNCC[C@@H](OC1=C(C)C=CC=C1)C2=CC=CC=C2
7130,atrazine,3A4-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)C
7131,azelastine,3A4-Substrate,CN1CCC[C@@H](CC1)[N]2N=C(CC3=CC=C(Cl)C=C3)C4=C(C=CC=C4)[C]2=O
7132,barnidipine_M8,3A4-Substrate,COC(=O)C1=C(C)N=C(C)C(=C1C2=CC(=CC=C2)[N](=O)=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4
7133,benzoyl_phenyl_urea,3A4-Substrate,CN(C)C1=CC=CC=C1C(=O)NC(=O)NC2=CC=C(OC3=NC=C(Br)C=N3)C(=C2)C
7134,benzphetamine,3A4-Substrate,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
7135,benzyl_oxy_resorufin,3A4-Substrate,O=[C]1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1
7136,beta_arteether,3A4-Substrate,CCO[C@H]1O[C@@H]2OC3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3
7137,bis_OH_methoxychlor,3A4-Substrate,OC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
7138,bisnor,3A4-Substrate,OC(=O)C\C=C\C[C@@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3
7139,bortezomib_M1_M2,3A4-Substrate,CC(C)CC(O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2
7140,BPR_0L075,3A4-Substrate,COC1=CC=C2C(=C1)[NH]C=C2C(=O)C3=CC(=C(OC)C(=C3)OC)OC
7141,budesonide,3A4-Substrate,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO
7142,bupivacaine_R,3A4-Substrate,CCCCN1CCCC[C@@H]1C(=O)NC2=C(C)C=CC=C2C
7143,caffeine,3A4-Substrate,C[N]1C=NC2=C1[C](=O)[N](C)[C](=O)[N]2C
7144,carbamazepine,3A4-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
7145,carbaryl,3A4-Substrate,CNC(=O)OC1=CC=CC2=C1C=CC=C2
7146,carbofuran,3A4-Substrate,CNC(=O)OC1=C2OC(C)(C)CC2=CC=C1
7147,carvedilol_S,3A4-Substrate,COC1=CC=CC=C1OCCNC[C@H](O)COC2=C3C(=CC=C2)[NH]C4=C3C=CC=C4
7148,celecoxib,3A4-Substrate,CC1=CC=C(C=C1)C2=CC(=N[N]2C3=CC=C(C=C3)[S](N)(=O)=O)C(F)(F)F
7149,cerivastatin,3A4-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(=C(N=C1C(C)C)C(C)C)\C=C\[C@@H](O)C[C@@H](O)CC(O)=O
7150,chloroquine_R,3A4-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=CC(=CC2=NC=C1)Cl
7151,chlorpyrifos,3A4-Substrate,CCO[P](=S)(OCC)OC1=NC(=C(Cl)C=C1Cl)Cl
7152,chlorzoxazone,3A4-Substrate,ClC1=CC2=C(O[C](=O)[NH]2)C=C1
7153,cisapride,3A4-Substrate,CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=CC(=C(N)C=C3OC)Cl
7154,citalopram_R,3A4-Substrate,CN(C)CCC[C@@]1(OCC2=C1C=CC(=C2)C#N)C3=CC=C(F)C=C3
7155,clobazam,3A4-Substrate,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
7156,clomipramine,3A4-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
7157,clozapine,3A4-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(=C3)Cl
7158,CMV_423,3A4-Substrate,NC(=O)C1=C2CCCC[N]2C(=C1Cl)C3=CC=CN=C3
7159,compound_A,3A4-Substrate,COC1=NC=C(C=C1)[C@H](CC(O)=O)N2CCN(CCCC3=NC4=C(CCCN4)C=C3)C2=O
7160,cp_122_721,3A4-Substrate,COC1=C(CN[C@H]2CCCN[C@H]2C3=CC=CC=C3)C=C(OC(F)(F)F)C=C1
7161,cp_677_623,3A4-Substrate,COC1=CC=C(OC(F)(F)F)C=C1CN
7162,dapsone,3A4-Substrate,NC1=CC=C(C=C1)[S](=O)(=O)C2=CC=C(N)C=C2
7163,DDB_aka_BDD,3A4-Substrate,COC(=O)C1=CC(=C2OCOC2=C1C3=C4OCOC4=C(OC)C=C3C(=O)OC)OC
7164,DDTC_Me,3A4-Substrate,CCN(CC)C(=S)SC
7165,delavirdine,3A4-Substrate,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(=CC=C4[NH]3)N[S](C)(=O)=O
7166,delta_9_tetrahydrocannabinol,3A4-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(=C1)O
7167,deoxy_podophyllotoxin,3A4-Substrate,COC1=C(OC)C(=CC(=C1)[C@@H]2[C@H]3[C@@H](COC3=O)CC4=CC5=C(OCO5)C=C24)OC
7168,deoxy_schizandrin,3A4-Substrate,COC1=C(OC)C(=C2C(=C1)C[C@H](C)[C@H](C)CC3=CC(=C(OC)C(=C23)OC)OC)OC
7169,DETC_Me,3A4-Substrate,CCN(CC)C(=O)SC
7170,dextropropoxyphene,3A4-Substrate,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C2=CC=CC=C2
7171,diazepam,3A4-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=CC(=CC=C13)Cl
7172,diazinion,3A4-Substrate,CCO[P](=S)(OCC)OC1=NC(=NC(=C1)C)C(C)C
7173,dibenzyl_fluorescein,3A4-Substrate,O=C1OC2(C3=CC=C(OCC4=CC=CC=C4)C=C3OC5=CC(=CC=C25)OCC6=CC=CC=C6)C7=CC=CC=C17
7174,diethyl_meta_toluamide,3A4-Substrate,CCN(CC)C(=O)C1=CC(=CC=C1)C
7175,dimemorfan,3A4-Substrate,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C)C=C4
7176,disulfoton,3A4-Substrate,CCO[P](=S)(OCC)SCCSCC
7177,diuron,3A4-Substrate,CN(C)C(=O)NC1=CC=C(Cl)C(=C1)Cl
7178,domperidone,3A4-Substrate,ClC1=CC=C2[N](C3CCN(CCC[N]4[C](=O)[NH]C5=CC=CC=C45)CC3)[C](=O)[NH]C2=C1
7179,DY_9760e,3A4-Substrate,COC1=CC2=C(C=C1OC)C(=N[N]2CC3=C[NH]C=N3)CCN4CCN(CC4)C5=CC=CC(=C5C)Cl
7180,efavirenz,3A4-Substrate,FC(F)(F)[C@]1(OC(=O)NC2=C1C=C(Cl)C=C2)C#CC3CC3
7181,ellipticine,3A4-Substrate,CC1=C2[NH]C3=CC=CC=C3C2=C(C)C4=CN=CC=C14
7182,endosulfan,3A4-Substrate,ClC1=C(Cl)C2(Cl)C3CO[S](=O)OCC3C1(Cl)C2(Cl)Cl
7183,erythromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@H](O)[C@@]1(C)O
7184,ethanol,3A4-Substrate,CCO
7185,ethinyl_estradiol,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@]2(O)C#C
7186,ethiprole,3A4-Substrate,CC[S@@](=O)C1=C(N)[N](N=C1C#N)C2=C(Cl)C=C(C=C2Cl)C(F)(F)F
7187,etoposide,3A4-Substrate,COC1=C(O)C(=CC(=C1)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4OC5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=C2C=C7OCOC7=C6)OC
7188,ezlopitant_alkene_CJ_12_458,3A4-Substrate,COC1=CC=C(C=C1CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C(C)=C
7189,FLU,3A4-Substrate,NC1=CC=C(C(=C1)C(F)(F)F)[N](=O)=O
7190,flunitrazepam,3A4-Substrate,CN1C(=O)CN=C(C2=C(F)C=CC=C2)C3=C1C=CC(=C3)[N](=O)=O
7191,fluoxetine_R,3A4-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
7192,fluticasone_proprionate,3A4-Substrate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF
7193,fluvastatin,3A4-Substrate,CC(C)[N]1C2=CC=CC=C2C(=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C3=CC=C(F)C=C3
7194,foxy,3A4-Substrate,COC1=CC=C2[NH]C=C(CCN(C(C)C)C(C)C)C2=C1
7195,gefitinib,3A4-Substrate,COC1=CC2=NC=NC(=C2C=C1OCCCN3CCOCC3)NC4=CC=C(F)C(=C4)Cl
7196,gepirone,3A4-Substrate,CC1(C)CC(=O)N(CCCCN2CCN(CC2)C3=NC=CC=N3)C(=O)C1
7197,H_259_31_R,3A4-Substrate,FC1=CC=C2N=C([NH]C2=C1)[S@](=O)CC3=NC=CC(=C3)OCC4CC4
7198,halofantrine_R,3A4-Substrate,CCCCN(CCCC)CC[C@@H](O)C1=CC2=C(Cl)C=C(Cl)C=C2C3=C1C=CC(=C3)C(F)(F)F
7199,haloperidol,3A4-Substrate,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
7200,ifosfamide,3A4-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
7201,iloperidone,3A4-Substrate,COC1=CC(=CC=C1OCCCN2CCC(CC2)C3=NOC4=CC(=CC=C34)F)C(C)=O
7202,imidacloprid,3A4-Substrate,ClC1=NC=C(CN2CCN=C2N[N](=O)=O)C=C1
7203,imipramine,3A4-Substrate,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C13
7204,indiplon,3A4-Substrate,CN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=N[N]23)C(=O)C4=CC=CS4
7205,indomethacin_phenethylamide,3A4-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCCC3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
7206,ipriflavone,3A4-Substrate,CC(C)OC1=CC=C2C(=C1)OC=C([C]2=O)C3=CC=CC=C3
7207,K11777,3A4-Substrate,CN1CCN(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCC3=CC=CC=C3)C=C[S](=O)(=O)C4=CC=CC=C4
7208,ketamine_R,3A4-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
7209,ketobemidone,3A4-Substrate,CCC(=O)C1(CCN(C)CC1)C2=CC=CC(=C2)O
7210,L_775_606,3A4-Substrate,FC1=CC=CC(=C1)CCN2CCN(CCCC3=C[NH]C4=CC=C(C=C34)[N]5C=NN=C5)CC2
7211,licofelone,3A4-Substrate,CC1(C)C[N]2C(=C(C3=CC=C(Cl)C=C3)C(=C2C1)C4=CC=CC=C4)CC(O)=O
7212,lidocaine,3A4-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
7213,lilopristone,3A4-Substrate,CN(C)C1=CC=C(C=C1)[C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)\C=C/CO)[C@@H]4CCC5=CC(=O)CCC5=C24
7214,limonene_S,3A4-Substrate,CC(=C)[C@H]1CCC(=CC1)C
7215,lithocholic_acid,3A4-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C
7216,loperamide,3A4-Substrate,CN(C)C(=O)C(CCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
7217,losartan,3A4-Substrate,CCCCC1=NC(=C(CO)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)Cl
7218,Lu_AA21004,3A4-Substrate,CC1=CC=C(SC2=CC=CC=C2N3CCNCC3)C(=C1)C
7219,MBDB,3A4-Substrate,CC[C@H](CC1=CC=C2OCOC2=C1)NC
7220,meloxicam,3A4-Substrate,CN1C(=C(O)C2=CC=CC=C2[S]1(=O)=O)C(=O)NC3=NC=C(C)S3
7221,meperidine,3A4-Substrate,CCOC(=O)C1(CCN(C)CC1)C2=CC=CC=C2
7222,methadone_R,3A4-Substrate,CCC(=O)C(C[C@@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
7223,methiocarb,3A4-Substrate,CNC(=S)OC1=CC(=C(SC)C(=C1)C)C
7224,mianserin_R,3A4-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CC=C24
7225,midazolam,3A4-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=CC(=CC=C4[N]12)Cl
7226,miocamycin_Mb2,3A4-Substrate,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C\C=C\C=C\[C@H](OC(C)=O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
7227,mirtazapine_R,3A4-Substrate,CN1CCN2[C@@H](C1)C3=CC=CC=C3CC4=CC=CN=C24
7228,MK_0457_tozasertib,3A4-Substrate,CN1CCN(CC1)C2=NC(=NC(=C2)NC3=N[NH]C(=C3)C)SC4=CC=C(NC(=O)C5CC5)C=C4
7229,ML_3403,3A4-Substrate,CSC1=NC(=C([NH]1)C2=CC=C(F)C=C2)C3=CC=NC(=C3)NC(C)C4=CC=CC=C4
7230,ML_3603,3A4-Substrate,CC(NC1=NC=CC(=C1)C2=C(N=C([NH]2)[S](C)=O)C3=CC=C(F)C=C3)C4=CC=CC=C4
7231,MOCA,3A4-Substrate,NC1=CC=C(CC2=CC=C(N)C(=C2)Cl)C=C1Cl
7232,montelukast,3A4-Substrate,CC(C)(O)C1=CC=CC=C1CC[C@@H](SCC2(CC2)CC(O)=O)C3=CC=CC(=C3)\C=C\C4=CC=C5C=CC(=CC5=N4)Cl
7233,morphine,3A4-Substrate,CN1CC[C@@]23[C@H]4OC5=C(O)C=CC(=C25)C[C@@H]1[C@@H]3C=C[C@@H]4O
7234,muraglitazar,3A4-Substrate,COC1=CC=C(OC(=O)N(CC(O)=O)CC2=CC=C(OCCC3=C(C)OC(=N3)C4=CC=CC=C4)C=C2)C=C1
7235,myristicin,3A4-Substrate,COC1=C2OCOC2=CC(=C1)CC=C
7236,N_amyl_N_methyl_nitrosamine,3A4-Substrate,CCCCCN(C)N=O
7237,N_desmethyl_diltiazem,3A4-Substrate,CNCCN1C(=O)[C@H](OC(C)=O)[C@@H](SC2=C1C=CC=C2)C3=CC=C(OC)C=C3
7238,N_methyl_ethyl_formamide,3A4-Substrate,CCN(C)C=O
7239,N_nitroso_nornicotine,3A4-Substrate,O=NN1CCC[C@H]1C2=CN=CC=C2
7240,naringenin,3A4-Substrate,OC1=CC=C(C=C1)[C@H]2CC(=O)C3=C(O)C=C(O)C=C3O2
7241,NE_100,3A4-Substrate,CCCN(CCC)CCC1=CC=C(OC)C(=C1)OCCC2=CC=CC=C2
7242,nevirapine,3A4-Substrate,CC1=CC=NC2=C1NC(=O)C3=C(N=CC=C3)N2C4CC4
7243,nifedipine,3A4-Substrate,COC(=O)C1=C(C)NC(=C(C1C2=C(C=CC=C2)[N](=O)=O)C(=O)OC)C
7244,NN_diamyl_nitrosoamine,3A4-Substrate,CCCCCN(CCCCC)N=O
7245,NN_diethyl_nitrosoamine,3A4-Substrate,CCN(CC)N=O
7246,NN_dimethyl_nitrosoamine,3A4-Substrate,CN(C)N=O
7247,NN_methyl_butyl_nitrosoamine,3A4-Substrate,CCCCN(C)N=O
7248,NN_methyl_ethyl_nitrosoamine,3A4-Substrate,CCN(C)N=O
7249,NNK,3A4-Substrate,CN(CCCC(=O)C1=CC=CN=C1)N=O
7250,NO_1886,3A4-Substrate,CCO[P](=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(Br)C=C2)C#N)OCC
7251,nordiazepam,3A4-Substrate,ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1
7252,norLAAM,3A4-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)NC)(C1=CC=CC=C1)C2=CC=CC=C2
7253,norverapamil_R,3A4-Substrate,COC1=C(OC)C=C(CCNCCC[C@@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
7254,O_phenylphenol,3A4-Substrate,OC1=C(C=CC=C1)C2=CC=CC=C2
7255,O6_benzylguanine,3A4-Substrate,NC1=NC2=C(N=C[NH]2)C(=N1)OCC3=CC=CC=C3
7256,ochratoxin_A,3A4-Substrate,C[C@@H]1CC2=C(C(=C(C=C2Cl)C(=O)N[C@@H](CC3=CC=CC=C3)C(O)=O)O)C(=O)O1
7257,olanzapine,3A4-Substrate,CN1CCN(CC1)C2=NC3=CC=CC=C3NC4=C2C=C(C)S4
7258,omeprazole_R,3A4-Substrate,COC1=CC=C2[NH]C(=NC2=C1)[S@](=O)CC3=NC=C(C)C(=C3C)OC
7259,ondansetron,3A4-Substrate,C[N]1C2=C(C(=O)[C@@H](CC2)C[N]3C=CN=C3C)C4=CC=CC=C14
7260,org_30659_tosagestin,3A4-Substrate,C[C@]12CC(=C)[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1C=C[C@@]2(O)C#C
7261,p_cresol,3A4-Substrate,CC1=CC=C(O)C=C1
7262,parathion,3A4-Substrate,CCO[P](=S)(OCC)OC1=CC=C(C=C1)[N](=O)=O
7263,PCB_101,3A4-Substrate,ClC1=CC=C(Cl)C(=C1)C2=CC(=C(Cl)C=C2Cl)Cl
7264,perhexiline,3A4-Substrate,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
7265,perphenazine,3A4-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
7266,phenprocoumon_S,3A4-Substrate,CC[C@@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
7267,phenytoin,3A4-Substrate,O=C1NC(=O)C(N1)(C2=CC=CC=C2)C3=CC=CC=C3
7268,phorate,3A4-Substrate,CCO[P](=S)(OCC)SCSCC
7269,pregnenolone,3A4-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
7270,propafenone_R,3A4-Substrate,CCCNC[C@@H](O)COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2
7271,pyrazolo_acridine,3A4-Substrate,COC1=CC2=C(NC3=C(C=CC4=C3C2=N[N]4CCCN(C)C)[N](=O)=O)C=C1
7272,quazepam,3A4-Substrate,FC1=CC=CC=C1C2=NCC(=S)N(CC(F)(F)F)C3=CC=C(Cl)C=C23
7273,quinidine,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
7274,quinoline,3A4-Substrate,C1=CC=C2N=CC=CC2=C1
7275,R_95913,3A4-Substrate,FC1=CC=CC=C1C(N2CCC3SC(=O)C=C3C2)C(=O)C4CC4
7276,rabeprazole_thioether,3A4-Substrate,COCCCOC1=CC=NC(=C1C)CSC2=NC3=CC=CC=C3[NH]2
7277,reduced_haloperidol,3A4-Substrate,OC(CCCN1CCC(O)(CC1)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3
7278,repaglinide,3A4-Substrate,CCOC1=CC(=CC=C1C(O)=O)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3
7279,RHP+,3A4-Substrate,OC(CCC[N+]1=CC=C(C=C1)C2=CC=C(Cl)C=C2)C3=CC=C(F)C=C3
7280,ropinirole,3A4-Substrate,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
7281,rutaecarpine,3A4-Substrate,O=[C]1[N]2CCC3=C([NH]C4=CC=CC=C34)C2=NC5=C1C=CC=C5
7282,S_145,3A4-Substrate,OC(=O)CCC\C=C/C[C@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3
7283,safrole,3A4-Substrate,C=CCC1=CC=C2OCOC2=C1
7284,salicylate,3A4-Substrate,OC(=O)C1=CC=CC=C1O
7285,selegiline,3A4-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
7286,senecionine,3A4-Substrate,C\C=C1\C[C@@H](C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@@H]23
7287,seratrodast_R,3A4-Substrate,CC1=C(C)C(=O)C(=C(C)C1=O)[C@H](CCCCCC(O)=O)C2=CC=CC=C2
7288,sertraline,3A4-Substrate,CN[C@H]1CC[C@@H](C2=CC(=C(Cl)C=C2)Cl)C3=C1C=CC=C3
7289,sibutramine,3A4-Substrate,CC(C)CC(N(C)C)C1(CCC1)C2=CC=C(Cl)C=C2
7290,sildenafil,3A4-Substrate,CCCC1=N[N](C)C2=C1N=C([NH][C]2=O)C3=CC(=CC=C3OCC)[S](=O)(=O)N4CCN(C)CC4
7291,simvastatin,3A4-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
7292,SNI_2011_R_R,3A4-Substrate,C[C@@H]1O[C@@]2(CS1)CN3CCC2CC3
7293,sulfinpyrazone,3A4-Substrate,O=C1C(CC[S](=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
7294,sulprofos,3A4-Substrate,CCCS[P](=S)(OCC)OC1=CC=C(SC)C=C1
7295,tamarixetin,3A4-Substrate,COC1=C(O)C=C(C=C1)C2=C(O)[C](=O)C3=C(O2)C=C(O)C=C3O
7296,tamsulosin,3A4-Substrate,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC=C(OC)C(=C2)[S](N)(=O)=O
7297,tauromustine,3A4-Substrate,CN(C)[S](=O)(=O)CCNC(=O)N(CCCl)N=O
7298,taxol,3A4-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(=C1C5(C)C)C
7299,temazepam,3A4-Substrate,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C3=C1C=CC(=C3)Cl
7300,terbinafine,3A4-Substrate,CN(C\C=C\C#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12
7301,terbutryn,3A4-Substrate,CCNC1=NC(=NC(=N1)SC)NC(C)(C)C
7302,territrem_A,3A4-Substrate,COC1=CC(=CC2=C1OCO2)C3=CC4=C(C[C@]5(O)[C@](C)(CC[C@@]6(O)C(C)(C)C=CC(=O)[C@]56C)O4)[C](=O)O3
7303,tetranor,3A4-Substrate,OC(=O)CC[C@@H]1[C@@H]2CCC(C2)[C@@H]1N[S](=O)(=O)C3=CC=CC=C3
7304,thioridazine_R,3A4-Substrate,CSC1=CC=C2SC3=CC=CC=C3N(CC[C@H]4CCCCN4C)C2=C1
7305,ticlopidine,3A4-Substrate,ClC1=CC=CC=C1CN2CCC3=C(C2)C=CS3
7306,tolterodine,3A4-Substrate,CC(C)N(CC[C@H](C1=CC=CC=C1)C2=CC(=CC=C2O)C)C(C)C
7307,TPA_023,3A4-Substrate,CC[N]1N=CN=C1COC2=N[N]3C(=NN=C3C4=CC=CC=C4F)C=C2C(C)(C)C
7308,tramadol,3A4-Substrate,COC1=CC=CC(=C1)[C@@]2(O)CCCC[C@@H]2CN(C)C
7309,trans_phenylpropene,3A4-Substrate,C\C=C\C1=CC=CC=C1
7310,trimethadione,3A4-Substrate,CN1C(=O)OC(C)(C)C1=O
7311,troglitazone,3A4-Substrate,CC1=C(O)C(=C2CC[C@](C)(COC3=CC=C(C[C@H]4SC(=O)NC4=O)C=C3)OC2=C1C)C
7312,tropisetron,3A4-Substrate,CN1[C@H]2CCC1CC(C2)OC(=O)C3=C[NH]C4=CC=CC=C34
7313,V_11294,3A4-Substrate,CCNC1=C2N=C(N=C2[N](CC3=CC=C(OC)C(=C3)OC4CCCC4)C=N1)C(C)C
7314,valdecoxib,3A4-Substrate,CC1=C(C2=CC=C(C=C2)[S](N)(=O)=O)C(=NO1)C3=CC=CC=C3
7315,venlafaxine_R,3A4-Substrate,COC1=CC=C(C=C1)[C@H](CN(C)C)C2(O)CCCCC2
7316,vicriviroc,3A4-Substrate,COC[C@H](N1CCN(C[C@@H]1C)C2(C)CCN(CC2)C(=O)C3=C(C)N=CN=C3C)C4=CC=C(C=C4)C(F)(F)F
7317,voriconazole,3A4-Substrate,C[C@@H](C1=NC=NC=C1F)[C@](O)(C[N]2C=NC=N2)C3=CC=C(F)C=C3F
7318,w_OH_finasteride,3A4-Substrate,CC(C)(CO)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
7319,yohimbine,3A4-Substrate,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C([NH]C5=CC=CC=C45)[C@@H]3C[C@H]12
7320,zileuton_R,3A4-Substrate,C[C@@H](N(O)C(N)=O)C1=CC2=CC=CC=C2S1
7321,zonisamide,3A4-Substrate,N[S](=O)(=O)CC1=NOC2=C1C=CC=C2
7322,zopiclone_R,3A4-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=C2N=CC=N3)C4=CC=C(Cl)C=N4
7323,zotepine,3A4-Substrate,CN(C)CCOC1=CC2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
7324,1_alpha_hydroxy_vitamin_D3,3A4-Substrate,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C
7325,13_cis_retinoic_acid,3A4-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1
7326,17_beta_estradiol,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CC[C@@H]2O
7327,2_hydroxy_indomethacin_phenethylamide,3A4-Substrate,COC1=CC=C2[N](C(=C(CC(=O)NCC(O)C3=CC=CC=C3)C2=C1)C)C(=O)C4=CC=C(Cl)C=C4
7328,2_oxo_quazepam,3A4-Substrate,FC1=CC=CC=C1C2=NCC(=O)N(CC(F)(F)F)C3=CC=C(Cl)C=C23
7329,3_methylether_estradiol,3A4-Substrate,COC1=CC=C2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCC2=C1
7330,4prime_hydroxy_clobazam,3A4-Substrate,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C3=CC(=CC=C13)Cl
7331,5beta_cholestane_3alpha_7alpha_12alpha_triol,3A4-Substrate,CC(C)CCC[C@@H](C)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3C[C@H](O)[C@]12C
7332,6_methylchrysene,3A4-Substrate,CC1=CC2=C3C=CC=CC3=CC=C2C4=CC=CC=C14
7333,7_butoxy_coumarin,3A4-Substrate,CCCCOC1=CC=C2C=C[C](=O)OC2=C1
7334,7_ethoxy_coumarin,3A4-Substrate,CCOC1=CC=C2C=C[C](=O)OC2=C1
7335,7_hexoxy_coumarin,3A4-Substrate,CCCCCCOC1=CC=C2C=C[C](=O)OC2=C1
7336,7_methyl_benzacridine,3A4-Substrate,CC1=C2C=CC3=C(C=CC=C3)C2=NC4=CC=CC=C14
7337,7_pentoxy_coumarin,3A4-Substrate,CCCCCOC1=CC=C2C=C[C](=O)OC2=C1
7338,9_anthraldehyde,3A4-Substrate,O=CC1=C2C=CC=CC2=CC3=CC=CC=C13
7339,9_cis_retinal,3A4-Substrate,CC(=C\C=O)/C=C/C=C(C)\C=C\C1=C(C)CCCC1(C)C
7340,ABT_438,3A4-Substrate,C[C@@H](NC(N)=O)C#CC1=CC=C(CC2=CC=C(F)C=C2)S1
7341,ABT_66193,3A4-Substrate,CC(NC(N)=O)C1=CC2=CC=CC=C2S1
7342,all_trans_retinoic_acid,3A4-Substrate,CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1
7343,ametryne,3A4-Substrate,CCNC1=NC(=NC(=N1)SC)NC(C)C
7344,apigenin,3A4-Substrate,OC1=CC=C(C=C1)C2=C[C](=O)C3=C(O2)C=C(O)C=C3O
7345,barnidipine,3A4-Substrate,COC(=O)C1=C(C)NC(=C([C@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)O[C@H]3CCN(C3)CC4=CC=CC=C4)C
7346,BDB,3A4-Substrate,CCC(N)CC1=CC=C2OCOC2=C1
7347,beta_thujone,3A4-Substrate,CC(C)[C@@]12C[C@@H]1[C@H](C)C(=O)C2
7348,bortezomib,3A4-Substrate,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
7349,buprenorphine,3A4-Substrate,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4CC5=C6C(=C(O)C=C5)O[C@@H]2[C@@]36CCN4CC7CC7
7350,chenodeoxycholic_acid,3A4-Substrate,C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
7351,cholic_acid,3A4-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
7352,clarithromycin,3A4-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
7353,deoxycholic_acid,3A4-Substrate,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
7354,dexamethasone,3A4-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
7355,DHEA,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
7356,dibenzacridine,3A4-Substrate,C1=CC=C2C(=C1)C=CC3=NC4=CC=C5C=CC=CC5=C4C=C23
7357,diltiazem,3A4-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
7358,DMBA,3A4-Substrate,CC1=C2C=CC=CC2=C(C)C3=C4C=CC=CC4=CC=C13
7359,estrone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(=C4)O)[C@@H]1CCC2=O
7360,ethyl_morphine,3A4-Substrate,CCOC1=C2O[C@H]3[C@@H](O)C=C[C@H]4[C@H]5CC(=C2[C@@]34CCN5C)C=C1
7361,ezlopitant,3A4-Substrate,COC1=C(CN[C@H]2C3CCN(CC3)[C@H]2C(C4=CC=CC=C4)C5=CC=CC=C5)C=C(C=C1)C(C)C
7362,finasteride,3A4-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
7363,fipronil,3A4-Substrate,NC1=C(C(=N[N]1C2=C(Cl)C=C(C=C2Cl)C(F)(F)F)C#N)[S@](=O)C(F)(F)F
7364,LAAM,3A4-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
7365,lansoprazole_R,3A4-Substrate,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3[NH]2
7366,losartan_carboxaldehyde_EXP_3179,3A4-Substrate,CCCCC1=NC(=C(C=O)[N]1CC2=CC=C(C=C2)C3=CC=CC=C3C4=N[NH]N=N4)Cl
7367,MDA_tenamfetamine,3A4-Substrate,CC(N)CC1=CC=C2OCOC2=C1
7368,MDE_R,3A4-Substrate,CCN[C@H](C)CC1=CC=C2OCOC2=C1
7369,MDMA_R,3A4-Substrate,CN[C@H](C)CC1=CC=C2OCOC2=C1
7370,miocamycin_Mb12,3A4-Substrate,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(C)=O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
7371,miocamycin_Mb6,3A4-Substrate,CCC(=O)O[C@@H]1CC(=O)O[C@H](C)C\C=C\C=C\[C@H](O)[C@H](C)C[C@H](CC=O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@H]1OC
7372,mono_OH_methoxychlor,3A4-Substrate,COC1=CC=C(C=C1)C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl
7373,N_desmethyl_clomipramine,3A4-Substrate,CNCCCN1C2=CC=CC=C2CCC3=CC=C(Cl)C=C13
7374,nicardipine_R,3A4-Substrate,COC(=O)C1=C(C)NC(=C([C@@H]1C2=CC=CC(=C2)[N](=O)=O)C(=O)OCCN(C)CC3=CC=CC=C3)C
7375,norverapamil_S,3A4-Substrate,COC1=C(OC)C=C(CCNCCC[C@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
7376,omeprazole_S,3A4-Substrate,COC1=CC=C2[NH]C(=NC2=C1)[S@@](=O)CC3=NC=C(C)C(=C3C)OC
7377,onapristone,3A4-Substrate,CN(C)C1=CC=C(C=C1)[C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]4CCC5=CC(=O)CCC5=C24
7378,org_4060,3A4-Substrate,CC[C@H]1C[C@@]2(C)[C@@H](CC[C@@]2(O)C#C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@@H]13
7379,oxycodone,3A4-Substrate,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(=C2[C@@]34CCN5C)C=C1
7380,perazine,3A4-Substrate,CN1CCN(CCCN2C3=CC=CC=C3SC4=C2C=CC=C4)CC1
7381,phenprocoumon_R,3A4-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=CC=CC=C3O[C]2=O
7382,progesterone,3A4-Substrate,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
7383,promazine,3A4-Substrate,CN(C)CCCN1C2=CC=CC=C2SC3=CC=CC=C13
7384,quinine,3A4-Substrate,COC1=CC=C2N=CC=C([C@@H](O)[C@@H]3C[C@@H]4CC[N@]3C[C@@H]4C=C)C2=C1
7385,retinol,3A4-Substrate,CC(=C\CO)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C
7386,ropivacaine,3A4-Substrate,CCCN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C
7387,RPR_127025,3A4-Substrate,NC(=O)C1=C2C(O)CCC[N]2C(=C1Cl)C3=CN=CC=C3
7388,simvastatin_hydroxy_acid,3A4-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
7389,sulfinpyrazone_sulfide,3A4-Substrate,O=C1C(CCSC2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
7390,tangeretin,3A4-Substrate,COC1=CC=C(C=C1)C2=C[C](=O)C3=C(OC)C(=C(OC)C(=C3O2)OC)OC
7391,terbutylazine,3A4-Substrate,CCNC1=NC(=NC(=N1)Cl)NC(C)(C)C
7392,testosterone,3A4-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O
7393,theobromine_deriv_10,3A4-Substrate,C[N]1C=NC2=C1[C](=O)[N](CCCCC=C)[C](=O)[N]2C
7394,theobromine_deriv_11,3A4-Substrate,CC\C=C/C[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O
7395,theobromine_deriv_12,3A4-Substrate,C[N]1C=NC2=C1[C](=O)[N](CCC=C)[C](=O)[N]2C
7396,theobromine_deriv_13,3A4-Substrate,C[N]1C=NC2=C1[C](=O)[N](CCCC=C)[C](=O)[N]2C
7397,theobromine_deriv_4,3A4-Substrate,CCCCC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O
7398,theobromine_deriv_5,3A4-Substrate,CCCCCC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O
7399,theobromine_deriv_6,3A4-Substrate,CC(C)CCC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O
7400,theobromine_deriv_7,3A4-Substrate,CCC(C)CC[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O
7401,theobromine_deriv_8,3A4-Substrate,CCCC(C)C[N]1[C](=O)[N](C)C2=C([N](C)C=N2)[C]1=O
7402,theobromine_deriv_9,3A4-Substrate,C[N]1C=NC2=C1[C](=O)[N](CC3CCCO3)[C](=O)[N]2C
7403,trofosfamide,3A4-Substrate,ClCCN(CCCl)[P@@]1(=O)OCCCN1CCCl
7404,ursodeoxycholic_acid,3A4-Substrate,C[C@H](CCC(O)=O)[C@@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
7405,verapamil_R,3A4-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
7406,verapamil_S,3A4-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(=C(OC)C=C2)OC)C=C1
7407,w_aldehyde_finasteride,3A4-Substrate,CC(C)(NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C)C=O
7408,Almotriptan,3A4-Inhibitor,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N3CCCC3)C=C2
7409,Avasimibe,3A4-Inhibitor,CC(C)C1=C(C(=CC=C1)C(C)C)OS(=O)(=O)NC(=O)CC2=C(C=C(C=C2C(C)C)C(C)C)C(C)C
7410,Azamulin,3A4-Inhibitor,CCC1(CC(C2(C(CCC3(C2C(=O)CC3)C(C1O)C)C)C)OC(=O)CSC4=NNC(=N4)N)C
7411,Betamethasone,3A4-Inhibitor,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C
7412,Calcium folinate,3A4-Inhibitor,C1C(N(C2=C(N1)N=C(N=C2[O-])N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)O.[Ca+2]
7413,Carbamazepine,3A4-Inhibitor,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
7414,Carvedilol,3A4-Inhibitor,COC1=C(OCCNC[C@@H](O)COC2=CC=CC3=C2C4=CC=CC=C4N3)C=CC=C1
7415,Cetirizine,3A4-Inhibitor,OC(=O)COCCN1CCN(CC1)[C@H](C2=CC=CC=C2)C3=CC=C(Cl)C=C3
7416,Chloroquine,3A4-Inhibitor,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
7417,Chlorpromazine,3A4-Inhibitor,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
7418,Chlorpyrifos,3A4-Inhibitor,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
7419,Cortisol,3A4-Inhibitor,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
7420,Coumarin,3A4-Inhibitor,C1=CC=C2C(=C1)C=CC(=O)O2
7421,Dalfopristin,3A4-Inhibitor,CCN(CC)CCS(=O)(=O)C1CCN2C1C(=O)OC(C(C=CC(=O)NCC=CC(=CC(CC(=O)CC3=NC(=CO3)C2=O)O)C)C)C(C)C
7422,Delapril,3A4-Inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N(CC(=O)O)C2CC3=CC=CC=C3C2
7423,Desloratadine,3A4-Inhibitor,ClC1=CC2=C(C=C1)C(=C3CCNCC3)C4=C(CC2)C=CC=N4
7424,Digoxin,3A4-Inhibitor,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@@H](CC[C@]67O)C8=CC(=O)OC8)C4
7425,Dimethyl sulfoxide,3A4-Inhibitor,CS(=O)C
7426,Dirithromycin,3A4-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O
7427,Disulfamide,3A4-Inhibitor,CC1=CC(=C(C=C1S(=O)(=O)N)S(=O)(=O)N)Cl
7428,Ditiocarb sodium,3A4-Inhibitor,CCN(CC)C(=S)[S-].[Na+]
7429,Drospirenone,3A4-Inhibitor,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
7430,Ebrotidine,3A4-Inhibitor,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br
7431,Efonidipine,3A4-Inhibitor,CC1=C(C(C(=C(N1)C)P2(=O)OCC(CO2)(C)C)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5
7432,Eplerenone,3A4-Inhibitor,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
7433,Famotidine,3A4-Inhibitor,NC(N)=NC1=NC(CSCCC(N)=N/S(N)(=O)=O)=CS1
7434,Fluphenazine,3A4-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
7435,Flutamide,3A4-Inhibitor,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
7436,Gallopamil,3A4-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@@](C#N)(C(C)C)C2=CC(OC)=C(OC)C(OC)=C2)C=C1
7437,Gestodene,3A4-Inhibitor,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
7438,Grepafloxacin,3A4-Inhibitor,C[C@H]1CN(CCN1)C2=C(F)C(C)=C3C(=O)C(=CN([C@@H]4CC4)C3=C2)C(O)=O
7439,Homochlorcyclizine,3A4-Inhibitor,CN1CCCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
7440,Malathion,3A4-Inhibitor,CCOC(=O)C[C@H](SP(=S)(OC)OC)C(=O)OCC
7441,Methoxsalen,3A4-Inhibitor,COC1=C2OC(=O)C=CC2=CC3=C1OC=C3
7442,Metoclopramide,3A4-Inhibitor,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
7443,Nimodipine,3A4-Inhibitor,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
7444,Oltipraz,3A4-Inhibitor,CC1=C(SSC1=S)C2=NC=CN=C2
7445,Onapristone,3A4-Inhibitor,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C
7446,Orphenadrine,3A4-Inhibitor,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
7447,Oxiconazole,3A4-Inhibitor,ClC1=CC(Cl)=C(CON=C(/CN2C=CN=C2)C3=C(Cl)C=C(Cl)C=C3)C=C1
7448,Papaverine,3A4-Inhibitor,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
7449,Parathion,3A4-Inhibitor,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
7450,Perphenazine,3A4-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
7451,Phencyclidine,3A4-Inhibitor,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
7452,Pilsicainide,3A4-Inhibitor,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
7453,Piroxicam,3A4-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
7454,Proadifen,3A4-Inhibitor,CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OCCN(CC)CC
7455,Quercetin,3A4-Inhibitor,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
7456,Quinelorane,3A4-Inhibitor,CCCN1CCCC2C1CC3=CN=C(N=C3C2)N
7457,Quinine,3A4-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
7458,Quinupristin,3A4-Inhibitor,CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CC(C(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CSC6CN7CCC6CC7)CC8=CC=C(C=C8)N(C)C)C
7459,Reboxetine,3A4-Inhibitor,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3
7460,Remacemide,3A4-Inhibitor,CC(CC1=CC=CC=C1)(C2=CC=CC=C2)NC(=O)CN
7461,Reserpine,3A4-Inhibitor,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
7462,Rosiglitazone,3A4-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
7463,Selegiline,3A4-Inhibitor,C[C@H](CC1=CC=CC=C1)N(C)CC#C
7464,Seratrodast,3A4-Inhibitor,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
7465,Sertindole,3A4-Inhibitor,FC1=CC=C(C=C1)N2C=C([C@@H]3CCN(CC3)CCN4CCNC4=O)C5=CC(Cl)=CC=C25
7466,Spironolactone,3A4-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
7467,Sulfaphenazole,3A4-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
7468,Sulfinpyrazone,3A4-Inhibitor,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
7469,Sulpiride,3A4-Inhibitor,CCN1CCC[C@H]1CNC(=O)C2=C(OC)C=CC(=C2)S(N)(=O)=O
7470,Tazanolast,3A4-Inhibitor,CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C2=NNN=N2
7471,Tecastemizole,3A4-Inhibitor,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
7472,Tegaserod,3A4-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
7473,Theophylline,3A4-Inhibitor,CN1C(=O)N(C)C2=C(NC=N2)C1=O
7474,Ticlopidine,3A4-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7475,Timoprazole,3A4-Inhibitor,C1=CC=C2C(=C1)NC(=N2)S(=O)CC3=CC=CC=N3
7476,Trimethoprim,3A4-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
7477,Valdecoxib,3A4-Inhibitor,CC1=C(C2=CC=C(C=C2)S(N)(=O)=O)C(=NO1)C3=CC=CC=C3
7478,Valproic acid,3A4-Inhibitor,CCCC(CCC)C(=O)O
7479,Valspodar,3A4-Inhibitor,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
7480,Vindesine,3A4-Inhibitor,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1
7481,Zaltoprofen,3A4-Inhibitor,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
7482,Zileuton,3A4-Inhibitor,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
7483,Zolpidem,3A4-Inhibitor,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
7484,Aranidipine,3A4-Inhibitor,CC1=C(C(C(=C(N1)C)C(=O)OCC(=O)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
7485,Corticosterone,3A4-Inhibitor,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
7486,Domperidone,3A4-Inhibitor,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
7487,Glipizide,3A4-Inhibitor,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
7488,Lilopristone,3A4-Inhibitor,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C
7489,Norfluoxetine,3A4-Inhibitor,C1=CC=C(C=C1)C(CCN)OC2=CC=C(C=C2)C(F)(F)F
7490,Pantoprazole,3A4-Inhibitor,COC1=C(OC)C(CS(=O)C2=NC3=CC(OC(F)F)=CC=C3N2)=NC=C1
7491,Pioglitazone,3A4-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
7492,Prednisolone,3A4-Inhibitor,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
7493,Stiripentol,3A4-Inhibitor,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O
7494,Sulfamethizole,3A4-Inhibitor,CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1
7495,Ondansetron,-,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
7496,Acenocoumarol,3A4-Substrate,CC(=O)C[C@H](C1=CC=C(C=C1)[N+]([O-])=O)C2=C(O)C3=C(OC2=O)C=CC=C3
7497,Alpidem,3A4-Substrate,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl
7498,Aminopyrine,3A4-Substrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C
7499,Amoxapine,3A4-Substrate,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
7500,Anastrozole,3A4-Substrate,CC(C)(C#N)C1=CC(CN2C=NC=N2)=CC(=C1)C(C)(C)C#N
7501,Apomorphine,3A4-Substrate,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(O)=C(O)C=C4
7502,Atomoxetine,3A4-Substrate,CNCC[C@@H](OC1=CC=CC=C1C)C2=CC=CC=C2
7503,Avitriptan,3A4-Substrate,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCCN3CCN(CC3)C4=NC=NC=C4OC
7504,Azimilide,3A4-Substrate,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl
7505,Benzfetamine,3A4-Substrate,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
7506,Bepridil,3A4-Substrate,CC(C)COC[C@H](CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
7507,Boldenone,3A4-Substrate,CC12CCC3C(C1CCC2O)CCC4=CC(=O)C=CC34C
7508,Bufuralol,3A4-Substrate,CCC1=CC=CC2=C1OC(=C2)C(CNC(C)(C)C)O
7509,Carbaril,3A4-Substrate,CNC(=O)OC1=CC=CC2=CC=CC=C21
7510,Chlorpyrifos,3A4-Substrate,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl
7511,Cimetidine,3A4-Substrate,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
7512,Clofibric acid,3A4-Substrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl
7513,Clotrimazole,3A4-Substrate,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
7514,Cortisol,3A4-Substrate,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O
7515,Cyproterone,3A4-Substrate,CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C
7516,Diethylstilbestrol,3A4-Substrate,CCC(C1=CC=C(O)C=C1)=C(CC)C2=CC=C(O)C=C2
7517,Dronabinol,3A4-Substrate,CCCCCC1=CC2=C([C@@H]3C=C(C)CC[C@H]3C(C)(C)O2)C(O)=C1
7518,Drospirenone,3A4-Substrate,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C
7519,Ecabapide,3A4-Substrate,CNC(=O)C1=CC(=CC=C1)NCC(=O)NCCC2=CC(=C(C=C2)OC)OC
7520,Emedastine,3A4-Substrate,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C
7521,Emivirine,3A4-Substrate,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2
7522,Ezlopitant,3A4-Substrate,CC(C)C1=CC(=C(C=C1)OC)CNC2C3CCN(C2C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
7523,Flucloxacillin,3A4-Substrate,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C4=C(Cl)C=CC=C4F
7524,Ganaxolone,3A4-Substrate,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C
7525,Gestodene,3A4-Substrate,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34
7526,Glyceryl trinitrate,3A4-Substrate,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
7527,Iloperidone,3A4-Substrate,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
7528,Isosorbide dinitrate,3A4-Substrate,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-]
7529,Leflunomide,3A4-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
7530,Levothyroxine sodium,3A4-Substrate,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.[Na+]
7531,Lidocaine,3A4-Substrate,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
7532,Lilopristone,3A4-Substrate,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(C=CCO)O)C5=CC=C(C=C5)N(C)C
7533,Lisofylline,3A4-Substrate,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O
7534,Lumefantrine,3A4-Substrate,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O
7535,Methiocarb,3A4-Substrate,CC1=CC(=CC(=C1SC)C)OC(=O)NC
7536,Methylphenidate,3A4-Substrate,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
7537,Metoclopramide,3A4-Substrate,CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Cl)=C1
7538,Mexazolam,3A4-Substrate,CC1COC2(N1CC(=O)NC3=C2C=C(C=C3)Cl)C4=CC=CC=C4Cl
7539,Mizolastine,3A4-Substrate,CN([C@H]1CCN(CC1)C2=NC3=C(C=CC=C3)N2CC4=CC=C(F)C=C4)C5=NC=CC(=O)N5
7540,Montelukast,3A4-Substrate,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
7541,Mosapride,3A4-Substrate,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
7542,Nefiracetam,3A4-Substrate,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O
7543,Niludipine,3A4-Substrate,CCCOCCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOCCC)C)C
7544,Nilvadipine,3A4-Substrate,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
7545,Orphenadrine,3A4-Substrate,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
7546,Oxodipine,3A4-Substrate,CCOC(=O)C1=C(NC(=C(C1C2=C3C(=CC=C2)OCO3)C(=O)OC)C)C
7547,Parathion,3A4-Substrate,CCOP(=S)(OCC)OC1=CC=C(C=C1)[N+](=O)[O-]
7548,Phencyclidine,3A4-Substrate,C1CCC(CC1)(C2=CC=CC=C2)N3CCCCC3
7549,Pimobendan,3A4-Substrate,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC
7550,Pranidipine,3A4-Substrate,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
7551,Pregnenolone,3A4-Substrate,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C
7552,Quercetin,3A4-Substrate,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O
7553,Quinine,3A4-Substrate,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O
7554,Rebamipide,3A4-Substrate,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
7555,Resiquimod,3A4-Substrate,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N
7556,Salicylic acid,3A4-Substrate,C1=CC=C(C(=C1)C(=O)O)O
7557,Sulfinpyrazone,3A4-Substrate,C1=CC=C(C=C1)N2C(=O)C(C(=O)N2C3=CC=CC=C3)CCS(=O)C4=CC=CC=C4
7558,Tauromustine,3A4-Substrate,CN(C)S(=O)(=O)CCNC(=O)N(CCCl)N=O
7559,Tazofelone,3A4-Substrate,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CC2C(=O)NCS2
7560,Tecastemizole,3A4-Substrate,C1CNCCC1NC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F
7561,Terguride,3A4-Substrate,CCN(CC)C(=O)NC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C
7562,Tipranavir,3A4-Substrate,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4
7563,Tolcapone,3A4-Substrate,CC1=CC=C(C=C1)C(=O)C2=CC(=C(O)C(O)=C2)[N+]([O-])=O
7564,Tretinoin,3A4-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
7565,Trimetrexate,3A4-Substrate,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC
7566,Valspodar,3A4-Substrate,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C
7567,Zatosetron,3A4-Substrate,CC1(CC2=C(O1)C(=CC(=C2)Cl)C(=O)NC3CC4CCC(C3)N4C)C
7568,Zileuton,3A4-Substrate,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
7569,Chenodeoxycholic acid,3A4-Substrate,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C
7570,Corticosterone,3A4-Substrate,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4C(=O)CO)C)O
7571,Dextrorphan,3A4-Substrate,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
7572,Dipotassium clorazepate,3A4-Substrate,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O.[OH-].[K+].[K+]
7573,Ergometrine,3A4-Substrate,C[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CNC4=CC=CC(C2=C1)=C34
7574,Manidipine,3A4-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN3CCN(CC3)C(C4=CC=CC=C4)C5=CC=CC=C5
7575,Onapristone,3A4-Substrate,CC12CC(C3=C4CCC(=O)C=C4CCC3C1CCC2(CCCO)O)C5=CC=C(C=C5)N(C)C
7576,Perospirone,3A4-Substrate,C1CCC2C(C1)C(=O)N(C2=O)CCCCN3CCN(CC3)C4=NSC5=CC=CC=C54
7577,Ranolazine,3A4-Substrate,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
7578,Vanoxerine,3A4-Substrate,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
7579,Vesnarinone,3A4-Substrate,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC
7580,Yohimbine,3A4-Substrate,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O
7581,Acetylsalicylic Acid,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)OC1=C(C=CC=C1)C(O)=O
7582,Aminophenazone,S_mephenytoin_4_hydroxylase-Substrate,CN(C)C1=C(C)N(C)N(C2=CC=CC=C2)C1=O
7583,Amiodarone,S_mephenytoin_4_hydroxylase-Substrate,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
7584,Amitriptyline,S_mephenytoin_4_hydroxylase-Inhibitor,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
7585,Amitriptyline,S_mephenytoin_4_hydroxylase-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
7586,Amlodipine,S_mephenytoin_4_hydroxylase-Inhibitor,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
7587,Amodiaquine,S_mephenytoin_4_hydroxylase-Substrate,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
7588,Amprenavir,S_mephenytoin_4_hydroxylase-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
7589,Atorvastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
7590,Bezafibrate,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
7591,Bortezomib,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=CN=CC=N2)B(O)O
7592,Brompheniramine,S_mephenytoin_4_hydroxylase-Substrate,CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C2=CC=CC=N2
7593,Buprenorphine,S_mephenytoin_4_hydroxylase-Substrate,CO[C@@]12CC[C@]3(C[C@H]1[C@](C)(O)C(C)(C)C)[C@@H]4CC5=CC=C(O)C6=C5[C@]3(CCN4C[C@@H]7CC7)[C@@H]2O6
7594,Bupropion,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1
7595,Caffeine,S_mephenytoin_4_hydroxylase-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
7596,Capsaicin,S_mephenytoin_4_hydroxylase-Substrate,COC1=C(O)C=CC(CNC(=O)CCCCC=CC(C)C)=C1
7597,Carbamazepine,S_mephenytoin_4_hydroxylase-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
7598,Carbamazepine,S_mephenytoin_4_hydroxylase-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
7599,Carbinoxamine,S_mephenytoin_4_hydroxylase-Substrate,CN(C)CCO[C@@H](C1=CC=C(Cl)C=C1)C2=NC=CC=C2
7600,Cefaloridine,S_mephenytoin_4_hydroxylase-Substrate,[O-]C(=O)C1=C(CS[C@@H]2[C@H](NC(=O)CC3=CC=CS3)C(=O)N12)C[N+]4=CC=CC=C4
7601,Cerivastatin,S_mephenytoin_4_hydroxylase-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
7602,Cerivastatin,S_mephenytoin_4_hydroxylase-Inhibitor,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
7603,Chinin,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
7604,Chloramphenicol,S_mephenytoin_4_hydroxylase-Inhibitor,OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C(C=C1)[N+]([O-])=O
7605,Chloroquine,S_mephenytoin_4_hydroxylase-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
7606,Ciclosporin,S_mephenytoin_4_hydroxylase-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
7607,Cimetidine,S_mephenytoin_4_hydroxylase-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
7608,Cisapride,S_mephenytoin_4_hydroxylase-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
7609,Clopidogrel,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
7610,Clotrimazole,S_mephenytoin_4_hydroxylase-Inhibitor,ClC1=C(C=CC=C1)C(N2C=CN=C2)(C3=CC=CC=C3)C4=CC=CC=C4
7611,Clozapine,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN(CC1)C2=NC3=C(NC4=C2C=CC=C4)C=CC(Cl)=C3
7612,Cocaine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
7613,Colchicine,S_mephenytoin_4_hydroxylase-Inducer,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
7614,Colchicine,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC=C2C(=CC1=O)[C@H](CCC3=CC(OC)=C(OC)C(OC)=C23)NC(C)=O
7615,Colecalciferol,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
7616,Cyamemazine,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](CN(C)C)CN1C2=C(SC3=C1C=C(C=C3)C#N)C=CC=C2
7617,Cyclophosphamide,S_mephenytoin_4_hydroxylase-Inducer,ClCCN(CCCl)[P@]1(=O)NCCCO1
7618,Cyclophosphamide,S_mephenytoin_4_hydroxylase-Substrate,ClCCN(CCCl)[P@]1(=O)NCCCO1
7619,Dapsone,S_mephenytoin_4_hydroxylase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
7620,Delavirdine,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)NC1=CC=CN=C1N2CCN(CC2)C(=O)C3=CC4=CC(NS(C)(=O)=O)=CC=C4N3
7621,Dexamethasone,S_mephenytoin_4_hydroxylase-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
7622,Dexmedetomidine,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H](C1=CNC=N1)C1=C(C)C(C)=CC=C1
7623,Dextromethorphan,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
7624,Dextropropoxyphene,S_mephenytoin_4_hydroxylase-Inhibitor,CCC(=O)O[C@@](CC1=CC=CC=C1)([C@H](C)CN(C)C)C1=CC=CC=C1
7625,Diazepam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
7626,Diclofenac,S_mephenytoin_4_hydroxylase-Substrate,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
7627,Diclofenac,S_mephenytoin_4_hydroxylase-Inhibitor,OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl
7628,Diltiazem,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
7629,Diltiazem,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
7630,Disulfiram,S_mephenytoin_4_hydroxylase-Inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC
7631,Dolasetron,S_mephenytoin_4_hydroxylase-Substrate,O=C1CN2[C@@H]3C[C@H](C[C@H]2C[C@H]1C3)OC(=O)C4=CNC5=CC=CC=C45
7632,Domperidone,S_mephenytoin_4_hydroxylase-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
7633,Dorzolamide,S_mephenytoin_4_hydroxylase-Substrate,CCN[C@@H]1C[C@@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O
7634,Efavirenz,S_mephenytoin_4_hydroxylase-Inhibitor,FC(F)(F)[C@]1(OC(=O)NC2=CC=C(Cl)C=C12)C#C[C@H]3CC3
7635,Entacapone,S_mephenytoin_4_hydroxylase-Inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(O)C(O)=C1)[N+]([O-])=O)C#N
7636,Eprosartan,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCC1=NC=C(C=C(/CC2=CC=CS2)C(O)=O)N1CC3=CC=C(C=C3)C(O)=O
7637,Estradiol,S_mephenytoin_4_hydroxylase-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
7638,Etoposide,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
7639,Felodipine,S_mephenytoin_4_hydroxylase-Inhibitor,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
7640,Fenofibrate,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
7641,Fluconazole,S_mephenytoin_4_hydroxylase-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
7642,Fluorouracil,S_mephenytoin_4_hydroxylase-Substrate,FC1=CNC(=O)NC1=O
7643,Fluoxetine,S_mephenytoin_4_hydroxylase-Inhibitor,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
7644,Fluoxetine,S_mephenytoin_4_hydroxylase-Substrate,CNCC[C@@H](OC1=CC=C(C=C1)C(F)(F)F)C2=CC=CC=C2
7645,Fluphenazine,S_mephenytoin_4_hydroxylase-Inhibitor,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(C=C4)C(F)(F)F)C=CC=C3)CC1
7646,Flurbiprofen,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
7647,Flurbiprofen,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](C(O)=O)C1=CC=C(C(F)=C1)C2=CC=CC=C2
7648,Fluvastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
7649,Fluvastatin,S_mephenytoin_4_hydroxylase-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
7650,Fluvoxamine,S_mephenytoin_4_hydroxylase-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
7651,Formoterol,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC=C(C[C@H](C)NC[C@@H](O)C2=CC=C(O)C(NC=O)=C2)C=C1
7652,Fosamprenavir,S_mephenytoin_4_hydroxylase-Substrate,CC(C)CN(C[C@@H](OP(O)(O)=O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
7653,Fosphenytoin,S_mephenytoin_4_hydroxylase-Inhibitor,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
7654,Fosphenytoin,S_mephenytoin_4_hydroxylase-Substrate,OP(O)(=O)OCN1C(=O)N[C@](C1=O)(C2=CC=CC=C2)C3=CC=CC=C3
7655,Gemfibrozil,S_mephenytoin_4_hydroxylase-Inducer,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
7656,Gemfibrozil,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
7657,Glimepiride,S_mephenytoin_4_hydroxylase-Substrate,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@@H]3CC[C@@H](C)CC3)C1=O
7658,Glipizide,S_mephenytoin_4_hydroxylase-Substrate,CC1=CC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]3CCCCC3
7659,Griseofulvin,S_mephenytoin_4_hydroxylase-Inducer,COC1=CC(OC)=C2C(=O)[C@]3(OC2=C1Cl)[C@H](C)CC(=O)C=C3OC
7660,Halofantrine,S_mephenytoin_4_hydroxylase-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
7661,Halothane,S_mephenytoin_4_hydroxylase-Substrate,FC(F)(F)[C@@H](Cl)Br
7662,Hydrocortisone,S_mephenytoin_4_hydroxylase-Inducer,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
7663,Ibuprofen,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
7664,Ibuprofen,S_mephenytoin_4_hydroxylase-Substrate,CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O
7665,Ifosfamide,S_mephenytoin_4_hydroxylase-Inducer,ClCCN[P@@]1(=O)OCCCN1CCCl
7666,Ifosfamide,S_mephenytoin_4_hydroxylase-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
7667,Imatinib,S_mephenytoin_4_hydroxylase-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
7668,Imatinib,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
7669,Indinavir,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
7670,Indometacin,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
7671,Indometacin,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C=C1)N(C(C)=C2CC(O)=O)C(=O)C3=CC=C(Cl)C=C3
7672,Ipriflavone,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C3=CC=CC=C3
7673,Irbesartan,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
7674,Irbesartan,S_mephenytoin_4_hydroxylase-Substrate,CCCCC1=N[C@@]2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C5=NN=NN5
7675,Isoniazid,S_mephenytoin_4_hydroxylase-Inhibitor,NNC(=O)C1=CC=NC=C1
7676,Ketamine,S_mephenytoin_4_hydroxylase-Substrate,CN[C@]1(CCCCC1=O)C2=C(Cl)C=CC=C2
7677,Ketobemidone,S_mephenytoin_4_hydroxylase-Substrate,CCC(=O)[C@@]1(CCN(C)CC1)C2=CC(O)=CC=C2
7678,Ketoconazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
7679,Ketoprofen,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H](C(O)=O)C1=CC(=CC=C1)C(=O)C2=CC=CC=C2
7680,Lansoprazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
7681,Lansoprazole,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F
7682,Leflunomide,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
7683,Leflunomide,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
7684,Lidocain,S_mephenytoin_4_hydroxylase-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
7685,Loperamide,S_mephenytoin_4_hydroxylase-Substrate,CN(C)C(=O)C(CCN1CC[C@@](O)(CC1)C2=CC=C(Cl)C=C2)(C3=CC=CC=C3)C4=CC=CC=C4
7686,Loratadine,S_mephenytoin_4_hydroxylase-Inhibitor,CCOC(=O)N1CCC(CC1)=C2/C3=C(CCC4=C2N=CC=C4)C=C(Cl)C=C3
7687,Losartan,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
7688,Losartan,S_mephenytoin_4_hydroxylase-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
7689,Lovastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
7690,Medroxyprogesterone,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14
7691,Mefenamic Acid,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
7692,Mefenamic Acid,S_mephenytoin_4_hydroxylase-Substrate,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C
7693,Meloxicam,S_mephenytoin_4_hydroxylase-Inhibitor,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
7694,Meloxicam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C3=CC=CC=C3S1(=O)=O
7695,Mephenytoin,S_mephenytoin_4_hydroxylase-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
7696,Methadone,S_mephenytoin_4_hydroxylase-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
7697,Metronidazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=NC=C(N1CCO)[N+]([O-])=O
7698,Mirtazapine,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN2[C@H](C1)C3=C(CC4=C2N=CC=C4)C=CC=C3
7699,Mometasone,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CCl
7700,Montelukast,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(O)C1=C(CC[C@@H](SC[C@]2(CC2)CC(O)=O)C3=CC(=CC=C3)C=CC4=NC5=CC(Cl)=CC=C5C=C4)C=CC=C1
7701,Morphine,S_mephenytoin_4_hydroxylase-Substrate,CN1CC[C@@]23[C@H]4OC5=C2C(C[C@@H]1[C@@H]3C=C[C@@H]4O)=CC=C5O
7702,Naloxone,S_mephenytoin_4_hydroxylase-Substrate,OC1=CC=C2C[C@H]3N(CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O)CC=C
7703,Naproxen,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O
7704,Nicardipine,S_mephenytoin_4_hydroxylase-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
7705,Nicardipine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
7706,Nicotine,S_mephenytoin_4_hydroxylase-Substrate,CN1CCC[C@H]1C2=CC=CN=C2
7707,Nifedipine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
7708,Nilutamide,S_mephenytoin_4_hydroxylase-Inhibitor,CC1(C)NC(=O)N(C2=CC(=C(C=C2)[N+]([O-])=O)C(F)(F)F)C1=O
7709,Nilvadipine,S_mephenytoin_4_hydroxylase-Inhibitor,COC(=O)C1=C(NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C)C#N
7710,Omeprazole,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
7711,Oxybutynin,S_mephenytoin_4_hydroxylase-Inhibitor,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
7712,Paclitaxel,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
7713,Paracetamol,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)NC1=CC=C(O)C=C1
7714,Paraoxon,S_mephenytoin_4_hydroxylase-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
7715,Paroxetine,S_mephenytoin_4_hydroxylase-Inhibitor,FC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(OCO4)C=C3
7716,Pentamidine Isethionate,S_mephenytoin_4_hydroxylase-Substrate,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
7717,Perphenazine,S_mephenytoin_4_hydroxylase-Substrate,OCCN1CCN(CCCN2C3=C(SC4=C2C=C(Cl)C=C4)C=CC=C3)CC1
7718,Phenazone,S_mephenytoin_4_hydroxylase-Substrate,CN1N(C(=O)C=C1C)C2=CC=CC=C2
7719,Phenelzine,S_mephenytoin_4_hydroxylase-Inhibitor,NNCCC1=CC=CC=C1
7720,Phenobarbital,S_mephenytoin_4_hydroxylase-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
7721,Phenobarbital,S_mephenytoin_4_hydroxylase-Substrate,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
7722,Phenprocoumon,S_mephenytoin_4_hydroxylase-Substrate,CC[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
7723,Phenytoin,S_mephenytoin_4_hydroxylase-Substrate,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
7724,Phenytoin,S_mephenytoin_4_hydroxylase-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
7725,Pioglitazone,S_mephenytoin_4_hydroxylase-Substrate,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
7726,Pioglitazone,S_mephenytoin_4_hydroxylase-Inhibitor,CCC1=CC=C(CCOC2=CC=C(C[C@@H]3SC(=O)NC3=O)C=C2)N=C1
7727,Piroxicam,S_mephenytoin_4_hydroxylase-Inhibitor,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
7728,Piroxicam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C3=C(C=CC=C3)S1(=O)=O
7729,Pravastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
7730,Primidone,S_mephenytoin_4_hydroxylase-Inducer,CC[C@@]1(C(=O)NCNC1=O)C2=CC=CC=C2
7731,Probenecid,S_mephenytoin_4_hydroxylase-Inducer,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
7732,Progesterone,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
7733,Propafenone,S_mephenytoin_4_hydroxylase-Inhibitor,CCCNC[C@@H](O)COC1=C(C=CC=C1)C(=O)CCC2=CC=CC=C2
7734,Propofol,S_mephenytoin_4_hydroxylase-Substrate,CC(C)C1=CC=CC(C(C)C)=C1O
7735,Pyrimethamine,S_mephenytoin_4_hydroxylase-Inhibitor,CCC1=C(C(N)=NC(N)=N1)C2=CC=C(Cl)C=C2
7736,Quinidine,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C
7737,Raloxifene,S_mephenytoin_4_hydroxylase-Inhibitor,OC1=CC=C(C=C1)C2=C(C(=O)C3=CC=C(OCCN4CCCCC4)C=C3)C5=CC=C(O)C=C5S2
7738,Repaglinide,S_mephenytoin_4_hydroxylase-Substrate,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N3CCCCC3)=C1)C(O)=O
7739,Retinol (vit A),S_mephenytoin_4_hydroxylase-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
7740,Retinol (vit A),S_mephenytoin_4_hydroxylase-Substrate,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
7741,Rifampicin,S_mephenytoin_4_hydroxylase-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7742,Rifampicin,S_mephenytoin_4_hydroxylase-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7743,Rifampicin,S_mephenytoin_4_hydroxylase-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7744,Rifapentine,S_mephenytoin_4_hydroxylase-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
7745,Ritonavir,S_mephenytoin_4_hydroxylase-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
7746,Ritonavir,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
7747,Rofecoxib,S_mephenytoin_4_hydroxylase-Substrate,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
7748,Rosiglitazone,S_mephenytoin_4_hydroxylase-Inhibitor,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
7749,Rosiglitazone,S_mephenytoin_4_hydroxylase-Substrate,CN(CCOC1=CC=C(C[C@@H]2SC(=O)NC2=O)C=C1)C3=NC=CC=C3
7750,Rutoside,S_mephenytoin_4_hydroxylase-Inhibitor,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(OC4=CC(O)=CC(O)=C4C3=O)C5=CC(O)=C(O)C=C5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
7751,Salmeterol,S_mephenytoin_4_hydroxylase-Inhibitor,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
7752,Saquinavir,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
7753,Secobarbital,S_mephenytoin_4_hydroxylase-Inducer,CCC[C@@H](C)[C@]1(CC=C)C(=O)NC(=O)NC1=O
7754,Selegiline,S_mephenytoin_4_hydroxylase-Substrate,C[C@H](CC1=CC=CC=C1)N(C)CC#C
7755,Seratrodast,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C)C(=O)C([C@H](CCCCCC(O)=O)C2=CC=CC=C2)=C(C)C1=O
7756,Simvastatin,S_mephenytoin_4_hydroxylase-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
7757,Simvastatin,S_mephenytoin_4_hydroxylase-Inhibitor,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
7758,Ezetimibe,S_mephenytoin_4_hydroxylase-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
7759,Spironolactone,S_mephenytoin_4_hydroxylase-Inhibitor,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
7760,Sulfadiazine,S_mephenytoin_4_hydroxylase-Substrate,NC1=CC=C(C=C1)S(=O)(=O)NC2=NC=CC=N2
7761,Sulfafurazole,S_mephenytoin_4_hydroxylase-Substrate,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
7762,Sulfafurazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C
7763,Sulfamethoxazole,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1
7764,Sulfaphenazole,S_mephenytoin_4_hydroxylase-Inhibitor,NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=NN2C3=CC=CC=C3
7765,Sulfinpyrazon,S_mephenytoin_4_hydroxylase-Substrate,O=C1[C@H](CCS(=O)C2=CC=CC=C2)C(=O)N(N1C3=CC=CC=C3)C4=CC=CC=C4
7766,Tamoxifen,S_mephenytoin_4_hydroxylase-Inhibitor,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
7767,Tazarotene,S_mephenytoin_4_hydroxylase-Substrate,CCOC(=O)C1=CC=C(N=C1)C#CC2=CC3=C(SCCC3(C)C)C=C2
7768,Tegafur,S_mephenytoin_4_hydroxylase-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
7769,Tegaserod,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCCNC(=N)NN=CC1=CNC2=C1C=C(CO)C=C2
7770,Temazepam,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)[C@H](O)N=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
7771,Terbinafine,S_mephenytoin_4_hydroxylase-Substrate,CN(CC=CC#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1
7772,Terfenadine,S_mephenytoin_4_hydroxylase-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
7773,Testosterone,S_mephenytoin_4_hydroxylase-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
7774,Tetrabenazine,S_mephenytoin_4_hydroxylase-Inducer,COC1=CC2=C(C=C1OC)[C@@H]3CC(=O)[C@@H](CC(C)C)CN3CC2
7775,Thalidomide,S_mephenytoin_4_hydroxylase-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
7776,Theophylline,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)N(C)C2=C(NC=N2)C1=O
7777,Thioridazine,S_mephenytoin_4_hydroxylase-Inhibitor,CSC1=CC2=C(SC3=C(C=CC=C3)N2CC[C@@H]4CCCCN4C)C=C1
7778,Ticlopidine,S_mephenytoin_4_hydroxylase-Inhibitor,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1
7779,Tioconazole,S_mephenytoin_4_hydroxylase-Inhibitor,ClC1=CC(Cl)=C(C=C1)[C@@H](CN2C=CN=C2)OCC3=C(Cl)SC=C3
7780,Tolbutamide,S_mephenytoin_4_hydroxylase-Substrate,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
7781,Tolbutamide,S_mephenytoin_4_hydroxylase-Inhibitor,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1
7782,Torasemide,S_mephenytoin_4_hydroxylase-Substrate,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC(C)=CC=C2)C=CN=C1
7783,Tretinoin,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
7784,Tretinoin,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C=CC(C)=CC=CC(C)=CC(O)=O)C(C)(C)CCC1
7785,Triazolam,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
7786,Trimethadione,S_mephenytoin_4_hydroxylase-Substrate,CN1C(=O)OC(C)(C)C1=O
7787,Trimethoprim,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
7788,Trimethoprim,S_mephenytoin_4_hydroxylase-Substrate,COC1=CC(CC2=C(N)N=C(N)N=C2)=CC(OC)=C1OC
7789,Troglitazone,S_mephenytoin_4_hydroxylase-Substrate,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
7790,Troglitazone,S_mephenytoin_4_hydroxylase-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
7791,Troleandomycin,S_mephenytoin_4_hydroxylase-Inhibitor,CO[C@H]1C[C@@H](O[C@@H](C)[C@@H]1OC(C)=O)O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(C)=O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C
7792,Valproic Acid,S_mephenytoin_4_hydroxylase-Inhibitor,CCCC(CCC)C(O)=O
7793,Verapamil,S_mephenytoin_4_hydroxylase-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
7794,Warfarin,S_mephenytoin_4_hydroxylase-Inhibitor,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
7795,Warfarin,S_mephenytoin_4_hydroxylase-Substrate,CC(=O)C[C@H](C1=CC=CC=C1)C2=C(O)C3=C(OC2=O)C=CC=C3
7796,Zafirlukast,S_mephenytoin_4_hydroxylase-Inhibitor,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
7797,Zafirlukast,S_mephenytoin_4_hydroxylase-Substrate,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)O[C@H]4CCCC4)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C5=CC=CC=C5C
7798,Zidovudine,S_mephenytoin_4_hydroxylase-Substrate,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O
7799,Zopiclone,S_mephenytoin_4_hydroxylase-Substrate,CN1CCN(CC1)C(=O)O[C@H]2N(C(=O)C3=NC=CN=C23)C4=CC=C(Cl)C=N4
7800,Acebutolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCC(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)C)C=C1
7801,Carbamide,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,NC(N)=O
7802,Celiprolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCN(CC)C(=O)NC1=CC(C(C)=O)=C(OC[C@@H](O)CNC(C)(C)C)C=C1
7803,Ciclosporin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
7804,Clarithromycin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
7805,Enalapril,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O
7806,Estradiol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
7807,Estrone,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
7808,Fexofenadine,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)(C(O)=O)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
7809,Fluvastatin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)N1C2=C(C=CC=C2)C(C3=CC=C(F)C=C3)=C1C=C[C@H](O)C[C@H](O)CC(O)=O
7810,G-strophanthin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
7811,Imatinib,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
7812,Levofloxacin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N4CCN(C)CC4
7813,Methotrexate,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
7814,Mifepristone,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
7815,Pravastatin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
7816,Probenecid,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
7817,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7818,Rifampicin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7819,Rifamycin,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CO[C@H]1C=CO[C@]2(C)OC3=C(C2=O)C4=C(O)C=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7820,Ritonavir,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
7821,Rosuvastatin,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
7822,Saquinavir,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
7823,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
7824,Sulfobromophthalein,Solute_carrier_organic_anion_transporter_family_member_1A2-Inhibitor,OC1=C(C=C(C=C1)[C@@]2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O)S(O)(=O)=O
7825,Talinolol,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CC(C)(C)NC[C@@H](O)COC1=CC=C(NC(=O)N[C@@H]2CCCCC2)C=C1
7826,Telmisartan,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCC1=NC2=C(C)C=C(C=C2N1CC3=CC=C(C=C3)C4=C(C=CC=C4)C(O)=O)C5=NC6=CC=CC=C6N5C
7827,Unoproston,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCCCCCC(=O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=C/CCCC(O)=O
7828,Valsartan,Solute_carrier_organic_anion_transporter_family_member_1A2-Substrate,CCCCC(=O)N(CC1=CC=C(C=C1)C2=C(C=CC=C2)C3=NN=NN3)[C@@H](C(C)C)C(O)=O
7829,Fluorouracil,ATP_binding_cassette_transporter_sub_family_C_member_11-Inducer,FC1=CNC(=O)NC1=O
7830,Methotrexate,ATP_binding_cassette_transporter_sub_family_C_member_11-Substrate,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
7831,Methotrexate,ATP_binding_cassette_transporter_sub_family_C_member_11-Inducer,CN(CC1=NC2=C(N=C1)N=C(N)N=C2N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O
7832,Prasterone,ATP_binding_cassette_transporter_sub_family_C_member_11-Substrate,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O
7833,Aldosterone,3A5-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O
7834,Alfentanil,3A5-Substrate,CCN1N=NN(CCN2CC[C@](CC2)(COC)N(C(=O)CC)C3=CC=CC=C3)C1=O
7835,Alprazolam,3A5-Substrate,CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
7836,Amiodarone,3A5-Inhibitor,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=CC=CC=C3O1
7837,Amitriptyline,3A5-Substrate,CN(C)CCC=C1/C2=C(CCC3=C1C=CC=C3)C=CC=C2
7838,Amlodipine,3A5-Substrate,CCOC(=O)C1=C(COCCN)NC(C)=C([C@H]1C2=C(Cl)C=CC=C2)C(=O)OC
7839,Amprenavir,3A5-Substrate,CC(C)CN(C[C@@H](O)[C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)C3=CC=C(N)C=C3
7840,Aprepitant,3A5-Substrate,C[C@@H](O[C@@H]1OCCN(CC2=NC(=O)NN2)[C@@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
7841,Argatroban,3A5-Substrate,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C2=C3NC[C@@H](C)CC3=CC=C2
7842,Aripiprazole,3A5-Substrate,ClC1=C(Cl)C(=CC=C1)N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2
7843,Astemizole,3A5-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
7844,Atazanavir,3A5-Inhibitor,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
7845,Atazanavir,3A5-Substrate,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C
7846,Atorvastatin,3A5-Substrate,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C3=CC=CC=C3)=C(N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C4=CC=C(F)C=C4
7847,Aztreonam,3A5-Substrate,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O
7848,Beclometasone,3A5-Inducer,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
7849,Buspirone,3A5-Substrate,O=C1C[C@]2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)C4=NC=CC=N4
7850,Caffeine,3A5-Substrate,CN1C=NC2=C1C(=O)N(C)C(=O)N2C
7851,Carbamazepine,3A5-Inducer,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
7852,Carbamazepine,3A5-Substrate,NC(=O)N1C2=C(C=CC=C2)C=CC3=C1C=CC=C3
7853,Cerivastatin,3A5-Substrate,COCC1=C(C2=CC=C(F)C=C2)C(C=C[C@@H](O)C[C@@H](O)CC(O)=O)=C(N=C1C(C)C)C(C)C
7854,Chinin,3A5-Substrate,COC1=CC2=C(C=CN=C2C=C1)[C@@H](O)[C@@H]3C[C@@H]4CCN3C[C@@H]4C=C
7855,Chloroquine,3A5-Substrate,CCN(CC)CCC[C@@H](C)NC1=CC=NC2=C1C=CC(Cl)=C2
7856,Chlorphenamine,3A5-Substrate,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C2=CC=CC=N2
7857,Chlorpromazine,3A5-Inducer,CN(C)CCCN1C2=C(SC3=C1C=C(Cl)C=C3)C=CC=C2
7858,Ciclosporin,3A5-Substrate,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
7859,Ciclosporin,3A5-Inhibitor,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
7860,Ciclosporin,3A5-Inducer,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)CC=CC)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@@H](CC(C)C)NC(=O)CN(C)C1=O)C(C)C
7861,Cimetidine,3A5-Inhibitor,CNC(NCCSCC1=C(C)NC=N1)=N/C#N
7862,Cisapride,3A5-Substrate,CO[C@@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C3=C(OC)C=C(N)C(Cl)=C3
7863,Clarithromycin,3A5-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2C[C@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
7864,Clopidogrel,3A5-Substrate,COC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=C(Cl)C=CC=C3
7865,Cocaine,3A5-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
7866,Cocaine,3A5-Substrate,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
7867,Codeine,3A5-Substrate,COC1=CC=C2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5OC1=C2[C@]45CCN3C
7868,Cortisone,3A5-Substrate,C[C@]12CC[C@@H](O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23
7869,Cyclobarbital,3A5-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CCCCC2
7870,Dapsone,3A5-Substrate,NC1=CC=C(C=C1)S(=O)(=O)C2=CC=C(N)C=C2
7871,Daunorubicin,3A5-Inducer,COC1=C2C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(C)=O)C(O)=C3C(=O)C2=CC=C1
7872,Dexamethasone,3A5-Inducer,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
7873,Dexamethasone,3A5-Substrate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO
7874,Dextromethorphan,3A5-Substrate,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1
7875,Diazepam,3A5-Substrate,CN1C(=O)CN=C(C2=CC=CC=C2)C3=C1C=CC(Cl)=C3
7876,Diethyltoluamide,3A5-Substrate,CCN(CC)C(=O)C1=CC=CC(C)=C1
7877,Diltiazem,3A5-Substrate,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
7878,Diltiazem,3A5-Inhibitor,COC1=CC=C(C=C1)[C@@H]2SC3=CC=CC=C3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O
7879,Disulfiram,3A5-Substrate,CCN(CC)C(=S)SSC(=S)N(CC)CC
7880,Docetaxel,3A5-Substrate,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@@H](O)[C@@H](NC(=O)OC(C)(C)C)C6=CC=CC=C6)C(C)=C([C@@H](O)C3=O)C5(C)C
7881,Domperidone,3A5-Substrate,ClC1=CC2=C(C=C1)N([C@@H]3CCN(CCCN4C(=O)NC5=C4C=CC=C5)CC3)C(=O)N2
7882,Doxorubicin,3A5-Substrate,COC1=CC=CC2=C1C(=O)C3=C(O)C4=C(C[C@](O)(C[C@@H]4O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C(=O)CO)C(O)=C3C2=O
7883,Doxylamin,3A5-Inducer,CN(C)CCO[C@@](C)(C1=CC=CC=C1)C2=CC=CC=N2
7884,Dutasteride,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC5=CC(=CC=C5C(F)(F)F)C(F)(F)F
7885,Eplerenone,3A5-Substrate,COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@@H]14
7886,Erythromycin,3A5-Substrate,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
7887,Erythromycin,3A5-Inhibitor,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@H]3O[C@@H](C)C[C@H]([C@@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
7888,Estradiol,3A5-Substrate,C[C@@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@H]2O
7889,Estrone,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O
7890,Ethinylestradiol,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C
7891,Ethosuximide,3A5-Substrate,CC[C@]1(C)CC(=O)NC1=O
7892,Etoposide,3A5-Inducer,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
7893,Etoposide,3A5-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)C6=CC7=C(OCO7)C=C26
7894,Felodipine,3A5-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(Cl)C(Cl)=CC=C2)C(=O)OC
7895,Fentanyl,3A5-Substrate,CCC(=O)N([C@H]1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
7896,Finasteride,3A5-Substrate,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C
7897,Fluconazole,3A5-Inducer,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
7898,Fluconazole,3A5-Inhibitor,OC(CN1C=NC=N1)(CN2C=NC=N2)C3=C(F)C=C(F)C=C3
7899,Flutamide,3A5-Substrate,CC(C)C(=O)NC1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F
7900,Fluvoxamine,3A5-Inhibitor,COCCCCC(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F
7901,Glycyrrhizic Acid,3A5-Inducer,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
7902,Glycyrrhizic Acid,3A5-Substrate,[H][C@@]12C[C@](C)(CC[C@]1(C)CC[C@]1(C)C2=CC(=O)[C@]2([H])[C@@]3(C)CC[C@H](O[C@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H]([C@@H](O)[C@H](O)[C@H]4O)C(O)=O)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O
7903,Granisetron,3A5-Substrate,CN1[C@H]2CCC[C@@H]1C[C@H](C2)NC(=O)C3=NN(C)C4=C3C=CC=C4
7904,Halofantrine,3A5-Substrate,CCCCN(CCCC)CC[C@H](O)C1=C2C=CC(=CC2=C3C=C(Cl)C=C(Cl)C3=C1)C(F)(F)F
7905,Haloperidol,3A5-Substrate,O[C@@]1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
7906,Hydrocortisone,3A5-Substrate,C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23
7907,Ifosfamide,3A5-Substrate,ClCCN[P@@]1(=O)OCCCN1CCCl
7908,Imatinib,3A5-Inhibitor,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
7909,Imatinib,3A5-Substrate,CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)NC3=CC(NC4=NC=CC(=N4)C5=CC=CN=C5)=C(C)C=C3
7910,Indinavir,3A5-Substrate,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
7911,Indinavir,3A5-Inhibitor,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@H](O)CC4=C3C=CC=C4)CC5=CC=CN=C5
7912,Irinotecan,3A5-Substrate,CCC1=C2CN3C(=O)C4=C(C=C3C2=NC5=CC=C(OC(=O)N6CC[C@@H](CC6)N7CCCCC7)C=C15)[C@@](O)(CC)C(=O)OC4
7913,Ketoconazole,3A5-Inducer,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
7914,Ketoconazole,3A5-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
7915,Ketoconazole,3A5-Substrate,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
7916,Lercanidipine,3A5-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC=CC(=C2)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C3=CC=CC=C3)C4=CC=CC=C4
7917,Levacetylmethadol,3A5-Substrate,CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
7918,Lidocain,3A5-Substrate,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C
7919,Linopirdine,3A5-Substrate,O=C1N(C2=CC=CC=C2)C3=C(C=CC=C3)C1(CC4=CC=NC=C4)CC5=CC=NC=C5
7920,Losartan,3A5-Substrate,CCCCC1=NC(Cl)=C(CO)N1CC2=CC=C(C=C2)C3=C(C=CC=C3)C4=NN=NN4
7921,Lovastatin,3A5-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
7922,Mepacrine,3A5-Substrate,CCN(CC)CCC[C@@H](C)NC1=C2C=C(OC)C=CC2=NC3=CC(Cl)=CC=C13
7923,Mephenytoin,3A5-Substrate,CC[C@]1(NC(=O)N(C)C1=O)C2=CC=CC=C2
7924,Methadone,3A5-Substrate,CCC(=O)C(C[C@H](C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
7925,Mibefradil,3A5-Inhibitor,COCC(=O)O[C@]3(CCN(C)CCCC1=NC2=C(N1)C=CC=C2)CCC4=C(C=CC(F)=C4)[C@@H]3C(C)C
7926,Midazolam,3A5-Substrate,CC1=NC=C2CN=C(C3=C(F)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
7927,Mifepristone,3A5-Substrate,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
7928,Mifepristone,3A5-Inhibitor,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C5=CC=C(C=C5)N(C)C
7929,Modafinil,3A5-Inducer,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
7930,Modafinil,3A5-Inhibitor,NC(=O)CS(=O)C(C1=CC=CC=C1)C2=CC=CC=C2
7931,Nateglinide,3A5-Substrate,CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(O)=O
7932,Nefazodone,3A5-Inhibitor,CCC1=NN(CCCN2CCN(CC2)C3=CC(Cl)=CC=C3)C(=O)N1CCOC4=CC=CC=C4
7933,Nelfinavir,3A5-Inhibitor,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
7934,Nelfinavir,3A5-Substrate,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C
7935,Neostigmine,3A5-Inhibitor,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C
7936,Nicardipine,3A5-Inhibitor,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OCCN(C)CC3=CC=CC=C3
7937,Nifedipine,3A5-Substrate,COC(=O)C1=C(C)NC(C)=C([C@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OC
7938,Nimodipine,3A5-Substrate,COCCOC(=O)C1=C(C)NC(C)=C([C@@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC(C)C
7939,Nisoldipine,3A5-Substrate,COC(=O)C1=C(C)NC(C)=C([C@@H]1C2=C(C=CC=C2)[N+]([O-])=O)C(=O)OCC(C)C
7940,Nitrendipine,3A5-Substrate,CCOC(=O)C1=C(C)NC(C)=C([C@H]1C2=CC(=CC=C2)[N+]([O-])=O)C(=O)OC
7941,Norethisterone,3A5-Substrate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C
7942,Norfloxacin,3A5-Inhibitor,CCN1C=C(C(O)=O)C(=O)C2=C1C=C(N3CCNCC3)C(F)=C2
7943,Octopamine,3A5-Substrate,NC[C@H](O)C1=CC=C(O)C=C1
7944,Omeprazole,3A5-Substrate,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
7945,Omeprazole,3A5-Inhibitor,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
7946,Omeprazole,3A5-Inducer,COC1=CC2=C(NC(=N2)S(=O)CC3=C(C)C(OC)=C(C)C=N3)C=C1
7947,Ondansetron,3A5-Substrate,CN1C2=C(C(=O)[C@H](CC2)CN3C=CN=C3C)C4=CC=CC=C14
7948,Ornidazole,3A5-Substrate,CC1=NC=C(N1C[C@H](O)CCl)[N+]([O-])=O
7949,Oxazepam,3A5-Substrate,O[C@@H]1N=C(C2=CC=CC=C2)C3=C(NC1=O)C=CC(Cl)=C3
7950,Oxcarbazepine,3A5-Inducer,NC(=O)N1C2=C(CC(=O)C3=C1C=CC=C3)C=CC=C2
7951,Oxybutynin,3A5-Substrate,CCN(CC)CC#CCOC(=O)[C@](O)([C@H]1CCCCC1)C2=CC=CC=C2
7952,Oxycodone,3A5-Substrate,COC1=CC=C2C[C@H]3N(C)CC[C@@]45[C@@H](OC1=C24)C(=O)CC[C@@]35O
7953,Paclitaxel,3A5-Substrate,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)C4=CC=CC=C4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C6=CC=CC=C6)C7=CC=CC=C7)C(C)=C1C5(C)C
7954,Paracetamol,3A5-Inducer,CC(=O)NC1=CC=C(O)C=C1
7955,Paracetamol,3A5-Substrate,CC(=O)NC1=CC=C(O)C=C1
7956,Paraoxon,3A5-Substrate,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O
7957,Pethidine,3A5-Inducer,CCOC(=O)[C@@]1(CCN(C)CC1)C2=CC=CC=C2
7958,Phenelzine,3A5-Inhibitor,NNCCC1=CC=CC=C1
7959,Phenelzine,3A5-Substrate,NNCCC1=CC=CC=C1
7960,Phenobarbital,3A5-Inducer,CC[C@@]1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
7961,Phenytoin,3A5-Inducer,O=C1NC(=O)[C@](N1)(C2=CC=CC=C2)C3=CC=CC=C3
7962,Physostigmine,3A5-Inhibitor,CNC(=O)OC1=CC2=C(C=C1)N(C)[C@H]3N(C)CC[C@@]23C
7963,Pimozide,3A5-Substrate,FC1=CC=C(C=C1)C(CCCN2CC[C@@H](CC2)N3C(=O)NC4=C3C=CC=C4)C5=CC=C(F)C=C5
7964,Pleconaril,3A5-Inducer,CC1=NOC(CCCOC2=C(C)C=C(C=C2C)C3=NOC(=N3)C(F)(F)F)=C1
7965,Pravastatin,3A5-Substrate,CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@@H]12
7966,Praziquantel,3A5-Substrate,O=C1CN(C[C@H]2N1CCC3=C2C=CC=C3)C(=O)[C@H]4CCCCC4
7967,Prednisolone,3A5-Substrate,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
7968,Prednisolone,3A5-Inducer,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO
7969,Progesterone,3A5-Substrate,CC(=O)[C@@H]1CC[C@@H]2[C@H]3CCC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C
7970,Propranolol,3A5-Substrate,CC(C)NC[C@@H](O)COC1=C2C=CC=CC2=CC=C1
7971,Quetiapine,3A5-Substrate,OCCOCCN1CCN(CC1)C2=NC3=C(SC4=C2C=CC=C4)C=CC=C3
7972,Ranitidine,3A5-Inhibitor,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C/[N+]([O-])=O
7973,Reserpine,3A5-Inducer,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C6=CC(OC)=C(OC)C(OC)=C6
7974,Rifampicin,3A5-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7975,Rifampicin,3A5-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7976,Rifampicin,3A5-Substrate,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
7977,Rifapentine,3A5-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C)C(O)=C4C(O)=C(NC(=O)C(C)=CC=C[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H]1C)C(C=NN5CCN(CC5)[C@H]6CCCC6)=C(O)C4=C3C2=O
7978,Risperidone,3A5-Substrate,CC1=C(CCN2CC[C@H](CC2)C3=NOC4=CC(F)=CC=C34)C(=O)N5CCCCC5=N1
7979,Ritonavir,3A5-Substrate,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
7980,Ritonavir,3A5-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
7981,Ritonavir,3A5-Inducer,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
7982,Rosuvastatin,3A5-Inhibitor,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@H](O)C[C@@H](O)CC(O)=O)N(C)S(C)(=O)=O
7983,Salmeterol,3A5-Substrate,OCC1=C(O)C=CC(=C1)[C@@H](O)CNCCCCCCOCCCCC2=CC=CC=C2
7984,Saquinavir,3A5-Inhibitor,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
7985,Saquinavir,3A5-Substrate,CC(C)(C)NC(=O)[C@@H]1C[C@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(N)=O)NC(=O)C4=NC5=CC=CC=C5C=C4
7986,Sildenafil,3A5-Substrate,CCCC1=NN(C)C2=C1N=C(NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(C)CC4
7987,Simvastatin,3A5-Substrate,CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12
7988,Sirolimus,3A5-Substrate,CO[C@@H]1C[C@@H](CC[C@H]1O)C[C@@H](C)[C@@H]2CC(=O)[C@H](C)C=C(C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)C=CC=CC=C(C)[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC
7989,Spironolactone,3A5-Inducer,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13
7990,Sulfasalazine,3A5-Substrate,OC(=O)C1=C(O)C=CC(=C1)N=NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3
7991,Tacrolimus,3A5-Substrate,CO[C@@H]1C[C@H](CC[C@H]1O)C=C(/C)[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(C)=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)OC)[C@H](C[C@H]4C)OC
7992,Tamoxifen,3A5-Substrate,CCC(C1=CC=CC=C1)=C(/C2=CC=CC=C2)C3=CC=C(OCCN(C)C)C=C3
7993,Tegafur,3A5-Substrate,FC1=CN([C@H]2CCCO2)C(=O)NC1=O
7994,Telithromycin,3A5-Substrate,CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCN4C=NC(=C4)C5=CC=CN=C5)C(=O)O[C@]13C)OC
7995,Teniposide,3A5-Substrate,COC1=CC(=CC(OC)=C1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@H](O[C@H]5[C@H](O)[C@H]4O)C6=CC=CS6)C7=C2C=C8OCOC8=C7
7996,Terfenadine,3A5-Substrate,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
7997,Testosterone,3A5-Substrate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C
7998,Thalidomide,3A5-Substrate,O=C1CC[C@@H](N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1
7999,Tocopherol (vit E),3A5-Inducer,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2
8000,Trazodone,3A5-Substrate,ClC1=CC=CC(=C1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2
8001,Triamcinolone,3A5-Inducer,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO
8002,Triazolam,3A5-Substrate,CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(Cl)=C4)N12
8003,Troglitazone,3A5-Inhibitor,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
8004,Troglitazone,3A5-Inducer,CC1=C(C)C2=C(CC[C@](C)(COC3=CC=C(C[C@@H]4SC(=O)NC4=O)C=C3)O2)C(C)=C1O
8005,Vardenafil,3A5-Substrate,CCCC1=NC(C)=C2N1NC(=NC2=O)C3=C(OCC)C=CC(=C3)S(=O)(=O)N4CCN(CC)CC4
8006,Verapamil,3A5-Inhibitor,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8007,Verapamil,3A5-Substrate,COC1=C(OC)C=C(CCN(C)CCC[C@](C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1
8008,Vinblastine,3A5-Substrate,CC[C@]1(O)C[C@@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
8009,Vincristine,3A5-Substrate,CC[C@]1(O)C[C@H]2CN(CCC3=C(NC4=C3C=CC=C4)[C@@](C2)(C(=O)OC)C5=CC6=C(C=C5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
8010,Zalcitabine,3A5-Substrate,NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2
8011,Zaleplon,3A5-Substrate,CCN(C(C)=O)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N
8012,Ziprasidone,3A5-Substrate,ClC1=CC2=C(CC(=O)N2)C=C1CCN3CCN(CC3)C4=NSC5=CC=CC=C45
8013,Zolpidem,3A5-Substrate,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C3=CC=C(C)C=C3
8014,Zonisamide,3A5-Substrate,NS(=O)(=O)CC1=NOC2=C1C=CC=C2
8015,Zotepine,3A5-Substrate,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(Cl)C=C3
8016,Bezafibrate,7A1-Inhibitor,CC(C)(OC1=CC=C(CCNC(=O)C2=CC=C(Cl)C=C2)C=C1)C(O)=O
8017,Ciprofibrate,7A1-Inhibitor,CC(C)(OC1=CC=C(C=C1)[C@H]2CC2(Cl)Cl)C(O)=O
8018,Colestyramine,7A1-Inducer,CCC1=CC=C(C=C1)[C@@H](C)CCC2=CC=C(C=C2)[N+](C)(C)C
8019,Ezetimibe,7A1-Inhibitor,O[C@@H](CC[C@H]1[C@H](N(C1=O)C2=CC=C(F)C=C2)C3=CC=C(O)C=C3)C4=CC=C(F)C=C4
8020,Fenofibrate,7A1-Inhibitor,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(Cl)C=C2
8021,Gemfibrozil,7A1-Inhibitor,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1
8022,Glucose,7A1-Inducer,OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O
8023,Insulin (human),7A1-Inhibitor,CC[C@H](C)[C@H](NC(=O)CN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC4=CC=CC=C4)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC5=CN=CN5)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC6=CC=C(O)C=C6)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC7=CC=C(O)C=C7)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC8=CC=C(O)C=C8)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC2=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC9=CC=CC=C9)C(=O)N[C@@H](CC%10=CC=CC=C%10)C(=O)N[C@@H](CC%11=CC=C(O)C=C%11)C(=O)N[C@@H]([C@@H](C)O)C(=O)N%12CCC[C@H]%12C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC
8024,Metyrapone,7A1-Inhibitor,CC(C)(C1=CC=CN=C1)C(=O)C2=CC=CN=C2
8025,Retinol (vit A),7A1-Inhibitor,CC(=C/CO)C=CC=C(C)C=CC1=C(C)CCCC1(C)C
8026,Rifampicin,7A1-Inhibitor,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
8027,Ritonavir,7A1-Inhibitor,CC(C)[C@@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC3=CN=CS3)CC4=CC=CC=C4
8028,Ursodeoxycholic Acid,7A1-Inhibitor,C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
8029,Astemizole,2J2-Substrate,COC1=CC=C(CCN2CC[C@@H](CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(F)C=C5)C=C1
8030,Cocaine,2J2-Inducer,COC(=O)[C@H]1[C@H](C[C@H]2CC[C@@H]1N2C)OC(=O)C3=CC=CC=C3
8031,Ebastine,2J2-Inhibitor,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
8032,Ebastine,2J2-Substrate,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CC[C@H](CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
8033,Ergocalciferol,2J2-Substrate,CC(C)[C@@H](C)C=C[C@@H](C)[C@H]1CC[C@H]2C(CCC[C@]12C)=CC=C3C[C@@H](O)CCC3=C
8034,Masoprocol,2J2-Inhibitor,C[C@H](CC1=CC=C(O)C(O)=C1)[C@@H](C)CC2=CC(O)=C(O)C=C2
8035,Terfenadine,2J2-Inhibitor,CC(C)(C)C1=CC=C(C=C1)[C@@H](O)CCCN2CC[C@@H](CC2)C(O)(C3=CC=CC=C3)C4=CC=CC=C4
8036,Ethanol,Choline_transporter_like_protein_2-Substrate,CCO
8037,Enflurane,2F1-Substrate,FC(F)OC(F)(F)[C@H](F)Cl
8038,Ketoconazole,2F1-Inhibitor,CC(=O)N1CCN(CC1)C2=CC=C(OC[C@@H]3CO[C@](CN4C=CN=C4)(O3)C5=C(Cl)C=C(Cl)C=C5)C=C2
8039,Phenol,2F1-Substrate,OC1=CC=CC=C1
8040,Rifampicin,2F1-Inducer,CO[C@H]1C=CO[C@@]2(C)OC3=C(C2=O)C4=C(O)C(C=NN5CCN(C)CC5)=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C4C(O)=C3C
